Name	Gene(s)	Protein change	Condition(s)	Accession	GRCh37Chromosome	GRCh37Location	GRCh38Chromosome	GRCh38Location	VariationID	AlleleID(s)	dbSNP ID	Canonical SPDI	Variant type	Molecular consequence	Germline classification	Germline date last evaluated	Germline review status	Somatic clinical impact	Somatic clinical impact date last evaluated	Somatic clinical impact review status	Oncogenicity classification	Oncogenicity date last evaluated	Oncogenicity review status	
NM_002878.4(RAD51D):c.*130A>C	RAD51D|RAD51L3-RFFL		not provided	VCV001276573	17	33427842	17	35100823	1276573	328013	rs28363292	NC_000017.11:35100822:T:G	single nucleotide variant	3 prime UTR variant|non-coding transcript variant	Benign	Jun 21, 2018	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.*49C>A	RAD51D|RAD51L3-RFFL		not specified	VCV002576265	17	33427923	17	35100904	2576265	2741161	rs2091526381	NC_000017.11:35100903:G:T	single nucleotide variant	3 prime UTR variant|non-coding transcript variant	Likely benign	Mar 4, 2025	criteria provided, single submitter							
NM_002878.4(RAD51D):c.*16G>T	RAD51L3-RFFL|RAD51D		Hereditary cancer-predisposing syndrome	VCV000926967	17	33427956	17	35100937	926967	913813	rs374939642	NC_000017.11:35100936:C:A	single nucleotide variant	3 prime UTR variant|non-coding transcript variant	Uncertain significance	Apr 24, 2019	criteria provided, single submitter							
NM_002878.4(RAD51D):c.*11T>C	RAD51L3-RFFL|RAD51D		Hereditary cancer-predisposing syndrome	VCV000920223	17	33427961	17	35100942	920223	913814	rs2091526784	NC_000017.11:35100941:A:G	single nucleotide variant	3 prime UTR variant|non-coding transcript variant	Uncertain significance	May 8, 2019	criteria provided, single submitter							
NM_002878.4(RAD51D):c.*10T>A	RAD51D|RAD51L3-RFFL		Hereditary cancer-predisposing syndrome	VCV000630038	17	33427962	17	35100943	630038	618521	rs759502122	NC_000017.11:35100942:A:T	single nucleotide variant	3 prime UTR variant|non-coding transcript variant	Likely benign	Oct 28, 2017	criteria provided, single submitter							
NM_002878.4(RAD51D):c.*7C>T	RAD51D|RAD51L3-RFFL		Hereditary cancer-predisposing syndrome|not provided|not specified	VCV000378464	17	33427965	17	35100946	378464	375976	rs370985675	NC_000017.11:35100945:G:A	single nucleotide variant	3 prime UTR variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Nov 30, 2021	criteria provided, conflicting classifications							
NM_002878.4(RAD51D):c.*4G>T	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV003903513	17	33427968	17	35100949	3903513	4019386		NC_000017.11:35100948:C:A	single nucleotide variant	3 prime UTR variant|non-coding transcript variant	Benign	Feb 25, 2025	criteria provided, single submitter							
NM_002878.4(RAD51D):c.*4G>C	RAD51D|RAD51L3-RFFL		Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV001171226	17	33427968	17	35100949	1171226	1161339	rs876659026	NC_000017.11:35100948:C:G	single nucleotide variant	3 prime UTR variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Feb 25, 2025	criteria provided, conflicting classifications							
NM_002878.4(RAD51D):c.*4G>A	RAD51D|RAD51L3-RFFL		Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 4|not specified	VCV000231210	17	33427968	17	35100949	231210	235854	rs876659026	NC_000017.11:35100948:C:T	single nucleotide variant	3 prime UTR variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Feb 25, 2025	criteria provided, conflicting classifications							
NM_002878.4(RAD51D):c.*3T>C	RAD51L3-RFFL|RAD51D		Breast-ovarian cancer, familial, susceptibility to, 4	VCV003903619	17	33427969	17	35100950	3903619	4019492		NC_000017.11:35100949:A:G	single nucleotide variant	3 prime UTR variant|non-coding transcript variant	Benign	Feb 25, 2025	criteria provided, single submitter							
NM_002878.4(RAD51D):c.*1C>T	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV003903532	17	33427971	17	35100952	3903532	4019405		NC_000017.11:35100951:G:A	single nucleotide variant	3 prime UTR variant|non-coding transcript variant	Benign	Feb 25, 2025	criteria provided, single submitter							
NM_002878.4(RAD51D):c.987A>C (p.Ter329Cys)	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV002749860	17	33427972	17	35100953	2749860	2908457	rs2091526907	NC_000017.11:35100952:T:G	single nucleotide variant	stop lost|non-coding transcript variant	Uncertain significance	Aug 3, 2023	criteria provided, single submitter							
NM_002878.4(RAD51D):c.987A>G (p.Ter329Trp)	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV000959118	17	33427972	17	35100953	959118	949873	rs2091526907	NC_000017.11:35100952:T:C	single nucleotide variant	stop lost|non-coding transcript variant	Uncertain significance	Sep 10, 2019	criteria provided, single submitter							
NM_002878.4(RAD51D):c.986G>A (p.Ter329=)	RAD51L3-RFFL|RAD51D		Breast-ovarian cancer, familial, susceptibility to, 4	VCV003903611	17	33427973	17	35100954	3903611	4019484		NC_000017.11:35100953:C:T	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign	Feb 25, 2025	criteria provided, single submitter							
NM_002878.4(RAD51D):c.986G>T (p.Ter329Leu)	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV000823523	17	33427973	17	35100954	823523	813540	rs1597855293	NC_000017.11:35100953:C:A	single nucleotide variant	stop lost|non-coding transcript variant	Uncertain significance	Aug 31, 2023	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.985T>C (p.Ter329Arg)	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV002999752	17	33427974	17	35100955	2999752	3163875	rs1376900239	NC_000017.11:35100954:A:G	single nucleotide variant	stop lost|non-coding transcript variant	Uncertain significance	May 24, 2023	criteria provided, single submitter							
NM_002878.4(RAD51D):c.984A>G (p.Thr328=)	RAD51D|RAD51L3-RFFL		Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000823505	17	33427975	17	35100956	823505	813541	rs1597855297	NC_000017.11:35100955:T:C	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign/Likely benign	Feb 25, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.983C>T (p.Thr328Ile)	RAD51D|RAD51L3-RFFL	T328I, T348I, T216I	not provided|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4|not specified	VCV000141343	17	33427976	17	35100957	141343	151057	rs138969595	NC_000017.11:35100956:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Benign/Likely benign	Feb 3, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.982A>G (p.Thr328Ala)	RAD51D|RAD51L3-RFFL	T328A, T348A, T216A	Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV001407757	17	33427977	17	35100958	1407757	1506636	rs2091527104	NC_000017.11:35100957:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Feb 28, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.982A>T (p.Thr328Ser)	RAD51D|RAD51L3-RFFL	T216S, T328S, T348S	Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome|not provided	VCV000947018	17	33427977	17	35100958	947018	928221	rs2091527104	NC_000017.11:35100957:T:A	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Mar 11, 2024	criteria provided, conflicting classifications							
NM_002878.4(RAD51D):c.981G>A (p.Gln327=)	RAD51D|RAD51L3-RFFL		Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV002847354	17	33427978	17	35100959	2847354	3012275	rs2142408600	NC_000017.11:35100958:C:T	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Feb 15, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.980A>T (p.Gln327Leu)	RAD51L3-RFFL|RAD51D	Q347L, Q215L, Q327L	Breast-ovarian cancer, familial, susceptibility to, 4	VCV000939479	17	33427979	17	35100960	939479	937885	rs2091527148	NC_000017.11:35100959:T:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	May 10, 2019	criteria provided, single submitter							
NM_002878.4(RAD51D):c.979C>T (p.Gln327Ter)	RAD51D|RAD51L3-RFFL	Q327*, Q215*, Q347*	not provided|Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV000187753	17	33427980	17	35100961	187753	184797	rs786203974	NC_000017.11:35100960:G:A	single nucleotide variant	nonsense|non-coding transcript variant	Uncertain significance	Mar 6, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.977A>C (p.Asp326Ala)	RAD51D|RAD51L3-RFFL	D326A, D346A, D214A	Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV000472633	17	33427982	17	35100963	472633	466732	rs1555566935	NC_000017.11:35100962:T:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Mar 6, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.974G>T (p.Gly325Val)	RAD51D|RAD51L3-RFFL	G325V, G213V, G345V	Breast-ovarian cancer, familial, susceptibility to, 4	VCV001380993	17	33427985	17	35100966	1380993	1499836	rs2142408660	NC_000017.11:35100965:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Mar 24, 2021	criteria provided, single submitter							
NM_002878.4(RAD51D):c.974G>A (p.Gly325Asp)	RAD51D|RAD51L3-RFFL	G213D, G325D, G345D	not provided	VCV001310728	17	33427985	17	35100966	1310728	1301432	rs2142408660	NC_000017.11:35100965:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Nov 27, 2019	criteria provided, single submitter							
NM_002878.4(RAD51D):c.973G>T (p.Gly325Cys)	RAD51D|RAD51L3-RFFL	G213C, G325C, G345C	Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV003222895	17	33427986	17	35100967	3222895	3386533	rs587780106	NC_000017.11:35100966:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Jul 30, 2024	criteria provided, conflicting classifications							
NM_002878.4(RAD51D):c.973G>C (p.Gly325Arg)	RAD51D|RAD51L3-RFFL	G325R, G213R, G345R	Breast-ovarian cancer, familial, susceptibility to, 4	VCV002011510	17	33427986	17	35100967	2011510	2070739	rs587780106	NC_000017.11:35100966:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jun 27, 2022	criteria provided, single submitter							
NM_002878.4(RAD51D):c.973G>A (p.Gly325Ser)	RAD51D|RAD51L3-RFFL	G325S, G213S, G345S	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 4|not specified|not provided	VCV000127898	17	33427986	17	35100967	127898	133355	rs587780106	NC_000017.11:35100966:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Feb 27, 2025	criteria provided, conflicting classifications							
NM_002878.4(RAD51D):c.972G>C (p.Gln324His)	RAD51D|RAD51L3-RFFL	Q324H, Q344H, Q212H	Breast-ovarian cancer, familial, susceptibility to, 4	VCV002701348	17	33427987	17	35100968	2701348	2862342	rs762625437	NC_000017.11:35100967:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Dec 7, 2023	criteria provided, single submitter							
NM_002878.4(RAD51D):c.972G>A (p.Gln324=)	RAD51D|RAD51L3-RFFL		Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV001768006	17	33427987	17	35100968	1768006	1825439	rs762625437	NC_000017.11:35100967:C:T	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign/Likely benign	Feb 25, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.972G>T (p.Gln324His)	RAD51D|RAD51L3-RFFL	Q324H, Q212H, Q344H	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4|not provided	VCV000185169	17	33427987	17	35100968	185169	184798	rs762625437	NC_000017.11:35100967:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Aug 31, 2024	criteria provided, conflicting classifications							
NM_002878.4(RAD51D):c.971A>T (p.Gln324Leu)	RAD51D|RAD51L3-RFFL	Q212L, Q324L, Q344L	Breast-ovarian cancer, familial, susceptibility to, 4	VCV001098871	17	33427988	17	35100969	1098871	1087617	rs2091527352	NC_000017.11:35100968:T:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Apr 21, 2023	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.971A>G (p.Gln324Arg)	RAD51D|RAD51L3-RFFL	Q212R, Q324R, Q344R	Breast-ovarian cancer, familial, susceptibility to, 4	VCV000837146	17	33427988	17	35100969	837146	845206	rs2091527352	NC_000017.11:35100968:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Feb 14, 2019	criteria provided, single submitter							
NM_002878.4(RAD51D):c.970C>A (p.Gln324Lys)	RAD51D|RAD51L3-RFFL	Q212K, Q324K, Q344K	Breast-ovarian cancer, familial, susceptibility to, 4	VCV002753664	17	33427989	17	35100970	2753664	2920030	rs1217001362	NC_000017.11:35100969:G:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Aug 18, 2023	criteria provided, single submitter							
NM_002878.4(RAD51D):c.970C>T (p.Gln324Ter)	RAD51D|RAD51L3-RFFL	Q212*, Q344*, Q324*	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV002709440	17	33427989	17	35100970	2709440	2878186	rs1217001362	NC_000017.11:35100969:G:A	single nucleotide variant	nonsense|non-coding transcript variant	Uncertain significance	Feb 26, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.969A>G (p.Leu323=)	RAD51L3-RFFL|RAD51D		Hereditary cancer-predisposing syndrome	VCV000927648	17	33427990	17	35100971	927648	913815	rs2091527428	NC_000017.11:35100970:T:C	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Aug 27, 2019	criteria provided, single submitter							
NM_002878.4(RAD51D):c.968T>G (p.Leu323Ter)	RAD51D|RAD51L3-RFFL	L323*, L343*, L211*	Hereditary cancer-predisposing syndrome	VCV002563038	17	33427991	17	35100972	2563038	2733495	rs2142408730	NC_000017.11:35100971:A:C	single nucleotide variant	nonsense|non-coding transcript variant	Uncertain significance	Jun 6, 2023	criteria provided, single submitter							
NM_002878.4(RAD51D):c.968T>C (p.Leu323Ser)	RAD51D|RAD51L3-RFFL	L343S, L211S, L323S	Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV001767798	17	33427991	17	35100972	1767798	1818449	rs2142408730	NC_000017.11:35100971:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Feb 26, 2024	criteria provided, conflicting classifications							
NM_002878.4(RAD51D):c.968T>A (p.Leu323Ter)	RAD51D|RAD51L3-RFFL	L323*, L343*, L211*	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV001391074	17	33427991	17	35100972	1391074	1489792	rs2142408730	NC_000017.11:35100971:A:T	single nucleotide variant	nonsense|non-coding transcript variant	Uncertain significance	Jun 7, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.967T>C (p.Leu323=)	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV003653746	17	33427992	17	35100973	3653746	3785750		NC_000017.11:35100972:A:G	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Jun 1, 2024	criteria provided, single submitter							
NM_002878.4(RAD51D):c.967T>G (p.Leu323Val)	RAD51D|RAD51L3-RFFL	L211V, L323V, L343V	Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV001416150	17	33427992	17	35100973	1416150	1382975	rs1281036710	NC_000017.11:35100972:A:C	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Feb 26, 2024	criteria provided, conflicting classifications							
NM_002878.4(RAD51D):c.966A>G (p.Thr322=)	RAD51D|RAD51L3-RFFL		not provided|Hereditary cancer-predisposing syndrome|not specified|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000186888	17	33427993	17	35100974	186888	184799	rs786203299	NC_000017.11:35100973:T:C	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign/Likely benign	Feb 25, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.965C>A (p.Thr322Lys)	RAD51D|RAD51L3-RFFL	T322K, T210K, T342K	Hereditary cancer-predisposing syndrome	VCV003942392	17	33427994	17	35100975	3942392	4064171		NC_000017.11:35100974:G:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	May 24, 2025	criteria provided, single submitter							
NM_002878.4(RAD51D):c.960T>C (p.Ser320=)	RAD51D|RAD51L3-RFFL		Hereditary cancer-predisposing syndrome	VCV001767570	17	33427999	17	35100980	1767570	1818221	rs2509122924	NC_000017.11:35100979:A:G	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Dec 4, 2020	criteria provided, single submitter							
NM_002878.4(RAD51D):c.959G>A (p.Ser320Asn)	RAD51D|RAD51L3-RFFL	S208N, S340N, S320N	Hereditary cancer-predisposing syndrome	VCV002563029	17	33428000	17	35100981	2563029	2733486	rs763683070	NC_000017.11:35100980:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Likely benign	Feb 26, 2024	criteria provided, single submitter							
NM_002878.4(RAD51D):c.959G>C (p.Ser320Thr)	RAD51D|RAD51L3-RFFL	S208T, S340T, S320T	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000844601	17	33428000	17	35100981	844601	845208	rs763683070	NC_000017.11:35100980:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Aug 9, 2022	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.959G>T (p.Ser320Ile)	RAD51D|RAD51L3-RFFL	S320I, S340I, S208I	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4|Familial ovarian cancer	VCV000480539	17	33428000	17	35100981	480539	479134	rs763683070	NC_000017.11:35100980:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Feb 16, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.957G>C (p.Gln319His)	RAD51D|RAD51L3-RFFL	Q339H, Q207H, Q319H	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV002866042	17	33428002	17	35100983	2866042	3023515	rs147669627	NC_000017.11:35100982:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Oct 29, 2024	criteria provided, conflicting classifications							
NM_002878.4(RAD51D):c.957G>T (p.Gln319His)	RAD51D|RAD51L3-RFFL	Q207H, Q319H, Q339H	Breast-ovarian cancer, familial, susceptibility to, 4	VCV001018277	17	33428002	17	35100983	1018277	1012705	rs147669627	NC_000017.11:35100982:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Mar 5, 2022	criteria provided, single submitter							
NM_002878.4(RAD51D):c.957G>A (p.Gln319=)	RAD51D|RAD51L3-RFFL		Hereditary breast ovarian cancer syndrome|not provided|Hereditary cancer-predisposing syndrome|not specified|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000184398	17	33428002	17	35100983	184398	184800	rs147669627	NC_000017.11:35100982:C:T	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign/Likely benign	Feb 25, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.955C>G (p.Gln319Glu)	RAD51D|RAD51L3-RFFL	Q207E, Q319E, Q339E	Hereditary cancer-predisposing syndrome	VCV003894140	17	33428004	17	35100985	3894140	4010021		NC_000017.11:35100984:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Likely benign	Oct 29, 2024	criteria provided, single submitter							
NM_002878.4(RAD51D):c.955C>T (p.Gln319Ter)	RAD51D|RAD51L3-RFFL	Q319*, Q207*, Q339*	not provided|Hereditary breast ovarian cancer syndrome|not specified|Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV000193645	17	33428004	17	35100985	193645	190808	rs794726988	NC_000017.11:35100984:G:A	single nucleotide variant	nonsense|non-coding transcript variant	Uncertain significance	Jan 17, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.954G>A (p.Glu318=)	RAD51L3-RFFL|RAD51D		Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000229668	17	33428005	17	35100986	229668	235855	rs876658131	NC_000017.11:35100985:C:T	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign/Likely benign	Feb 25, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.953A>G (p.Glu318Gly)	RAD51D|RAD51L3-RFFL	E338G, E318G, E206G	Hereditary cancer-predisposing syndrome	VCV000823321	17	33428006	17	35100987	823321	813543	rs1597855377	NC_000017.11:35100986:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Aug 23, 2018	criteria provided, single submitter							
NM_002878.4(RAD51D):c.952G>A (p.Glu318Lys)	RAD51D|RAD51L3-RFFL	E318K, E338K, E206K	not provided|Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV000230736	17	33428007	17	35100988	230736	235856	rs876658737	NC_000017.11:35100987:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jan 28, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.950C>T (p.Ser317Leu)	RAD51L3-RFFL|RAD51D	S337L, S205L, S317L	Hereditary cancer-predisposing syndrome	VCV001767212	17	33428009	17	35100990	1767212	1821553	rs2142408915	NC_000017.11:35100989:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Dec 21, 2020	criteria provided, single submitter							
NM_002878.4(RAD51D):c.948C>T (p.Thr316=)	RAD51D|RAD51L3-RFFL		Hereditary cancer-predisposing syndrome	VCV001767113	17	33428011	17	35100992	1767113	1821455	rs1195107125	NC_000017.11:35100991:G:A	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Jun 15, 2021	criteria provided, single submitter							
NM_002878.4(RAD51D):c.948C>G (p.Thr316=)	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV001576230	17	33428011	17	35100992	1576230	1521092	rs1195107125	NC_000017.11:35100991:G:C	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign/Likely benign	Feb 25, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.945G>A (p.Gly315=)	RAD51L3-RFFL|RAD51D		Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000231010	17	33428014	17	35100995	231010	235857	rs142316409	NC_000017.11:35100994:C:T	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign/Likely benign	Feb 25, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.944G>T (p.Gly315Val)	RAD51D|RAD51L3-RFFL	G315V, G335V, G203V	Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV000231621	17	33428015	17	35100996	231621	235858	rs786203144	NC_000017.11:35100995:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Nov 7, 2023	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.944G>A (p.Gly315Glu)	RAD51D|RAD51L3-RFFL	G315E, G335E, G203E	Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV000186687	17	33428015	17	35100996	186687	184801	rs786203144	NC_000017.11:35100995:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Oct 2, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.943G>C (p.Gly315Arg)	RAD51L3-RFFL|RAD51D	G315R, G203R, G335R	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000185649	17	33428016	17	35100997	185649	184802	rs786202342	NC_000017.11:35100996:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Aug 22, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.942G>C (p.Trp314Cys)	RAD51D|RAD51L3-RFFL	W202C, W314C, W334C	Breast-ovarian cancer, familial, susceptibility to, 4	VCV002114668	17	33428017	17	35100998	2114668	2164671	rs2142409011	NC_000017.11:35100997:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Mar 19, 2022	criteria provided, single submitter							
NM_002878.4(RAD51D):c.941G>C (p.Trp314Ser)	RAD51D|RAD51L3-RFFL	W314S, W334S, W202S	Hereditary cancer-predisposing syndrome	VCV002448044	17	33428018	17	35100999	2448044	2428988	rs2142409021	NC_000017.11:35100998:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Dec 14, 2022	criteria provided, single submitter							
NM_002878.4(RAD51D):c.940T>C (p.Trp314Arg)	RAD51D|RAD51L3-RFFL	W314R, W202R, W334R	Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV000141612	17	33428019	17	35101000	141612	151326	rs587781878	NC_000017.11:35100999:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Sep 23, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.939C>G (p.Thr313=)	RAD51D|RAD51L3-RFFL		Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV001140247	17	33428020	17	35101001	1140247	1126141	rs374318553	NC_000017.11:35101000:G:C	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign/Likely benign	Feb 25, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.939C>A (p.Thr313=)	RAD51D|RAD51L3-RFFL		Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000630700	17	33428020	17	35101001	630700	618522	rs374318553	NC_000017.11:35101000:G:T	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign/Likely benign	Feb 25, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.938C>T (p.Thr313Ile)	RAD51D|RAD51L3-RFFL	T333I, T201I, T313I	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV002809575	17	33428021	17	35101002	2809575	2971944	rs756616712	NC_000017.11:35101001:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Nov 13, 2023	criteria provided, conflicting classifications							
NM_002878.4(RAD51D):c.938C>G (p.Thr313Ser)	RAD51D|RAD51L3-RFFL	T201S, T313S, T333S	Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV001017562	17	33428021	17	35101002	1017562	1012706	rs756616712	NC_000017.11:35101001:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Oct 30, 2024	criteria provided, conflicting classifications							
NM_002878.4(RAD51D):c.938C>A (p.Thr313Asn)	RAD51D|RAD51L3-RFFL	T201N, T313N, T333N	Hereditary cancer-predisposing syndrome	VCV000823206	17	33428021	17	35101002	823206	813544	rs756616712	NC_000017.11:35101001:G:T	single nucleotide variant	missense variant|non-coding transcript variant	Likely benign	Feb 26, 2024	criteria provided, single submitter							
NM_002878.4(RAD51D):c.936G>C (p.Gly312=)	RAD51D|RAD51L3-RFFL		Hereditary cancer-predisposing syndrome	VCV001766711	17	33428023	17	35101004	1766711	1824954	rs2142409076	NC_000017.11:35101003:C:G	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Sep 8, 2022	criteria provided, single submitter							
NM_002878.4(RAD51D):c.935G>A (p.Gly312Glu)	RAD51D|RAD51L3-RFFL	G200E, G312E, G332E	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV001171622	17	33428024	17	35101005	1171622	1161340	rs1597855435	NC_000017.11:35101004:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Mar 6, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.935G>C (p.Gly312Ala)	RAD51D|RAD51L3-RFFL	G312A, G332A, G200A	Hereditary cancer-predisposing syndrome	VCV000922195	17	33428024	17	35101005	922195	913816	rs1597855435	NC_000017.11:35101004:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Dec 5, 2023	criteria provided, single submitter							
NM_002878.4(RAD51D):c.935G>T (p.Gly312Val)	RAD51D|RAD51L3-RFFL	G200V, G312V, G332V	Hereditary cancer-predisposing syndrome	VCV000823188	17	33428024	17	35101005	823188	813545	rs1597855435	NC_000017.11:35101004:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Feb 24, 2024	criteria provided, single submitter							
NM_002878.4(RAD51D):c.934G>A (p.Gly312Arg)	RAD51L3-RFFL|RAD51D	G200R, G332R, G312R	Hereditary cancer-predisposing syndrome	VCV003312408	17	33428025	17	35101006	3312408	3461950		NC_000017.11:35101005:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	May 22, 2024	criteria provided, single submitter							
NM_002878.4(RAD51D):c.934G>T (p.Gly312Trp)	RAD51D|RAD51L3-RFFL	G200W, G312W, G332W	Breast-ovarian cancer, familial, susceptibility to, 4	VCV002678188	17	33428025	17	35101006	2678188	2833211	rs2142409102	NC_000017.11:35101005:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	May 24, 2023	criteria provided, single submitter							
NM_002878.4(RAD51D):c.933T>C (p.Ile311=)	RAD51D|RAD51L3-RFFL		Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV001645830	17	33428026	17	35101007	1645830	1565434	rs886052817	NC_000017.11:35101006:A:G	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Apr 10, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.933T>G (p.Ile311Met)	RAD51D|RAD51L3-RFFL	I311M, I199M, I331M	Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV000322623	17	33428026	17	35101007	322623	344098	rs886052817	NC_000017.11:35101006:A:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Apr 23, 2023	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.932T>C (p.Ile311Thr)	RAD51D|RAD51L3-RFFL	I311T, I199T, I331T	Breast-ovarian cancer, familial, susceptibility to, 4|not provided|Hereditary cancer-predisposing syndrome|not specified	VCV000127897	17	33428027	17	35101008	127897	133354	rs145309168	NC_000017.11:35101007:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jun 30, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.932T>A (p.Ile311Asn)	RAD51D|RAD51L3-RFFL	I311N, I199N, I331N	Breast and/or ovarian cancer|Hereditary cancer-predisposing syndrome|not provided|Breast-ovarian cancer, familial, susceptibility to, 4|not specified|Hereditary cancer|Hereditary breast ovarian cancer syndrome	VCV000127896	17	33428027	17	35101008	127896	133353	rs145309168	NC_000017.11:35101007:A:T	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Mar 4, 2025	criteria provided, conflicting classifications							
NM_002878.4(RAD51D):c.931A>T (p.Ile311Phe)	RAD51D|RAD51L3-RFFL	I199F, I311F, I331F	Hereditary cancer-predisposing syndrome	VCV002448043	17	33428028	17	35101009	2448043	2428987	rs755265519	NC_000017.11:35101008:T:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Nov 16, 2022	criteria provided, single submitter							
NM_002878.4(RAD51D):c.931A>C (p.Ile311Leu)	RAD51D|RAD51L3-RFFL	I311L, I199L, I331L	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000960865	17	33428028	17	35101009	960865	949874	rs755265519	NC_000017.11:35101008:T:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jul 26, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.931A>G (p.Ile311Val)	RAD51D|RAD51L3-RFFL	I311V, I199V, I331V	not provided|Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV000584560	17	33428028	17	35101009	584560	575607	rs755265519	NC_000017.11:35101008:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Dec 29, 2024	criteria provided, conflicting classifications							
NM_002878.4(RAD51D):c.930C>G (p.Asp310Glu)	RAD51D|RAD51L3-RFFL	D198E, D310E, D330E	Hereditary cancer-predisposing syndrome	VCV003222894	17	33428029	17	35101010	3222894	3386532	rs2142409178	NC_000017.11:35101009:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Nov 14, 2023	criteria provided, single submitter							
NM_002878.4(RAD51D):c.930C>T (p.Asp310=)	RAD51D|RAD51L3-RFFL		Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV001088506	17	33428029	17	35101010	1088506	1082923	rs2142409178	NC_000017.11:35101009:G:A	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign/Likely benign	Feb 25, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.929A>G (p.Asp310Gly)	RAD51L3-RFFL|RAD51D	D310G, D198G, D330G	Hereditary cancer-predisposing syndrome	VCV000482188	17	33428030	17	35101011	482188	478433	rs886052818	NC_000017.11:35101010:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Nov 23, 2022	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.929A>C (p.Asp310Ala)	RAD51D|RAD51L3-RFFL	D310A, D198A, D330A	not provided|Hereditary cancer-predisposing syndrome	VCV000322624	17	33428030	17	35101011	322624	328022	rs886052818	NC_000017.11:35101010:T:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Apr 12, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.925G>A (p.Val309Ile)	RAD51D|RAD51L3-RFFL	V197I, V309I, V329I	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV001721205	17	33428034	17	35101015	1721205	1775187	rs1555566979	NC_000017.11:35101014:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Feb 26, 2024	criteria provided, conflicting classifications							
NM_002878.4(RAD51D):c.925G>T (p.Val309Leu)	RAD51D|RAD51L3-RFFL	V309L, V197L, V329L	Hereditary cancer-predisposing syndrome	VCV000490148	17	33428034	17	35101015	490148	482967	rs1555566979	NC_000017.11:35101014:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Dec 5, 2023	criteria provided, single submitter							
NM_002878.4(RAD51D):c.924G>T (p.Met308Ile)	RAD51D|RAD51L3-RFFL	M196I, M308I, M328I	Hereditary cancer-predisposing syndrome	VCV001766326	17	33428035	17	35101016	1766326	1814904	rs1555566981	NC_000017.11:35101015:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Likely benign	Feb 26, 2024	criteria provided, single submitter							
NM_002878.4(RAD51D):c.924G>A (p.Met308Ile)	RAD51L3-RFFL|RAD51D	M308I, M196I, M328I	Hereditary cancer-predisposing syndrome	VCV000484772	17	33428035	17	35101016	484772	479138	rs1555566981	NC_000017.11:35101015:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Likely benign	Feb 26, 2024	criteria provided, single submitter							
NM_002878.4(RAD51D):c.922A>T (p.Met308Leu)	RAD51D|RAD51L3-RFFL	M196L, M308L, M328L	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000823108	17	33428037	17	35101018	823108	813546	rs786201961	NC_000017.11:35101017:T:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Apr 21, 2022	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.922A>G (p.Met308Val)	RAD51D|RAD51L3-RFFL	M308V, M196V, M328V	Hereditary cancer-predisposing syndrome|not specified|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000185144	17	33428037	17	35101018	185144	184803	rs786201961	NC_000017.11:35101017:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Dec 19, 2024	criteria provided, conflicting classifications							
NM_002878.4(RAD51D):c.921G>A (p.Glu307=)	RAD51D|RAD51L3-RFFL		not specified|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000389259	17	33428038	17	35101019	389259	375864	rs1057523377	NC_000017.11:35101018:C:T	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign/Likely benign	Feb 25, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.920A>C (p.Glu307Ala)	RAD51D|RAD51L3-RFFL	E307A, E195A, E327A	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000849748	17	33428039	17	35101020	849748	845209	rs2091528823	NC_000017.11:35101019:T:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Mar 6, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.919G>T (p.Glu307Ter)	RAD51D|RAD51L3-RFFL	E307*, E195*, E327*	Breast-ovarian cancer, familial, susceptibility to, 4	VCV001377880	17	33428040	17	35101021	1377880	1469685	rs115031549	NC_000017.11:35101020:C:A	single nucleotide variant	nonsense|non-coding transcript variant	Uncertain significance	Apr 4, 2024	criteria provided, single submitter							
NM_002878.4(RAD51D):c.919G>A (p.Glu307Lys)	RAD51D|RAD51L3-RFFL	E307K, E195K, E327K	Breast and/or ovarian cancer|Hereditary cancer|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4|not specified|not provided	VCV000127895	17	33428040	17	35101021	127895	133352	rs115031549	NC_000017.11:35101020:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Feb 2, 2025	criteria provided, conflicting classifications							
NM_002878.4(RAD51D):c.918G>A (p.Gln306=)	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV003904213	17	33428041	17	35101022	3904213	4020086		NC_000017.11:35101021:C:T	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign	Feb 25, 2025	criteria provided, single submitter							
NM_002878.4(RAD51D):c.918G>T (p.Gln306His)	RAD51D|RAD51L3-RFFL	Q306H, Q194H, Q326H	Hereditary cancer-predisposing syndrome	VCV000482202	17	33428041	17	35101022	482202	479140	rs1555566990	NC_000017.11:35101021:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Mar 9, 2017	criteria provided, single submitter							
NM_002878.4(RAD51D):c.917A>G (p.Gln306Arg)	RAD51D|RAD51L3-RFFL	Q326R, Q194R, Q306R	Childhood neoplasm|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000639463	17	33428042	17	35101023	639463	645793	rs748398937	NC_000017.11:35101022:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Apr 24, 2020	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.916C>T (p.Gln306Ter)	RAD51D|RAD51L3-RFFL	Q194*, Q306*, Q326*	Breast-ovarian cancer, familial, susceptibility to, 4	VCV001709588	17	33428043	17	35101024	1709588	1707942	rs2142409312	NC_000017.11:35101023:G:A	single nucleotide variant	nonsense|non-coding transcript variant	Uncertain significance	Jul 29, 2022	criteria provided, single submitter							
NM_002878.4(RAD51D):c.915C>G (p.Phe305Leu)	RAD51D|RAD51L3-RFFL	F305L, F193L, F325L	Breast-ovarian cancer, familial, susceptibility to, 4|not provided|Hereditary cancer-predisposing syndrome	VCV000480950	17	33428044	17	35101025	480950	478443	rs1316114457	NC_000017.11:35101024:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Sep 19, 2024	criteria provided, conflicting classifications							
NM_002878.4(RAD51D):c.912T>C (p.Gly304=)	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV001531912	17	33428047	17	35101028	1531912	1582832	rs2142409341	NC_000017.11:35101027:A:G	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign/Likely benign	Feb 25, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.911G>T (p.Gly304Val)	RAD51D|RAD51L3-RFFL	G304V, G192V, G324V	Hereditary cancer-predisposing syndrome	VCV000630954	17	33428048	17	35101029	630954	618523	rs200615280	NC_000017.11:35101028:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Dec 5, 2023	criteria provided, single submitter							
NM_002878.4(RAD51D):c.911G>A (p.Gly304Asp)	RAD51D|RAD51L3-RFFL	G304D, G324D, G192D	Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome|not provided|not specified	VCV000141707	17	33428048	17	35101029	141707	151421	rs200615280	NC_000017.11:35101028:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Nov 26, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.910G>T (p.Gly304Cys)	RAD51D|RAD51L3-RFFL	G304C, G192C, G324C	Hereditary cancer-predisposing syndrome|not provided|not specified|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000232482	17	33428049	17	35101030	232482	235859	rs759392029	NC_000017.11:35101029:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jan 11, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.909A>G (p.Thr303=)	RAD51D|RAD51L3-RFFL		Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV002123712	17	33428050	17	35101031	2123712	2173840	rs2142409375	NC_000017.11:35101030:T:C	single nucleotide variant	synonymous variant|non-coding transcript variant	Uncertain significance	Jun 28, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.908C>G (p.Thr303Arg)	RAD51D|RAD51L3-RFFL	T191R, T323R, T303R	Hereditary cancer-predisposing syndrome	VCV000919534	17	33428051	17	35101032	919534	913817	rs1597855538	NC_000017.11:35101031:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Dec 5, 2023	criteria provided, single submitter							
NM_002878.4(RAD51D):c.908C>T (p.Thr303Ile)	RAD51D|RAD51L3-RFFL	T323I, T191I, T303I	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000823000	17	33428051	17	35101032	823000	813547	rs1597855538	NC_000017.11:35101031:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Dec 14, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.907A>G (p.Thr303Ala)	RAD51D|RAD51L3-RFFL	T303A, T191A, T323A	Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV000187065	17	33428052	17	35101033	187065	184804	rs786203444	NC_000017.11:35101032:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Sep 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.906A>G (p.Pro302=)	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV003903840	17	33428053	17	35101034	3903840	4019713		NC_000017.11:35101033:T:C	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign	Feb 25, 2025	criteria provided, single submitter							
NM_002878.4(RAD51D):c.905C>T (p.Pro302Leu)	RAD51D|RAD51L3-RFFL	P302L, P322L, P190L	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000539858	17	33428054	17	35101035	539858	531087	rs1555567003	NC_000017.11:35101034:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jul 19, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.904-1G>A	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV000663363	17	33428056	17	35101037	663363	653433	rs1597855564	NC_000017.11:35101036:C:T	single nucleotide variant	splice acceptor variant	Uncertain significance	Aug 1, 2018	criteria provided, single submitter							
NM_002878.4(RAD51D):c.904-2A>C	RAD51L3-RFFL|RAD51D		Hereditary cancer-predisposing syndrome	VCV002448046	17	33428057	17	35101038	2448046	2428990	rs1403784434	NC_000017.11:35101037:T:G	single nucleotide variant	splice acceptor variant	Likely pathogenic	Jan 6, 2023	criteria provided, single submitter							
NM_002878.4(RAD51D):c.904-2A>T	RAD51D|RAD51L3-RFFL		Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 4|not provided|Hereditary cancer-predisposing syndrome	VCV000472631	17	33428057	17	35101038	472631	467801	rs1403784434	NC_000017.11:35101037:T:A	single nucleotide variant	splice acceptor variant	Pathogenic/Likely pathogenic	Nov 13, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.904-3C>T	RAD51L3-RFFL|RAD51D		not provided|not specified|Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV000138877	17	33428058	17	35101039	138877	142580	rs45478491	NC_000017.11:35101038:G:A	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Mar 4, 2025	criteria provided, conflicting classifications							
NM_002878.4(RAD51D):c.904-4C>G	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV001662699	17	33428059	17	35101040	1662699	1642922	rs2142409463	NC_000017.11:35101039:G:C	single nucleotide variant	intron variant	Likely benign	Jul 28, 2021	criteria provided, single submitter							
NM_002878.4(RAD51D):c.904-5T>C	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV000954225	17	33428060	17	35101041	954225	960213	rs2091529489	NC_000017.11:35101040:A:G	single nucleotide variant	intron variant	Likely benign	Jul 19, 2022	criteria provided, single submitter							
NM_002878.4(RAD51D):c.904-7C>T	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV001588057	17	33428062	17	35101043	1588057	1574600	rs2091529553	NC_000017.11:35101042:G:A	single nucleotide variant	intron variant	Likely benign	Nov 8, 2022	criteria provided, single submitter							
NM_002878.4(RAD51D):c.904-7C>A	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV001039391	17	33428062	17	35101043	1039391	1033223	rs2091529553	NC_000017.11:35101042:G:T	single nucleotide variant	intron variant	Likely benign	Nov 27, 2023	criteria provided, single submitter							
NM_002878.4(RAD51D):c.904-9T>G	RAD51L3-RFFL|RAD51D		Hereditary cancer-predisposing syndrome	VCV000492454	17	33428064	17	35101045	492454	485205	rs1555567012	NC_000017.11:35101044:A:C	single nucleotide variant	intron variant	Likely benign	Dec 5, 2016	criteria provided, single submitter							
NM_002878.4(RAD51D):c.904-10C>T	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV002102634	17	33428065	17	35101046	2102634	2151353	rs2142409522	NC_000017.11:35101045:G:A	single nucleotide variant	intron variant	Likely benign	Feb 25, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.904-11T>C	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000920351	17	33428066	17	35101047	920351	916714	rs374449943	NC_000017.11:35101046:A:G	single nucleotide variant	intron variant	Likely benign	Feb 25, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.904-11T>A	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4|not specified|not provided|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000182854	17	33428066	17	35101047	182854	180791	rs374449943	NC_000017.11:35101046:A:T	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Mar 4, 2025	criteria provided, conflicting classifications							
NM_002878.4(RAD51D):c.904-13C>A	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4|not provided|Hereditary cancer-predisposing syndrome	VCV001279943	17	33428068	17	35101049	1279943	1269808	rs964696175	NC_000017.11:35101048:G:T	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Dec 18, 2024	criteria provided, conflicting classifications							
NM_002878.4(RAD51D):c.904-14A>T	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV002024384	17	33428069	17	35101050	2024384	2077161	rs2142409569	NC_000017.11:35101049:T:A	single nucleotide variant	intron variant	Likely benign	Feb 25, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.904-14A>C	RAD51D|RAD51L3-RFFL		Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4|not specified	VCV001576726	17	33428069	17	35101050	1576726	1587057	rs2142409569	NC_000017.11:35101049:T:G	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Mar 4, 2025	criteria provided, conflicting classifications							
NM_002878.4(RAD51D):c.904-15T>C	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV003903529	17	33428070	17	35101051	3903529	4019402		NC_000017.11:35101050:A:G	single nucleotide variant	intron variant	Likely benign	Feb 25, 2025	criteria provided, single submitter							
NM_002878.4(RAD51D):c.904-16T>G	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV001606298	17	33428071	17	35101052	1606298	1625438	rs2142409576	NC_000017.11:35101051:A:C	single nucleotide variant	intron variant	Likely benign	Nov 22, 2024	criteria provided, single submitter							
NM_002878.4(RAD51D):c.904-17C>T	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4|not specified	VCV000507042	17	33428072	17	35101053	507042	505838	rs181816960	NC_000017.11:35101052:G:A	single nucleotide variant	intron variant	Likely benign	Feb 25, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.904-19T>A	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV002831108	17	33428074	17	35101055	2831108	2990909	rs2091529737	NC_000017.11:35101054:A:T	single nucleotide variant	intron variant	Likely benign	Jan 22, 2023	criteria provided, single submitter							
NM_002878.4(RAD51D):c.904-19T>G	RAD51L3-RFFL|RAD51D		Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000924643	17	33428074	17	35101055	924643	916715	rs2091529737	NC_000017.11:35101054:A:C	single nucleotide variant	intron variant	Likely benign	Apr 11, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.904-20C>A	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV000927346	17	33428075	17	35101056	927346	916716	rs2091529783	NC_000017.11:35101055:G:T	single nucleotide variant	intron variant	Likely benign	Feb 29, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.903+61A>G	RAD51D|RAD51L3-RFFL		not provided	VCV001196211	17	33428159	17	35101140	1196211	1188517	rs9914109	NC_000017.11:35101139:T:C	single nucleotide variant	intron variant	Likely benign	Jun 23, 2018	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.903+53C>T	RAD51L3-RFFL|RAD51D		not provided	VCV000676537	17	33428167	17	35101148	676537	669233	rs45496096	NC_000017.11:35101147:G:A	single nucleotide variant	intron variant	Likely benign	Jun 18, 2018	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.903+19G>A	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV002762256	17	33428201	17	35101182	2762256	2930752	rs2142410641	NC_000017.11:35101181:C:T	single nucleotide variant	intron variant	Likely benign	Sep 21, 2023	criteria provided, single submitter							
NM_002878.4(RAD51D):c.903+16G>T	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV002776204	17	33428204	17	35101185	2776204	2936496	rs2142410666	NC_000017.11:35101184:C:A	single nucleotide variant	intron variant	Likely benign	Jan 31, 2023	criteria provided, single submitter							
NM_002878.4(RAD51D):c.903+15G>C	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV001669410	17	33428205	17	35101186	1669410	1665664	rs2142410673	NC_000017.11:35101185:C:G	single nucleotide variant	intron variant	Likely benign	Jun 21, 2021	criteria provided, single submitter							
NM_002878.4(RAD51D):c.903+13C>T	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV002134303	17	33428207	17	35101188	2134303	2187022	rs2142410685	NC_000017.11:35101187:G:A	single nucleotide variant	intron variant	Likely benign	May 23, 2023	criteria provided, single submitter							
NM_002878.4(RAD51D):c.903+12C>T	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV001555436	17	33428208	17	35101189	1555436	1550141	rs1417869713	NC_000017.11:35101188:G:A	single nucleotide variant	intron variant	Likely benign	Aug 28, 2024	criteria provided, single submitter							
NM_002878.4(RAD51D):c.903+10C>A	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV001956166	17	33428210	17	35101191	1956166	2018887	rs1325605461	NC_000017.11:35101190:G:T	single nucleotide variant	intron variant	Likely benign	Feb 25, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.903+10C>T	RAD51L3-RFFL|RAD51D		Breast-ovarian cancer, familial, susceptibility to, 4	VCV001587993	17	33428210	17	35101191	1587993	1606015	rs1325605461	NC_000017.11:35101190:G:A	single nucleotide variant	intron variant	Likely benign	Feb 25, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.903+9G>A	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV001608666	17	33428211	17	35101192	1608666	1660084	rs2142410729	NC_000017.11:35101191:C:T	single nucleotide variant	intron variant	Likely benign	Feb 25, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.903+8A>C	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV001096224	17	33428212	17	35101193	1096224	1082924	rs2142410735	NC_000017.11:35101192:T:G	single nucleotide variant	intron variant	Likely benign	Oct 13, 2020	criteria provided, single submitter							
NM_002878.4(RAD51D):c.903+6C>T	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV002742821	17	33428214	17	35101195	2742821	2900584	rs2142410756	NC_000017.11:35101194:G:A	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Feb 25, 2025	criteria provided, conflicting classifications							
NM_002878.4(RAD51D):c.903+5G>A	RAD51D|RAD51L3-RFFL		Hereditary cancer-predisposing syndrome	VCV000822918	17	33428215	17	35101196	822918	815672	rs1597855749	NC_000017.11:35101195:C:T	single nucleotide variant	intron variant	Likely benign	Jul 17, 2020	criteria provided, single submitter							
NM_002878.4(RAD51D):c.903+3G>A	RAD51D|RAD51L3-RFFL		Hereditary cancer-predisposing syndrome	VCV002625303	17	33428217	17	35101198	2625303	2787286	rs2142410788	NC_000017.11:35101197:C:T	single nucleotide variant	intron variant	Uncertain significance	Sep 13, 2023	criteria provided, single submitter							
NM_002878.4(RAD51D):c.903+2T>G	RAD51D|RAD51L3-RFFL		not provided	VCV003390029	17	33428218	17	35101199	3390029	3549152		NC_000017.11:35101198:A:C	single nucleotide variant	splice donor variant	Uncertain significance	Nov 1, 2024	criteria provided, single submitter							
NM_002878.4(RAD51D):c.903+1G>T	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV002702803	17	33428219	17	35101200	2702803	2866354	rs2142410813	NC_000017.11:35101199:C:A	single nucleotide variant	splice donor variant	Uncertain significance	Dec 13, 2023	criteria provided, single submitter							
NM_002878.4(RAD51D):c.903+1G>A	RAD51D|RAD51L3-RFFL		RAD51D-related cancer predisposition|Breast-ovarian cancer, familial, susceptibility to, 4	VCV001347094	17	33428219	17	35101200	1347094	1453207	rs2142410813	NC_000017.11:35101199:C:T	single nucleotide variant	splice donor variant	Conflicting classifications of pathogenicity	Apr 10, 2024	criteria provided, conflicting classifications							
NM_002878.4(RAD51D):c.903G>A (p.Gln301=)	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV002713403	17	33428220	17	35101201	2713403	2875701	rs2142410821	NC_000017.11:35101200:C:T	single nucleotide variant	non-coding transcript variant|synonymous variant	Uncertain significance	Jan 27, 2024	criteria provided, single submitter							
NM_002878.4(RAD51D):c.903G>C (p.Gln301His)	RAD51D|RAD51L3-RFFL	Q189H, Q301H, Q321H	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV001055667	17	33428220	17	35101201	1055667	1050197	rs2142410821	NC_000017.11:35101200:C:G	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Feb 28, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.902A>G (p.Gln301Arg)	RAD51L3-RFFL|RAD51D	Q301R, Q189R, Q321R	Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV002726961	17	33428221	17	35101202	2726961	2886151	rs2142410841	NC_000017.11:35101201:T:C	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Jun 12, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.901C>A (p.Gln301Lys)	RAD51D|RAD51L3-RFFL	Q301K, Q189K, Q321K	Breast-ovarian cancer, familial, susceptibility to, 4	VCV003653984	17	33428222	17	35101203	3653984	3785987		NC_000017.11:35101202:G:T	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	May 21, 2024	criteria provided, single submitter							
NM_002878.4(RAD51D):c.901C>T (p.Gln301Ter)	RAD51D|RAD51L3-RFFL	Q301*, Q189*, Q321*	Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome	VCV000410561	17	33428222	17	35101203	410561	402560	rs1060502959	NC_000017.11:35101202:G:A	single nucleotide variant	non-coding transcript variant|nonsense	Likely pathogenic	Jan 23, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.900A>G (p.Arg300=)	RAD51L3-RFFL|RAD51D		not specified|not provided|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000185315	17	33428223	17	35101204	185315	184805	rs370634278	NC_000017.11:35101203:T:C	single nucleotide variant	non-coding transcript variant|synonymous variant	Benign/Likely benign	Feb 25, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.899G>C (p.Arg300Pro)	RAD51D|RAD51L3-RFFL	R188P, R320P, R300P	Breast-ovarian cancer, familial, susceptibility to, 4	VCV002751810	17	33428224	17	35101205	2751810	2919472	rs761290755	NC_000017.11:35101204:C:G	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Aug 11, 2023	criteria provided, single submitter							
NM_002878.4(RAD51D):c.899G>T (p.Arg300Leu)	RAD51D|RAD51L3-RFFL	R188L, R300L, R320L	Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV001692735	17	33428224	17	35101205	1692735	1685175	rs761290755	NC_000017.11:35101204:C:A	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Jan 14, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.899G>A (p.Arg300Gln)	RAD51L3-RFFL|RAD51D	R300Q, R320Q, R188Q	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|not provided|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000239405	17	33428224	17	35101205	239405	242720	rs761290755	NC_000017.11:35101204:C:T	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Aug 5, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.898C>A (p.Arg300=)	RAD51D|RAD51L3-RFFL		Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV001765341	17	33428225	17	35101206	1765341	1820982	rs750621215	NC_000017.11:35101205:G:T	single nucleotide variant	non-coding transcript variant|synonymous variant	Likely benign	Feb 21, 2023	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.898C>T (p.Arg300Ter)	RAD51D|RAD51L3-RFFL	R300*, R188*, R320*	not provided|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 4|Familial ovarian cancer|Breast and/or ovarian cancer|Hereditary cancer-predisposing syndrome	VCV000185048	17	33428225	17	35101206	185048	184806	rs750621215	NC_000017.11:35101205:G:A	single nucleotide variant	non-coding transcript variant|nonsense	Pathogenic/Likely pathogenic	Apr 17, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.897C>T (p.Ser299=)	RAD51D|RAD51L3-RFFL		Hereditary cancer-predisposing syndrome	VCV001765307	17	33428226	17	35101207	1765307	1824801	rs2142410901	NC_000017.11:35101206:G:A	single nucleotide variant	non-coding transcript variant|synonymous variant	Likely benign	Dec 12, 2020	criteria provided, single submitter							
NM_002878.4(RAD51D):c.896C>T (p.Ser299Phe)	RAD51L3-RFFL|RAD51D	S187F, S319F, S299F	Hereditary cancer-predisposing syndrome	VCV000926859	17	33428227	17	35101208	926859	913818	rs1379526157	NC_000017.11:35101207:G:A	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Dec 4, 2023	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.894T>A (p.Ser298=)	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV003903901	17	33428229	17	35101210	3903901	4019774		NC_000017.11:35101209:A:T	single nucleotide variant	non-coding transcript variant|synonymous variant	Benign	Feb 25, 2025	criteria provided, single submitter							
NM_002878.4(RAD51D):c.894T>C (p.Ser298=)	RAD51D|RAD51L3-RFFL		Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV001171699	17	33428229	17	35101210	1171699	1161341	rs2142410928	NC_000017.11:35101209:A:G	single nucleotide variant	non-coding transcript variant|synonymous variant	Benign/Likely benign	Feb 25, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.893C>T (p.Ser298Phe)	RAD51D|RAD51L3-RFFL	S186F, S318F, S298F	Breast-ovarian cancer, familial, susceptibility to, 4	VCV000844909	17	33428230	17	35101211	844909	845210	rs2091531714	NC_000017.11:35101210:G:A	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Feb 8, 2020	criteria provided, single submitter							
NM_002878.4(RAD51D):c.892T>G (p.Ser298Ala)	RAD51D|RAD51L3-RFFL	S186A, S298A, S318A	Breast-ovarian cancer, familial, susceptibility to, 4	VCV003665847	17	33428231	17	35101212	3665847	3795720		NC_000017.11:35101211:A:C	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Oct 13, 2024	criteria provided, single submitter							
NM_002878.4(RAD51D):c.891A>C (p.Lys297Asn)	RAD51D|RAD51L3-RFFL	K185N, K317N, K297N	Hereditary cancer-predisposing syndrome	VCV003429753	17	33428232	17	35101213	3429753	3585764		NC_000017.11:35101212:T:G	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Nov 18, 2024	criteria provided, single submitter							
NM_002878.4(RAD51D):c.891A>G (p.Lys297=)	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV002118299	17	33428232	17	35101213	2118299	2176081	rs2142410949	NC_000017.11:35101212:T:C	single nucleotide variant	non-coding transcript variant|synonymous variant	Likely benign	Mar 27, 2022	criteria provided, single submitter							
NM_002878.4(RAD51D):c.890A>G (p.Lys297Arg)	RAD51D|RAD51L3-RFFL	K297R, K317R, K185R	Breast-ovarian cancer, familial, susceptibility to, 4	VCV002114539	17	33428233	17	35101214	2114539	2168544	rs2142410956	NC_000017.11:35101213:T:C	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Mar 19, 2022	criteria provided, single submitter							
NM_002878.4(RAD51D):c.889A>C (p.Lys297Gln)	RAD51D|RAD51L3-RFFL	K297Q, K185Q, K317Q	Hereditary cancer-predisposing syndrome	VCV000480545	17	33428234	17	35101215	480545	479147	rs1555567051	NC_000017.11:35101214:T:G	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Sep 26, 2024	criteria provided, single submitter							
NM_002878.4(RAD51D):c.888C>G (p.Ala296=)	RAD51D|RAD51L3-RFFL		Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000472630	17	33428235	17	35101216	472630	466735	rs755177638	NC_000017.11:35101215:G:C	single nucleotide variant	non-coding transcript variant|synonymous variant	Likely benign	Feb 29, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.887C>T (p.Ala296Val)	RAD51D|RAD51L3-RFFL	A184V, A316V, A296V	Hereditary cancer-predisposing syndrome	VCV003312409	17	33428236	17	35101217	3312409	3461951		NC_000017.11:35101216:G:A	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	May 25, 2024	criteria provided, single submitter							
NM_002878.4(RAD51D):c.886G>T (p.Ala296Ser)	RAD51L3-RFFL|RAD51D	A296S, A184S, A316S	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000539854	17	33428237	17	35101218	539854	531151	rs374019782	NC_000017.11:35101217:C:A	single nucleotide variant	non-coding transcript variant|missense variant	Conflicting classifications of pathogenicity	Nov 27, 2024	criteria provided, conflicting classifications							
NM_002878.4(RAD51D):c.885G>T (p.Leu295=)	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV000822780	17	33428238	17	35101219	822780	813548	rs876659714	NC_000017.11:35101218:C:A	single nucleotide variant	non-coding transcript variant|synonymous variant	Benign/Likely benign	Feb 25, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.885G>A (p.Leu295=)	RAD51D|RAD51L3-RFFL		Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000232351	17	33428238	17	35101219	232351	235860	rs876659714	NC_000017.11:35101218:C:T	single nucleotide variant	non-coding transcript variant|synonymous variant	Benign/Likely benign	Feb 25, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.883C>T (p.Leu295=)	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV001162086	17	33428240	17	35101221	1162086	1147038	rs752910287	NC_000017.11:35101220:G:A	single nucleotide variant	non-coding transcript variant|synonymous variant	Likely benign	Feb 17, 2024	criteria provided, single submitter							
NM_002878.4(RAD51D):c.883C>G (p.Leu295Val)	RAD51D|RAD51L3-RFFL	L295V, L183V, L315V	Hereditary cancer-predisposing syndrome|not specified|not provided|Familial ovarian cancer|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000410562	17	33428240	17	35101221	410562	401926	rs752910287	NC_000017.11:35101220:G:C	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Jan 3, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.882T>C (p.Cys294=)	RAD51D|RAD51L3-RFFL		Hereditary cancer-predisposing syndrome	VCV001764811	17	33428241	17	35101222	1764811	1814632	rs2142411050	NC_000017.11:35101221:A:G	single nucleotide variant	non-coding transcript variant|synonymous variant	Likely benign	Feb 3, 2020	criteria provided, single submitter							
NM_002878.4(RAD51D):c.881G>A (p.Cys294Tyr)	RAD51D|RAD51L3-RFFL	C294Y, C182Y, C314Y	Breast-ovarian cancer, familial, susceptibility to, 4	VCV000933645	17	33428242	17	35101223	933645	937886	rs2091532002	NC_000017.11:35101222:C:T	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Sep 23, 2019	criteria provided, single submitter							
NM_002878.4(RAD51D):c.879G>C (p.Ala293=)	RAD51D|RAD51L3-RFFL		not specified|Breast-ovarian cancer, familial, susceptibility to, 4|not provided|Hereditary cancer-predisposing syndrome	VCV000472629	17	33428244	17	35101225	472629	467922	rs368209468	NC_000017.11:35101224:C:G	single nucleotide variant	non-coding transcript variant|synonymous variant	Benign/Likely benign	Mar 24, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.879G>T (p.Ala293=)	RAD51D|RAD51L3-RFFL		not specified|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000416197	17	33428244	17	35101225	416197	401851	rs368209468	NC_000017.11:35101224:C:A	single nucleotide variant	non-coding transcript variant|synonymous variant	Benign/Likely benign	Feb 25, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.879G>A (p.Ala293=)	RAD51D|RAD51L3-RFFL		not specified|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4|not provided	VCV000186175	17	33428244	17	35101225	186175	184808	rs368209468	NC_000017.11:35101224:C:T	single nucleotide variant	non-coding transcript variant|synonymous variant	Conflicting classifications of pathogenicity	Feb 25, 2025	criteria provided, conflicting classifications							
NM_002878.4(RAD51D):c.878C>A (p.Ala293Glu)	RAD51L3-RFFL|RAD51D	A293E, A313E, A181E	Breast-ovarian cancer, familial, susceptibility to, 4	VCV000472628	17	33428245	17	35101226	472628	466738	rs769732230	NC_000017.11:35101225:G:T	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Apr 14, 2018	criteria provided, single submitter							
NM_002878.4(RAD51D):c.878C>T (p.Ala293Val)	RAD51L3-RFFL|RAD51D	A293V, A181V, A313V	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4|not specified|not provided	VCV000187161	17	33428245	17	35101226	187161	184809	rs769732230	NC_000017.11:35101225:G:A	single nucleotide variant	non-coding transcript variant|missense variant	Conflicting classifications of pathogenicity	Jan 23, 2025	criteria provided, conflicting classifications							
NM_002878.4(RAD51D):c.877G>T (p.Ala293Ser)	RAD51D|RAD51L3-RFFL	A181S, A293S, A313S	Hereditary cancer-predisposing syndrome	VCV001764639	17	33428246	17	35101227	1764639	1814460	rs1555567073	NC_000017.11:35101226:C:A	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Oct 21, 2022	criteria provided, single submitter							
NM_002878.4(RAD51D):c.877G>A (p.Ala293Thr)	RAD51D|RAD51L3-RFFL	A293T, A181T, A313T	Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV000480543	17	33428246	17	35101227	480543	478448	rs1555567073	NC_000017.11:35101226:C:T	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Feb 24, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.876G>A (p.Met292Ile)	RAD51D|RAD51L3-RFFL	M312I, M180I, M292I	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000926698	17	33428247	17	35101228	926698	913820	rs2091532238	NC_000017.11:35101227:C:T	single nucleotide variant	non-coding transcript variant|missense variant	Conflicting classifications of pathogenicity	Feb 26, 2024	criteria provided, conflicting classifications							
NM_002878.4(RAD51D):c.875T>G (p.Met292Arg)	RAD51D|RAD51L3-RFFL	M312R, M180R, M292R	Breast-ovarian cancer, familial, susceptibility to, 4	VCV002855027	17	33428248	17	35101229	2855027	3017207	rs2142411132	NC_000017.11:35101228:A:C	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Apr 11, 2023	criteria provided, single submitter							
NM_002878.4(RAD51D):c.875T>C (p.Met292Thr)	RAD51D|RAD51L3-RFFL	M180T, M292T, M312T	Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary breast ovarian cancer syndrome	VCV002683740	17	33428248	17	35101229	2683740	2844773	rs2142411132	NC_000017.11:35101228:A:G	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Nov 14, 2023	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.874A>G (p.Met292Val)	RAD51D|RAD51L3-RFFL	M292V, M180V, M312V	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000472627	17	33428249	17	35101230	472627	467586	rs1555567076	NC_000017.11:35101229:T:C	single nucleotide variant	non-coding transcript variant|missense variant	Conflicting classifications of pathogenicity	Jan 22, 2025	criteria provided, conflicting classifications							
NM_002878.4(RAD51D):c.873C>T (p.Arg291=)	RAD51D|RAD51L3-RFFL		Hereditary cancer-predisposing syndrome|not specified|Breast and/or ovarian cancer|not provided|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000138876	17	33428250	17	35101231	138876	142579	rs140848654	NC_000017.11:35101230:G:A	single nucleotide variant	non-coding transcript variant|synonymous variant	Benign/Likely benign	Mar 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.872G>T (p.Arg291Leu)	RAD51D|RAD51L3-RFFL	R311L, R179L, R291L	Breast-ovarian cancer, familial, susceptibility to, 4	VCV002806783	17	33428251	17	35101232	2806783	2967872	rs150134822	NC_000017.11:35101231:C:A	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Sep 10, 2023	criteria provided, single submitter							
NM_002878.4(RAD51D):c.872G>A (p.Arg291His)	RAD51D|RAD51L3-RFFL	R291H, R311H, R179H	Hereditary cancer-predisposing syndrome|not specified|not provided|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000182865	17	33428251	17	35101232	182865	180792	rs150134822	NC_000017.11:35101231:C:T	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Mar 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.871C>G (p.Arg291Gly)	RAD51D|RAD51L3-RFFL	R291G, R311G, R179G	Breast-ovarian cancer, familial, susceptibility to, 4	VCV002715835	17	33428252	17	35101233	2715835	2869073	rs372038369	NC_000017.11:35101232:G:C	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Jan 4, 2024	criteria provided, single submitter							
NM_002878.4(RAD51D):c.871C>A (p.Arg291Ser)	RAD51D|RAD51L3-RFFL	R291S, R179S, R311S	Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV000484769	17	33428252	17	35101233	484769	478450	rs372038369	NC_000017.11:35101232:G:T	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Jan 7, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.871C>T (p.Arg291Cys)	RAD51D|RAD51L3-RFFL	R291C, R179C, R311C	not specified|not provided|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV000231161	17	33428252	17	35101233	231161	235861	rs372038369	NC_000017.11:35101232:G:A	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Apr 7, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.870G>A (p.Arg290=)	RAD51L3-RFFL|RAD51D		Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV000926507	17	33428253	17	35101234	926507	913821	rs2091532491	NC_000017.11:35101233:C:T	single nucleotide variant	non-coding transcript variant|synonymous variant	Benign/Likely benign	Feb 25, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.869G>C (p.Arg290Pro)	RAD51D|RAD51L3-RFFL	R290P, R310P, R178P	Breast-ovarian cancer, familial, susceptibility to, 4	VCV001490585	17	33428254	17	35101235	1490585	1433654	rs773883374	NC_000017.11:35101234:C:G	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Nov 23, 2021	criteria provided, single submitter							
NM_002878.4(RAD51D):c.869G>A (p.Arg290Gln)	RAD51L3-RFFL|RAD51D	R290Q, R178Q, R310Q	Hereditary cancer-predisposing syndrome|not provided|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000231338	17	33428254	17	35101235	231338	235862	rs773883374	NC_000017.11:35101234:C:T	single nucleotide variant	non-coding transcript variant|missense variant	Conflicting classifications of pathogenicity	Jan 14, 2025	criteria provided, conflicting classifications							
NM_002878.4(RAD51D):c.868C>A (p.Arg290=)	RAD51D|RAD51L3-RFFL		Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV001764307	17	33428255	17	35101236	1764307	1817434	rs527964137	NC_000017.11:35101235:G:T	single nucleotide variant	non-coding transcript variant|synonymous variant	Benign/Likely benign	Feb 25, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.868C>T (p.Arg290Trp)	RAD51D|RAD51L3-RFFL	R290W, R178W, R310W	not provided|Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000187277	17	33428255	17	35101236	187277	184810	rs527964137	NC_000017.11:35101235:G:A	single nucleotide variant	non-coding transcript variant|missense variant	Conflicting classifications of pathogenicity	Apr 5, 2025	criteria provided, conflicting classifications							
NM_002878.4(RAD51D):c.867C>G (p.Gly289=)	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV002811131	17	33428256	17	35101237	2811131	2975644	rs2091532621	NC_000017.11:35101236:G:C	single nucleotide variant	non-coding transcript variant|synonymous variant	Benign/Likely benign	Feb 25, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.867C>T (p.Gly289=)	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV000861584	17	33428256	17	35101237	861584	845211	rs2091532621	NC_000017.11:35101236:G:A	single nucleotide variant	non-coding transcript variant|synonymous variant	Benign/Likely benign	Feb 25, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.866G>T (p.Gly289Val)	RAD51D|RAD51L3-RFFL	G309V, G177V, G289V	not provided|Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV000652553	17	33428257	17	35101238	652553	645794	rs1597855853	NC_000017.11:35101237:C:A	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Oct 23, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.865G>A (p.Gly289Ser)	RAD51D|RAD51L3-RFFL	G289S, G177S, G309S	not provided|not specified|Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV000141945	17	33428258	17	35101239	141945	151659	rs587782129	NC_000017.11:35101238:C:T	single nucleotide variant	non-coding transcript variant|missense variant	Conflicting classifications of pathogenicity	Nov 29, 2024	criteria provided, conflicting classifications							
NM_002878.4(RAD51D):c.864C>G (p.Gly288=)	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV003903743	17	33428259	17	35101240	3903743	4019616		NC_000017.11:35101239:G:C	single nucleotide variant	non-coding transcript variant|synonymous variant	Benign	Feb 25, 2025	criteria provided, single submitter							
NM_002878.4(RAD51D):c.864C>A (p.Gly288=)	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV002848723	17	33428259	17	35101240	2848723	3015620	rs138557828	NC_000017.11:35101239:G:T	single nucleotide variant	non-coding transcript variant|synonymous variant	Likely benign	Mar 24, 2023	criteria provided, single submitter							
NM_002878.4(RAD51D):c.864C>T (p.Gly288=)	RAD51D|RAD51L3-RFFL		Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|not provided|Breast-ovarian cancer, familial, susceptibility to, 4|not specified	VCV000182853	17	33428259	17	35101240	182853	180793	rs138557828	NC_000017.11:35101239:G:A	single nucleotide variant	non-coding transcript variant|synonymous variant	Conflicting classifications of pathogenicity	Mar 4, 2025	criteria provided, conflicting classifications							
NM_002878.4(RAD51D):c.862G>A (p.Gly288Ser)	RAD51D|RAD51L3-RFFL	G288S, G176S, G308S	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV003015738	17	33428261	17	35101242	3015738	3174715	rs1391505912	NC_000017.11:35101241:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jan 5, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.862G>C (p.Gly288Arg)	RAD51D|RAD51L3-RFFL	G288R, G176R, G308R	Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV000472625	17	33428261	17	35101242	472625	467929	rs1391505912	NC_000017.11:35101241:C:G	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Mar 28, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.861A>C (p.Ser287=)	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV001764046	17	33428262	17	35101243	1764046	1820909	rs2142411289	NC_000017.11:35101242:T:G	single nucleotide variant	non-coding transcript variant|synonymous variant	Likely benign	Mar 30, 2023	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.860C>T (p.Ser287Leu)	RAD51D|RAD51L3-RFFL	S287L, S175L, S307L	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV001395136	17	33428263	17	35101244	1395136	1412150	rs2142411300	NC_000017.11:35101243:G:A	single nucleotide variant	non-coding transcript variant|missense variant	Conflicting classifications of pathogenicity	Feb 26, 2024	criteria provided, conflicting classifications							
NM_002878.4(RAD51D):c.859T>C (p.Ser287Pro)	RAD51D|RAD51L3-RFFL	S175P, S307P, S287P	Breast-ovarian cancer, familial, susceptibility to, 4	VCV000662153	17	33428264	17	35101245	662153	645795	rs1597855868	NC_000017.11:35101244:A:G	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Nov 22, 2018	criteria provided, single submitter							
NM_002878.4(RAD51D):c.858A>G (p.Ala286=)	RAD51L3-RFFL|RAD51D		Breast-ovarian cancer, familial, susceptibility to, 4	VCV003904487	17	33428265	17	35101246	3904487	4020359		NC_000017.11:35101245:T:C	single nucleotide variant	non-coding transcript variant|synonymous variant	Benign	Feb 25, 2025	criteria provided, single submitter							
NM_002878.4(RAD51D):c.858A>T (p.Ala286=)	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV003904443	17	33428265	17	35101246	3904443	4020315		NC_000017.11:35101245:T:A	single nucleotide variant	non-coding transcript variant|synonymous variant	Benign	Feb 25, 2025	criteria provided, single submitter							
NM_002878.4(RAD51D):c.856G>A (p.Ala286Thr)	RAD51D|RAD51L3-RFFL	A174T, A286T, A306T	Hereditary cancer-predisposing syndrome	VCV001172381	17	33428267	17	35101248	1172381	1161342	rs761054054	NC_000017.11:35101247:C:T	single nucleotide variant	non-coding transcript variant|missense variant	Conflicting classifications of pathogenicity	Mar 6, 2024	criteria provided, conflicting classifications							
NM_002878.4(RAD51D):c.855A>T (p.Gly285=)	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV003646901	17	33428268	17	35101249	3646901	3784035		NC_000017.11:35101248:T:A	single nucleotide variant	non-coding transcript variant|synonymous variant	Benign/Likely benign	Feb 25, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.855A>C (p.Gly285=)	RAD51D|RAD51L3-RFFL		Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000921625	17	33428268	17	35101249	921625	913822	rs2091532932	NC_000017.11:35101248:T:G	single nucleotide variant	non-coding transcript variant|synonymous variant	Likely benign	Oct 24, 2023	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.854G>A (p.Gly285Glu)	RAD51D|RAD51L3-RFFL	G285E, G305E, G173E	Breast-ovarian cancer, familial, susceptibility to, 4	VCV000849999	17	33428269	17	35101250	849999	845212	rs878854565	NC_000017.11:35101249:C:T	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Oct 10, 2023	criteria provided, single submitter							
NM_002878.4(RAD51D):c.854G>T (p.Gly285Val)	RAD51D|RAD51L3-RFFL	G285V, G305V, G173V	Breast-ovarian cancer, familial, susceptibility to, 4	VCV000239404	17	33428269	17	35101250	239404	242721	rs878854565	NC_000017.11:35101249:C:A	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Dec 11, 2015	criteria provided, single submitter							
NM_002878.4(RAD51D):c.853G>A (p.Gly285Arg)	RAD51D|RAD51L3-RFFL	G173R, G285R, G305R	Breast-ovarian cancer, familial, susceptibility to, 4	VCV000999531	17	33428270	17	35101251	999531	997495	rs2091533035	NC_000017.11:35101250:C:T	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Feb 14, 2023	criteria provided, single submitter							
NM_002878.4(RAD51D):c.852A>C (p.Ala284=)	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV003903924	17	33428271	17	35101252	3903924	4019797		NC_000017.11:35101251:T:G	single nucleotide variant	non-coding transcript variant|synonymous variant	Benign	Feb 25, 2025	criteria provided, single submitter							
NM_002878.4(RAD51D):c.851C>T (p.Ala284Val)	RAD51D|RAD51L3-RFFL	A172V, A284V, A304V	Breast-ovarian cancer, familial, susceptibility to, 4	VCV001716660	17	33428272	17	35101253	1716660	1778341	rs2142411425	NC_000017.11:35101252:G:A	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Aug 18, 2022	criteria provided, single submitter							
NM_002878.4(RAD51D):c.850G>A (p.Ala284Thr)	RAD51L3-RFFL|RAD51D	A284T, A304T, A172T	Hereditary cancer-predisposing syndrome	VCV000492452	17	33428273	17	35101254	492452	484945	rs1555567101	NC_000017.11:35101253:C:T	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Dec 5, 2023	criteria provided, single submitter							
NM_002878.4(RAD51D):c.849A>T (p.Gly283=)	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV003904285	17	33428274	17	35101255	3904285	4020158		NC_000017.11:35101254:T:A	single nucleotide variant	non-coding transcript variant|synonymous variant	Benign	Feb 25, 2025	criteria provided, single submitter							
NM_002878.4(RAD51D):c.849A>G (p.Gly283=)	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV003903438	17	33428274	17	35101255	3903438	4019312		NC_000017.11:35101254:T:C	single nucleotide variant	non-coding transcript variant|synonymous variant	Benign	Feb 25, 2025	criteria provided, single submitter							
NM_002878.4(RAD51D):c.849A>C (p.Gly283=)	RAD51D|RAD51L3-RFFL		not provided|Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV000539871	17	33428274	17	35101255	539871	531152	rs766847072	NC_000017.11:35101254:T:G	single nucleotide variant	non-coding transcript variant|synonymous variant	Benign/Likely benign	Feb 24, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.848G>A (p.Gly283Glu)	RAD51D|RAD51L3-RFFL	G171E, G283E, G303E	Breast-ovarian cancer, familial, susceptibility to, 4	VCV001719068	17	33428275	17	35101256	1719068	1774372	rs2142411459	NC_000017.11:35101255:C:T	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Sep 8, 2022	criteria provided, single submitter							
NM_002878.4(RAD51D):c.844G>C (p.Glu282Gln)	RAD51D|RAD51L3-RFFL	E170Q, E302Q, E282Q	Hereditary cancer-predisposing syndrome	VCV001763434	17	33428279	17	35101260	1763434	1824158	rs1447892901	NC_000017.11:35101259:C:G	single nucleotide variant	non-coding transcript variant|missense variant	Likely benign	Feb 26, 2024	criteria provided, single submitter							
NM_002878.4(RAD51D):c.844G>A (p.Glu282Lys)	RAD51D|RAD51L3-RFFL	E282K, E170K, E302K	not provided|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4|not specified	VCV000570552	17	33428279	17	35101260	570552	571265	rs1447892901	NC_000017.11:35101259:C:T	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Mar 25, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.843C>G (p.Ile281Met)	RAD51D|RAD51L3-RFFL	I281M, I169M, I301M	Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV000484785	17	33428280	17	35101261	484785	478451	rs754455433	NC_000017.11:35101260:G:C	single nucleotide variant	non-coding transcript variant|missense variant	Conflicting classifications of pathogenicity	Mar 7, 2024	criteria provided, conflicting classifications							
NM_002878.4(RAD51D):c.843C>T (p.Ile281=)	RAD51D|RAD51L3-RFFL		Hereditary cancer-predisposing syndrome|not specified|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000185270	17	33428280	17	35101261	185270	184811	rs754455433	NC_000017.11:35101260:G:A	single nucleotide variant	non-coding transcript variant|synonymous variant	Benign/Likely benign	Feb 24, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.842T>C (p.Ile281Thr)	RAD51D|RAD51L3-RFFL	I281T, I301T, I169T	Breast-ovarian cancer, familial, susceptibility to, 4|not specified|Hereditary cancer-predisposing syndrome	VCV000410558	17	33428281	17	35101262	410558	401855	rs1060502957	NC_000017.11:35101261:A:G	single nucleotide variant	non-coding transcript variant|missense variant	Conflicting classifications of pathogenicity	Nov 12, 2024	criteria provided, conflicting classifications							
NM_002878.4(RAD51D):c.841A>G (p.Ile281Val)	RAD51D|RAD51L3-RFFL	I169V, I301V, I281V	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV002123093	17	33428282	17	35101263	2123093	2180987	rs2509124620	NC_000017.11:35101262:T:C	single nucleotide variant	non-coding transcript variant|missense variant	Conflicting classifications of pathogenicity	Feb 26, 2024	criteria provided, conflicting classifications							
NM_002878.4(RAD51D):c.840C>T (p.Thr280=)	RAD51D|RAD51L3-RFFL		not specified|Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV000416196	17	33428283	17	35101264	416196	401857	rs751885496	NC_000017.11:35101263:G:A	single nucleotide variant	non-coding transcript variant|synonymous variant	Benign/Likely benign	Feb 24, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.839C>T (p.Thr280Ile)	RAD51D|RAD51L3-RFFL	T168I, T280I, T300I	not provided|Breast-ovarian cancer, familial, susceptibility to, 4	VCV001006420	17	33428284	17	35101265	1006420	997496	rs548111162	NC_000017.11:35101264:G:A	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Mar 6, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.839C>G (p.Thr280Ser)	RAD51D|RAD51L3-RFFL	T280S, T300S, T168S	Hereditary cancer-predisposing syndrome|not provided|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000230436	17	33428284	17	35101265	230436	235863	rs548111162	NC_000017.11:35101264:G:C	single nucleotide variant	non-coding transcript variant|missense variant	Conflicting classifications of pathogenicity	Nov 27, 2024	criteria provided, conflicting classifications							
NM_002878.4(RAD51D):c.838A>G (p.Thr280Ala)	RAD51D|RAD51L3-RFFL	T300A, T168A, T280A	Hereditary cancer-predisposing syndrome	VCV003786510	17	33428285	17	35101266	3786510	3908951		NC_000017.11:35101265:T:C	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Dec 12, 2024	criteria provided, single submitter							
NM_002878.4(RAD51D):c.837C>T (p.Asp279=)	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV001081714	17	33428286	17	35101267	1081714	1082925	rs2142411560	NC_000017.11:35101266:G:A	single nucleotide variant	non-coding transcript variant|synonymous variant	Benign/Likely benign	Apr 6, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.836A>G (p.Asp279Gly)	RAD51D|RAD51L3-RFFL	D167G, D279G, D299G	not provided|Breast-ovarian cancer, familial, susceptibility to, 4	VCV002574360	17	33428287	17	35101268	2574360	2739294	rs1468391995	NC_000017.11:35101267:T:C	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Dec 24, 2023	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.835G>A (p.Asp279Asn)	RAD51D|RAD51L3-RFFL	D279N, D167N, D299N	Hereditary cancer-predisposing syndrome|not specified|Breast-ovarian cancer, familial, susceptibility to, 4|not provided|Hereditary breast ovarian cancer syndrome|Familial ovarian cancer	VCV000231837	17	33428288	17	35101269	231837	235864	rs765271127	NC_000017.11:35101268:C:T	single nucleotide variant	non-coding transcript variant|missense variant	Conflicting classifications of pathogenicity	Mar 4, 2025	criteria provided, conflicting classifications							
NM_002878.4(RAD51D):c.834G>C (p.Leu278=)	RAD51D|RAD51L3-RFFL		Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000758708	17	33428289	17	35101270	758708	771430	rs876658123	NC_000017.11:35101269:C:G	single nucleotide variant	non-coding transcript variant|synonymous variant	Likely benign	Aug 19, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.834G>A (p.Leu278=)	RAD51D|RAD51L3-RFFL		not specified|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4|not provided	VCV000229657	17	33428289	17	35101270	229657	235865	rs876658123	NC_000017.11:35101269:C:T	single nucleotide variant	non-coding transcript variant|synonymous variant	Benign/Likely benign	Feb 24, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.833T>C (p.Leu278Pro)	RAD51D|RAD51L3-RFFL	L278P, L166P, L298P	Familial ovarian cancer|Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome|RAD51D-related disorder	VCV000568973	17	33428290	17	35101271	568973	571267	rs1567724873	NC_000017.11:35101270:A:G	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Mar 28, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.832C>T (p.Leu278=)	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV000923439	17	33428291	17	35101272	923439	913823	rs2091533606	NC_000017.11:35101271:G:A	single nucleotide variant	non-coding transcript variant|synonymous variant	Benign/Likely benign	Feb 24, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.831C>T (p.Leu277=)	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV003904228	17	33428292	17	35101273	3904228	4020101		NC_000017.11:35101272:G:A	single nucleotide variant	non-coding transcript variant|synonymous variant	Benign	Feb 24, 2025	criteria provided, single submitter							
NM_002878.4(RAD51D):c.829C>G (p.Leu277Val)	RAD51D|RAD51L3-RFFL	L277V, L297V, L165V	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000539856	17	33428294	17	35101275	539856	530956	rs1285339297	NC_000017.11:35101274:G:C	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Apr 7, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.828T>C (p.Ile276=)	RAD51L3-RFFL|RAD51D		Breast-ovarian cancer, familial, susceptibility to, 4	VCV003903627	17	33428295	17	35101276	3903627	4019500		NC_000017.11:35101275:A:G	single nucleotide variant	non-coding transcript variant|synonymous variant	Benign	Feb 24, 2025	criteria provided, single submitter							
NM_002878.4(RAD51D):c.828T>G (p.Ile276Met)	RAD51D|RAD51L3-RFFL	I276M, I164M, I296M	Breast-ovarian cancer, familial, susceptibility to, 4	VCV002837650	17	33428295	17	35101276	2837650	2996207	rs2142411641	NC_000017.11:35101275:A:C	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Feb 15, 2023	criteria provided, single submitter							
NM_002878.4(RAD51D):c.826A>C (p.Ile276Leu)	RAD51D|RAD51L3-RFFL	I276L, I164L, I296L	not provided|Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV000472623	17	33428297	17	35101278	472623	467592	rs1555567119	NC_000017.11:35101277:T:G	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Nov 11, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.825G>A (p.Arg275=)	RAD51D|RAD51L3-RFFL		Hereditary cancer-predisposing syndrome	VCV000827538	17	33428298	17	35101279	827538	813549	rs1597855962	NC_000017.11:35101278:C:T	single nucleotide variant	non-coding transcript variant|synonymous variant	Likely benign	Aug 6, 2018	criteria provided, single submitter							
NM_002878.4(RAD51D):c.824G>A (p.Arg275Gln)	RAD51D|RAD51L3-RFFL	R275Q, R295Q, R163Q	Breast-ovarian cancer, familial, susceptibility to, 4|not provided|Hereditary cancer-predisposing syndrome	VCV000185774	17	33428299	17	35101280	185774	184812	rs368914740	NC_000017.11:35101279:C:T	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Jan 29, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.823C>G (p.Arg275Gly)	RAD51D|RAD51L3-RFFL	R275G, R295G, R163G	Hereditary cancer-predisposing syndrome	VCV003942395	17	33428300	17	35101281	3942395	4064174		NC_000017.11:35101280:G:C	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Jun 12, 2025	criteria provided, single submitter							
NM_002878.4(RAD51D):c.823C>T (p.Arg275Trp)	RAD51D|RAD51L3-RFFL	R275W, R163W, R295W	Hereditary cancer-predisposing syndrome|not provided|Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary breast ovarian cancer syndrome|Familial ovarian cancer	VCV000245669	17	33428300	17	35101281	245669	245014	rs752780416	NC_000017.11:35101280:G:A	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Feb 19, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.823C>A (p.Arg275=)	RAD51D|RAD51L3-RFFL		Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000233914	17	33428300	17	35101281	233914	235866	rs752780416	NC_000017.11:35101280:G:T	single nucleotide variant	non-coding transcript variant|synonymous variant	Benign/Likely benign	Feb 24, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.822T>C (p.Thr274=)	RAD51D|RAD51L3-RFFL		Hereditary cancer-predisposing syndrome	VCV001762554	17	33428301	17	35101282	1762554	1816952	rs2142411707	NC_000017.11:35101281:A:G	single nucleotide variant	non-coding transcript variant|synonymous variant	Likely benign	Oct 18, 2020	criteria provided, single submitter							
NM_002878.4(RAD51D):c.821C>T (p.Thr274Ile)	RAD51L3-RFFL|RAD51D	T274I, T162I, T294I	not provided|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000182864	17	33428302	17	35101283	182864	180794	rs730881951	NC_000017.11:35101282:G:A	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Aug 31, 2022	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.820A>C (p.Thr274Pro)	RAD51L3-RFFL|RAD51D	T294P, T162P, T274P	Hereditary cancer-predisposing syndrome	VCV001762458	17	33428303	17	35101284	1762458	1816857	rs2142411729	NC_000017.11:35101283:T:G	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Sep 27, 2024	criteria provided, single submitter							
NM_002878.4(RAD51D):c.819C>T (p.Ser273=)	RAD51D|RAD51L3-RFFL		Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV001616264	17	33428304	17	35101285	1616264	1526454	rs2142411738	NC_000017.11:35101284:G:A	single nucleotide variant	non-coding transcript variant|synonymous variant	Likely benign	Nov 10, 2021	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.818G>A (p.Ser273Asn)	RAD51D|RAD51L3-RFFL	S161N, S273N, S293N	Breast-ovarian cancer, familial, susceptibility to, 4	VCV003710619	17	33428305	17	35101286	3710619	3847508		NC_000017.11:35101285:C:T	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Oct 27, 2024	criteria provided, single submitter							
NM_002878.4(RAD51D):c.818G>C (p.Ser273Thr)	RAD51D|RAD51L3-RFFL	S293T, S161T, S273T	Hereditary cancer-predisposing syndrome	VCV001762347	17	33428305	17	35101286	1762347	1820482	rs2142411742	NC_000017.11:35101285:C:G	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	May 18, 2021	criteria provided, single submitter							
NM_002878.4(RAD51D):c.817A>C (p.Ser273Arg)	RAD51D|RAD51L3-RFFL	S161R, S293R, S273R	Hereditary cancer-predisposing syndrome	VCV001762299	17	33428306	17	35101287	1762299	1820435	rs876660376	NC_000017.11:35101286:T:G	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Oct 26, 2020	criteria provided, single submitter							
NM_002878.4(RAD51D):c.817A>T (p.Ser273Cys)	RAD51L3-RFFL|RAD51D	S273C, S161C, S293C	Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome|not provided	VCV000233393	17	33428306	17	35101287	233393	235867	rs876660376	NC_000017.11:35101286:T:A	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Jul 12, 2023	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.816C>T (p.Pro272=)	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV002812403	17	33428307	17	35101288	2812403	2965795	rs565863781	NC_000017.11:35101287:G:A	single nucleotide variant	non-coding transcript variant|synonymous variant	Benign/Likely benign	Feb 24, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.816C>G (p.Pro272=)	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV001762259	17	33428307	17	35101288	1762259	1820395	rs565863781	NC_000017.11:35101287:G:C	single nucleotide variant	non-coding transcript variant|synonymous variant	Benign/Likely benign	Feb 24, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.814C>T (p.Pro272Ser)	RAD51D|RAD51L3-RFFL	P272S, P160S, P292S	Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV000482206	17	33428309	17	35101290	482206	478420	rs1458813748	NC_000017.11:35101289:G:A	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	May 19, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.812T>C (p.Val271Ala)	RAD51D|RAD51L3-RFFL	V159A, V271A, V291A	Breast-ovarian cancer, familial, susceptibility to, 4	VCV001098874	17	33428311	17	35101292	1098874	1087619	rs2142411798	NC_000017.11:35101291:A:G	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	May 3, 2021	criteria provided, single submitter							
NM_002878.4(RAD51D):c.811G>A (p.Val271Met)	RAD51D|RAD51L3-RFFL	V159M, V291M, V271M	Breast-ovarian cancer, familial, susceptibility to, 4	VCV001502406	17	33428312	17	35101293	1502406	1504178	rs758570839	NC_000017.11:35101292:C:T	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Jan 14, 2021	criteria provided, single submitter							
NM_002878.4(RAD51D):c.811G>T (p.Val271Leu)	RAD51D|RAD51L3-RFFL	V291L, V271L, V159L	Hereditary cancer-predisposing syndrome	VCV000928307	17	33428312	17	35101293	928307	913824	rs758570839	NC_000017.11:35101292:C:A	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Dec 5, 2023	criteria provided, single submitter							
NM_002878.4(RAD51D):c.810T>A (p.Phe270Leu)	RAD51D|RAD51L3-RFFL	F270L, F158L, F290L	Hereditary cancer-predisposing syndrome	VCV001762039	17	33428313	17	35101294	1762039	1820175	rs2142411820	NC_000017.11:35101293:A:T	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Sep 1, 2021	criteria provided, single submitter							
NM_002878.4(RAD51D):c.809T>C (p.Phe270Ser)	RAD51L3-RFFL|RAD51D	F290S, F270S, F158S	Breast-ovarian cancer, familial, susceptibility to, 4	VCV001041684	17	33428314	17	35101295	1041684	1033224	rs2091534078	NC_000017.11:35101294:A:G	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Apr 13, 2021	criteria provided, single submitter							
NM_002878.4(RAD51D):c.807C>A (p.Ser269Arg)	RAD51D|RAD51L3-RFFL	S157R, S269R, S289R	not provided	VCV004057159	17	33428316	17	35101297	4057159	4171089		NC_000017.11:35101296:G:T	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Jan 12, 2025	criteria provided, single submitter							
NM_002878.4(RAD51D):c.807C>G (p.Ser269Arg)	RAD51D|RAD51L3-RFFL	S269R, S289R, S157R	Breast-ovarian cancer, familial, susceptibility to, 4	VCV003651423	17	33428316	17	35101297	3651423	3778101		NC_000017.11:35101296:G:C	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Apr 29, 2024	criteria provided, single submitter							
NM_002878.4(RAD51D):c.807C>T (p.Ser269=)	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV001134945	17	33428316	17	35101297	1134945	1126142	rs764319986	NC_000017.11:35101296:G:A	single nucleotide variant	non-coding transcript variant|synonymous variant	Benign/Likely benign	Feb 24, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.806G>C (p.Ser269Thr)	RAD51D|RAD51L3-RFFL	S269T, S289T, S157T	Hereditary cancer-predisposing syndrome	VCV002774202	17	33428317	17	35101298	2774202	2934932	rs876658762	NC_000017.11:35101297:C:G	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Mar 2, 2022	criteria provided, single submitter							
NM_002878.4(RAD51D):c.806G>A (p.Ser269Asn)	RAD51D|RAD51L3-RFFL	S269N, S157N, S289N	not specified|Breast-ovarian cancer, familial, susceptibility to, 4|not provided|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000484771	17	33428317	17	35101298	484771	478455	rs876658762	NC_000017.11:35101297:C:T	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Sep 27, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.806G>T (p.Ser269Ile)	RAD51D|RAD51L3-RFFL	S269I, S157I, S289I	Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV000230772	17	33428317	17	35101298	230772	235868	rs876658762	NC_000017.11:35101297:C:A	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Aug 5, 2023	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.804G>T (p.Trp268Cys)	RAD51D|RAD51L3-RFFL	W268C, W156C, W288C	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4|not provided	VCV000827417	17	33428319	17	35101300	827417	813550	rs1597856016	NC_000017.11:35101299:C:A	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Jun 6, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.803G>A (p.Trp268Ter)	RAD51D|RAD51L3-RFFL	W268*, W288*, W156*	not provided|Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000410552	17	33428320	17	35101301	410552	402564	rs750219200	NC_000017.11:35101300:C:T	single nucleotide variant	non-coding transcript variant|nonsense	Pathogenic	Oct 31, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.802T>C (p.Trp268Arg)	RAD51D|RAD51L3-RFFL	W156R, W268R, W288R	Hereditary cancer-predisposing syndrome	VCV002625296	17	33428321	17	35101302	2625296	2787279	rs755965977	NC_000017.11:35101301:A:G	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Jul 23, 2023	criteria provided, single submitter							
NM_002878.4(RAD51D):c.802T>A (p.Trp268Arg)	RAD51D|RAD51L3-RFFL	W268R, W156R, W288R	not provided|Breast-ovarian cancer, familial, susceptibility to, 4|not specified|Hereditary cancer-predisposing syndrome	VCV000234037	17	33428321	17	35101302	234037	235869	rs755965977	NC_000017.11:35101301:A:T	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	May 3, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.801C>G (p.Ser267=)	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV002563026	17	33428322	17	35101303	2563026	2733483	rs2509124901	NC_000017.11:35101302:G:C	single nucleotide variant	non-coding transcript variant|synonymous variant	Benign/Likely benign	Feb 24, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.801C>T (p.Ser267=)	RAD51D|RAD51L3-RFFL		Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV001761678	17	33428322	17	35101303	1761678	1823620	rs2509124901	NC_000017.11:35101302:G:A	single nucleotide variant	non-coding transcript variant|synonymous variant	Benign/Likely benign	Feb 24, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.800C>A (p.Ser267Tyr)	RAD51D|RAD51L3-RFFL	S155Y, S287Y, S267Y	Hereditary cancer-predisposing syndrome	VCV001761631	17	33428323	17	35101304	1761631	1823573	rs1064793702	NC_000017.11:35101303:G:T	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Mar 30, 2021	criteria provided, single submitter							
NM_002878.4(RAD51D):c.800C>T (p.Ser267Phe)	RAD51D|RAD51L3-RFFL	S267F, S287F, S155F	Hereditary cancer-predisposing syndrome|not provided|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000419184	17	33428323	17	35101304	419184	409890	rs1064793702	NC_000017.11:35101303:G:A	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Jul 2, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.799T>C (p.Ser267Pro)	RAD51D|RAD51L3-RFFL	S155P, S287P, S267P	Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV003671407	17	33428324	17	35101305	3671407	3793310		NC_000017.11:35101304:A:G	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	May 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.798C>A (p.Arg266=)	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV003660434	17	33428325	17	35101306	3660434	3797575		NC_000017.11:35101305:G:T	single nucleotide variant	non-coding transcript variant|synonymous variant	Likely benign	Jul 24, 2024	criteria provided, single submitter							
NM_002878.4(RAD51D):c.798C>T (p.Arg266=)	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV001130550	17	33428325	17	35101306	1130550	1126143	rs2142411928	NC_000017.11:35101305:G:A	single nucleotide variant	non-coding transcript variant|synonymous variant	Likely benign	Feb 17, 2022	criteria provided, single submitter							
NM_002878.4(RAD51D):c.797G>A (p.Arg266His)	RAD51D|RAD51L3-RFFL	R266H, R154H, R286H	Familial ovarian cancer|not provided|Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome|not specified	VCV000186248	17	33428326	17	35101307	186248	184813	rs779808083	NC_000017.11:35101306:C:T	single nucleotide variant	non-coding transcript variant|missense variant	Conflicting classifications of pathogenicity	Mar 4, 2025	criteria provided, conflicting classifications							
NM_002878.4(RAD51D):c.796C>T (p.Arg266Cys)	RAD51D|RAD51L3-RFFL	R266C, R154C, R286C	Cancer or benign tumor|Breast and/or ovarian cancer|Hereditary cancer-predisposing syndrome|not specified|not provided|Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary breast ovarian cancer syndrome	VCV000141519	17	33428327	17	35101308	141519	151233	rs587781813	NC_000017.11:35101307:G:A	single nucleotide variant	non-coding transcript variant|missense variant	Conflicting classifications of pathogenicity	Mar 12, 2025	criteria provided, conflicting classifications							
NM_002878.4(RAD51D):c.795A>T (p.Gly265=)	RAD51D|RAD51L3-RFFL		Hereditary cancer-predisposing syndrome	VCV003942380	17	33428328	17	35101309	3942380	4064159		NC_000017.11:35101308:T:A	single nucleotide variant	non-coding transcript variant|synonymous variant	Likely benign	Mar 25, 2025	criteria provided, single submitter							
NM_002878.4(RAD51D):c.795A>C (p.Gly265=)	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV003903923	17	33428328	17	35101309	3903923	4019796		NC_000017.11:35101308:T:G	single nucleotide variant	non-coding transcript variant|synonymous variant	Benign	Feb 24, 2025	criteria provided, single submitter							
NM_002878.4(RAD51D):c.795A>G (p.Gly265=)	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV002750084	17	33428328	17	35101309	2750084	2919042	rs2509124952	NC_000017.11:35101308:T:C	single nucleotide variant	non-coding transcript variant|synonymous variant	Likely benign	May 22, 2024	criteria provided, single submitter							
NM_002878.4(RAD51D):c.794G>C (p.Gly265Ala)	RAD51D|RAD51L3-RFFL	G265A, G153A, G285A	Hereditary cancer-predisposing syndrome	VCV000490146	17	33428329	17	35101310	490146	482979	rs1466324380	NC_000017.11:35101309:C:G	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Mar 18, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.793G>T (p.Gly265Ter)	RAD51D|RAD51L3-RFFL	G153*, G265*, G285*	Breast-ovarian cancer, familial, susceptibility to, 4	VCV003613710	17	33428330	17	35101311	3613710	3738643		NC_000017.11:35101310:C:A	single nucleotide variant	non-coding transcript variant|nonsense	Pathogenic	Jan 8, 2025	criteria provided, single submitter							
NM_002878.4(RAD51D):c.793G>A (p.Gly265Arg)	RAD51D|RAD51L3-RFFL	G265R, G153R, G285R	Breast-ovarian cancer, familial, susceptibility to, 4|Breast and/or ovarian cancer|not provided|Hereditary cancer-predisposing syndrome|Familial ovarian cancer	VCV000142125	17	33428330	17	35101311	142125	151839	rs140285068	NC_000017.11:35101310:C:T	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Mar 24, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.792C>G (p.Leu264=)	RAD51D|RAD51L3-RFFL		not provided|Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome|not specified	VCV000539864	17	33428331	17	35101312	539864	531446	rs536544621	NC_000017.11:35101311:G:C	single nucleotide variant	non-coding transcript variant|synonymous variant	Benign/Likely benign	Feb 24, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.792C>T (p.Leu264=)	RAD51L3-RFFL|RAD51D		Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000185964	17	33428331	17	35101312	185964	184814	rs536544621	NC_000017.11:35101311:G:A	single nucleotide variant	non-coding transcript variant|synonymous variant	Benign/Likely benign	Feb 24, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.791T>C (p.Leu264Pro)	RAD51D|RAD51L3-RFFL	L264P, L152P, L284P	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000630555	17	33428332	17	35101313	630555	618524	rs1567724947	NC_000017.11:35101312:A:G	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Jan 23, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.790C>A (p.Leu264Ile)	RAD51D|RAD51L3-RFFL	L152I, L284I, L264I	Hereditary cancer-predisposing syndrome	VCV003429746	17	33428333	17	35101314	3429746	3585757		NC_000017.11:35101313:G:T	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Jul 31, 2024	criteria provided, single submitter							
NM_002878.4(RAD51D):c.790C>T (p.Leu264Phe)	RAD51L3-RFFL|RAD51D	L152F, L264F, L284F	Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV000854491	17	33428333	17	35101314	854491	845213	rs2091534659	NC_000017.11:35101313:G:A	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Feb 23, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.789C>T (p.Ala263=)	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4|not specified|Hereditary cancer-predisposing syndrome	VCV000512022	17	33428334	17	35101315	512022	506017	rs1555567153	NC_000017.11:35101314:G:A	single nucleotide variant	non-coding transcript variant|synonymous variant	Likely benign	Oct 19, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.788C>T (p.Ala263Val)	RAD51D|RAD51L3-RFFL	A263V, A151V, A283V	Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV000662647	17	33428335	17	35101316	662647	645797	rs1269011999	NC_000017.11:35101315:G:A	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Oct 18, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.787G>A (p.Ala263Thr)	RAD51L3-RFFL|RAD51D	A263T, A151T, A283T	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000923498	17	33428336	17	35101317	923498	913825	rs1555567161	NC_000017.11:35101316:C:T	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Aug 23, 2023	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.787G>T (p.Ala263Ser)	RAD51L3-RFFL|RAD51D	A263S, A151S, A283S	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000492445	17	33428336	17	35101317	492445	485208	rs1555567161	NC_000017.11:35101316:C:A	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Dec 5, 2023	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.786T>G (p.Pro262=)	RAD51L3-RFFL|RAD51D		Breast-ovarian cancer, familial, susceptibility to, 4	VCV002844705	17	33428337	17	35101318	2844705	3004506	rs771631684	NC_000017.11:35101317:A:C	single nucleotide variant	non-coding transcript variant|synonymous variant	Benign/Likely benign	Feb 24, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.786T>C (p.Pro262=)	RAD51D|RAD51L3-RFFL		not specified|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000186708	17	33428337	17	35101318	186708	184815	rs771631684	NC_000017.11:35101317:A:G	single nucleotide variant	non-coding transcript variant|synonymous variant	Benign/Likely benign	Feb 24, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.785C>T (p.Pro262Leu)	RAD51L3-RFFL|RAD51D	P262L, P282L, P150L	Breast-ovarian cancer, familial, susceptibility to, 4|not provided|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000182863	17	33428338	17	35101319	182863	180795	rs730881950	NC_000017.11:35101318:G:A	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Jan 19, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.784C>T (p.Pro262Ser)	RAD51D|RAD51L3-RFFL	P150S, P262S, P282S	Breast-ovarian cancer, familial, susceptibility to, 4	VCV001062133	17	33428339	17	35101320	1062133	1050198	rs1340405420	NC_000017.11:35101319:G:A	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Oct 20, 2020	criteria provided, single submitter							
NM_002878.4(RAD51D):c.784C>A (p.Pro262Thr)	RAD51L3-RFFL|RAD51D	P262T, P150T, P282T	not provided|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000492444	17	33428339	17	35101320	492444	484959	rs1340405420	NC_000017.11:35101319:G:T	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	May 22, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.782A>G (p.Lys261Arg)	RAD51D|RAD51L3-RFFL	K149R, K261R, K281R	Breast-ovarian cancer, familial, susceptibility to, 4	VCV001425786	17	33428341	17	35101322	1425786	1428160	rs1060502964	NC_000017.11:35101321:T:C	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Sep 29, 2023	criteria provided, single submitter							
NM_002878.4(RAD51D):c.782A>C (p.Lys261Thr)	RAD51D|RAD51L3-RFFL	K261T, K281T, K149T	Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV000410569	17	33428341	17	35101322	410569	402394	rs1060502964	NC_000017.11:35101321:T:G	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Mar 15, 2023	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.781A>G (p.Lys261Glu)	RAD51D|RAD51L3-RFFL	K149E, K261E, K281E	Hereditary cancer-predisposing syndrome	VCV003942388	17	33428342	17	35101323	3942388	4064167		NC_000017.11:35101322:T:C	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	May 8, 2025	criteria provided, single submitter							
NM_002878.4(RAD51D):c.780C>T (p.Leu260=)	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV000827271	17	33428343	17	35101324	827271	813551	rs772985579	NC_000017.11:35101323:G:A	single nucleotide variant	non-coding transcript variant|synonymous variant	Likely benign	Oct 14, 2023	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.780C>A (p.Leu260=)	RAD51L3-RFFL|RAD51D		Hereditary cancer-predisposing syndrome	VCV000482201	17	33428343	17	35101324	482201	479149	rs772985579	NC_000017.11:35101323:G:T	single nucleotide variant	non-coding transcript variant|synonymous variant	Likely benign	Mar 9, 2017	criteria provided, single submitter							
NM_002878.4(RAD51D):c.779T>C (p.Leu260Pro)	RAD51D|RAD51L3-RFFL	L148P, L260P, L280P	Breast-ovarian cancer, familial, susceptibility to, 4	VCV002122969	17	33428344	17	35101325	2122969	2180863	rs2142412140	NC_000017.11:35101324:A:G	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Apr 8, 2022	criteria provided, single submitter							
NM_002878.4(RAD51D):c.778C>G (p.Leu260Val)	RAD51D|RAD51L3-RFFL	L260V, L148V, L280V	Hereditary cancer-predisposing syndrome	VCV002774203	17	33428345	17	35101326	2774203	2934933	rs2142412146	NC_000017.11:35101325:G:C	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Mar 7, 2024	criteria provided, single submitter							
NM_002878.4(RAD51D):c.778C>T (p.Leu260Phe)	RAD51D|RAD51L3-RFFL	L260F, L280F, L148F	Breast-ovarian cancer, familial, susceptibility to, 4	VCV002700987	17	33428345	17	35101326	2700987	2865827	rs2142412146	NC_000017.11:35101325:G:A	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Dec 5, 2023	criteria provided, single submitter							
NM_002878.4(RAD51D):c.777G>T (p.Arg259Ser)	RAD51D|RAD51L3-RFFL	R279S, R147S, R259S	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV002625295	17	33428346	17	35101327	2625295	2787278	rs746648511	NC_000017.11:35101326:C:A	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Apr 18, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.776G>A (p.Arg259Lys)	RAD51D|RAD51L3-RFFL	R259K, R279K, R147K	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000641158	17	33428347	17	35101328	641158	645798	rs771473156	NC_000017.11:35101327:C:T	single nucleotide variant	non-coding transcript variant|missense variant	Conflicting classifications of pathogenicity	Oct 18, 2024	criteria provided, conflicting classifications							
NM_002878.4(RAD51D):c.775A>T (p.Arg259Trp)	RAD51L3-RFFL|RAD51D	R147W, R259W, R279W	Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV001760481	17	33428348	17	35101329	1760481	1819909	rs2142412187	NC_000017.11:35101328:T:A	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Jun 24, 2023	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.774G>A (p.Gly258=)	RAD51D|RAD51L3-RFFL		Hereditary cancer-predisposing syndrome	VCV000918257	17	33428349	17	35101330	918257	913826	rs1597856114	NC_000017.11:35101329:C:T	single nucleotide variant	non-coding transcript variant|synonymous variant	Likely benign	Oct 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.774G>C (p.Gly258=)	RAD51D|RAD51L3-RFFL		Hereditary cancer-predisposing syndrome	VCV000827240	17	33428349	17	35101330	827240	813552	rs1597856114	NC_000017.11:35101329:C:G	single nucleotide variant	non-coding transcript variant|synonymous variant	Likely benign	Nov 27, 2019	criteria provided, single submitter							
NM_002878.4(RAD51D):c.773G>A (p.Gly258Glu)	RAD51L3-RFFL|RAD51D	G258E, G146E, G278E	Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV000484780	17	33428350	17	35101331	484780	478589	rs777103576	NC_000017.11:35101330:C:T	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Mar 9, 2021	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.772G>C (p.Gly258Arg)	RAD51D|RAD51L3-RFFL	G146R, G258R, G278R	Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV001475403	17	33428351	17	35101332	1475403	1404312	rs181695922	NC_000017.11:35101331:C:G	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	May 4, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.772G>T (p.Gly258Trp)	RAD51D|RAD51L3-RFFL	G278W, G146W, G258W	Hereditary cancer-predisposing syndrome	VCV000827227	17	33428351	17	35101332	827227	813553	rs181695922	NC_000017.11:35101331:C:A	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	May 29, 2019	criteria provided, single submitter							
NM_002878.4(RAD51D):c.772G>A (p.Gly258Arg)	RAD51D|RAD51L3-RFFL	G258R, G278R, G146R	Familial ovarian cancer|Breast-ovarian cancer, familial, susceptibility to, 4|not provided|Hereditary cancer-predisposing syndrome	VCV000186803	17	33428351	17	35101332	186803	184816	rs181695922	NC_000017.11:35101331:C:T	single nucleotide variant	non-coding transcript variant|missense variant	Conflicting classifications of pathogenicity	Mar 25, 2025	criteria provided, conflicting classifications							
NM_002878.4(RAD51D):c.771C>A (p.Ser257Arg)	RAD51D|RAD51L3-RFFL	S257R, S145R, S277R	Breast-ovarian cancer, familial, susceptibility to, 4	VCV002918411	17	33428352	17	35101333	2918411	3080531	rs146212490	NC_000017.11:35101332:G:T	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Jan 6, 2023	criteria provided, single submitter							
NM_002878.4(RAD51D):c.771C>T (p.Ser257=)	RAD51D|RAD51L3-RFFL		not specified|not provided|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000138875	17	33428352	17	35101333	138875	142578	rs146212490	NC_000017.11:35101332:G:A	single nucleotide variant	non-coding transcript variant|synonymous variant	Benign/Likely benign	Jan 30, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.770G>A (p.Ser257Asn)	RAD51D|RAD51L3-RFFL	S145N, S257N, S277N	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000998561	17	33428353	17	35101334	998561	997497	rs2091535410	NC_000017.11:35101333:C:T	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Apr 19, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.769A>G (p.Ser257Gly)	RAD51D|RAD51L3-RFFL	S257G, S145G, S277G	Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome|not specified	VCV000628572	17	33428354	17	35101335	628572	618525	rs1567724999	NC_000017.11:35101334:T:C	single nucleotide variant	non-coding transcript variant|missense variant	Conflicting classifications of pathogenicity	Mar 28, 2024	criteria provided, conflicting classifications							
NM_002878.4(RAD51D):c.768C>G (p.Asp256Glu)	RAD51D|RAD51L3-RFFL	D256E, D144E, D276E	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000630039	17	33428355	17	35101336	630039	618526	rs569428131	NC_000017.11:35101335:G:C	single nucleotide variant	non-coding transcript variant|missense variant	Conflicting classifications of pathogenicity	Apr 8, 2024	criteria provided, conflicting classifications							
NM_002878.4(RAD51D):c.768C>T (p.Asp256=)	RAD51D|RAD51L3-RFFL		Hereditary cancer-predisposing syndrome|not specified|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000378463	17	33428355	17	35101336	378463	378118	rs569428131	NC_000017.11:35101335:G:A	single nucleotide variant	non-coding transcript variant|synonymous variant	Benign/Likely benign	Feb 24, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.767A>T (p.Asp256Val)	RAD51L3-RFFL|RAD51D	D144V, D256V, D276V	Breast-ovarian cancer, familial, susceptibility to, 4	VCV001043726	17	33428356	17	35101337	1043726	1033225	rs371350110	NC_000017.11:35101336:T:A	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Jun 22, 2021	criteria provided, single submitter							
NM_002878.4(RAD51D):c.767A>C (p.Asp256Ala)	RAD51D|RAD51L3-RFFL	D256A, D144A, D276A	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4|not provided	VCV000246302	17	33428356	17	35101337	246302	245015	rs371350110	NC_000017.11:35101336:T:G	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Jun 12, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.766G>T (p.Asp256Tyr)	RAD51D|RAD51L3-RFFL	D144Y, D256Y, D276Y	not provided|Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV001313516	17	33428357	17	35101338	1313516	1303777	rs1567725026	NC_000017.11:35101337:C:A	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Mar 7, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.766G>C (p.Asp256His)	RAD51D|RAD51L3-RFFL	D256H, D276H, D144H	Breast and/or ovarian cancer|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000628228	17	33428357	17	35101338	628228	618527	rs1567725026	NC_000017.11:35101337:C:G	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Sep 12, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.765G>A (p.Arg255=)	RAD51L3-RFFL|RAD51D		Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|not specified|Breast-ovarian cancer, familial, susceptibility to, 4|not provided	VCV000239403	17	33428358	17	35101339	239403	242722	rs751833940	NC_000017.11:35101338:C:T	single nucleotide variant	non-coding transcript variant|synonymous variant	Benign/Likely benign	Feb 24, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.764G>A (p.Arg255Lys)	RAD51D|RAD51L3-RFFL	R255K, R143K, R275K	Hereditary cancer-predisposing syndrome|not provided|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000482193	17	33428359	17	35101340	482193	479153	rs1056851142	NC_000017.11:35101339:C:T	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Oct 1, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.763A>G (p.Arg255Gly)	RAD51D|RAD51L3-RFFL	R255G, R275G, R143G	Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV000410553	17	33428360	17	35101341	410553	402570	rs1060502953	NC_000017.11:35101340:T:C	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Apr 12, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.762C>G (p.Asp254Glu)	RAD51D|RAD51L3-RFFL	D254E, D142E, D274E	Breast-ovarian cancer, familial, susceptibility to, 4	VCV003665856	17	33428361	17	35101342	3665856	3795729		NC_000017.11:35101341:G:C	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Nov 27, 2024	criteria provided, single submitter							
NM_002878.4(RAD51D):c.762C>A (p.Asp254Glu)	RAD51D|RAD51L3-RFFL	D142E, D274E, D254E	Hereditary cancer-predisposing syndrome	VCV001759873	17	33428361	17	35101342	1759873	1813474	rs2142412351	NC_000017.11:35101341:G:T	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Mar 23, 2021	criteria provided, single submitter							
NM_002878.4(RAD51D):c.762C>T (p.Asp254=)	RAD51D|RAD51L3-RFFL		Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV001171033	17	33428361	17	35101342	1171033	1161343	rs2142412351	NC_000017.11:35101341:G:A	single nucleotide variant	non-coding transcript variant|synonymous variant	Benign/Likely benign	Feb 24, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.761A>G (p.Asp254Gly)	RAD51D|RAD51L3-RFFL	D142G, D254G, D274G	Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV001717033	17	33428362	17	35101343	1717033	1775858	rs1555567178	NC_000017.11:35101342:T:C	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Aug 11, 2023	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.761A>T (p.Asp254Val)	RAD51L3-RFFL|RAD51D	D254V, D274V, D142V	Hereditary cancer-predisposing syndrome	VCV000490145	17	33428362	17	35101343	490145	482973	rs1555567178	NC_000017.11:35101342:T:A	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Dec 5, 2023	criteria provided, single submitter							
NM_002878.4(RAD51D):c.760G>A (p.Asp254Asn)	RAD51D|RAD51L3-RFFL	D142N, D254N, D274N	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000648365	17	33428363	17	35101344	648365	645800	rs757446541	NC_000017.11:35101343:C:T	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Jul 2, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.759A>G (p.Arg253=)	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV003904632	17	33428364	17	35101345	3904632	4020504		NC_000017.11:35101344:T:C	single nucleotide variant	non-coding transcript variant|synonymous variant	Benign	Feb 24, 2025	criteria provided, single submitter							
NM_002878.4(RAD51D):c.759A>C (p.Arg253=)	RAD51D|RAD51L3-RFFL		Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000492443	17	33428364	17	35101345	492443	484963	rs1555567179	NC_000017.11:35101344:T:G	single nucleotide variant	non-coding transcript variant|synonymous variant	Likely benign	Apr 23, 2021	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.758G>T (p.Arg253Leu)	RAD51D|RAD51L3-RFFL	R273L, R253L, R141L	Breast-ovarian cancer, familial, susceptibility to, 4	VCV002103120	17	33428365	17	35101346	2103120	2158424	rs1060502963	NC_000017.11:35101345:C:A	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	May 17, 2023	criteria provided, single submitter							
NM_002878.4(RAD51D):c.758G>A (p.Arg253Gln)	RAD51D|RAD51L3-RFFL	R253Q, R141Q, R273Q	Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome|not provided|not specified	VCV000410568	17	33428365	17	35101346	410568	401865	rs1060502963	NC_000017.11:35101345:C:T	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Mar 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.757C>G (p.Arg253Gly)	RAD51D|RAD51L3-RFFL	R253G, R141G, R273G	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000484783	17	33428366	17	35101347	484783	478463	rs137886232	NC_000017.11:35101346:G:C	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Mar 27, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.757C>A (p.Arg253=)	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4|not provided|Breast and/or ovarian cancer|Hereditary cancer-predisposing syndrome	VCV000184337	17	33428366	17	35101347	184337	184817	rs137886232	NC_000017.11:35101346:G:T	single nucleotide variant	non-coding transcript variant|synonymous variant	Benign/Likely benign	Jan 28, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.757C>T (p.Arg253Ter)	RAD51D|RAD51L3-RFFL	R253*, R273*, R141*	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|not provided|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000030288	17	33428366	17	35101347	30288	39244	rs137886232	NC_000017.11:35101346:G:A	single nucleotide variant	non-coding transcript variant|nonsense	Pathogenic	Jan 16, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.756T>C (p.Thr252=)	RAD51L3-RFFL|RAD51D		Breast-ovarian cancer, familial, susceptibility to, 4	VCV003903906	17	33428367	17	35101348	3903906	4019779		NC_000017.11:35101347:A:G	single nucleotide variant	non-coding transcript variant|synonymous variant	Benign	Feb 24, 2025	criteria provided, single submitter							
NM_002878.4(RAD51D):c.755C>T (p.Thr252Ile)	RAD51D|RAD51L3-RFFL	T140I, T252I, T272I	not provided|Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV000658955	17	33428368	17	35101349	658955	645801	rs1467844944	NC_000017.11:35101348:G:A	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	May 22, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.754A>C (p.Thr252Pro)	RAD51D|RAD51L3-RFFL	T272P, T140P, T252P	Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000949331	17	33428369	17	35101350	949331	928222	rs1173524549	NC_000017.11:35101349:T:G	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Feb 17, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.752T>G (p.Ile251Arg)	RAD51D|RAD51L3-RFFL	I251R, I139R, I271R	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4|not provided	VCV000482192	17	33428371	17	35101352	482192	478466	rs778847822	NC_000017.11:35101351:A:C	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Jun 28, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.752T>A (p.Ile251Lys)	RAD51D|RAD51L3-RFFL	I251K, I139K, I271K	not provided|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000418446	17	33428371	17	35101352	418446	409893	rs778847822	NC_000017.11:35101351:A:T	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Jan 29, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.751A>G (p.Ile251Val)	RAD51L3-RFFL|RAD51D	I251V, I139V, I271V	Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome|not provided	VCV000141300	17	33428372	17	35101353	141300	151014	rs540273429	NC_000017.11:35101352:T:C	single nucleotide variant	non-coding transcript variant|missense variant	Conflicting classifications of pathogenicity	Feb 3, 2025	criteria provided, conflicting classifications							
NM_002878.4(RAD51D):c.750C>T (p.His250=)	RAD51D|RAD51L3-RFFL		Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV001612571	17	33428373	17	35101354	1612571	1601654	rs1300633211	NC_000017.11:35101353:G:A	single nucleotide variant	non-coding transcript variant|synonymous variant	Benign/Likely benign	Feb 24, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.748C>G (p.His250Asp)	RAD51D|RAD51L3-RFFL	H270D, H138D, H250D	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4|Neoplasm	VCV001759141	17	33428375	17	35101356	1759141	1816048	rs1400104355	NC_000017.11:35101355:G:C	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Feb 23, 2023	criteria provided, multiple submitters, no conflicts				Uncertain significance	Mar 4, 2025	criteria provided, single submitter	
NM_002878.4(RAD51D):c.748C>A (p.His250Asn)	RAD51L3-RFFL|RAD51D	H250N, H270N, H138N	Hereditary cancer-predisposing syndrome	VCV000630738	17	33428375	17	35101356	630738	618528	rs1400104355	NC_000017.11:35101355:G:T	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Dec 5, 2023	criteria provided, single submitter							
NM_002878.4(RAD51D):c.746A>G (p.Asn249Ser)	RAD51D|RAD51L3-RFFL	N249S, N269S, N137S	Breast-ovarian cancer, familial, susceptibility to, 4	VCV000963521	17	33428377	17	35101358	963521	949875	rs2091536171	NC_000017.11:35101357:T:C	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Jul 25, 2023	criteria provided, single submitter							
NM_002878.4(RAD51D):c.745A>C (p.Asn249His)	RAD51D|RAD51L3-RFFL	N137H, N249H, N269H	not provided	VCV003369811	17	33428378	17	35101359	3369811	3529002		NC_000017.11:35101358:T:G	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Mar 5, 2024	criteria provided, single submitter							
NM_002878.4(RAD51D):c.745A>G (p.Asn249Asp)	RAD51D|RAD51L3-RFFL	N249D, N137D, N269D	not provided|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000182862	17	33428378	17	35101359	182862	180796	rs730881949	NC_000017.11:35101358:T:C	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Mar 25, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.741G>A (p.Val247=)	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV001758830	17	33428382	17	35101363	1758830	1819541	rs757986080	NC_000017.11:35101362:C:T	single nucleotide variant	non-coding transcript variant|synonymous variant	Benign/Likely benign	Feb 24, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.741G>C (p.Val247=)	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV000920412	17	33428382	17	35101363	920412	913827	rs757986080	NC_000017.11:35101362:C:G	single nucleotide variant	non-coding transcript variant|synonymous variant	Benign/Likely benign	Feb 24, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.740T>C (p.Val247Ala)	RAD51D|RAD51L3-RFFL	V247A, V267A, V135A	Hereditary cancer-predisposing syndrome	VCV002625297	17	33428383	17	35101364	2625297	2787280	rs2142412589	NC_000017.11:35101363:A:G	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Jul 26, 2023	criteria provided, single submitter							
NM_002878.4(RAD51D):c.739G>A (p.Val247Met)	RAD51D|RAD51L3-RFFL	V135M, V267M, V247M	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000846591	17	33428384	17	35101365	846591	845214	rs1060502952	NC_000017.11:35101364:C:T	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Apr 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.739G>T (p.Val247Leu)	RAD51L3-RFFL|RAD51D	V247L, V135L, V267L	Hereditary cancer-predisposing syndrome	VCV000629589	17	33428384	17	35101365	629589	618529	rs1060502952	NC_000017.11:35101364:C:A	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Aug 10, 2023	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.739G>C (p.Val247Leu)	RAD51D|RAD51L3-RFFL	V247L, V135L, V267L	Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV000410547	17	33428384	17	35101365	410547	402572	rs1060502952	NC_000017.11:35101364:C:G	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Nov 3, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.739-1G>C	RAD51D|RAD51L3-RFFL		Hereditary cancer-predisposing syndrome	VCV000919697	17	33428385	17	35101366	919697	916432	rs1555567202	NC_000017.11:35101365:C:G	single nucleotide variant	splice acceptor variant	Likely pathogenic	Oct 20, 2021	criteria provided, single submitter							
NM_002878.4(RAD51D):c.739-1G>A	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome|not provided	VCV000480532	17	33428385	17	35101366	480532	478590	rs1555567202	NC_000017.11:35101365:C:T	single nucleotide variant	splice acceptor variant	Likely pathogenic	Dec 6, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.739-2A>T	RAD51D|RAD51L3-RFFL		Hereditary cancer-predisposing syndrome	VCV000827013	17	33428386	17	35101367	827013	815673	rs1597856297	NC_000017.11:35101366:T:A	single nucleotide variant	splice acceptor variant	Likely pathogenic	Oct 23, 2019	criteria provided, single submitter							
NM_002878.4(RAD51D):c.739-3C>G	RAD51L3-RFFL|RAD51D		Hereditary cancer-predisposing syndrome	VCV003312401	17	33428387	17	35101368	3312401	3461943		NC_000017.11:35101367:G:C	single nucleotide variant	intron variant	Uncertain significance	Apr 15, 2024	criteria provided, single submitter							
NM_002878.4(RAD51D):c.739-3C>T	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4|RAD51D-related cancer predisposition|Hereditary cancer-predisposing syndrome	VCV000484774	17	33428387	17	35101368	484774	478468	rs1235042092	NC_000017.11:35101367:G:A	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Oct 7, 2024	criteria provided, conflicting classifications							
NM_002878.4(RAD51D):c.739-4G>A	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV000747686	17	33428388	17	35101369	747686	760544	rs1555567205	NC_000017.11:35101368:C:T	single nucleotide variant	intron variant	Likely benign	Feb 14, 2018	criteria provided, single submitter							
NM_002878.4(RAD51D):c.739-4G>T	RAD51D|RAD51L3-RFFL		not specified|Hereditary cancer-predisposing syndrome	VCV000513067	17	33428388	17	35101369	513067	506260	rs1555567205	NC_000017.11:35101368:C:A	single nucleotide variant	intron variant	Likely benign	Sep 10, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.739-5T>C	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV000772503	17	33428389	17	35101370	772503	778376	rs777400873	NC_000017.11:35101369:A:G	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Feb 24, 2025	criteria provided, conflicting classifications							
NM_002878.4(RAD51D):c.739-6C>T	RAD51L3-RFFL|RAD51D		Breast-ovarian cancer, familial, susceptibility to, 4	VCV000741724	17	33428390	17	35101371	741724	760402	rs374512855	NC_000017.11:35101370:G:A	single nucleotide variant	intron variant	Likely benign	Feb 24, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.739-7G>A	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV001130548	17	33428391	17	35101372	1130548	1126145	rs2142412675	NC_000017.11:35101371:C:T	single nucleotide variant	intron variant	Likely benign	Apr 23, 2019	criteria provided, single submitter							
NM_002878.4(RAD51D):c.739-7G>C	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV001126129	17	33428391	17	35101372	1126129	1126144	rs2142412675	NC_000017.11:35101371:C:G	single nucleotide variant	intron variant	Likely benign	Mar 14, 2020	criteria provided, single submitter							
NM_002878.4(RAD51D):c.739-9C>T	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV003904053	17	33428393	17	35101374	3904053	4019926		NC_000017.11:35101373:G:A	single nucleotide variant	intron variant	Likely benign	Feb 24, 2025	criteria provided, single submitter							
NM_002878.4(RAD51D):c.739-10T>C	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome|not provided	VCV000371977	17	33428394	17	35101375	371977	358919	rs199998187	NC_000017.11:35101374:A:G	single nucleotide variant	intron variant	Benign/Likely benign	Jan 1, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.739-11T>G	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV002830889	17	33428395	17	35101376	2830889	2994534	rs2509125341	NC_000017.11:35101375:A:C	single nucleotide variant	intron variant	Likely benign	Jan 22, 2023	criteria provided, single submitter							
NM_002878.4(RAD51D):c.739-12T>C	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV002805343	17	33428396	17	35101377	2805343	2963869	rs2142412703	NC_000017.11:35101376:A:G	single nucleotide variant	intron variant	Uncertain significance	Feb 23, 2023	criteria provided, single submitter							
NM_002878.4(RAD51D):c.739-14T>C	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV001531428	17	33428398	17	35101379	1531428	1604846	rs2142412715	NC_000017.11:35101378:A:G	single nucleotide variant	intron variant	Likely benign	Feb 24, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.739-16T>C	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV003690234	17	33428400	17	35101381	3690234	3820532		NC_000017.11:35101380:A:G	single nucleotide variant	intron variant	Likely benign	Jul 2, 2024	criteria provided, single submitter							
NM_002878.4(RAD51D):c.739-17G>C	RAD51L3-RFFL|RAD51D		Breast-ovarian cancer, familial, susceptibility to, 4	VCV003904180	17	33428401	17	35101382	3904180	4020053		NC_000017.11:35101381:C:G	single nucleotide variant	intron variant	Likely benign	Feb 24, 2025	criteria provided, single submitter							
NM_002878.4(RAD51D):c.739-17G>A	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV003904063	17	33428401	17	35101382	3904063	4019936		NC_000017.11:35101381:C:T	single nucleotide variant	intron variant	Likely benign	Feb 24, 2025	criteria provided, single submitter							
NM_002878.4(RAD51D):c.739-17G>T	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV000631270	17	33428401	17	35101382	631270	619570	rs1567725135	NC_000017.11:35101381:C:A	single nucleotide variant	intron variant	Likely benign	Feb 24, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.739-18A>C	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV003903775	17	33428402	17	35101383	3903775	4019648		NC_000017.11:35101382:T:G	single nucleotide variant	intron variant	Likely benign	Feb 24, 2025	criteria provided, single submitter							
NM_002878.4(RAD51D):c.739-18A>G	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV002678193	17	33428402	17	35101383	2678193	2833216	rs2142412744	NC_000017.11:35101382:T:C	single nucleotide variant	intron variant	Uncertain significance	Mar 10, 2022	criteria provided, single submitter							
NM_002878.4(RAD51D):c.739-19A>G	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV002845571	17	33428403	17	35101384	2845571	3011770	rs746701739	NC_000017.11:35101383:T:C	single nucleotide variant	intron variant	Likely benign	Feb 24, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.739-35A>G	RAD51D|RAD51L3-RFFL		not specified	VCV003256338	17	33428419	17	35101400	3256338	3415100		NC_000017.11:35101399:T:C	single nucleotide variant	intron variant	Likely benign	Mar 4, 2025	criteria provided, single submitter							
NM_002878.4(RAD51D):c.739-103T>C	RAD51D|RAD51L3-RFFL		not provided	VCV001269566	17	33428487	17	35101468	1269566	1259425	rs28363289	NC_000017.11:35101467:A:G	single nucleotide variant	intron variant	Benign	Jun 23, 2018	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.739-235G>A	RAD51D|RAD51L3-RFFL		not provided	VCV001183185	17	33428619	17	35101600	1183185	1172982	rs28363288	NC_000017.11:35101599:C:T	single nucleotide variant	intron variant	Likely benign	Jan 10, 2019	criteria provided, single submitter							
NM_002878.4(RAD51D):c.738+131G>T	RAD51D|RAD51L3-RFFL		not provided	VCV000676528	17	33430142	17	35103123	676528	669238	rs28363285	NC_000017.11:35103122:C:A	single nucleotide variant	intron variant	Benign	Jun 16, 2018	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.738+29T>G	RAD51D|RAD51L3-RFFL		not specified	VCV003256339	17	33430244	17	35103225	3256339	3415101		NC_000017.11:35103224:A:C	single nucleotide variant	intron variant	Likely benign	Mar 4, 2025	criteria provided, single submitter							
NM_002878.4(RAD51D):c.738+20C>A	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV002195504	17	33430253	17	35103234	2195504	1926394	rs2142417802	NC_000017.11:35103233:G:T	single nucleotide variant	intron variant	Likely benign	Feb 4, 2023	criteria provided, single submitter							
NM_002878.4(RAD51D):c.738+20C>T	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV001671099	17	33430253	17	35103234	1671099	1529989	rs2142417802	NC_000017.11:35103233:G:A	single nucleotide variant	intron variant	Likely benign	Jul 14, 2021	criteria provided, single submitter							
NM_002878.4(RAD51D):c.738+18G>T	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV001645844	17	33430255	17	35103236	1645844	1565448	rs957449574	NC_000017.11:35103235:C:A	single nucleotide variant	intron variant	Likely benign	Jan 30, 2025	criteria provided, single submitter							
NM_002878.4(RAD51D):c.738+17G>A	RAD51D|RAD51L3-RFFL		not specified|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000387038	17	33430256	17	35103237	387038	378123	rs753635983	NC_000017.11:35103236:C:T	single nucleotide variant	intron variant	Likely benign	Jul 10, 2023	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.738+15T>C	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV002096452	17	33430258	17	35103239	2096452	2146603	rs2142417843	NC_000017.11:35103238:A:G	single nucleotide variant	intron variant	Likely benign	Feb 20, 2023	criteria provided, single submitter							
NM_002878.4(RAD51D):c.738+14C>G	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV001480407	17	33430259	17	35103240	1480407	1432486	rs374761868	NC_000017.11:35103239:G:C	single nucleotide variant	intron variant	Likely benign	Nov 11, 2024	criteria provided, single submitter							
NM_002878.4(RAD51D):c.738+14C>T	RAD51D|RAD51L3-RFFL		Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000492442	17	33430259	17	35103240	492442	484968	rs374761868	NC_000017.11:35103239:G:A	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Jan 29, 2025	criteria provided, conflicting classifications							
NM_002878.4(RAD51D):c.738+13G>C	RAD51L3-RFFL|RAD51D		Breast-ovarian cancer, familial, susceptibility to, 4	VCV002107229	17	33430260	17	35103241	2107229	2170283	rs752733014	NC_000017.11:35103240:C:G	single nucleotide variant	intron variant	Likely benign	Mar 5, 2022	criteria provided, single submitter							
NM_002878.4(RAD51D):c.738+13G>A	RAD51L3-RFFL|RAD51D		Breast-ovarian cancer, familial, susceptibility to, 4	VCV001653410	17	33430260	17	35103241	1653410	1547983	rs752733014	NC_000017.11:35103240:C:T	single nucleotide variant	intron variant	Likely benign	Nov 5, 2024	criteria provided, single submitter							
NM_002878.4(RAD51D):c.738+13G>T	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome|not specified	VCV000383855	17	33430260	17	35103241	383855	378126	rs752733014	NC_000017.11:35103240:C:A	single nucleotide variant	intron variant	Likely benign	Dec 15, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.738+11A>G	RAD51L3-RFFL|RAD51D		not specified|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000492441	17	33430262	17	35103243	492441	484762	rs758241019	NC_000017.11:35103242:T:C	single nucleotide variant	intron variant	Likely benign	Nov 12, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.738+10C>G	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV002132473	17	33430263	17	35103244	2132473	2186474	rs777453585	NC_000017.11:35103243:G:C	single nucleotide variant	intron variant	Likely benign	May 1, 2022	criteria provided, single submitter							
NM_002878.4(RAD51D):c.738+10C>T	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV000949509	17	33430263	17	35103244	949509	941179	rs777453585	NC_000017.11:35103243:G:A	single nucleotide variant	intron variant	Likely benign	Feb 24, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.738+10C>A	RAD51L3-RFFL|RAD51D		not specified|Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV000472621	17	33430263	17	35103244	472621	467593	rs777453585	NC_000017.11:35103243:G:T	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Feb 24, 2025	criteria provided, conflicting classifications							
NM_002878.4(RAD51D):c.738+9G>A	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV003903753	17	33430264	17	35103245	3903753	4019626		NC_000017.11:35103244:C:T	single nucleotide variant	intron variant	Likely benign	Feb 24, 2025	criteria provided, single submitter							
NM_002878.4(RAD51D):c.738+9G>C	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV001545265	17	33430264	17	35103245	1545265	1644671	rs2091559543	NC_000017.11:35103244:C:G	single nucleotide variant	intron variant	Likely benign	Apr 1, 2021	criteria provided, single submitter							
NM_002878.4(RAD51D):c.738+9G>T	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV001103081	17	33430264	17	35103245	1103081	1104717	rs2091559543	NC_000017.11:35103244:C:A	single nucleotide variant	intron variant	Likely benign	Jun 20, 2022	criteria provided, single submitter							
NM_002878.4(RAD51D):c.738+4A>G	RAD51L3-RFFL|RAD51D		Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV000480880	17	33430269	17	35103250	480880	478421	rs78969643	NC_000017.11:35103249:T:C	single nucleotide variant	intron variant	Uncertain significance	Nov 1, 2023	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.738+3G>A	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4|not specified|Hereditary cancer-predisposing syndrome|RAD51D-related cancer predisposition	VCV000480529	17	33430270	17	35103251	480529	478425	rs751062153	NC_000017.11:35103250:C:T	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Feb 24, 2025	criteria provided, conflicting classifications							
NM_002878.4(RAD51D):c.738+2T>C	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV002861844	17	33430271	17	35103252	2861844	3029206	rs1597858201	NC_000017.11:35103251:A:G	single nucleotide variant	splice donor variant	Likely pathogenic	Jun 27, 2023	criteria provided, single submitter							
NM_002878.4(RAD51D):c.738+1G>T	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV002018478	17	33430272	17	35103253	2018478	1166233	rs1567726124	NC_000017.11:35103252:C:A	single nucleotide variant	splice donor variant	Likely pathogenic	Jan 5, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.738+1G>A	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4|not provided|Hereditary cancer-predisposing syndrome	VCV000580022	17	33430272	17	35103253	580022	571079	rs1567726124	NC_000017.11:35103252:C:T	single nucleotide variant	splice donor variant	Pathogenic/Likely pathogenic	Mar 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.738G>C (p.Val246=)	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV003021788	17	33430273	17	35103254	3021788	3183348	rs1210620444	NC_000017.11:35103253:C:G	single nucleotide variant	non-coding transcript variant|synonymous variant	Uncertain significance	Feb 15, 2024	criteria provided, single submitter							
NM_002878.4(RAD51D):c.738G>A (p.Val246=)	RAD51L3-RFFL|RAD51D		not provided|Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV000482200	17	33430273	17	35103254	482200	479161	rs1210620444	NC_000017.11:35103253:C:T	single nucleotide variant	non-coding transcript variant|synonymous variant	Conflicting classifications of pathogenicity	Jun 18, 2024	criteria provided, conflicting classifications							
NM_002878.4(RAD51D):c.736G>A (p.Val246Met)	RAD51D|RAD51L3-RFFL	V134M, V246M, V266M	not specified|Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV000826995	17	33430275	17	35103256	826995	813554	rs1597858213	NC_000017.11:35103255:C:T	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Dec 14, 2023	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.734T>C (p.Val245Ala)	RAD51L3-RFFL|RAD51D	V245A, V265A, V133A	Breast-ovarian cancer, familial, susceptibility to, 4|not specified|Hereditary cancer-predisposing syndrome	VCV000410556	17	33430277	17	35103258	410556	402578	rs1060502956	NC_000017.11:35103257:A:G	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Mar 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.733G>A (p.Val245Met)	RAD51D|RAD51L3-RFFL	V265M, V133M, V245M	Breast-ovarian cancer, familial, susceptibility to, 4	VCV002202605	17	33430278	17	35103259	2202605	1928255	rs1266969371	NC_000017.11:35103258:C:T	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Apr 5, 2022	criteria provided, single submitter							
NM_002878.4(RAD51D):c.730G>A (p.Ala244Thr)	RAD51D|RAD51L3-RFFL	A132T, A244T, A264T	Breast-ovarian cancer, familial, susceptibility to, 4	VCV002014247	17	33430281	17	35103262	2014247	2064460	rs1180904206	NC_000017.11:35103261:C:T	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Mar 21, 2024	criteria provided, single submitter							
NM_002878.4(RAD51D):c.727A>C (p.Met243Leu)	RAD51D|RAD51L3-RFFL	M243L, M131L, M263L	Breast-ovarian cancer, familial, susceptibility to, 4	VCV002815149	17	33430284	17	35103265	2815149	2969820	rs1381391199	NC_000017.11:35103264:T:G	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Nov 18, 2022	criteria provided, single submitter							
NM_002878.4(RAD51D):c.727A>G (p.Met243Val)	RAD51D|RAD51L3-RFFL	M243V, M263V, M131V	Hereditary cancer-predisposing syndrome	VCV001758045	17	33430284	17	35103265	1758045	1812926	rs1381391199	NC_000017.11:35103264:T:C	single nucleotide variant	non-coding transcript variant|missense variant	Likely benign	Mar 15, 2021	criteria provided, single submitter							
NM_002878.4(RAD51D):c.727A>T (p.Met243Leu)	RAD51D|RAD51L3-RFFL	M131L, M243L, M263L	Breast-ovarian cancer, familial, susceptibility to, 4	VCV000934414	17	33430284	17	35103265	934414	937887	rs1381391199	NC_000017.11:35103264:T:A	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	May 21, 2024	criteria provided, single submitter							
NM_002878.4(RAD51D):c.726C>T (p.Gly242=)	RAD51L3-RFFL|RAD51D		Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome|not provided	VCV000480527	17	33430285	17	35103266	480527	479165	rs1555567496	NC_000017.11:35103265:G:A	single nucleotide variant	non-coding transcript variant|synonymous variant	Conflicting classifications of pathogenicity	Nov 14, 2023	criteria provided, conflicting classifications							
NM_002878.4(RAD51D):c.725G>T (p.Gly242Val)	RAD51D|RAD51L3-RFFL	G242V, G262V, G130V	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000230770	17	33430286	17	35103267	230770	235870	rs876658760	NC_000017.11:35103266:C:A	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Jan 2, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.724G>A (p.Gly242Ser)	RAD51L3-RFFL|RAD51D	G242S, G130S, G262S	Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV000575578	17	33430287	17	35103268	575578	574437	rs1567726178	NC_000017.11:35103267:C:T	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Nov 1, 2023	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.723T>C (p.Leu241=)	RAD51D|RAD51L3-RFFL		Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV002817782	17	33430288	17	35103269	2817782	2987423	rs2142418208	NC_000017.11:35103268:A:G	single nucleotide variant	non-coding transcript variant|synonymous variant	Likely benign	Dec 1, 2022	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.722T>G (p.Leu241Arg)	RAD51D|RAD51L3-RFFL	L129R, L241R, L261R	Breast-ovarian cancer, familial, susceptibility to, 4	VCV000849020	17	33430289	17	35103270	849020	845215	rs2091560206	NC_000017.11:35103269:A:C	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	May 14, 2023	criteria provided, single submitter							
NM_002878.4(RAD51D):c.721C>G (p.Leu241Val)	RAD51D|RAD51L3-RFFL	L129V, L261V, L241V	Breast-ovarian cancer, familial, susceptibility to, 4	VCV001520593	17	33430290	17	35103271	1520593	1355952	rs2142418230	NC_000017.11:35103270:G:C	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Dec 31, 2023	criteria provided, single submitter							
NM_002878.4(RAD51D):c.720C>T (p.Asp240=)	RAD51L3-RFFL|RAD51D		Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV000492440	17	33430291	17	35103272	492440	484947	rs1555567499	NC_000017.11:35103271:G:A	single nucleotide variant	non-coding transcript variant|synonymous variant	Benign/Likely benign	Feb 24, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.718G>C (p.Asp240His)	RAD51D|RAD51L3-RFFL	D128H, D240H, D260H	Breast-ovarian cancer, familial, susceptibility to, 4	VCV001098876	17	33430293	17	35103274	1098876	1087621	rs2091560282	NC_000017.11:35103273:C:G	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	May 10, 2021	criteria provided, single submitter							
NM_002878.4(RAD51D):c.718G>A (p.Asp240Asn)	RAD51D|RAD51L3-RFFL	D260N, D240N, D128N	Hereditary cancer-predisposing syndrome	VCV000920700	17	33430293	17	35103274	920700	913828	rs2091560282	NC_000017.11:35103273:C:T	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Dec 5, 2023	criteria provided, single submitter							
NM_002878.4(RAD51D):c.717G>A (p.Arg239=)	RAD51D|RAD51L3-RFFL		Hereditary cancer-predisposing syndrome	VCV003429735	17	33430294	17	35103275	3429735	3585746		NC_000017.11:35103274:C:T	single nucleotide variant	non-coding transcript variant|synonymous variant	Likely benign	Oct 12, 2024	criteria provided, single submitter							
NM_002878.4(RAD51D):c.717G>T (p.Arg239=)	RAD51D|RAD51L3-RFFL		Hereditary cancer-predisposing syndrome	VCV001757529	17	33430294	17	35103275	1757529	1815727	rs2142418274	NC_000017.11:35103274:C:A	single nucleotide variant	non-coding transcript variant|synonymous variant	Likely benign	May 14, 2021	criteria provided, single submitter							
NM_002878.4(RAD51D):c.716G>C (p.Arg239Pro)	RAD51D|RAD51L3-RFFL	R259P, R127P, R239P	Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV001757474	17	33430295	17	35103276	1757474	1815672	rs780921112	NC_000017.11:35103275:C:G	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Jan 28, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.716G>T (p.Arg239Leu)	RAD51D|RAD51L3-RFFL	R127L, R239L, R259L	Breast-ovarian cancer, familial, susceptibility to, 4	VCV000953350	17	33430295	17	35103276	953350	949877	rs780921112	NC_000017.11:35103275:C:A	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Nov 11, 2019	criteria provided, single submitter							
NM_002878.4(RAD51D):c.716G>A (p.Arg239Gln)	RAD51D|RAD51L3-RFFL	R239Q, R259Q, R127Q	Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary breast ovarian cancer syndrome|not specified|Hereditary cancer-predisposing syndrome|not provided	VCV000229883	17	33430295	17	35103276	229883	235871	rs780921112	NC_000017.11:35103275:C:T	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Mar 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.715C>G (p.Arg239Gly)	RAD51D|RAD51L3-RFFL	R239G, R259G, R127G	not provided|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000472620	17	33430296	17	35103277	472620	467607	rs770250516	NC_000017.11:35103276:G:C	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Feb 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.715C>T (p.Arg239Trp)	RAD51L3-RFFL|RAD51D	R239W, R127W, R259W	Familial ovarian cancer|not provided|Hereditary cancer|Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV000187225	17	33430296	17	35103277	187225	184818	rs770250516	NC_000017.11:35103276:G:A	single nucleotide variant	non-coding transcript variant|missense variant	Conflicting classifications of pathogenicity	Apr 30, 2025	criteria provided, conflicting classifications							
NM_002878.4(RAD51D):c.714C>G (p.Ala238=)	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV003903759	17	33430297	17	35103278	3903759	4019632		NC_000017.11:35103277:G:C	single nucleotide variant	non-coding transcript variant|synonymous variant	Benign	Feb 24, 2025	criteria provided, single submitter							
NM_002878.4(RAD51D):c.714C>A (p.Ala238=)	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV001114003	17	33430297	17	35103278	1114003	1104718	rs780258990	NC_000017.11:35103277:G:T	single nucleotide variant	non-coding transcript variant|synonymous variant	Benign/Likely benign	Feb 24, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.714C>T (p.Ala238=)	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV000630040	17	33430297	17	35103278	630040	618530	rs780258990	NC_000017.11:35103277:G:A	single nucleotide variant	non-coding transcript variant|synonymous variant	Benign/Likely benign	Feb 24, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.713C>G (p.Ala238Gly)	RAD51D|RAD51L3-RFFL	A238G, A258G, A126G	Breast-ovarian cancer, familial, susceptibility to, 4	VCV000655410	17	33430298	17	35103279	655410	645803	rs1567726199	NC_000017.11:35103278:G:C	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Jul 19, 2022	criteria provided, single submitter							
NM_002878.4(RAD51D):c.713C>T (p.Ala238Val)	RAD51D|RAD51L3-RFFL	A238V, A126V, A258V	Breast-ovarian cancer, familial, susceptibility to, 4	VCV000567884	17	33430298	17	35103279	567884	571271	rs1567726199	NC_000017.11:35103278:G:A	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Jul 14, 2021	criteria provided, single submitter							
NM_002878.4(RAD51D):c.712G>A (p.Ala238Thr)	RAD51D|RAD51L3-RFFL	A238T, A258T, A126T	not provided|Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV000141910	17	33430299	17	35103280	141910	151624	rs587782104	NC_000017.11:35103279:C:T	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Dec 19, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.711G>A (p.Leu237=)	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV003904760	17	33430300	17	35103281	3904760	4020632		NC_000017.11:35103280:C:T	single nucleotide variant	non-coding transcript variant|synonymous variant	Benign	Feb 24, 2025	criteria provided, single submitter							
NM_002878.4(RAD51D):c.710T>C (p.Leu237Pro)	RAD51D|RAD51L3-RFFL	L125P, L257P, L237P	Breast-ovarian cancer, familial, susceptibility to, 4	VCV003664918	17	33430301	17	35103282	3664918	3802040		NC_000017.11:35103281:A:G	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Oct 9, 2024	criteria provided, single submitter							
NM_002878.4(RAD51D):c.709C>T (p.Leu237=)	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 3|Breast-ovarian cancer, familial, susceptibility to, 4	VCV001092560	17	33430302	17	35103283	1092560	1082926	rs1555567510	NC_000017.11:35103282:G:A	single nucleotide variant	non-coding transcript variant|synonymous variant	Likely benign	Aug 19, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.709C>G (p.Leu237Val)	RAD51D|RAD51L3-RFFL	L237V, L125V, L257V	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000631140	17	33430302	17	35103283	631140	618531	rs1555567510	NC_000017.11:35103282:G:C	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Jan 20, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.709C>A (p.Leu237Met)	RAD51L3-RFFL|RAD51D	L237M, L257M, L125M	Hereditary cancer-predisposing syndrome	VCV000482191	17	33430302	17	35103283	482191	478429	rs1555567510	NC_000017.11:35103282:G:T	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Apr 29, 2016	criteria provided, single submitter							
NM_002878.4(RAD51D):c.708C>T (p.Thr236=)	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4|not provided	VCV003026716	17	33430303	17	35103284	3026716	3187026	rs1393289643	NC_000017.11:35103283:G:A	single nucleotide variant	non-coding transcript variant|synonymous variant	Benign/Likely benign	Feb 24, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.707C>T (p.Thr236Ile)	RAD51D|RAD51L3-RFFL	T236I, T124I, T256I	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV002749663	17	33430304	17	35103285	2749663	2908260	rs2142418390	NC_000017.11:35103284:G:A	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Nov 13, 2023	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.707C>A (p.Thr236Asn)	RAD51L3-RFFL|RAD51D	T124N, T236N, T256N	Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV001757034	17	33430304	17	35103285	1757034	1819039	rs2142418390	NC_000017.11:35103284:G:T	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Jan 10, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.705G>A (p.Lys235=)	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV002723918	17	33430306	17	35103287	2723918	2881830	rs2142418419	NC_000017.11:35103286:C:T	single nucleotide variant	non-coding transcript variant|synonymous variant	Likely benign	Jun 22, 2023	criteria provided, single submitter							
NM_002878.4(RAD51D):c.705G>T (p.Lys235Asn)	RAD51D|RAD51L3-RFFL	K123N, K235N, K255N	Breast-ovarian cancer, familial, susceptibility to, 4	VCV001483803	17	33430306	17	35103287	1483803	1458587	rs2142418419	NC_000017.11:35103286:C:A	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Apr 18, 2021	criteria provided, single submitter							
NM_002878.4(RAD51D):c.704A>T (p.Lys235Met)	RAD51L3-RFFL|RAD51D	K235M, K123M, K255M	not provided|Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV000482194	17	33430307	17	35103288	482194	478591	rs1040279995	NC_000017.11:35103287:T:A	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Oct 22, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.702G>A (p.Leu234=)	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV003222888	17	33430309	17	35103290	3222888	3386526	rs901491798	NC_000017.11:35103289:C:T	single nucleotide variant	non-coding transcript variant|synonymous variant	Conflicting classifications of pathogenicity	Feb 24, 2025	criteria provided, conflicting classifications							
NM_002878.4(RAD51D):c.701T>C (p.Leu234Pro)	RAD51D|RAD51L3-RFFL	L122P, L234P, L254P	Breast-ovarian cancer, familial, susceptibility to, 4	VCV001013719	17	33430310	17	35103291	1013719	1012708	rs2091560784	NC_000017.11:35103290:A:G	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Sep 17, 2020	criteria provided, single submitter							
NM_002878.4(RAD51D):c.699G>C (p.Glu233Asp)	RAD51L3-RFFL|RAD51D	E233D, E253D, E121D	Hereditary cancer-predisposing syndrome	VCV003312405	17	33430312	17	35103293	3312405	3461947		NC_000017.11:35103292:C:G	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Apr 14, 2024	criteria provided, single submitter							
NM_002878.4(RAD51D):c.699G>A (p.Glu233=)	RAD51L3-RFFL|RAD51D		Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000492439	17	33430312	17	35103293	492439	484970	rs1555567518	NC_000017.11:35103292:C:T	single nucleotide variant	non-coding transcript variant|synonymous variant	Likely benign	Aug 24, 2023	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.698A>G (p.Glu233Gly)	RAD51D|RAD51L3-RFFL	E233G, E253G, E121G	not specified|not provided|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000138873	17	33430313	17	35103294	138873	142576	rs28363284	NC_000017.11:35103293:T:C	single nucleotide variant	non-coding transcript variant|missense variant	Benign/Likely benign	Mar 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.697G>A (p.Glu233Lys)	RAD51D|RAD51L3-RFFL	E121K, E233K, E253K	Breast-ovarian cancer, familial, susceptibility to, 4	VCV002910426	17	33430314	17	35103295	2910426	3072896	rs2142418505	NC_000017.11:35103294:C:T	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Jan 4, 2024	criteria provided, single submitter							
NM_002878.4(RAD51D):c.695G>T (p.Arg232Leu)	RAD51D|RAD51L3-RFFL	R232L, R252L, R120L	Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV000826728	17	33430316	17	35103297	826728	813556	rs28363283	NC_000017.11:35103296:C:A	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Oct 17, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.695G>C (p.Arg232Pro)	RAD51D|RAD51L3-RFFL	R232P, R252P, R120P	Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome|not provided	VCV000581983	17	33430316	17	35103297	581983	574439	rs28363283	NC_000017.11:35103296:C:G	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Aug 22, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.695G>A (p.Arg232Gln)	RAD51D|RAD51L3-RFFL	R232Q, R252Q, R120Q	Breast-ovarian cancer, familial, susceptibility to, 4|Breast and/or ovarian cancer|Hereditary cancer-predisposing syndrome|not provided|not specified	VCV000138872	17	33430316	17	35103297	138872	142575	rs28363283	NC_000017.11:35103296:C:T	single nucleotide variant	non-coding transcript variant|missense variant	Benign/Likely benign	Mar 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.694C>A (p.Arg232=)	RAD51L3-RFFL|RAD51D		Breast-ovarian cancer, familial, susceptibility to, 4	VCV000539867	17	33430317	17	35103298	539867	531089	rs587780104	NC_000017.11:35103297:G:T	single nucleotide variant	non-coding transcript variant|synonymous variant	Benign/Likely benign	Feb 24, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.694C>G (p.Arg232Gly)	RAD51D|RAD51L3-RFFL	R232G, R252G, R120G	Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV000484786	17	33430317	17	35103298	484786	478471	rs587780104	NC_000017.11:35103297:G:C	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Oct 13, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.694C>T (p.Arg232Ter)	RAD51L3-RFFL|RAD51D	R232*, R120*, R252*	not provided|Colorectal cancer|Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|Diffuse midline glioma, H3 K27-altered	VCV000127893	17	33430317	17	35103298	127893	133350	rs587780104	NC_000017.11:35103297:G:A	single nucleotide variant	nonsense|non-coding transcript variant	Pathogenic/Likely pathogenic	Jul 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.693C>T (p.Ala231=)	RAD51D|RAD51L3-RFFL		Hereditary cancer-predisposing syndrome	VCV001756237	17	33430318	17	35103299	1756237	1812415	rs1597858361	NC_000017.11:35103298:G:A	single nucleotide variant	non-coding transcript variant|synonymous variant	Likely benign	Aug 7, 2022	criteria provided, single submitter							
NM_002878.4(RAD51D):c.693C>G (p.Ala231=)	RAD51D|RAD51L3-RFFL		Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000826714	17	33430318	17	35103299	826714	813557	rs1597858361	NC_000017.11:35103298:G:C	single nucleotide variant	non-coding transcript variant|synonymous variant	Benign/Likely benign	Feb 24, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.692C>T (p.Ala231Val)	RAD51D|RAD51L3-RFFL	A119V, A251V, A231V	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV002839108	17	33430319	17	35103300	2839108	2996379	rs535851875	NC_000017.11:35103299:G:A	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Nov 1, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.692C>A (p.Ala231Asp)	RAD51D|RAD51L3-RFFL	A231D, A119D, A251D	Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV000628382	17	33430319	17	35103300	628382	618532	rs535851875	NC_000017.11:35103299:G:T	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	May 23, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.691G>T (p.Ala231Ser)	RAD51D|RAD51L3-RFFL	A231S, A251S, A119S	Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome|not provided	VCV000480531	17	33430320	17	35103301	480531	478474	rs772135704	NC_000017.11:35103300:C:A	single nucleotide variant	non-coding transcript variant|missense variant	Conflicting classifications of pathogenicity	Jan 14, 2025	criteria provided, conflicting classifications							
NM_002878.4(RAD51D):c.690G>A (p.Leu230=)	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV000486280	17	33430321	17	35103302	486280	478475	rs1555567526	NC_000017.11:35103301:C:T	single nucleotide variant	non-coding transcript variant|synonymous variant	Benign/Likely benign	Feb 24, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.687G>C (p.Gln229His)	RAD51D|RAD51L3-RFFL	Q229H, Q117H, Q249H	Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV000482187	17	33430324	17	35103305	482187	478592	rs1555567528	NC_000017.11:35103304:C:G	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Jul 23, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.686A>G (p.Gln229Arg)	RAD51D|RAD51L3-RFFL	Q117R, Q229R, Q249R	Hereditary cancer-predisposing syndrome	VCV001755872	17	33430325	17	35103306	1755872	1815367	rs2142418648	NC_000017.11:35103305:T:C	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Aug 9, 2022	criteria provided, single submitter							
NM_002878.4(RAD51D):c.685C>T (p.Gln229Ter)	RAD51D|RAD51L3-RFFL	Q229*, Q117*, Q249*	Breast-ovarian cancer, familial, susceptibility to, 4	VCV000539851	17	33430326	17	35103307	539851	530958	rs1555567529	NC_000017.11:35103306:G:A	single nucleotide variant	non-coding transcript variant|nonsense	Pathogenic	Jun 4, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.683T>G (p.Met228Arg)	RAD51D|RAD51L3-RFFL	M116R, M248R, M228R	Breast-ovarian cancer, familial, susceptibility to, 4	VCV002707007	17	33430328	17	35103309	2707007	2870580	rs2142418676	NC_000017.11:35103308:A:C	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Jan 2, 2024	criteria provided, single submitter							
NM_002878.4(RAD51D):c.683T>A (p.Met228Lys)	RAD51D|RAD51L3-RFFL	M116K, M248K, M228K	Hereditary cancer-predisposing syndrome	VCV002560406	17	33430328	17	35103309	2560406	2720578	rs2142418676	NC_000017.11:35103308:A:T	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Apr 7, 2023	criteria provided, single submitter							
NM_002878.4(RAD51D):c.683T>C (p.Met228Thr)	RAD51D|RAD51L3-RFFL	M116T, M248T, M228T	Breast-ovarian cancer, familial, susceptibility to, 4	VCV002198865	17	33430328	17	35103309	2198865	1930613	rs2142418676	NC_000017.11:35103308:A:G	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Jan 15, 2024	criteria provided, single submitter							
NM_002878.4(RAD51D):c.682A>G (p.Met228Val)	RAD51D|RAD51L3-RFFL	M116V, M228V, M248V	not specified|Hereditary cancer-predisposing syndrome	VCV002576266	17	33430329	17	35103310	2576266	2741162	rs1222420549	NC_000017.11:35103309:T:C	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Mar 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.681G>A (p.Met227Ile)	RAD51D|RAD51L3-RFFL	M115I, M227I, M247I	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000826642	17	33430330	17	35103311	826642	813558	rs1597858400	NC_000017.11:35103310:C:T	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Dec 5, 2023	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.680T>C (p.Met227Thr)	RAD51D|RAD51L3-RFFL	M227T, M115T, M247T	Hereditary cancer-predisposing syndrome|not provided|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000472619	17	33430331	17	35103312	472619	467805	rs773485482	NC_000017.11:35103311:A:G	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Dec 9, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.678G>C (p.Leu226Phe)	RAD51D|RAD51L3-RFFL	L246F, L114F, L226F	not provided|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV003018128	17	33430333	17	35103314	3018128	3182305	rs927883139	NC_000017.11:35103313:C:G	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	May 28, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.677T>C (p.Leu226Ser)	RAD51D|RAD51L3-RFFL	L226S, L246S, L114S	Hereditary cancer-predisposing syndrome	VCV003312397	17	33430334	17	35103315	3312397	3461939		NC_000017.11:35103314:A:G	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Mar 22, 2024	criteria provided, single submitter							
NM_002878.4(RAD51D):c.677T>G (p.Leu226Trp)	RAD51D|RAD51L3-RFFL	L114W, L246W, L226W	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000640026	17	33430334	17	35103315	640026	645804	rs1597858423	NC_000017.11:35103314:A:C	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Mar 6, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.676T>A (p.Leu226Met)	RAD51D|RAD51L3-RFFL	L114M, L246M, L226M	Hereditary cancer-predisposing syndrome	VCV001755352	17	33430335	17	35103316	1755352	1818642	rs1555567533	NC_000017.11:35103315:A:T	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Jun 21, 2019	criteria provided, single submitter							
NM_002878.4(RAD51D):c.676T>G (p.Leu226Val)	RAD51L3-RFFL|RAD51D	L226V, L114V, L246V	Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV000482185	17	33430335	17	35103316	482185	478478	rs1555567533	NC_000017.11:35103315:A:C	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	May 31, 2023	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.675C>A (p.Ala225=)	RAD51D|RAD51L3-RFFL		Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV001755273	17	33430336	17	35103317	1755273	1818563	rs760789270	NC_000017.11:35103316:G:T	single nucleotide variant	non-coding transcript variant|synonymous variant	Benign/Likely benign	Feb 24, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.675C>T (p.Ala225=)	RAD51D|RAD51L3-RFFL		Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000630961	17	33430336	17	35103317	630961	618533	rs760789270	NC_000017.11:35103316:G:A	single nucleotide variant	non-coding transcript variant|synonymous variant	Benign/Likely benign	Apr 6, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.674C>T (p.Ala225Val)	RAD51D|RAD51L3-RFFL	A113V, A225V, A245V	Hereditary cancer-predisposing syndrome	VCV001171745	17	33430337	17	35103318	1171745	1161344	rs2142418784	NC_000017.11:35103317:G:A	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Nov 16, 2020	criteria provided, single submitter							
NM_002878.4(RAD51D):c.673G>T (p.Ala225Ser)	RAD51D|RAD51L3-RFFL	A225S, A245S, A113S	Hereditary cancer-predisposing syndrome	VCV001755188	17	33430338	17	35103319	1755188	1808271	rs28363282	NC_000017.11:35103318:C:A	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Jun 15, 2021	criteria provided, single submitter							
NM_002878.4(RAD51D):c.673G>A (p.Ala225Thr)	RAD51D|RAD51L3-RFFL	A225T, A113T, A245T	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4|not provided	VCV000229842	17	33430338	17	35103319	229842	235872	rs28363282	NC_000017.11:35103318:C:T	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Jan 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.672G>C (p.Leu224Phe)	RAD51D|RAD51L3-RFFL	L224F, L244F, L112F	Hereditary cancer-predisposing syndrome	VCV002625299	17	33430339	17	35103320	2625299	2787282	rs1200819197	NC_000017.11:35103319:C:G	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Aug 4, 2023	criteria provided, single submitter							
NM_002878.4(RAD51D):c.671T>A (p.Leu224Ter)	RAD51D|RAD51L3-RFFL	L224*, L112*, L244*	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000629951	17	33430340	17	35103321	629951	618534	rs1567726305	NC_000017.11:35103320:A:T	single nucleotide variant	non-coding transcript variant|nonsense	Pathogenic/Likely pathogenic	Jun 4, 2023	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.669C>A (p.Gly223=)	RAD51D|RAD51L3-RFFL		Hereditary cancer-predisposing syndrome	VCV001754941	17	33430342	17	35103323	1754941	1822031	rs1567726315	NC_000017.11:35103322:G:T	single nucleotide variant	non-coding transcript variant|synonymous variant	Likely benign	Dec 17, 2019	criteria provided, single submitter							
NM_002878.4(RAD51D):c.669C>G (p.Gly223=)	RAD51L3-RFFL|RAD51D		not specified|Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV000627987	17	33430342	17	35103323	627987	618535	rs1567726315	NC_000017.11:35103322:G:C	single nucleotide variant	non-coding transcript variant|synonymous variant	Conflicting classifications of pathogenicity	Feb 24, 2025	criteria provided, conflicting classifications							
NM_002878.4(RAD51D):c.668G>T (p.Gly223Val)	RAD51D|RAD51L3-RFFL	G111V, G223V, G243V	Hereditary cancer-predisposing syndrome	VCV001754907	17	33430343	17	35103324	1754907	1821997	rs1064793588	NC_000017.11:35103323:C:A	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Aug 3, 2020	criteria provided, single submitter							
NM_002878.4(RAD51D):c.668G>C (p.Gly223Ala)	RAD51L3-RFFL|RAD51D	G223A, G111A, G243A	not provided|Hereditary cancer-predisposing syndrome	VCV000419019	17	33430343	17	35103324	419019	409894	rs1064793588	NC_000017.11:35103323:C:G	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Apr 25, 2019	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.668-1G>A	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV001066641	17	33430344	17	35103325	1066641	1056413	rs2142418872	NC_000017.11:35103324:C:T	single nucleotide variant	splice acceptor variant	Likely pathogenic	Sep 7, 2023	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.668-2A>C	RAD51D|RAD51L3-RFFL		Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000568391	17	33430345	17	35103326	568391	568996	rs1567726325	NC_000017.11:35103325:T:G	single nucleotide variant	splice acceptor variant	Likely pathogenic	Jul 12, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.668-3C>T	RAD51D|RAD51L3-RFFL		Hereditary cancer-predisposing syndrome|not provided	VCV002496864	17	33430346	17	35103327	2496864	2468003	rs2142418884	NC_000017.11:35103326:G:A	single nucleotide variant	intron variant	Uncertain significance	Dec 19, 2022	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.668-3C>A	RAD51D|RAD51L3-RFFL		Hereditary cancer-predisposing syndrome	VCV001754864	17	33430346	17	35103327	1754864	1821954	rs2142418884	NC_000017.11:35103326:G:T	single nucleotide variant	intron variant	Likely pathogenic	May 10, 2024	criteria provided, single submitter							
NM_002878.4(RAD51D):c.668-3C>G	RAD51L3-RFFL|RAD51D		Hereditary cancer-predisposing syndrome	VCV001172263	17	33430346	17	35103327	1172263	1161345	rs2142418884	NC_000017.11:35103326:G:C	single nucleotide variant	intron variant	Uncertain significance	Oct 14, 2020	criteria provided, single submitter							
NM_002878.4(RAD51D):c.668-4G>C	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV001082297	17	33430347	17	35103328	1082297	1082927	rs1001440122	NC_000017.11:35103327:C:G	single nucleotide variant	intron variant	Likely benign	Apr 8, 2024	criteria provided, single submitter							
NM_002878.4(RAD51D):c.668-4G>A	RAD51D|RAD51L3-RFFL		Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4|not specified	VCV000416200	17	33430347	17	35103328	416200	401872	rs1001440122	NC_000017.11:35103327:C:T	single nucleotide variant	intron variant	Likely benign	Feb 24, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.668-4G>T	RAD51D|RAD51L3-RFFL		not provided|Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV000382950	17	33430347	17	35103328	382950	374918	rs1001440122	NC_000017.11:35103327:C:A	single nucleotide variant	intron variant	Likely benign	Feb 24, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.668-6C>T	RAD51L3-RFFL|RAD51D		Breast-ovarian cancer, familial, susceptibility to, 4	VCV001114266	17	33430349	17	35103330	1114266	1104719	rs2142418915	NC_000017.11:35103329:G:A	single nucleotide variant	intron variant	Likely benign	Feb 24, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.668-8T>C	RAD51D|RAD51L3-RFFL		Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV001538232	17	33430351	17	35103332	1538232	1619458	rs2142418939	NC_000017.11:35103331:A:G	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Sep 9, 2021	criteria provided, conflicting classifications							
NM_002878.4(RAD51D):c.668-9C>G	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV002765313	17	33430352	17	35103333	2765313	2926060	rs1555567544	NC_000017.11:35103332:G:C	single nucleotide variant	intron variant	Likely benign	Oct 4, 2023	criteria provided, single submitter							
NM_002878.4(RAD51D):c.668-9C>T	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV000472618	17	33430352	17	35103333	472618	467931	rs1555567544	NC_000017.11:35103332:G:A	single nucleotide variant	intron variant	Likely benign	Feb 24, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.668-10C>T	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV000760500	17	33430353	17	35103334	760500	776297	rs1597858472	NC_000017.11:35103333:G:A	single nucleotide variant	intron variant	Likely benign	Feb 24, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.668-11T>C	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV002888102	17	33430354	17	35103335	2888102	3054514	rs2142418965	NC_000017.11:35103334:A:G	single nucleotide variant	intron variant	Likely benign	May 19, 2023	criteria provided, single submitter							
NM_002878.4(RAD51D):c.668-12C>T	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV003904107	17	33430355	17	35103336	3904107	4019980		NC_000017.11:35103335:G:A	single nucleotide variant	intron variant	Likely benign	Feb 24, 2025	criteria provided, single submitter							
NM_002878.4(RAD51D):c.668-12C>G	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV002718084	17	33430355	17	35103336	2718084	2880328	rs2142418974	NC_000017.11:35103335:G:C	single nucleotide variant	intron variant	Likely benign	Oct 30, 2023	criteria provided, single submitter							
NM_002878.4(RAD51D):c.668-13C>T	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV000920352	17	33430356	17	35103337	920352	915961	rs765122620	NC_000017.11:35103336:G:A	single nucleotide variant	intron variant	Likely benign	Feb 24, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.668-15C>T	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary breast ovarian cancer syndrome	VCV003780522	17	33430358	17	35103339	3780522	3896488		NC_000017.11:35103338:G:A	single nucleotide variant	intron variant	Likely benign	Feb 24, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.668-17T>A	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV002750889	17	33430360	17	35103341	2750889	2912927	rs2142419026	NC_000017.11:35103340:A:T	single nucleotide variant	intron variant	Likely benign	Aug 7, 2023	criteria provided, single submitter							
NM_002878.4(RAD51D):c.668-17T>C	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV001534931	17	33430360	17	35103341	1534931	1531643	rs2142419026	NC_000017.11:35103340:A:G	single nucleotide variant	intron variant	Likely benign	Feb 24, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.668-18C>T	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV003657509	17	33430361	17	35103342	3657509	3779464		NC_000017.11:35103341:G:A	single nucleotide variant	intron variant	Likely benign	Jun 23, 2024	criteria provided, single submitter							
NM_002878.4(RAD51D):c.668-19G>C	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV002415151	17	33430362	17	35103343	2415151	1943585	rs2091561999	NC_000017.11:35103342:C:G	single nucleotide variant	intron variant	Likely benign	Feb 24, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.668-20T>C	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV002859989	17	33430363	17	35103344	2859989	3028626	rs2509129323	NC_000017.11:35103343:A:G	single nucleotide variant	intron variant	Likely benign	Feb 24, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.668-30C>G	RAD51D|RAD51L3-RFFL		not specified	VCV003256340	17	33430373	17	35103354	3256340	3415102		NC_000017.11:35103353:G:C	single nucleotide variant	intron variant	Likely benign	Mar 4, 2025	criteria provided, single submitter							
NM_002878.4(RAD51D):c.668-36C>T	RAD51D|RAD51L3-RFFL		not specified	VCV003765189	17	33430379	17	35103360	3765189	3881358		NC_000017.11:35103359:G:A	single nucleotide variant	intron variant	Likely benign	Mar 4, 2025	criteria provided, single submitter							
NM_002878.4(RAD51D):c.667+48C>T	RAD51D|RAD51L3-RFFL		not specified	VCV001697593	17	33430425	17	35103406	1697593	1689977	rs751115328	NC_000017.11:35103405:G:A	single nucleotide variant	intron variant	Likely benign	Mar 4, 2025	criteria provided, single submitter							
NM_002878.4(RAD51D):c.667+43C>T	RAD51D|RAD51L3-RFFL		not specified	VCV003765190	17	33430430	17	35103411	3765190	3881359		NC_000017.11:35103410:G:A	single nucleotide variant	intron variant	Likely benign	Mar 4, 2025	criteria provided, single submitter							
NM_002878.4(RAD51D):c.667+24G>A	RAD51L3-RFFL|RAD51D		Hereditary cancer-predisposing syndrome	VCV000492436	17	33430449	17	35103430	492436	484992	rs371610084	NC_000017.11:35103429:C:T	single nucleotide variant	intron variant	Likely benign	Dec 9, 2015	criteria provided, single submitter							
NM_002878.4(RAD51D):c.667+20C>T	RAD51L3-RFFL|RAD51D		Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome|not specified|not provided	VCV000380537	17	33430453	17	35103434	380537	374921	rs373473666	NC_000017.11:35103433:G:A	single nucleotide variant	intron variant	Likely benign	Jan 29, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.667+17A>T	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV003661327	17	33430456	17	35103437	3661327	3790986		NC_000017.11:35103436:T:A	single nucleotide variant	intron variant	Likely benign	Aug 4, 2024	criteria provided, single submitter							
NM_002878.4(RAD51D):c.667+16G>A	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV001605948	17	33430457	17	35103438	1605948	1560443	rs2142420008	NC_000017.11:35103437:C:T	single nucleotide variant	intron variant	Likely benign	Jun 28, 2021	criteria provided, single submitter							
NM_002878.4(RAD51D):c.667+15A>G	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV002916004	17	33430458	17	35103439	2916004	3071513	rs2142420019	NC_000017.11:35103438:T:C	single nucleotide variant	intron variant	Likely benign	Dec 8, 2023	criteria provided, single submitter							
NM_002878.4(RAD51D):c.667+14C>T	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary breast ovarian cancer syndrome	VCV001528651	17	33430459	17	35103440	1528651	1581733	rs748640723	NC_000017.11:35103439:G:A	single nucleotide variant	intron variant	Likely benign	Jun 14, 2023	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.667+9T>A	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV003903682	17	33430464	17	35103445	3903682	4019555		NC_000017.11:35103444:A:T	single nucleotide variant	intron variant	Likely benign	Feb 24, 2025	criteria provided, single submitter							
NM_002878.4(RAD51D):c.667+9T>C	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4|Breast and/or ovarian cancer|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000472617	17	33430464	17	35103445	472617	467611	rs772193051	NC_000017.11:35103444:A:G	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Feb 24, 2025	criteria provided, conflicting classifications							
NM_002878.4(RAD51D):c.667+8A>T	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4|not specified	VCV000517722	17	33430465	17	35103446	517722	506772	rs941079937	NC_000017.11:35103445:T:A	single nucleotide variant	intron variant	Likely benign	Feb 24, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.667+7G>C	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV003714249	17	33430466	17	35103447	3714249	3841647		NC_000017.11:35103446:C:G	single nucleotide variant	intron variant	Likely benign	Jun 17, 2024	criteria provided, single submitter							
NM_002878.4(RAD51D):c.667+7G>A	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV000492437	17	33430466	17	35103447	492437	484764	rs1483859285	NC_000017.11:35103446:C:T	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Feb 24, 2025	criteria provided, conflicting classifications							
NM_002878.4(RAD51D):c.667+5G>C	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV002187609	17	33430468	17	35103449	2187609	1911248	rs2142420121	NC_000017.11:35103448:C:G	single nucleotide variant	intron variant	Uncertain significance	Jun 20, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.667+5G>A	RAD51D|RAD51L3-RFFL		Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV001426327	17	33430468	17	35103449	1426327	1450934	rs2142420121	NC_000017.11:35103448:C:T	single nucleotide variant	intron variant	Uncertain significance	Apr 9, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.667+4A>T	RAD51L3-RFFL|RAD51D		Breast-ovarian cancer, familial, susceptibility to, 4	VCV001375574	17	33430469	17	35103450	1375574	1392346	rs2142420128	NC_000017.11:35103449:T:A	single nucleotide variant	intron variant	Uncertain significance	Aug 17, 2021	criteria provided, single submitter							
NM_002878.4(RAD51D):c.667+3G>A	RAD51L3-RFFL|RAD51D		not provided|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV001060905	17	33430470	17	35103451	1060905	1050199	rs773138393	NC_000017.11:35103450:C:T	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Feb 24, 2025	criteria provided, conflicting classifications							
NM_002878.4(RAD51D):c.667+2T>C	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV002074258	17	33430471	17	35103452	2074258	2141220	rs2142420150	NC_000017.11:35103451:A:G	single nucleotide variant	splice donor variant	Conflicting classifications of pathogenicity	Jun 26, 2024	criteria provided, conflicting classifications							
NM_002878.4(RAD51D):c.667+1G>A	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV001754801	17	33430472	17	35103453	1754801	1821891	rs1597858666	NC_000017.11:35103452:C:T	single nucleotide variant	splice donor variant	Conflicting classifications of pathogenicity	Jun 26, 2024	criteria provided, conflicting classifications							
NM_002878.4(RAD51D):c.667+1G>T	RAD51D|RAD51L3-RFFL		Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000826546	17	33430472	17	35103453	826546	815674	rs1597858666	NC_000017.11:35103452:C:A	single nucleotide variant	splice donor variant	Likely pathogenic	Jun 24, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.667G>T (p.Gly223Cys)	RAD51D|RAD51L3-RFFL	G111C, G223C, G243C	Hereditary cancer-predisposing syndrome	VCV001754850	17	33430473	17	35103454	1754850	1821940	rs1064793247	NC_000017.11:35103453:C:A	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Jun 10, 2020	criteria provided, single submitter							
NM_002878.4(RAD51D):c.667G>A (p.Gly223Ser)	RAD51D|RAD51L3-RFFL	G223S, G111S, G243S	not provided|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000418445	17	33430473	17	35103454	418445	409895	rs1064793247	NC_000017.11:35103453:C:T	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Oct 3, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.666A>C (p.Glu222Asp)	RAD51D|RAD51L3-RFFL	E242D, E222D, E110D	Breast-ovarian cancer, familial, susceptibility to, 4	VCV003641813	17	33430474	17	35103455	3641813	3772535		NC_000017.11:35103454:T:G	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Feb 18, 2024	criteria provided, single submitter							
NM_002878.4(RAD51D):c.666A>G (p.Glu222=)	RAD51D|RAD51L3-RFFL		Hereditary cancer-predisposing syndrome|not specified|Breast-ovarian cancer, familial, susceptibility to, 4|not provided|Hereditary breast ovarian cancer syndrome	VCV000182852	17	33430474	17	35103455	182852	180797	rs114012742	NC_000017.11:35103454:T:C	single nucleotide variant	non-coding transcript variant|synonymous variant	Benign/Likely benign	Mar 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.663G>A (p.Arg221=)	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4|not specified|Hereditary cancer-predisposing syndrome	VCV000234167	17	33430477	17	35103458	234167	235873	rs876660896	NC_000017.11:35103457:C:T	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Mar 14, 2023	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.661A>T (p.Arg221Trp)	RAD51D|RAD51L3-RFFL	R109W, R221W, R241W	Breast-ovarian cancer, familial, susceptibility to, 4	VCV003240257	17	33430479	17	35103460	3240257	3399244	rs2142420234	NC_000017.11:35103459:T:A	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Jan 4, 2024	criteria provided, single submitter							
NM_002878.4(RAD51D):c.661A>G (p.Arg221Gly)	RAD51D|RAD51L3-RFFL	R109G, R221G, R241G	Breast-ovarian cancer, familial, susceptibility to, 4	VCV003240255	17	33430479	17	35103460	3240255	3399242	rs2142420234	NC_000017.11:35103459:T:C	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Mar 4, 2024	criteria provided, single submitter							
NM_002878.4(RAD51D):c.660G>A (p.Gln220=)	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV003903882	17	33430480	17	35103461	3903882	4019755		NC_000017.11:35103460:C:T	single nucleotide variant	non-coding transcript variant|synonymous variant	Benign	Feb 24, 2025	criteria provided, single submitter							
NM_002878.4(RAD51D):c.660G>T (p.Gln220His)	RAD51D|RAD51L3-RFFL	Q108H, Q220H, Q240H	Breast-ovarian cancer, familial, susceptibility to, 4	VCV002767280	17	33430480	17	35103461	2767280	2922854	rs2142420247	NC_000017.11:35103460:C:A	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Oct 9, 2023	criteria provided, single submitter							
NM_002878.4(RAD51D):c.659A>G (p.Gln220Arg)	RAD51D|RAD51L3-RFFL	Q108R, Q240R, Q220R	Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV001040100	17	33430481	17	35103462	1040100	1033226	rs1254341673	NC_000017.11:35103461:T:C	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Oct 21, 2022	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.658C>G (p.Gln220Glu)	RAD51D|RAD51L3-RFFL	Q108E, Q220E, Q240E	Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV001754342	17	33430482	17	35103463	1754342	1811800	rs2142420266	NC_000017.11:35103462:G:C	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Mar 19, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.657G>A (p.Gln219=)	RAD51L3-RFFL|RAD51D		Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV000628436	17	33430483	17	35103464	628436	618536	rs1567726462	NC_000017.11:35103463:C:T	single nucleotide variant	non-coding transcript variant|synonymous variant	Likely benign	Jul 16, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.655C>T (p.Gln219Ter)	RAD51D|RAD51L3-RFFL	Q219*, Q107*, Q239*	not provided|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV000484763	17	33430485	17	35103466	484763	478431	rs771007945	NC_000017.11:35103465:G:A	single nucleotide variant	non-coding transcript variant|nonsense	Pathogenic/Likely pathogenic	Feb 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.654T>A (p.Gly218=)	RAD51D|RAD51L3-RFFL		Hereditary cancer-predisposing syndrome|not specified	VCV000381798	17	33430486	17	35103467	381798	375867	rs1057521173	NC_000017.11:35103466:A:T	single nucleotide variant	non-coding transcript variant|synonymous variant	Likely benign	Aug 30, 2019	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.653G>C (p.Gly218Ala)	RAD51D|RAD51L3-RFFL	G218A, G106A, G238A	Breast-ovarian cancer, familial, susceptibility to, 4	VCV002839100	17	33430487	17	35103468	2839100	2996371	rs2091563809	NC_000017.11:35103467:C:G	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Feb 20, 2023	criteria provided, single submitter							
NM_002878.4(RAD51D):c.653G>A (p.Gly218Asp)	RAD51D|RAD51L3-RFFL	G238D, G106D, G218D	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000919068	17	33430487	17	35103468	919068	913829	rs2091563809	NC_000017.11:35103467:C:T	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Jan 17, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.652G>A (p.Gly218Ser)	RAD51D|RAD51L3-RFFL	G106S, G218S, G238S	Hereditary cancer-predisposing syndrome	VCV001692734	17	33430488	17	35103469	1692734	1685174	rs2142420350	NC_000017.11:35103468:C:T	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Jun 25, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.650G>C (p.Gly217Ala)	RAD51D|RAD51L3-RFFL	G105A, G217A, G237A	Hereditary cancer-predisposing syndrome	VCV002774205	17	33430490	17	35103471	2774205	2934935	rs2142420356	NC_000017.11:35103470:C:G	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Jul 5, 2022	criteria provided, single submitter							
NM_002878.4(RAD51D):c.649G>T (p.Gly217Ter)	RAD51D|RAD51L3-RFFL	G217*, G105*, G237*	not provided|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV000484764	17	33430491	17	35103472	484764	478481	rs775365939	NC_000017.11:35103471:C:A	single nucleotide variant	non-coding transcript variant|nonsense	Pathogenic/Likely pathogenic	Feb 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.649G>A (p.Gly217Arg)	RAD51D|RAD51L3-RFFL	G217R, G105R, G237R	Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV000482196	17	33430491	17	35103472	482196	478434	rs775365939	NC_000017.11:35103471:C:T	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Aug 8, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.647T>C (p.Leu216Pro)	RAD51D|RAD51L3-RFFL	L216P, L104P, L236P	Breast-ovarian cancer, familial, susceptibility to, 4	VCV003674926	17	33430493	17	35103474	3674926	3810116		NC_000017.11:35103473:A:G	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Jul 18, 2024	criteria provided, single submitter							
NM_002878.4(RAD51D):c.646C>T (p.Leu216=)	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV003904027	17	33430494	17	35103475	3904027	4019900		NC_000017.11:35103474:G:A	single nucleotide variant	non-coding transcript variant|synonymous variant	Benign	Feb 24, 2025	criteria provided, single submitter							
NM_002878.4(RAD51D):c.645T>G (p.Leu215=)	RAD51D|RAD51L3-RFFL		Hereditary cancer-predisposing syndrome	VCV003222887	17	33430495	17	35103476	3222887	3386525	rs1597858726	NC_000017.11:35103475:A:C	single nucleotide variant	non-coding transcript variant|synonymous variant	Likely benign	Dec 23, 2023	criteria provided, single submitter							
NM_002878.4(RAD51D):c.645T>A (p.Leu215=)	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV001086305	17	33430495	17	35103476	1086305	1082928	rs1597858726	NC_000017.11:35103475:A:T	single nucleotide variant	non-coding transcript variant|synonymous variant	Benign/Likely benign	Feb 24, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.644T>A (p.Leu215His)	RAD51D|RAD51L3-RFFL	L103H, L215H, L235H	Breast-ovarian cancer, familial, susceptibility to, 4	VCV003362730	17	33430496	17	35103477	3362730	3521939		NC_000017.11:35103476:A:T	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Sep 22, 2024	criteria provided, single submitter							
NM_002878.4(RAD51D):c.643C>G (p.Leu215Val)	RAD51D|RAD51L3-RFFL	L235V, L103V, L215V	Hereditary cancer-predisposing syndrome	VCV003942394	17	33430497	17	35103478	3942394	4064173		NC_000017.11:35103477:G:C	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	May 31, 2025	criteria provided, single submitter							
NM_002878.4(RAD51D):c.643C>T (p.Leu215Phe)	RAD51D|RAD51L3-RFFL	L103F, L215F, L235F	Hereditary cancer-predisposing syndrome	VCV001753530	17	33430497	17	35103478	1753530	1807913	rs1597858743	NC_000017.11:35103477:G:A	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Jun 22, 2021	criteria provided, single submitter							
NM_002878.4(RAD51D):c.642A>G (p.Pro214=)	RAD51L3-RFFL|RAD51D		Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000234099	17	33430498	17	35103479	234099	235874	rs876660847	NC_000017.11:35103478:T:C	single nucleotide variant	non-coding transcript variant|synonymous variant	Benign/Likely benign	Feb 24, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.641C>G (p.Pro214Arg)	RAD51D|RAD51L3-RFFL	P102R, P214R, P234R	Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV003429752	17	33430499	17	35103480	3429752	3585763		NC_000017.11:35103479:G:C	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Dec 15, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.641C>T (p.Pro214Leu)	RAD51D|RAD51L3-RFFL	P214L, P102L, P234L	Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome|not provided	VCV000574602	17	33430499	17	35103480	574602	571272	rs910355512	NC_000017.11:35103479:G:A	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Nov 22, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.641C>A (p.Pro214Gln)	RAD51D|RAD51L3-RFFL	P214Q, P234Q, P102Q	Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome|not provided	VCV000410545	17	33430499	17	35103480	410545	401873	rs910355512	NC_000017.11:35103479:G:T	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Mar 6, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.640C>T (p.Pro214Ser)	RAD51L3-RFFL|RAD51D	P214S, P102S, P234S	Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV000410555	17	33430500	17	35103481	410555	402582	rs1060502955	NC_000017.11:35103480:G:A	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Dec 4, 2023	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.639C>G (p.Ser213=)	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV003429745	17	33430501	17	35103482	3429745	3585756		NC_000017.11:35103481:G:C	single nucleotide variant	non-coding transcript variant|synonymous variant	Benign/Likely benign	Feb 24, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.639C>A (p.Ser213=)	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV001992714	17	33430501	17	35103482	1992714	2059235	rs2091564148	NC_000017.11:35103481:G:T	single nucleotide variant	non-coding transcript variant|synonymous variant	Likely benign	May 10, 2022	criteria provided, single submitter							
NM_002878.4(RAD51D):c.638C>T (p.Ser213Phe)	RAD51D|RAD51L3-RFFL	S101F, S213F, S233F	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV003653028	17	33430502	17	35103483	3653028	3778417		NC_000017.11:35103482:G:A	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	May 8, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.638C>G (p.Ser213Cys)	RAD51D|RAD51L3-RFFL	S101C, S213C, S233C	Breast-ovarian cancer, familial, susceptibility to, 4	VCV003362243	17	33430502	17	35103483	3362243	3521453		NC_000017.11:35103482:G:C	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Oct 8, 2024	criteria provided, single submitter							
NM_002878.4(RAD51D):c.634G>T (p.Val212Phe)	RAD51D|RAD51L3-RFFL	V100F, V212F, V232F	Hereditary cancer-predisposing syndrome	VCV001753000	17	33430506	17	35103487	1753000	1801432	rs730881948	NC_000017.11:35103486:C:A	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Jul 29, 2021	criteria provided, single submitter							
NM_002878.4(RAD51D):c.634G>C (p.Val212Leu)	RAD51D|RAD51L3-RFFL	V212L, V232L, V100L	Hereditary cancer-predisposing syndrome	VCV000230132	17	33430506	17	35103487	230132	235875	rs730881948	NC_000017.11:35103486:C:G	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Dec 5, 2023	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.634G>A (p.Val212Ile)	RAD51L3-RFFL|RAD51D	V212I, V232I, V100I	not provided|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000182861	17	33430506	17	35103487	182861	180798	rs730881948	NC_000017.11:35103486:C:T	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Jan 6, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.633G>A (p.Val211=)	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV003903747	17	33430507	17	35103488	3903747	4019620		NC_000017.11:35103487:C:T	single nucleotide variant	non-coding transcript variant|synonymous variant	Benign	Feb 24, 2025	criteria provided, single submitter							
NM_002878.4(RAD51D):c.633G>C (p.Val211=)	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV001083918	17	33430507	17	35103488	1083918	1082929	rs2142420526	NC_000017.11:35103487:C:G	single nucleotide variant	non-coding transcript variant|synonymous variant	Likely benign	Jul 5, 2019	criteria provided, single submitter							
NM_002878.4(RAD51D):c.632T>A (p.Val211Glu)	RAD51D|RAD51L3-RFFL	V211E, V231E, V99E	Hereditary cancer-predisposing syndrome|not specified	VCV001338118	17	33430508	17	35103489	1338118	1329127	rs2142420542	NC_000017.11:35103488:A:T	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Jan 17, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.631G>T (p.Val211Leu)	RAD51D|RAD51L3-RFFL	V99L, V211L, V231L	Hereditary cancer-predisposing syndrome	VCV001752842	17	33430509	17	35103490	1752842	1801275	rs1567726508	NC_000017.11:35103489:C:A	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Dec 15, 2021	criteria provided, single submitter							
NM_002878.4(RAD51D):c.631G>C (p.Val211Leu)	RAD51D|RAD51L3-RFFL	V211L, V231L, V99L	Breast-ovarian cancer, familial, susceptibility to, 4	VCV001026291	17	33430509	17	35103490	1026291	1012709	rs1567726508	NC_000017.11:35103489:C:G	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Sep 15, 2020	criteria provided, single submitter							
NM_002878.4(RAD51D):c.631G>A (p.Val211Met)	RAD51D|RAD51L3-RFFL	V211M, V99M, V231M	Breast-ovarian cancer, familial, susceptibility to, 4	VCV000580692	17	33430509	17	35103490	580692	571280	rs1567726508	NC_000017.11:35103489:C:T	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Jan 11, 2020	criteria provided, single submitter							
NM_002878.4(RAD51D):c.630G>C (p.Ala210=)	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV000762119	17	33430510	17	35103491	762119	771431	rs762585552	NC_000017.11:35103490:C:G	single nucleotide variant	non-coding transcript variant|synonymous variant	Benign/Likely benign	Feb 24, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.630G>A (p.Ala210=)	RAD51D|RAD51L3-RFFL		Hereditary cancer-predisposing syndrome|not specified|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000385031	17	33430510	17	35103491	385031	375978	rs762585552	NC_000017.11:35103490:C:T	single nucleotide variant	non-coding transcript variant|synonymous variant	Benign/Likely benign	Mar 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.629C>A (p.Ala210Glu)	RAD51L3-RFFL|RAD51D	A210E, A230E, A98E	Breast-ovarian cancer, familial, susceptibility to, 4|not provided|Hereditary cancer-predisposing syndrome|not specified	VCV000410563	17	33430511	17	35103492	410563	402397	rs376855484	NC_000017.11:35103491:G:T	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Mar 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.629C>T (p.Ala210Val)	RAD51D|RAD51L3-RFFL	A210V, A230V, A98V	Familial ovarian cancer|Hereditary cancer-predisposing syndrome|not specified|not provided|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000141969	17	33430511	17	35103492	141969	151683	rs376855484	NC_000017.11:35103491:G:A	single nucleotide variant	non-coding transcript variant|missense variant	Conflicting classifications of pathogenicity	Aug 4, 2025	criteria provided, conflicting classifications							
NM_002878.4(RAD51D):c.627T>G (p.Thr209=)	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV002830277	17	33430513	17	35103494	2830277	2997755	rs141545966	NC_000017.11:35103493:A:C	single nucleotide variant	non-coding transcript variant|synonymous variant	Likely benign	Jan 19, 2023	criteria provided, single submitter							
NM_002878.4(RAD51D):c.627T>C (p.Thr209=)	RAD51D|RAD51L3-RFFL		Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000230158	17	33430513	17	35103494	230158	235876	rs141545966	NC_000017.11:35103493:A:G	single nucleotide variant	non-coding transcript variant|synonymous variant	Benign/Likely benign	Feb 24, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.626C>T (p.Thr209Ile)	RAD51D|RAD51L3-RFFL	T209I, T97I, T229I	Breast-ovarian cancer, familial, susceptibility to, 4	VCV000946840	17	33430514	17	35103495	946840	928223	rs2091564459	NC_000017.11:35103494:G:A	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Jun 27, 2019	criteria provided, single submitter							
NM_002878.4(RAD51D):c.625A>G (p.Thr209Ala)	RAD51D|RAD51L3-RFFL	T97A, T229A, T209A	Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV001752473	17	33430515	17	35103496	1752473	1804328	rs1555567603	NC_000017.11:35103495:T:C	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Jul 26, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.625A>C (p.Thr209Pro)	RAD51D|RAD51L3-RFFL	T209P, T229P, T97P	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000484765	17	33430515	17	35103496	484765	478436	rs1555567603	NC_000017.11:35103495:T:G	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	May 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.624C>T (p.Val208=)	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome|not provided	VCV000826269	17	33430516	17	35103497	826269	813559	rs1597858797	NC_000017.11:35103496:G:A	single nucleotide variant	non-coding transcript variant|synonymous variant	Conflicting classifications of pathogenicity	Feb 24, 2025	criteria provided, conflicting classifications							
NM_002878.4(RAD51D):c.623T>C (p.Val208Ala)	RAD51D|RAD51L3-RFFL	V208A, V228A, V96A	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4|not provided	VCV000422273	17	33430517	17	35103498	422273	409896	rs1064795673	NC_000017.11:35103497:A:G	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Jun 28, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.621G>C (p.Ser207=)	RAD51D|RAD51L3-RFFL		Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV001752286	17	33430519	17	35103500	1752286	1804141	rs749859221	NC_000017.11:35103499:C:G	single nucleotide variant	non-coding transcript variant|synonymous variant	Benign/Likely benign	Feb 24, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.621G>A (p.Ser207=)	RAD51D|RAD51L3-RFFL		Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|not specified|Breast-ovarian cancer, familial, susceptibility to, 4|not provided	VCV000231230	17	33430519	17	35103500	231230	235877	rs749859221	NC_000017.11:35103499:C:T	single nucleotide variant	non-coding transcript variant|synonymous variant	Benign/Likely benign	Mar 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.621G>T (p.Ser207=)	RAD51D|RAD51L3-RFFL		Hereditary cancer-predisposing syndrome|not provided|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000185908	17	33430519	17	35103500	185908	184819	rs749859221	NC_000017.11:35103499:C:A	single nucleotide variant	non-coding transcript variant|synonymous variant	Benign/Likely benign	Feb 24, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.620C>A (p.Ser207Ter)	RAD51D|RAD51L3-RFFL	S207*, S227*, S95*	Deleterious RAD51D Gene Mutation	VCV001232294	17	33430520	17	35103501	1232294	1222283	rs370228071	NC_000017.11:35103500:G:T	single nucleotide variant	non-coding transcript variant|nonsense	Likely pathogenic	Aug 24, 2021	criteria provided, single submitter							
NM_002878.4(RAD51D):c.620C>G (p.Ser207Trp)	RAD51L3-RFFL|RAD51D	S207W, S227W, S95W	Breast-ovarian cancer, familial, susceptibility to, 4|not specified|Hereditary cancer-predisposing syndrome	VCV000480538	17	33430520	17	35103501	480538	478439	rs370228071	NC_000017.11:35103500:G:C	single nucleotide variant	non-coding transcript variant|missense variant	Conflicting classifications of pathogenicity	Dec 27, 2024	criteria provided, conflicting classifications							
NM_002878.4(RAD51D):c.620C>T (p.Ser207Leu)	RAD51D|RAD51L3-RFFL	S207L, S227L, S95L	Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome|Breast and/or ovarian cancer|Hereditary breast ovarian cancer syndrome|not provided|Familial ovarian cancer	VCV000142102	17	33430520	17	35103501	142102	151816	rs370228071	NC_000017.11:35103500:G:A	single nucleotide variant	non-coding transcript variant|missense variant	Pathogenic/Likely pathogenic	Apr 11, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.619T>C (p.Ser207Pro)	RAD51D|RAD51L3-RFFL	S207P, S95P, S227P	Hereditary cancer-predisposing syndrome|Breast cancer, susceptibility to|Breast-ovarian cancer, familial, susceptibility to, 4|not provided|Hereditary breast ovarian cancer syndrome|Familial ovarian cancer	VCV000229719	17	33430521	17	35103502	229719	235878	rs372365287	NC_000017.11:35103501:A:G	single nucleotide variant	non-coding transcript variant|missense variant	Conflicting classifications of pathogenicity	May 14, 2025	criteria provided, conflicting classifications							
NM_002878.4(RAD51D):c.618C>T (p.Asp206=)	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV001086031	17	33430522	17	35103503	1086031	1082930	rs2142420737	NC_000017.11:35103502:G:A	single nucleotide variant	non-coding transcript variant|synonymous variant	Benign/Likely benign	Feb 24, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.617A>C (p.Asp206Ala)	RAD51D|RAD51L3-RFFL	D206A, D94A, D226A	Breast-ovarian cancer, familial, susceptibility to, 4	VCV003702896	17	33430523	17	35103504	3702896	3838947		NC_000017.11:35103503:T:G	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Oct 21, 2024	criteria provided, single submitter							
NM_002878.4(RAD51D):c.617A>G (p.Asp206Gly)	RAD51D|RAD51L3-RFFL	D94G, D206G, D226G	Breast-ovarian cancer, familial, susceptibility to, 4	VCV002756850	17	33430523	17	35103504	2756850	2910251	rs2509130367	NC_000017.11:35103503:T:C	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	May 22, 2024	criteria provided, single submitter							
NM_002878.4(RAD51D):c.617A>T (p.Asp206Val)	RAD51D|RAD51L3-RFFL	D226V, D94V, D206V	Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV001752043	17	33430523	17	35103504	1752043	1807724	rs2509130367	NC_000017.11:35103503:T:A	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Jul 3, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.616G>C (p.Asp206His)	RAD51D|RAD51L3-RFFL	D206H, D226H, D94H	Breast-ovarian cancer, familial, susceptibility to, 4	VCV001006029	17	33430524	17	35103505	1006029	997498	rs2091564754	NC_000017.11:35103504:C:G	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Jun 26, 2020	criteria provided, single submitter							
NM_002878.4(RAD51D):c.615G>A (p.Val205=)	RAD51L3-RFFL|RAD51D		Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV000472616	17	33430525	17	35103506	472616	466739	rs1555567620	NC_000017.11:35103505:C:T	single nucleotide variant	non-coding transcript variant|synonymous variant	Benign/Likely benign	Feb 24, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.614T>C (p.Val205Ala)	RAD51D|RAD51L3-RFFL	V205A, V225A, V93A	Hereditary cancer-predisposing syndrome	VCV000141310	17	33430526	17	35103507	141310	151024	rs587781649	NC_000017.11:35103506:A:G	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Mar 20, 2014	criteria provided, single submitter							
NM_002878.4(RAD51D):c.612T>C (p.Val204=)	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV002119243	17	33430528	17	35103509	2119243	2183590	rs2509130404	NC_000017.11:35103508:A:G	single nucleotide variant	non-coding transcript variant|synonymous variant	Likely benign	Mar 29, 2022	criteria provided, single submitter							
NM_002878.4(RAD51D):c.610G>C (p.Val204Leu)	RAD51D|RAD51L3-RFFL	V224L, V204L, V92L	Hereditary cancer-predisposing syndrome	VCV003786514	17	33430530	17	35103511	3786514	3908955		NC_000017.11:35103510:C:G	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Feb 1, 2025	criteria provided, single submitter							
NM_002878.4(RAD51D):c.610G>A (p.Val204Ile)	RAD51D|RAD51L3-RFFL	V204I, V224I, V92I	Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV000484787	17	33430530	17	35103511	484787	478596	rs765881830	NC_000017.11:35103510:C:T	single nucleotide variant	non-coding transcript variant|missense variant	Conflicting classifications of pathogenicity	Aug 11, 2021	criteria provided, conflicting classifications							
NM_002878.4(RAD51D):c.609G>A (p.Val203=)	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV002836874	17	33430531	17	35103512	2836874	2999253	rs876660256	NC_000017.11:35103511:C:T	single nucleotide variant	non-coding transcript variant|synonymous variant	Likely benign	Feb 14, 2023	criteria provided, single submitter							
NM_002878.4(RAD51D):c.609G>C (p.Val203=)	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV001088174	17	33430531	17	35103512	1088174	1082931	rs876660256	NC_000017.11:35103511:C:G	single nucleotide variant	non-coding transcript variant|synonymous variant	Benign/Likely benign	Feb 24, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.609G>T (p.Val203=)	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV000233200	17	33430531	17	35103512	233200	235879	rs876660256	NC_000017.11:35103511:C:A	single nucleotide variant	non-coding transcript variant|synonymous variant	Likely benign	Feb 25, 2022	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.607G>T (p.Val203Leu)	RAD51D|RAD51L3-RFFL	V203L, V223L, V91L	Hereditary cancer-predisposing syndrome	VCV003222886	17	33430533	17	35103514	3222886	3386524	rs730881947	NC_000017.11:35103513:C:A	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Nov 21, 2023	criteria provided, single submitter							
NM_002878.4(RAD51D):c.607G>A (p.Val203Met)	RAD51D|RAD51L3-RFFL	V203M, V223M, V91M	Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 4|not provided|Hereditary cancer-predisposing syndrome	VCV000182860	17	33430533	17	35103514	182860	180800	rs730881947	NC_000017.11:35103513:C:T	single nucleotide variant	non-coding transcript variant|missense variant	Conflicting classifications of pathogenicity	Apr 1, 2025	criteria provided, conflicting classifications							
NM_002878.4(RAD51D):c.606G>A (p.Val202=)	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV003903816	17	33430534	17	35103515	3903816	4019689		NC_000017.11:35103514:C:T	single nucleotide variant	non-coding transcript variant|synonymous variant	Benign	Feb 24, 2025	criteria provided, single submitter							
NM_002878.4(RAD51D):c.606G>T (p.Val202=)	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV002777082	17	33430534	17	35103515	2777082	2943418	rs1555567627	NC_000017.11:35103514:C:A	single nucleotide variant	non-coding transcript variant|synonymous variant	Likely benign	Jan 23, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.606G>C (p.Val202=)	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV000472615	17	33430534	17	35103515	472615	466741	rs1555567627	NC_000017.11:35103514:C:G	single nucleotide variant	non-coding transcript variant|synonymous variant	Benign/Likely benign	Feb 24, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.604G>C (p.Val202Leu)	RAD51D|RAD51L3-RFFL	V90L, V222L, V202L	Hereditary cancer-predisposing syndrome	VCV003942382	17	33430536	17	35103517	3942382	4064161		NC_000017.11:35103516:C:G	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Apr 3, 2025	criteria provided, single submitter							
NM_002878.4(RAD51D):c.604G>T (p.Val202Leu)	RAD51D|RAD51L3-RFFL	V202L, V222L, V90L	Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV001751275	17	33430536	17	35103517	1751275	1810896	rs1567726587	NC_000017.11:35103516:C:A	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Feb 5, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.604G>A (p.Val202Met)	RAD51L3-RFFL|RAD51D	V202M, V222M, V90M	Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV000572704	17	33430536	17	35103517	572704	571082	rs1567726587	NC_000017.11:35103516:C:T	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Mar 12, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.603G>A (p.Lys201=)	RAD51D|RAD51L3-RFFL		Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV001078707	17	33430537	17	35103518	1078707	1082932	rs2091565129	NC_000017.11:35103517:C:T	single nucleotide variant	non-coding transcript variant|synonymous variant	Benign/Likely benign	Feb 24, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.603G>T (p.Lys201Asn)	RAD51D|RAD51L3-RFFL	K221N, K201N, K89N	Breast-ovarian cancer, familial, susceptibility to, 4	VCV001042785	17	33430537	17	35103518	1042785	1033227	rs2091565129	NC_000017.11:35103517:C:A	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Sep 3, 2020	criteria provided, single submitter							
NM_002878.4(RAD51D):c.600G>A (p.Val200=)	RAD51D|RAD51L3-RFFL		Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV001751067	17	33430540	17	35103521	1751067	1800796	rs755393515	NC_000017.11:35103520:C:T	single nucleotide variant	non-coding transcript variant|synonymous variant	Likely benign	Dec 17, 2023	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.600G>C (p.Val200=)	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV001107185	17	33430540	17	35103521	1107185	1104720	rs755393515	NC_000017.11:35103520:C:G	single nucleotide variant	non-coding transcript variant|synonymous variant	Likely benign	Aug 12, 2020	criteria provided, single submitter							
NM_002878.4(RAD51D):c.600G>T (p.Val200=)	RAD51L3-RFFL|RAD51D		Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV000239400	17	33430540	17	35103521	239400	242723	rs755393515	NC_000017.11:35103520:C:A	single nucleotide variant	non-coding transcript variant|synonymous variant	Likely benign	Jul 16, 2023	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.598G>C (p.Val200Leu)	RAD51D|RAD51L3-RFFL	V200L, V220L, V88L	Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV001750895	17	33430542	17	35103523	1750895	1800624	rs1567726600	NC_000017.11:35103522:C:G	single nucleotide variant	non-coding transcript variant|missense variant	Conflicting classifications of pathogenicity	Apr 25, 2024	criteria provided, conflicting classifications							
NM_002878.4(RAD51D):c.598G>A (p.Val200Met)	RAD51D|RAD51L3-RFFL	V200M, V220M, V88M	Breast-ovarian cancer, familial, susceptibility to, 4|not provided|Hereditary cancer-predisposing syndrome	VCV000578475	17	33430542	17	35103523	578475	568998	rs1567726600	NC_000017.11:35103522:C:T	single nucleotide variant	non-coding transcript variant|missense variant	Conflicting classifications of pathogenicity	Sep 22, 2024	criteria provided, conflicting classifications							
NM_002878.4(RAD51D):c.597T>G (p.Thr199=)	RAD51D|RAD51L3-RFFL		Hereditary cancer-predisposing syndrome	VCV002625301	17	33430543	17	35103524	2625301	2787284	rs1597858897	NC_000017.11:35103523:A:C	single nucleotide variant	non-coding transcript variant|synonymous variant	Likely benign	Aug 24, 2023	criteria provided, single submitter							
NM_002878.4(RAD51D):c.597T>C (p.Thr199=)	RAD51L3-RFFL|RAD51D		Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV000755485	17	33430543	17	35103524	755485	771432	rs1597858897	NC_000017.11:35103523:A:G	single nucleotide variant	non-coding transcript variant|synonymous variant	Benign/Likely benign	Feb 24, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.594A>T (p.Gly198=)	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV003712828	17	33430546	17	35103527	3712828	3844537		NC_000017.11:35103526:T:A	single nucleotide variant	non-coding transcript variant|synonymous variant	Likely benign	Apr 24, 2024	criteria provided, single submitter							
NM_002878.4(RAD51D):c.593G>T (p.Gly198Val)	RAD51L3-RFFL|RAD51D	G198V, G218V, G86V	Hereditary cancer-predisposing syndrome	VCV000186491	17	33430547	17	35103528	186491	184820	rs786202993	NC_000017.11:35103527:C:A	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Oct 9, 2014	criteria provided, single submitter							
NM_002878.4(RAD51D):c.590C>G (p.Ser197Ter)	RAD51D|RAD51L3-RFFL	S197*, S85*, S217*	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV002193058	17	33430550	17	35103531	2193058	1932207	rs2091565327	NC_000017.11:35103530:G:C	single nucleotide variant	non-coding transcript variant|nonsense	Pathogenic	May 2, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.590C>T (p.Ser197Leu)	RAD51D|RAD51L3-RFFL	S217L, S197L, S85L	not provided|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000839302	17	33430550	17	35103531	839302	845217	rs2091565327	NC_000017.11:35103530:G:A	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Aug 17, 2023	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.589T>G (p.Ser197Ala)	RAD51D|RAD51L3-RFFL	S197A, S85A, S217A	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000486283	17	33430551	17	35103532	486283	478441	rs1281145358	NC_000017.11:35103531:A:C	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Oct 31, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.587C>T (p.Ser196Phe)	RAD51D|RAD51L3-RFFL	S196F, S84F, S216F	Breast-ovarian cancer, familial, susceptibility to, 4	VCV002095833	17	33430553	17	35103534	2095833	2149750	rs2142421076	NC_000017.11:35103533:G:A	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Apr 15, 2024	criteria provided, single submitter							
NM_002878.4(RAD51D):c.585T>C (p.Gly195=)	RAD51L3-RFFL|RAD51D		Breast-ovarian cancer, familial, susceptibility to, 4	VCV003903668	17	33430555	17	35103536	3903668	4019541		NC_000017.11:35103535:A:G	single nucleotide variant	non-coding transcript variant|synonymous variant	Benign	Feb 24, 2025	criteria provided, single submitter							
NM_002878.4(RAD51D):c.584G>A (p.Gly195Asp)	RAD51D|RAD51L3-RFFL	G195D, G83D, G215D	not provided|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000848749	17	33430556	17	35103537	848749	845218	rs779231465	NC_000017.11:35103536:C:T	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Dec 19, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.583G>C (p.Gly195Arg)	RAD51D|RAD51L3-RFFL	G215R, G195R, G83R	Breast-ovarian cancer, familial, susceptibility to, 4	VCV001470335	17	33430557	17	35103538	1470335	1372297	rs1567726625	NC_000017.11:35103537:C:G	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Nov 16, 2020	criteria provided, single submitter							
NM_002878.4(RAD51D):c.583G>A (p.Gly195Ser)	RAD51D|RAD51L3-RFFL	G195S, G215S, G83S	Breast-ovarian cancer, familial, susceptibility to, 4	VCV000567812	17	33430557	17	35103538	567812	571287	rs1567726625	NC_000017.11:35103537:C:T	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Mar 3, 2018	criteria provided, single submitter							
NM_002878.4(RAD51D):c.582T>A (p.Thr194=)	RAD51D|RAD51L3-RFFL		Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV001692733	17	33430558	17	35103539	1692733	1685173	rs1555567645	NC_000017.11:35103538:A:T	single nucleotide variant	non-coding transcript variant|synonymous variant	Benign/Likely benign	Feb 24, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.582T>G (p.Thr194=)	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV001139052	17	33430558	17	35103539	1139052	1126146	rs1555567645	NC_000017.11:35103538:A:C	single nucleotide variant	non-coding transcript variant|synonymous variant	Likely benign	Jan 29, 2019	criteria provided, single submitter							
NM_002878.4(RAD51D):c.582T>C (p.Thr194=)	RAD51L3-RFFL|RAD51D		Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000492433	17	33430558	17	35103539	492433	485212	rs1555567645	NC_000017.11:35103538:A:G	single nucleotide variant	non-coding transcript variant|synonymous variant	Likely benign	May 21, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.580A>C (p.Thr194Pro)	RAD51D|RAD51L3-RFFL	T82P, T214P, T194P	Breast-ovarian cancer, familial, susceptibility to, 4	VCV001434011	17	33430560	17	35103541	1434011	1497709	rs2142421166	NC_000017.11:35103540:T:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Aug 24, 2022	criteria provided, single submitter							
NM_002878.4(RAD51D):c.579G>T (p.Val193=)	RAD51L3-RFFL|RAD51D		Breast-ovarian cancer, familial, susceptibility to, 4	VCV003651605	17	33430561	17	35103542	3651605	3788316		NC_000017.11:35103541:C:A	single nucleotide variant	non-coding transcript variant|synonymous variant	Benign/Likely benign	Feb 24, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.577G>A (p.Val193Met)	RAD51D|RAD51L3-RFFL	V213M, V81M, V193M	Breast-ovarian cancer, familial, susceptibility to, 4	VCV002775685	17	33430563	17	35103544	2775685	2942877	rs2142421210	NC_000017.11:35103543:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Oct 17, 2023	criteria provided, single submitter							
NM_002878.4(RAD51D):c.577G>T (p.Val193Leu)	RAD51D|RAD51L3-RFFL	V81L, V213L, V193L	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV001392467	17	33430563	17	35103544	1392467	1502370	rs2142421210	NC_000017.11:35103543:C:A	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Aug 10, 2023	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.577-1G>A	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV002763364	17	33430564	17	35103545	2763364	2925403	rs2142421220	NC_000017.11:35103544:C:T	single nucleotide variant	splice acceptor variant	Pathogenic	Apr 17, 2024	criteria provided, single submitter							
NM_002878.4(RAD51D):c.577-2A>T	RAD51L3-RFFL|RAD51D		Hereditary cancer-predisposing syndrome	VCV003894341	17	33430565	17	35103546	3894341	4010221		NC_000017.11:35103545:T:A	single nucleotide variant	splice acceptor variant	Likely pathogenic	Jan 22, 2024	criteria provided, single submitter							
NM_002878.4(RAD51D):c.577-2A>G	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|not provided	VCV000482184	17	33430565	17	35103546	482184	479169	rs1555567649	NC_000017.11:35103545:T:C	single nucleotide variant	splice acceptor variant	Pathogenic/Likely pathogenic	Apr 30, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.577-3C>T	RAD51D|RAD51L3-RFFL		Hereditary cancer-predisposing syndrome	VCV000825957	17	33430566	17	35103547	825957	815675	rs1597858942	NC_000017.11:35103546:G:A	single nucleotide variant	intron variant	Uncertain significance	Jan 4, 2023	criteria provided, single submitter							
NM_002878.4(RAD51D):c.577-5T>C	RAD51D|RAD51L3-RFFL		Hereditary cancer-predisposing syndrome	VCV000825963	17	33430568	17	35103549	825963	815676	rs1597858947	NC_000017.11:35103548:A:G	single nucleotide variant	intron variant	Uncertain significance	Dec 15, 2019	criteria provided, single submitter							
NM_002878.4(RAD51D):c.577-6C>A	RAD51D|RAD51L3-RFFL		Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000839212	17	33430569	17	35103550	839212	851713	rs1210749655	NC_000017.11:35103549:G:T	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Oct 2, 2024	criteria provided, conflicting classifications							
NM_002878.4(RAD51D):c.577-7C>T	RAD51L3-RFFL|RAD51D		Familial ovarian cancer|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000539863	17	33430570	17	35103551	539863	531448	rs1438561890	NC_000017.11:35103550:G:A	single nucleotide variant	intron variant	Likely benign	Feb 24, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.577-10A>T	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV000745502	17	33430573	17	35103554	745502	760405	rs1060504767	NC_000017.11:35103553:T:A	single nucleotide variant	intron variant	Likely benign	May 6, 2024	criteria provided, single submitter							
NM_002878.4(RAD51D):c.577-10A>C	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV000539869	17	33430573	17	35103554	539869	531450	rs1060504767	NC_000017.11:35103553:T:G	single nucleotide variant	intron variant	Likely benign	Nov 23, 2019	criteria provided, single submitter							
NM_002878.4(RAD51D):c.577-10A>G	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV000416204	17	33430573	17	35103554	416204	401875	rs1060504767	NC_000017.11:35103553:T:C	single nucleotide variant	intron variant	Likely benign	May 22, 2023	criteria provided, single submitter							
NM_002878.4(RAD51D):c.577-11C>T	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV003904258	17	33430574	17	35103555	3904258	4020131		NC_000017.11:35103554:G:A	single nucleotide variant	intron variant	Likely benign	Feb 24, 2025	criteria provided, single submitter							
NM_002878.4(RAD51D):c.577-11C>A	RAD51L3-RFFL|RAD51D		Breast-ovarian cancer, familial, susceptibility to, 4	VCV002061687	17	33430574	17	35103555	2061687	2120835	rs2142421322	NC_000017.11:35103554:G:T	single nucleotide variant	intron variant	Likely benign	Jul 29, 2023	criteria provided, single submitter							
NM_002878.4(RAD51D):c.577-13C>G	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary breast ovarian cancer syndrome	VCV002094115	17	33430576	17	35103557	2094115	2149329	rs748697766	NC_000017.11:35103556:G:C	single nucleotide variant	intron variant	Likely benign	Oct 6, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.577-13C>A	RAD51L3-RFFL|RAD51D		Hereditary cancer-predisposing syndrome|not provided|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000492432	17	33430576	17	35103557	492432	484954	rs748697766	NC_000017.11:35103556:G:T	single nucleotide variant	intron variant	Likely benign	Oct 2, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.577-14C>T	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV002727831	17	33430577	17	35103558	2727831	2893037	rs901774537	NC_000017.11:35103557:G:A	single nucleotide variant	intron variant	Likely benign	Feb 24, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.577-15C>T	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV003903746	17	33430578	17	35103559	3903746	4019619		NC_000017.11:35103558:G:A	single nucleotide variant	intron variant	Likely benign	Feb 24, 2025	criteria provided, single submitter							
NM_002878.4(RAD51D):c.577-15C>G	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV002023145	17	33430578	17	35103559	2023145	2087467	rs1289194720	NC_000017.11:35103558:G:C	single nucleotide variant	intron variant	Likely benign	Aug 9, 2022	criteria provided, single submitter							
NM_002878.4(RAD51D):c.577-15C>A	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV001585731	17	33430578	17	35103559	1585731	1540247	rs1289194720	NC_000017.11:35103558:G:T	single nucleotide variant	intron variant	Likely benign	Jan 20, 2022	criteria provided, single submitter							
NM_002878.4(RAD51D):c.577-17C>G	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4|not specified	VCV000510758	17	33430580	17	35103561	510758	506773	rs758865282	NC_000017.11:35103560:G:C	single nucleotide variant	intron variant	Likely benign	Nov 22, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.577-18T>A	RAD51D|RAD51L3-RFFL		Hereditary cancer-predisposing syndrome	VCV000927509	17	33430581	17	35103562	927509	916717	rs2091565854	NC_000017.11:35103561:A:T	single nucleotide variant	intron variant	Likely benign	Sep 30, 2019	criteria provided, single submitter							
NM_002878.4(RAD51D):c.577-19T>G	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV002802094	17	33430582	17	35103563	2802094	2952857	rs2142421405	NC_000017.11:35103562:A:C	single nucleotide variant	intron variant	Likely benign	Jan 11, 2024	criteria provided, single submitter							
NM_002878.4(RAD51D):c.577-20C>T	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV003904055	17	33430583	17	35103564	3904055	4019928		NC_000017.11:35103563:G:A	single nucleotide variant	intron variant	Likely benign	Feb 24, 2025	criteria provided, single submitter							
NM_002878.4(RAD51D):c.577-211T>C	RAD51D|RAD51L3-RFFL		not provided	VCV000679768	17	33430774	17	35103755	679768	667874	rs28363281	NC_000017.11:35103754:A:G	single nucleotide variant	intron variant	Likely benign	Jun 15, 2018	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.576+35C>T	RAD51D|RAD51L3-RFFL		not specified	VCV001697594	17	33433370	17	35106351	1697594	1689978	rs2142428463	NC_000017.11:35106350:G:A	single nucleotide variant	intron variant	Likely benign	Mar 4, 2025	criteria provided, single submitter							
NM_002878.4(RAD51D):c.576+19C>T	RAD51L3-RFFL|RAD51D		not provided|not specified|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000388072	17	33433386	17	35106367	388072	375868	rs749835057	NC_000017.11:35106366:G:A	single nucleotide variant	intron variant	Likely benign	Dec 15, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.576+18C>T	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome|not specified	VCV000378462	17	33433387	17	35106368	378462	375979	rs752051995	NC_000017.11:35106367:G:A	single nucleotide variant	intron variant	Benign/Likely benign	Jan 29, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.576+17G>A	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV002801635	17	33433388	17	35106369	2801635	2956277	rs2142428627	NC_000017.11:35106368:C:T	single nucleotide variant	intron variant	Likely benign	Jul 22, 2023	criteria provided, single submitter							
NM_002878.4(RAD51D):c.576+16T>C	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV002990363	17	33433389	17	35106370	2990363	3144268	rs2142428640	NC_000017.11:35106369:A:G	single nucleotide variant	intron variant	Likely benign	Nov 11, 2022	criteria provided, single submitter							
NM_002878.4(RAD51D):c.576+12G>A	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome|not specified|Hereditary breast ovarian cancer syndrome	VCV000516567	17	33433393	17	35106374	516567	505846	rs757751100	NC_000017.11:35106373:C:T	single nucleotide variant	intron variant	Likely benign	Mar 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.576+12G>C	RAD51D|RAD51L3-RFFL		not specified	VCV000392781	17	33433393	17	35106374	392781	375984	rs757751100	NC_000017.11:35106373:C:G	single nucleotide variant	intron variant	Likely benign	Jan 9, 2017	criteria provided, single submitter							
NM_002878.4(RAD51D):c.576+11T>C	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV001606723	17	33433394	17	35106375	1606723	1658586	rs2142428684	NC_000017.11:35106374:A:G	single nucleotide variant	intron variant	Likely benign	Dec 26, 2024	criteria provided, single submitter							
NM_002878.4(RAD51D):c.576+10C>T	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV001652486	17	33433395	17	35106376	1652486	1664399	rs1319671342	NC_000017.11:35106375:G:A	single nucleotide variant	intron variant	Likely benign	Mar 5, 2022	criteria provided, single submitter							
NM_002878.4(RAD51D):c.576+9G>C	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV003903502	17	33433396	17	35106377	3903502	4019375		NC_000017.11:35106376:C:G	single nucleotide variant	intron variant	Likely benign	Feb 24, 2025	criteria provided, single submitter							
NM_002878.4(RAD51D):c.576+5G>A	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV002563031	17	33433400	17	35106381	2563031	2733488	rs2142428725	NC_000017.11:35106380:C:T	single nucleotide variant	intron variant	Uncertain significance	Oct 30, 2023	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.576+4A>C	RAD51D|RAD51L3-RFFL		Hereditary cancer-predisposing syndrome	VCV003942387	17	33433401	17	35106382	3942387	4064166		NC_000017.11:35106381:T:G	single nucleotide variant	intron variant	Uncertain significance	May 15, 2025	criteria provided, single submitter							
NM_002878.4(RAD51D):c.576+3G>T	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV002023593	17	33433402	17	35106383	2023593	2084074	rs2142428750	NC_000017.11:35106382:C:A	single nucleotide variant	intron variant	Uncertain significance	Aug 17, 2022	criteria provided, single submitter							
NM_002878.4(RAD51D):c.576+3G>A	RAD51D|RAD51L3-RFFL		Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV001749480	17	33433402	17	35106383	1749480	1800508	rs2142428750	NC_000017.11:35106382:C:T	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Feb 24, 2025	criteria provided, conflicting classifications							
NM_002878.4(RAD51D):c.576+3G>C	RAD51D|RAD51L3-RFFL		Hereditary cancer-predisposing syndrome	VCV001692731	17	33433402	17	35106383	1692731	1685171	rs2142428750	NC_000017.11:35106382:C:G	single nucleotide variant	intron variant	Uncertain significance	Oct 30, 2021	criteria provided, single submitter							
NM_002878.4(RAD51D):c.576+2T>G	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV003727993	17	33433403	17	35106384	3727993	3855193		NC_000017.11:35106383:A:C	single nucleotide variant	splice donor variant	Likely pathogenic	Dec 24, 2024	criteria provided, single submitter							
NM_002878.4(RAD51D):c.576+2T>C	RAD51L3-RFFL|RAD51D		Breast-ovarian cancer, familial, susceptibility to, 4	VCV001472197	17	33433403	17	35106384	1472197	1385345	rs2142428757	NC_000017.11:35106383:A:G	single nucleotide variant	splice donor variant	Pathogenic	Oct 28, 2022	criteria provided, single submitter							
NM_002878.4(RAD51D):c.576+1G>T	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome|not provided	VCV000641144	17	33433404	17	35106385	641144	653444	rs781161543	NC_000017.11:35106384:C:A	single nucleotide variant	splice donor variant	Conflicting classifications of pathogenicity	Oct 7, 2024	criteria provided, conflicting classifications							
NM_002878.4(RAD51D):c.576+1G>A	RAD51D|RAD51L3-RFFL		Hereditary cancer-predisposing syndrome|not provided|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000371839	17	33433404	17	35106385	371839	358920	rs781161543	NC_000017.11:35106384:C:T	single nucleotide variant	splice donor variant	Pathogenic/Likely pathogenic	Jun 5, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.576G>T (p.Gln192His)	RAD51D|RAD51L3-RFFL	Q192H, Q212H, Q80H	Breast-ovarian cancer, familial, susceptibility to, 4	VCV001044475	17	33433405	17	35106386	1044475	1033228	rs2091602856	NC_000017.11:35106385:C:A	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	May 21, 2024	criteria provided, single submitter							
NM_002878.4(RAD51D):c.576G>A (p.Gln192=)	RAD51D|RAD51L3-RFFL		Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV001005922	17	33433405	17	35106386	1005922	997499	rs2091602856	NC_000017.11:35106385:C:T	single nucleotide variant	non-coding transcript variant|synonymous variant	Uncertain significance	Jul 8, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.575A>C (p.Gln192Pro)	RAD51D|RAD51L3-RFFL	Q192P, Q212P, Q80P	Breast-ovarian cancer, familial, susceptibility to, 4	VCV001504398	17	33433406	17	35106387	1504398	1337273	rs876660090	NC_000017.11:35106386:T:G	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Jan 22, 2021	criteria provided, single submitter							
NM_002878.4(RAD51D):c.575A>G (p.Gln192Arg)	RAD51D|RAD51L3-RFFL	Q192R, Q212R, Q80R	Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000232943	17	33433406	17	35106387	232943	235880	rs876660090	NC_000017.11:35106386:T:C	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Aug 28, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.574C>T (p.Gln192Ter)	RAD51D|RAD51L3-RFFL	Q192*, Q212*, Q80*	Hereditary cancer-predisposing syndrome	VCV000989429	17	33433407	17	35106388	989429	977349	rs2091602962	NC_000017.11:35106387:G:A	single nucleotide variant	non-coding transcript variant|nonsense	Pathogenic	Nov 10, 2020	criteria provided, single submitter							
NM_002878.4(RAD51D):c.573G>A (p.Gln191=)	RAD51D|RAD51L3-RFFL		Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 4|not provided|Hereditary cancer-predisposing syndrome	VCV000794648	17	33433408	17	35106389	794648	785538	rs1597861626	NC_000017.11:35106388:C:T	single nucleotide variant	non-coding transcript variant|synonymous variant	Conflicting classifications of pathogenicity	Feb 24, 2025	criteria provided, conflicting classifications							
NM_002878.4(RAD51D):c.572A>T (p.Gln191Leu)	RAD51D|RAD51L3-RFFL	Q211L, Q79L, Q191L	Breast-ovarian cancer, familial, susceptibility to, 4	VCV002826667	17	33433409	17	35106390	2826667	2986469	rs2509135048	NC_000017.11:35106389:T:A	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Mar 13, 2023	criteria provided, single submitter							
NM_002878.4(RAD51D):c.571C>T (p.Gln191Ter)	RAD51D|RAD51L3-RFFL	Q191*, Q79*, Q211*	Familial ovarian cancer|Breast-ovarian cancer, familial, susceptibility to, 4	VCV002102431	17	33433410	17	35106391	2102431	2165476	rs2142428821	NC_000017.11:35106390:G:A	single nucleotide variant	non-coding transcript variant|nonsense	Pathogenic	Jan 31, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.570C>T (p.Ala190=)	RAD51D|RAD51L3-RFFL		not provided|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000187328	17	33433411	17	35106392	187328	184821	rs750479232	NC_000017.11:35106391:G:A	single nucleotide variant	non-coding transcript variant|synonymous variant	Benign/Likely benign	Feb 24, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.569C>A (p.Ala190Asp)	RAD51D|RAD51L3-RFFL	A190D, A210D, A78D	Breast-ovarian cancer, familial, susceptibility to, 4	VCV002505283	17	33433412	17	35106393	2505283	2670250	rs1435997941	NC_000017.11:35106392:G:T	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Jun 14, 2023	criteria provided, single submitter							
NM_002878.4(RAD51D):c.569C>T (p.Ala190Val)	RAD51D|RAD51L3-RFFL	A210V, A190V, A78V	not provided|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000952052	17	33433412	17	35106393	952052	928224	rs1435997941	NC_000017.11:35106392:G:A	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Sep 10, 2019	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.568G>A (p.Ala190Thr)	RAD51D|RAD51L3-RFFL	A190T, A78T, A210T	Breast and/or ovarian cancer|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4|not specified|not provided|Hereditary cancer	VCV000127892	17	33433413	17	35106394	127892	133349	rs80116829	NC_000017.11:35106393:C:T	single nucleotide variant	non-coding transcript variant|missense variant	Conflicting classifications of pathogenicity	Feb 3, 2025	criteria provided, conflicting classifications							
NM_002878.4(RAD51D):c.567G>T (p.Val189=)	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV003904458	17	33433414	17	35106395	3904458	4020330		NC_000017.11:35106394:C:A	single nucleotide variant	non-coding transcript variant|synonymous variant	Benign	Feb 24, 2025	criteria provided, single submitter							
NM_002878.4(RAD51D):c.567G>A (p.Val189=)	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV000539868	17	33433414	17	35106395	539868	531453	rs373975416	NC_000017.11:35106394:C:T	single nucleotide variant	non-coding transcript variant|synonymous variant	Benign/Likely benign	Feb 24, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.566T>C (p.Val189Ala)	RAD51D|RAD51L3-RFFL	V77A, V209A, V189A	Hereditary cancer-predisposing syndrome	VCV003786517	17	33433415	17	35106396	3786517	3908958		NC_000017.11:35106395:A:G	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Feb 27, 2025	criteria provided, single submitter							
NM_002878.4(RAD51D):c.564T>C (p.Thr188=)	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV001670694	17	33433417	17	35106398	1670694	1605001	rs1258276444	NC_000017.11:35106397:A:G	single nucleotide variant	non-coding transcript variant|synonymous variant	Benign/Likely benign	Feb 24, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.564T>A (p.Thr188=)	RAD51D|RAD51L3-RFFL		not provided|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV001116875	17	33433417	17	35106398	1116875	1104721	rs1258276444	NC_000017.11:35106397:A:T	single nucleotide variant	non-coding transcript variant|synonymous variant	Conflicting classifications of pathogenicity	Mar 4, 2025	criteria provided, conflicting classifications							
NM_002878.4(RAD51D):c.563C>T (p.Thr188Ile)	RAD51D|RAD51L3-RFFL	T188I, T76I, T208I	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV003000425	17	33433418	17	35106399	3000425	3156896	rs2142428909	NC_000017.11:35106398:G:A	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	May 11, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.561C>T (p.Gly187=)	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV002701474	17	33433420	17	35106401	2701474	2862468	rs2142428930	NC_000017.11:35106400:G:A	single nucleotide variant	non-coding transcript variant|synonymous variant	Uncertain significance	Dec 8, 2023	criteria provided, single submitter							
NM_002878.4(RAD51D):c.560G>A (p.Gly187Asp)	RAD51L3-RFFL|RAD51D	G187D, G207D, G75D	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000936234	17	33433421	17	35106402	936234	937888	rs2091603358	NC_000017.11:35106401:C:T	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Apr 1, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.559G>C (p.Gly187Arg)	RAD51D|RAD51L3-RFFL	G187R, G207R, G75R	Breast-ovarian cancer, familial, susceptibility to, 4	VCV003626438	17	33433422	17	35106403	3626438	3758269		NC_000017.11:35106402:C:G	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Sep 29, 2024	criteria provided, single submitter							
NM_002878.4(RAD51D):c.559G>A (p.Gly187Ser)	RAD51D|RAD51L3-RFFL	G187S, G207S, G75S	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV001376524	17	33433422	17	35106403	1376524	1479389	rs1474938268	NC_000017.11:35106402:C:T	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Oct 21, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.558A>G (p.Arg186=)	RAD51D|RAD51L3-RFFL		Hereditary cancer-predisposing syndrome	VCV001748463	17	33433423	17	35106404	1748463	1806711	rs2142428955	NC_000017.11:35106403:T:C	single nucleotide variant	non-coding transcript variant|synonymous variant	Likely benign	Oct 17, 2019	criteria provided, single submitter							
NM_002878.4(RAD51D):c.557G>A (p.Arg186Gln)	RAD51D|RAD51L3-RFFL	R186Q, R206Q, R74Q	Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV000480526	17	33433424	17	35106405	480526	479171	rs780491769	NC_000017.11:35106404:C:T	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Oct 25, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.556C>A (p.Arg186=)	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV003903947	17	33433425	17	35106406	3903947	4019820		NC_000017.11:35106405:G:T	single nucleotide variant	non-coding transcript variant|synonymous variant	Benign	Feb 24, 2025	criteria provided, single submitter							
NM_002878.4(RAD51D):c.556C>T (p.Arg186Ter)	RAD51D|RAD51L3-RFFL	R186*, R206*, R74*	Inherited ovarian cancer (without breast cancer)|Inherited breast cancer and ovarian cancer|Hereditary cancer-predisposing syndrome|not provided|Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary breast ovarian cancer syndrome	VCV000030285	17	33433425	17	35106406	30285	39241	rs387906843	NC_000017.11:35106405:G:A	single nucleotide variant	nonsense|non-coding transcript variant	Pathogenic/Likely pathogenic	Apr 9, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.555C>T (p.Leu185=)	RAD51D|RAD51L3-RFFL		Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV001748283	17	33433426	17	35106407	1748283	1806531	rs2142428984	NC_000017.11:35106406:G:A	single nucleotide variant	non-coding transcript variant|synonymous variant	Benign/Likely benign	Feb 24, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.554T>C (p.Leu185Pro)	RAD51D|RAD51L3-RFFL	L73P, L205P, L185P	Breast-ovarian cancer, familial, susceptibility to, 4	VCV001380116	17	33433427	17	35106408	1380116	1506165	rs2142429006	NC_000017.11:35106407:A:G	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Jun 23, 2023	criteria provided, single submitter							
NM_002878.4(RAD51D):c.553C>T (p.Leu185Phe)	RAD51D|RAD51L3-RFFL	L205F, L73F, L185F	Breast-ovarian cancer, familial, susceptibility to, 4	VCV001443477	17	33433428	17	35106409	1443477	1384423	rs2142429012	NC_000017.11:35106408:G:A	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Jun 2, 2023	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.552G>A (p.Glu184=)	RAD51D|RAD51L3-RFFL		not specified|Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV000753131	17	33433429	17	35106410	753131	771433	rs1462752398	NC_000017.11:35106409:C:T	single nucleotide variant	non-coding transcript variant|synonymous variant	Likely benign	Mar 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.551A>T (p.Glu184Val)	RAD51D|RAD51L3-RFFL	E184V, E72V, E204V	Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV000410564	17	33433430	17	35106411	410564	402588	rs1060502960	NC_000017.11:35106410:T:A	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Jan 8, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.550G>T (p.Glu184Ter)	RAD51D|RAD51L3-RFFL	E184*, E72*, E204*	Breast-ovarian cancer, familial, susceptibility to, 4	VCV001453715	17	33433431	17	35106412	1453715	1451242	rs200009601	NC_000017.11:35106411:C:A	single nucleotide variant	non-coding transcript variant|nonsense	Pathogenic	Jul 12, 2022	criteria provided, single submitter							
NM_002878.4(RAD51D):c.550G>A (p.Glu184Lys)	RAD51D|RAD51L3-RFFL	E184K, E204K, E72K	Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome|not provided	VCV000187314	17	33433431	17	35106412	187314	184823	rs200009601	NC_000017.11:35106411:C:T	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Mar 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.549G>A (p.Gln183=)	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV000472612	17	33433432	17	35106413	472612	467936	rs1555568122	NC_000017.11:35106412:C:T	single nucleotide variant	non-coding transcript variant|synonymous variant	Likely benign	May 7, 2024	criteria provided, single submitter							
NM_002878.4(RAD51D):c.548A>C (p.Gln183Pro)	RAD51D|RAD51L3-RFFL	Q183P, Q71P, Q203P	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000825768	17	33433433	17	35106414	825768	813561	rs1597861698	NC_000017.11:35106413:T:G	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Sep 18, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.547C>T (p.Gln183Ter)	RAD51D|RAD51L3-RFFL	Q183*, Q71*, Q203*	Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome|not provided|Familial ovarian cancer	VCV000142754	17	33433434	17	35106415	142754	152468	rs587782695	NC_000017.11:35106414:G:A	single nucleotide variant	non-coding transcript variant|nonsense	Pathogenic/Likely pathogenic	Dec 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.546G>T (p.Leu182=)	RAD51D|RAD51L3-RFFL		Hereditary cancer-predisposing syndrome	VCV003942389	17	33433435	17	35106416	3942389	4064168		NC_000017.11:35106415:C:A	single nucleotide variant	non-coding transcript variant|synonymous variant	Likely benign	May 16, 2025	criteria provided, single submitter							
NM_002878.4(RAD51D):c.546G>A (p.Leu182=)	RAD51D|RAD51L3-RFFL		Hereditary cancer-predisposing syndrome	VCV001747725	17	33433435	17	35106416	1747725	1800023	rs1597861704	NC_000017.11:35106415:C:T	single nucleotide variant	non-coding transcript variant|synonymous variant	Likely benign	Jan 21, 2021	criteria provided, single submitter							
NM_002878.4(RAD51D):c.546G>C (p.Leu182=)	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV000755647	17	33433435	17	35106416	755647	771434	rs1597861704	NC_000017.11:35106415:C:G	single nucleotide variant	non-coding transcript variant|synonymous variant	Likely benign	Oct 5, 2018	criteria provided, single submitter							
NM_002878.4(RAD51D):c.544C>A (p.Leu182Met)	RAD51D|RAD51L3-RFFL	L70M, L182M, L202M	Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV002696474	17	33433437	17	35106418	2696474	2857894	rs937006542	NC_000017.11:35106417:G:T	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Feb 10, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.544C>T (p.Leu182=)	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV001654220	17	33433437	17	35106418	1654220	1527038	rs937006542	NC_000017.11:35106417:G:A	single nucleotide variant	non-coding transcript variant|synonymous variant	Likely benign	Jan 13, 2021	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.543G>A (p.Val181=)	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV000482195	17	33433438	17	35106419	482195	478597	rs1555568135	NC_000017.11:35106418:C:T	single nucleotide variant	non-coding transcript variant|synonymous variant	Benign/Likely benign	Feb 24, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.541G>A (p.Val181Met)	RAD51L3-RFFL|RAD51D	V181M, V201M, V69M	Hereditary cancer-predisposing syndrome|not provided|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000230636	17	33433440	17	35106421	230636	235881	rs876658678	NC_000017.11:35106420:C:T	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Nov 22, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.540T>G (p.Asp180Glu)	RAD51D|RAD51L3-RFFL	D180E, D200E, D68E	Breast-ovarian cancer, familial, susceptibility to, 4	VCV000836020	17	33433441	17	35106422	836020	845220	rs2091603952	NC_000017.11:35106421:A:C	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Nov 26, 2019	criteria provided, single submitter							
NM_002878.4(RAD51D):c.538G>A (p.Asp180Asn)	RAD51D|RAD51L3-RFFL	D180N, D200N, D68N	Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV001446164	17	33433443	17	35106424	1446164	1390993	rs2142429135	NC_000017.11:35106423:C:T	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Aug 12, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.537G>C (p.Leu179=)	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV003904203	17	33433444	17	35106425	3904203	4020076		NC_000017.11:35106424:C:G	single nucleotide variant	non-coding transcript variant|synonymous variant	Benign	Feb 24, 2025	criteria provided, single submitter							
NM_002878.4(RAD51D):c.537G>A (p.Leu179=)	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV000484773	17	33433444	17	35106425	484773	478444	rs1555568141	NC_000017.11:35106424:C:T	single nucleotide variant	non-coding transcript variant|synonymous variant	Likely benign	Oct 16, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.536T>C (p.Leu179Pro)	RAD51D|RAD51L3-RFFL	L179P, L67P, L199P	Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV001747099	17	33433445	17	35106426	1747099	1802850	rs777593941	NC_000017.11:35106425:A:G	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Feb 11, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.536T>G (p.Leu179Arg)	RAD51D|RAD51L3-RFFL	L179R, L199R, L67R	Breast-ovarian cancer, familial, susceptibility to, 4	VCV001007823	17	33433445	17	35106426	1007823	997501	rs777593941	NC_000017.11:35106425:A:C	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Mar 7, 2024	criteria provided, single submitter							
NM_002878.4(RAD51D):c.535C>T (p.Leu179=)	RAD51D|RAD51L3-RFFL		Hereditary cancer-predisposing syndrome	VCV003893987	17	33433446	17	35106427	3893987	4009868		NC_000017.11:35106426:G:A	single nucleotide variant	non-coding transcript variant|synonymous variant	Likely benign	Jul 8, 2024	criteria provided, single submitter							
NM_002878.4(RAD51D):c.535C>G (p.Leu179Val)	RAD51L3-RFFL|RAD51D	L67V, L179V, L199V	Breast-ovarian cancer, familial, susceptibility to, 4	VCV000657969	17	33433446	17	35106427	657969	645805	rs1597861729	NC_000017.11:35106426:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Sep 5, 2023	criteria provided, single submitter							
NM_002878.4(RAD51D):c.533T>C (p.Met178Thr)	RAD51D|RAD51L3-RFFL	M178T, M198T, M66T	not provided|Breast-ovarian cancer, familial, susceptibility to, 4	VCV002575698	17	33433448	17	35106429	2575698	2740594	rs2142429197	NC_000017.11:35106428:A:G	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Nov 8, 2023	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.532A>T (p.Met178Leu)	RAD51D|RAD51L3-RFFL	M198L, M66L, M178L	Hereditary cancer-predisposing syndrome	VCV000825655	17	33433449	17	35106430	825655	813562	rs786202505	NC_000017.11:35106429:T:A	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Nov 22, 2019	criteria provided, single submitter							
NM_002878.4(RAD51D):c.532A>G (p.Met178Val)	RAD51D|RAD51L3-RFFL	M178V, M66V, M198V	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000185851	17	33433449	17	35106430	185851	184824	rs786202505	NC_000017.11:35106429:T:C	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Jun 14, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.531G>T (p.Gln177His)	RAD51D|RAD51L3-RFFL	Q177H, Q197H, Q65H	Hereditary cancer-predisposing syndrome	VCV003222885	17	33433450	17	35106431	3222885	3386523	rs1555568143	NC_000017.11:35106430:C:A	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Nov 10, 2023	criteria provided, single submitter							
NM_002878.4(RAD51D):c.531G>A (p.Gln177=)	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV000490143	17	33433450	17	35106431	490143	482985	rs1555568143	NC_000017.11:35106430:C:T	single nucleotide variant	non-coding transcript variant|synonymous variant	Benign/Likely benign	Feb 24, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.530A>G (p.Gln177Arg)	RAD51D|RAD51L3-RFFL	Q177R, Q65R, Q197R	Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV002965685	17	33433451	17	35106432	2965685	3127803	rs786201960	NC_000017.11:35106431:T:C	single nucleotide variant	non-coding transcript variant|missense variant	Conflicting classifications of pathogenicity	Jun 6, 2025	criteria provided, conflicting classifications							
NM_002878.4(RAD51D):c.530A>T (p.Gln177Leu)	RAD51D|RAD51L3-RFFL	Q177L, Q197L, Q65L	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000185143	17	33433451	17	35106432	185143	184825	rs786201960	NC_000017.11:35106431:T:A	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Jun 10, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.529C>T (p.Gln177Ter)	RAD51L3-RFFL|RAD51D	Q177*, Q197*, Q65*	Breast-ovarian cancer, familial, susceptibility to, 4	VCV002891421	17	33433452	17	35106433	2891421	3055231	rs2142429256	NC_000017.11:35106432:G:A	single nucleotide variant	non-coding transcript variant|nonsense	Pathogenic	Mar 24, 2023	criteria provided, single submitter							
NM_002878.4(RAD51D):c.528C>T (p.Phe176=)	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV003903853	17	33433453	17	35106434	3903853	4019726		NC_000017.11:35106433:G:A	single nucleotide variant	non-coding transcript variant|synonymous variant	Benign	Feb 24, 2025	criteria provided, single submitter							
NM_002878.4(RAD51D):c.527T>A (p.Phe176Tyr)	RAD51D|RAD51L3-RFFL	F176Y, F64Y, F196Y	Breast-ovarian cancer, familial, susceptibility to, 4	VCV000653386	17	33433454	17	35106435	653386	645806	rs1064794153	NC_000017.11:35106434:A:T	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Nov 8, 2018	criteria provided, single submitter							
NM_002878.4(RAD51D):c.527T>C (p.Phe176Ser)	RAD51D|RAD51L3-RFFL	F176S, F196S, F64S	not provided|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000419859	17	33433454	17	35106435	419859	409898	rs1064794153	NC_000017.11:35106434:A:G	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Aug 22, 2022	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.526T>C (p.Phe176Leu)	RAD51D|RAD51L3-RFFL	F196L, F176L, F64L	Breast-ovarian cancer, familial, susceptibility to, 4	VCV002758434	17	33433455	17	35106436	2758434	2910533	rs2142429290	NC_000017.11:35106435:A:G	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Sep 6, 2023	criteria provided, single submitter							
NM_002878.4(RAD51D):c.525C>T (p.Ile175=)	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV002707482	17	33433456	17	35106437	2707482	2867172	rs2142429301	NC_000017.11:35106436:G:A	single nucleotide variant	non-coding transcript variant|synonymous variant	Likely benign	Jan 11, 2024	criteria provided, single submitter							
NM_002878.4(RAD51D):c.524T>C (p.Ile175Thr)	RAD51D|RAD51L3-RFFL	I175T, I195T, I63T	Hereditary cancer-predisposing syndrome	VCV003893842	17	33433457	17	35106438	3893842	4009723		NC_000017.11:35106437:A:G	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	May 13, 2024	criteria provided, single submitter							
NM_002878.4(RAD51D):c.523A>G (p.Ile175Val)	RAD51D|RAD51L3-RFFL	I63V, I175V, I195V	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000646627	17	33433458	17	35106439	646627	645807	rs1314057673	NC_000017.11:35106438:T:C	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Jul 24, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.523A>C (p.Ile175Leu)	RAD51L3-RFFL|RAD51D	I175L, I63L, I195L	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000484778	17	33433458	17	35106439	484778	478482	rs1314057673	NC_000017.11:35106438:T:G	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	May 6, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.522C>T (p.Asp174=)	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV003712586	17	33433459	17	35106440	3712586	3844296		NC_000017.11:35106439:G:A	single nucleotide variant	non-coding transcript variant|synonymous variant	Benign/Likely benign	Feb 24, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.521A>T (p.Asp174Val)	RAD51D|RAD51L3-RFFL	D174V, D194V, D62V	Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV001718468	17	33433460	17	35106441	1718468	1778828	rs2142429336	NC_000017.11:35106440:T:A	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	May 22, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.520G>A (p.Asp174Asn)	RAD51D|RAD51L3-RFFL	D194N, D62N, D174N	Breast-ovarian cancer, familial, susceptibility to, 4	VCV000845449	17	33433461	17	35106442	845449	845221	rs1555568152	NC_000017.11:35106441:C:T	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Mar 25, 2019	criteria provided, single submitter							
NM_002878.4(RAD51D):c.520G>T (p.Asp174Tyr)	RAD51D|RAD51L3-RFFL	D174Y, D194Y, D62Y	Hereditary cancer-predisposing syndrome	VCV000480528	17	33433461	17	35106442	480528	479174	rs1555568152	NC_000017.11:35106441:C:A	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Jan 26, 2016	criteria provided, single submitter							
NM_002878.4(RAD51D):c.519T>A (p.Phe173Leu)	RAD51D|RAD51L3-RFFL	F173L, F193L, F61L	Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV000230203	17	33433462	17	35106443	230203	235882	rs876658447	NC_000017.11:35106442:A:T	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Dec 30, 2023	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.516A>T (p.Ala172=)	RAD51D|RAD51L3-RFFL		Hereditary cancer-predisposing syndrome	VCV003222884	17	33433465	17	35106446	3222884	3386522	rs2142429380	NC_000017.11:35106445:T:A	single nucleotide variant	non-coding transcript variant|synonymous variant	Likely benign	Jan 3, 2023	criteria provided, single submitter							
NM_002878.4(RAD51D):c.516A>C (p.Ala172=)	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV001993930	17	33433465	17	35106446	1993930	2059592	rs2142429380	NC_000017.11:35106445:T:G	single nucleotide variant	non-coding transcript variant|synonymous variant	Benign/Likely benign	Feb 24, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.516A>G (p.Ala172=)	RAD51D|RAD51L3-RFFL		Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV001154461	17	33433465	17	35106446	1154461	1147039	rs2142429380	NC_000017.11:35106445:T:C	single nucleotide variant	non-coding transcript variant|synonymous variant	Benign/Likely benign	Feb 24, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.515C>T (p.Ala172Val)	RAD51D|RAD51L3-RFFL	A172V, A192V, A60V	not provided|Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV000565779	17	33433466	17	35106447	565779	569003	rs1413648665	NC_000017.11:35106446:G:A	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Apr 10, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.514G>A (p.Ala172Thr)	RAD51D|RAD51L3-RFFL	A172T, A60T, A192T	Hereditary cancer-predisposing syndrome	VCV000482198	17	33433467	17	35106448	482198	479182	rs1555568157	NC_000017.11:35106447:C:T	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Dec 14, 2016	criteria provided, single submitter							
NM_002878.4(RAD51D):c.511C>T (p.His171Tyr)	RAD51D|RAD51L3-RFFL	H171Y, H59Y, H191Y	Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV000484776	17	33433470	17	35106451	484776	479186	rs1555568159	NC_000017.11:35106450:G:A	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Sep 24, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.510G>A (p.Val170=)	RAD51D|RAD51L3-RFFL		Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 4|not provided	VCV000184638	17	33433471	17	35106452	184638	184826	rs142134504	NC_000017.11:35106451:C:T	single nucleotide variant	non-coding transcript variant|synonymous variant	Benign/Likely benign	Feb 24, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.509T>G (p.Val170Gly)	RAD51D|RAD51L3-RFFL	V190G, V170G, V58G	Breast-ovarian cancer, familial, susceptibility to, 4	VCV002823700	17	33433472	17	35106453	2823700	2982214	rs370679685	NC_000017.11:35106452:A:C	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Dec 27, 2022	criteria provided, single submitter							
NM_002878.4(RAD51D):c.509T>C (p.Val170Ala)	RAD51D|RAD51L3-RFFL	V170A, V58A, V190A	Hereditary cancer-predisposing syndrome|not provided|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000231261	17	33433472	17	35106453	231261	235883	rs370679685	NC_000017.11:35106452:A:G	single nucleotide variant	non-coding transcript variant|missense variant	Conflicting classifications of pathogenicity	Jun 10, 2024	criteria provided, conflicting classifications							
NM_002878.4(RAD51D):c.508G>A (p.Val170Met)	RAD51D|RAD51L3-RFFL	V190M, V170M, V58M	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000969170	17	33433473	17	35106454	969170	958085	rs2091604712	NC_000017.11:35106453:C:T	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Feb 2, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.507G>A (p.Val169=)	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV000484781	17	33433474	17	35106455	484781	478453	rs1555568162	NC_000017.11:35106454:C:T	single nucleotide variant	non-coding transcript variant|synonymous variant	Benign/Likely benign	Feb 24, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.505G>A (p.Val169Met)	RAD51D|RAD51L3-RFFL	V57M, V169M, V189M	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV001745092	17	33433476	17	35106457	1745092	1805938	rs2142429489	NC_000017.11:35106456:C:T	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Mar 16, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.504G>A (p.Gln168=)	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV001153803	17	33433477	17	35106458	1153803	1147040	rs2142429500	NC_000017.11:35106457:C:T	single nucleotide variant	non-coding transcript variant|synonymous variant	Likely benign	Jan 26, 2020	criteria provided, single submitter							
NM_002878.4(RAD51D):c.503A>G (p.Gln168Arg)	RAD51D|RAD51L3-RFFL	Q168R, Q188R, Q56R	Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV000825391	17	33433478	17	35106459	825391	813564	rs1597861822	NC_000017.11:35106458:T:C	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Jan 23, 2020	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.503A>C (p.Gln168Pro)	RAD51D|RAD51L3-RFFL	Q56P, Q168P, Q188P	Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV000825390	17	33433478	17	35106459	825390	813565	rs1597861822	NC_000017.11:35106458:T:G	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Aug 22, 2022	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.502C>T (p.Gln168Ter)	RAD51D|RAD51L3-RFFL	Q168*, Q188*, Q56*	Breast-ovarian cancer, familial, susceptibility to, 4	VCV001074527	17	33433479	17	35106460	1074527	1064141	rs2142429527	NC_000017.11:35106459:G:A	single nucleotide variant	non-coding transcript variant|nonsense	Pathogenic	Jan 4, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.499A>G (p.Ile167Val)	RAD51D|RAD51L3-RFFL	I167V, I187V, I55V	Breast-ovarian cancer, familial, susceptibility to, 4	VCV002809390	17	33433482	17	35106463	2809390	2975186	rs2142429553	NC_000017.11:35106462:T:C	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Oct 23, 2022	criteria provided, single submitter							
NM_002878.4(RAD51D):c.499A>T (p.Ile167Phe)	RAD51L3-RFFL|RAD51D	I167F, I55F, I187F	Hereditary cancer-predisposing syndrome	VCV001744637	17	33433482	17	35106463	1744637	1809417	rs2142429553	NC_000017.11:35106462:T:A	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Dec 29, 2021	criteria provided, single submitter							
NM_002878.4(RAD51D):c.498G>T (p.Arg166Ser)	RAD51D|RAD51L3-RFFL	R186S, R54S, R166S	Breast-ovarian cancer, familial, susceptibility to, 4	VCV000648006	17	33433483	17	35106464	648006	645808	rs1597861829	NC_000017.11:35106463:C:A	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Nov 7, 2022	criteria provided, single submitter							
NM_002878.4(RAD51D):c.497G>A (p.Arg166Lys)	RAD51D|RAD51L3-RFFL	R166K, R186K, R54K	Breast-ovarian cancer, familial, susceptibility to, 4	VCV000999055	17	33433484	17	35106465	999055	997502	rs1227781897	NC_000017.11:35106464:C:T	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Jan 27, 2022	criteria provided, single submitter							
NM_002878.4(RAD51D):c.496A>G (p.Arg166Gly)	RAD51D|RAD51L3-RFFL	R166G, R54G, R186G	Hereditary cancer-predisposing syndrome|not provided|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000418444	17	33433485	17	35106466	418444	409899	rs1064793246	NC_000017.11:35106465:T:C	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	May 4, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.494G>T (p.Arg165Leu)	RAD51D|RAD51L3-RFFL	R165L, R185L, R53L	Hereditary cancer-predisposing syndrome	VCV000928001	17	33433487	17	35106468	928001	913830	rs4796033	NC_000017.11:35106467:C:A	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Nov 28, 2018	criteria provided, single submitter							
NM_002878.4(RAD51D):c.494G>A (p.Arg165Gln)	RAD51D|RAD51L3-RFFL	R165Q, R185Q, R53Q	not specified|not provided|Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV000142159	17	33433487	17	35106468	142159	151873	rs4796033	NC_000017.11:35106467:C:T	single nucleotide variant	non-coding transcript variant|missense variant	Benign	Feb 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.493C>A (p.Arg165=)	RAD51D|RAD51L3-RFFL		Hereditary cancer-predisposing syndrome	VCV001744252	17	33433488	17	35106469	1744252	1799148	rs544654228	NC_000017.11:35106468:G:T	single nucleotide variant	non-coding transcript variant|synonymous variant	Likely benign	Jun 10, 2021	criteria provided, single submitter							
NM_002878.4(RAD51D):c.493C>T (p.Arg165Trp)	RAD51D|RAD51L3-RFFL	R165W, R185W, R53W	not provided|Familial ovarian cancer|not specified|Breast-ovarian cancer, familial, susceptibility to, 4|Breast and/or ovarian cancer|Lynch syndrome 1|Hereditary cancer-predisposing syndrome	VCV000127891	17	33433488	17	35106469	127891	133348	rs544654228	NC_000017.11:35106468:G:A	single nucleotide variant	non-coding transcript variant|missense variant	Conflicting classifications of pathogenicity	May 29, 2025	criteria provided, conflicting classifications							
NM_002878.4(RAD51D):c.493C>G (p.Arg165Gly)	RAD51L3-RFFL|RAD51D	R165G, R53G, R185G	not specified|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 4|not provided	VCV000127890	17	33433488	17	35106469	127890	133347	rs544654228	NC_000017.11:35106468:G:C	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Mar 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.491T>C (p.Leu164Pro)	RAD51D|RAD51L3-RFFL	L164P, L184P, L52P	Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV000185310	17	33433490	17	35106471	185310	184827	rs769287847	NC_000017.11:35106470:A:G	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Mar 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.490C>G (p.Leu164Val)	RAD51D|RAD51L3-RFFL	L164V, L184V, L52V	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000239399	17	33433491	17	35106472	239399	242724	rs878854564	NC_000017.11:35106471:G:C	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Aug 19, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.489T>C (p.Ala163=)	RAD51D|RAD51L3-RFFL		Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV001743918	17	33433492	17	35106473	1743918	1802262	rs2142429662	NC_000017.11:35106472:A:G	single nucleotide variant	non-coding transcript variant|synonymous variant	Benign/Likely benign	Feb 24, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.488C>T (p.Ala163Val)	RAD51D|RAD51L3-RFFL	A183V, A163V, A51V	Breast-ovarian cancer, familial, susceptibility to, 4|not provided|not specified|Hereditary cancer-predisposing syndrome	VCV000825260	17	33433493	17	35106474	825260	813566	rs775176916	NC_000017.11:35106473:G:A	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	May 14, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.488C>A (p.Ala163Asp)	RAD51D|RAD51L3-RFFL	A163D, A51D, A183D	Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV000187440	17	33433493	17	35106474	187440	184828	rs775176916	NC_000017.11:35106473:G:T	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Jul 24, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.487G>T (p.Ala163Ser)	RAD51D|RAD51L3-RFFL	A163S, A183S, A51S	Hereditary cancer-predisposing syndrome	VCV003312407	17	33433494	17	35106475	3312407	3461949		NC_000017.11:35106474:C:A	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	May 6, 2024	criteria provided, single submitter							
NM_002878.4(RAD51D):c.487G>C (p.Ala163Pro)	RAD51D|RAD51L3-RFFL	A163P, A183P, A51P	Breast-ovarian cancer, familial, susceptibility to, 4	VCV002824915	17	33433494	17	35106475	2824915	2989417	rs2142429681	NC_000017.11:35106474:C:G	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Dec 30, 2022	criteria provided, single submitter							
NM_002878.4(RAD51D):c.487G>A (p.Ala163Thr)	RAD51D|RAD51L3-RFFL	A183T, A51T, A163T	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV001417706	17	33433494	17	35106475	1417706	1374193	rs2142429681	NC_000017.11:35106474:C:T	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Mar 30, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.485A>C (p.Glu162Ala)	RAD51D|RAD51L3-RFFL	E162A, E50A, E182A	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000857442	17	33433496	17	35106477	857442	845223	rs2091605338	NC_000017.11:35106476:T:G	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Sep 3, 2020	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.483A>C (p.Ala161=)	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV002895947	17	33433498	17	35106479	2895947	3056722	rs2142429725	NC_000017.11:35106478:T:G	single nucleotide variant	non-coding transcript variant|synonymous variant	Uncertain significance	Jun 23, 2023	criteria provided, single submitter							
NM_002878.4(RAD51D):c.483A>G (p.Ala161=)	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV001610582	17	33433498	17	35106479	1610582	1585400	rs2142429725	NC_000017.11:35106478:T:C	single nucleotide variant	non-coding transcript variant|synonymous variant	Benign/Likely benign	Feb 24, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.481G>T (p.Ala161Ser)	RAD51D|RAD51L3-RFFL	A161S, A181S, A49S	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000584936	17	33433500	17	35106481	584936	575985	rs1567727951	NC_000017.11:35106480:C:A	single nucleotide variant	non-coding transcript variant|missense variant	Uncertain significance	Feb 24, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.481-1G>T	RAD51L3-RFFL|RAD51D		Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV001743291	17	33433501	17	35106482	1743291	1805437	rs2091605445	NC_000017.11:35106481:C:A	single nucleotide variant	splice acceptor variant	Conflicting classifications of pathogenicity	Mar 10, 2023	criteria provided, conflicting classifications							
NM_002878.4(RAD51D):c.481-1G>A	RAD51L3-RFFL|RAD51D		Breast-ovarian cancer, familial, susceptibility to, 4	VCV000849827	17	33433501	17	35106482	849827	852195	rs2091605445	NC_000017.11:35106481:C:T	single nucleotide variant	splice acceptor variant	Likely pathogenic	Jan 17, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.481-2A>T	RAD51D|RAD51L3-RFFL		Hereditary cancer-predisposing syndrome	VCV001743293	17	33433502	17	35106483	1743293	1805439	rs2091605461	NC_000017.11:35106482:T:A	single nucleotide variant	splice acceptor variant	Uncertain significance	May 24, 2022	criteria provided, single submitter							
NM_002878.4(RAD51D):c.481-2A>G	RAD51D|RAD51L3-RFFL		Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV001692729	17	33433502	17	35106483	1692729	1685169	rs2091605461	NC_000017.11:35106482:T:C	single nucleotide variant	splice acceptor variant	Conflicting classifications of pathogenicity	Jun 13, 2025	criteria provided, conflicting classifications							
NM_002878.4(RAD51D):c.481-4T>G	RAD51D|RAD51L3-RFFL		Hereditary cancer-predisposing syndrome|not provided|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000231752	17	33433504	17	35106485	231752	235884	rs876659339	NC_000017.11:35106484:A:C	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Aug 27, 2024	criteria provided, conflicting classifications							
NM_002878.4(RAD51D):c.481-5T>C	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV000628090	17	33433505	17	35106486	628090	619667	rs374382703	NC_000017.11:35106485:A:G	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Feb 24, 2025	criteria provided, conflicting classifications							
NM_002878.4(RAD51D):c.481-5T>G	RAD51D|RAD51L3-RFFL		not specified|Breast-ovarian cancer, familial, susceptibility to, 4|not provided|Hereditary cancer-predisposing syndrome	VCV000182859	17	33433505	17	35106486	182859	180801	rs374382703	NC_000017.11:35106485:A:C	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Apr 29, 2025	criteria provided, conflicting classifications							
NM_002878.4(RAD51D):c.481-6C>T	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV003724759	17	33433506	17	35106487	3724759	3854539		NC_000017.11:35106486:G:A	single nucleotide variant	intron variant	Likely benign	Nov 6, 2024	criteria provided, single submitter							
NM_002878.4(RAD51D):c.481-7G>T	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV000764500	17	33433507	17	35106488	764500	776298	rs145832514	NC_000017.11:35106487:C:A	single nucleotide variant	intron variant	Likely benign	Feb 21, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.481-7G>A	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4|not specified|Breast and/or ovarian cancer|Hereditary cancer-predisposing syndrome|not provided	VCV000138871	17	33433507	17	35106488	138871	142574	rs145832514	NC_000017.11:35106487:C:T	single nucleotide variant	intron variant	Benign/Likely benign	Feb 3, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.481-8C>T	RAD51D|RAD51L3-RFFL		Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4|not specified|not provided	VCV000239398	17	33433508	17	35106489	239398	242725	rs762247126	NC_000017.11:35106488:G:A	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Apr 29, 2025	criteria provided, conflicting classifications							
NM_002878.4(RAD51D):c.481-9C>A	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV002883741	17	33433509	17	35106490	2883741	3046496	rs2142429838	NC_000017.11:35106489:G:T	single nucleotide variant	intron variant	Likely benign	Mar 4, 2023	criteria provided, single submitter							
NM_002878.4(RAD51D):c.481-9C>T	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV001612003	17	33433509	17	35106490	1612003	1535631	rs2142429838	NC_000017.11:35106489:G:A	single nucleotide variant	intron variant	Likely benign	Feb 21, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.481-10A>G	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV000539866	17	33433510	17	35106491	539866	531457	rs1555568182	NC_000017.11:35106490:T:C	single nucleotide variant	intron variant	Likely benign	Jun 4, 2023	criteria provided, single submitter							
NM_002878.4(RAD51D):c.481-11C>T	RAD51L3-RFFL|RAD51D		Breast-ovarian cancer, familial, susceptibility to, 4|RAD51D-related cancer predisposition|not provided|Hereditary cancer-predisposing syndrome	VCV000379333	17	33433511	17	35106492	379333	374924	rs372690151	NC_000017.11:35106491:G:A	single nucleotide variant	intron variant	Likely benign	Feb 21, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.481-12C>T	RAD51L3-RFFL|RAD51D		Hereditary cancer-predisposing syndrome	VCV000920417	17	33433512	17	35106493	920417	916474	rs2091605824	NC_000017.11:35106492:G:A	single nucleotide variant	intron variant	Uncertain significance	Dec 18, 2018	criteria provided, single submitter							
NM_002878.4(RAD51D):c.481-14T>C	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV001544412	17	33433514	17	35106495	1544412	1524690	rs2142429873	NC_000017.11:35106494:A:G	single nucleotide variant	intron variant	Likely benign	Jul 14, 2021	criteria provided, single submitter							
NM_002878.4(RAD51D):c.481-15T>C	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV002196898	17	33433515	17	35106496	2196898	1929957	rs2509135771	NC_000017.11:35106495:A:G	single nucleotide variant	intron variant	Likely benign	Feb 21, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.481-17C>G	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV003645485	17	33433517	17	35106498	3645485	3783900		NC_000017.11:35106497:G:C	single nucleotide variant	intron variant	Likely benign	Mar 12, 2024	criteria provided, single submitter							
NM_002878.4(RAD51D):c.481-17C>A	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV002844237	17	33433517	17	35106498	2844237	3007878	rs2142429897	NC_000017.11:35106497:G:T	single nucleotide variant	intron variant	Likely benign	Mar 8, 2023	criteria provided, single submitter							
NM_002878.4(RAD51D):c.481-18T>G	RAD51L3-RFFL|RAD51D		Breast-ovarian cancer, familial, susceptibility to, 4	VCV003691120	17	33433518	17	35106499	3691120	3827907		NC_000017.11:35106498:A:C	single nucleotide variant	intron variant	Likely benign	Apr 17, 2024	criteria provided, single submitter							
NM_002878.4(RAD51D):c.481-20T>G	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV002823789	17	33433520	17	35106501	2823789	2982302	rs2142429916	NC_000017.11:35106500:A:C	single nucleotide variant	intron variant	Likely benign	Dec 24, 2022	criteria provided, single submitter							
NM_002878.4(RAD51D):c.481-26C>T	RAD51D|RAD51L3-RFFL		not specified	VCV001697595	17	33433526	17	35106507	1697595	1689979	rs1185393926	NC_000017.11:35106506:G:A	single nucleotide variant	intron variant	Likely benign	Mar 4, 2025	criteria provided, single submitter							
NM_002878.4(RAD51D):c.481-29G>A	RAD51D|RAD51L3-RFFL		not specified	VCV003256341	17	33433529	17	35106510	3256341	3415103		NC_000017.11:35106509:C:T	single nucleotide variant	intron variant	Likely benign	Mar 4, 2025	criteria provided, single submitter							
NM_002878.4(RAD51D):c.481-80G>T	RAD51D|RAD51L3-RFFL		not provided	VCV001264059	17	33433580	17	35106561	1264059	1253957	rs28363273	NC_000017.11:35106560:C:A	single nucleotide variant	intron variant	Benign	Jun 26, 2018	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.481-144T>C	RAD51D|RAD51L3-RFFL		not provided	VCV000676556	17	33433644	17	35106625	676556	668784	rs8067218	NC_000017.11:35106624:A:G	single nucleotide variant	intron variant	Benign	Jun 18, 2018	criteria provided, single submitter							
NM_002878.4(RAD51D):c.481-205A>G	RAD51D|RAD51L3-RFFL		not provided	VCV001178052	17	33433705	17	35106686	1178052	1167681	rs8071313	NC_000017.11:35106685:T:C	single nucleotide variant	intron variant	Benign	Jun 25, 2018	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.480+187T>C	RAD51D|RAD51L3-RFFL		not provided	VCV000679676	17	33433820	17	35106801	679676	668941	rs936656	NC_000017.11:35106800:A:G	single nucleotide variant	intron variant	Benign	Jun 20, 2018	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.480+75T>G	RAD51D|RAD51L3-RFFL		not provided	VCV001270143	17	33433932	17	35106913	1270143	1258755	rs8067688	NC_000017.11:35106912:A:C	single nucleotide variant	intron variant	Benign	Mar 3, 2015	criteria provided, single submitter							
NM_002878.4(RAD51D):c.480+19G>A	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV001550481	17	33433988	17	35106969	1550481	1574170	rs2142431838	NC_000017.11:35106968:C:T	single nucleotide variant	intron variant	Likely benign	Jul 7, 2023	criteria provided, single submitter							
NM_002878.4(RAD51D):c.480+18G>A	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV002710216	17	33433989	17	35106970	2710216	2871240	rs1435211888	NC_000017.11:35106969:C:T	single nucleotide variant	intron variant	Likely benign	Jan 27, 2024	criteria provided, single submitter							
NM_002878.4(RAD51D):c.480+18G>C	RAD51D|RAD51L3-RFFL		Hereditary cancer-predisposing syndrome	VCV000629035	17	33433989	17	35106970	629035	619621	rs1435211888	NC_000017.11:35106969:C:G	single nucleotide variant	intron variant	Likely benign	Aug 13, 2018	criteria provided, single submitter							
NM_002878.4(RAD51D):c.480+15C>G	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV002153575	17	33433992	17	35106973	2153575	1882437	rs2142431871	NC_000017.11:35106972:G:C	single nucleotide variant	intron variant	Likely benign	Aug 4, 2022	criteria provided, single submitter							
NM_002878.4(RAD51D):c.480+14G>T	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV001531121	17	33433993	17	35106974	1531121	1604539	rs374605203	NC_000017.11:35106973:C:A	single nucleotide variant	intron variant	Likely benign	May 16, 2024	criteria provided, single submitter							
NM_002878.4(RAD51D):c.480+14G>C	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV000927022	17	33433993	17	35106974	927022	916475	rs374605203	NC_000017.11:35106973:C:G	single nucleotide variant	intron variant	Likely benign	Mar 19, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.480+9A>C	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV001141697	17	33433998	17	35106979	1141697	1147041	rs2142431942	NC_000017.11:35106978:T:G	single nucleotide variant	intron variant	Likely benign	Mar 8, 2022	criteria provided, single submitter							
NM_002878.4(RAD51D):c.480+9A>G	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV001128359	17	33433998	17	35106979	1128359	1126147	rs2142431942	NC_000017.11:35106978:T:C	single nucleotide variant	intron variant	Likely benign	Mar 3, 2020	criteria provided, single submitter							
NM_002878.4(RAD51D):c.480+8C>T	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV001709959	17	33433999	17	35106980	1709959	1708312	rs2142431951	NC_000017.11:35106979:G:A	single nucleotide variant	intron variant	Uncertain significance	Aug 20, 2021	criteria provided, single submitter							
NM_002878.4(RAD51D):c.480+7G>A	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV003903701	17	33434000	17	35106981	3903701	4019574		NC_000017.11:35106980:C:T	single nucleotide variant	intron variant	Likely benign	Feb 21, 2025	criteria provided, single submitter							
NM_002878.4(RAD51D):c.480+7G>T	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV000927231	17	33434000	17	35106981	927231	916481	rs774590973	NC_000017.11:35106980:C:A	single nucleotide variant	intron variant	Likely benign	Jan 7, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.480+6G>T	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV003904062	17	33434001	17	35106982	3904062	4019935		NC_000017.11:35106981:C:A	single nucleotide variant	intron variant	Likely benign	Feb 21, 2025	criteria provided, single submitter							
NM_002878.4(RAD51D):c.480+6G>A	RAD51L3-RFFL|RAD51D		Hereditary cancer-predisposing syndrome|not specified|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000388549	17	33434001	17	35106982	388549	374928	rs1057523143	NC_000017.11:35106981:C:T	single nucleotide variant	intron variant	Likely benign	Jan 21, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.480+5G>A	RAD51D|RAD51L3-RFFL		Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000630840	17	33434002	17	35106983	630840	619573	rs1567728209	NC_000017.11:35106982:C:T	single nucleotide variant	intron variant	Uncertain significance	Dec 24, 2023	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.480+4A>G	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV000584937	17	33434003	17	35106984	584937	575986	rs1567728211	NC_000017.11:35106983:T:C	single nucleotide variant	intron variant	Uncertain significance	May 28, 2019	criteria provided, single submitter							
NM_002878.4(RAD51D):c.480+3A>G	RAD51D|RAD51L3-RFFL		Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000232038	17	33434004	17	35106985	232038	235885	rs876659511	NC_000017.11:35106984:T:C	single nucleotide variant	intron variant	Uncertain significance	Oct 26, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.480+2T>C	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV001495850	17	33434005	17	35106986	1495850	1362765	rs2142432010	NC_000017.11:35106985:A:G	single nucleotide variant	splice donor variant|intron variant	Likely pathogenic	Sep 23, 2021	criteria provided, single submitter							
NM_002878.4(RAD51D):c.480+1G>T	RAD51D|RAD51L3-RFFL		not provided|Breast-ovarian cancer, familial, susceptibility to, 4	VCV001199875	17	33434006	17	35106987	1199875	1191947	rs1597862471	NC_000017.11:35106986:C:A	single nucleotide variant	splice donor variant|intron variant	Likely pathogenic	Jan 4, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.480+1G>A	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV000030286	17	33434006	17	35106987	30286	39242	rs1597862471	NC_000017.11:35106986:C:T	single nucleotide variant	splice donor variant|intron variant	Conflicting classifications of pathogenicity	Sep 11, 2023	criteria provided, conflicting classifications							
NM_002878.4(RAD51D):c.480G>C (p.Gln160His)	RAD51D|RAD51L3-RFFL	Q160H, Q180H	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000573293	17	33434007	17	35106988	573293	571288	rs1567728219	NC_000017.11:35106987:C:G	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Aug 20, 2018	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.479A>T (p.Gln160Leu)	RAD51D|RAD51L3-RFFL	Q180L, Q160L	Hereditary cancer-predisposing syndrome	VCV003942393	17	33434008	17	35106989	3942393	4064172		NC_000017.11:35106988:T:A	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	May 24, 2025	criteria provided, single submitter							
NM_002878.4(RAD51D):c.479A>G (p.Gln160Arg)	RAD51D|RAD51L3-RFFL	Q180R, Q160R	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV001485112	17	33434008	17	35106989	1485112	1393838	rs2142432043	NC_000017.11:35106988:T:C	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Aug 26, 2023	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.478C>G (p.Gln160Glu)	RAD51L3-RFFL|RAD51D	Q160E, Q180E	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000472611	17	33434009	17	35106990	472611	467942	rs1057521922	NC_000017.11:35106989:G:C	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Dec 13, 2022	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.478C>T (p.Gln160Ter)	RAD51D|RAD51L3-RFFL	Q160*, Q180*	Breast-ovarian cancer, familial, susceptibility to, 4|not provided|Hereditary cancer-predisposing syndrome	VCV000384322	17	33434009	17	35106990	384322	374931	rs1057521922	NC_000017.11:35106989:G:A	single nucleotide variant	nonsense|non-coding transcript variant|intron variant	Pathogenic	May 12, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.477A>G (p.Glu159=)	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV003663975	17	33434010	17	35106991	3663975	3795134		NC_000017.11:35106990:T:C	single nucleotide variant	synonymous variant|non-coding transcript variant|intron variant	Likely benign	Aug 29, 2024	criteria provided, single submitter							
NM_002878.4(RAD51D):c.476A>G (p.Glu159Gly)	RAD51D|RAD51L3-RFFL	E159G, E179G	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000472610	17	33434011	17	35106992	472610	467612	rs1555568282	NC_000017.11:35106991:T:C	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Sep 2, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.474G>A (p.Glu158=)	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV002448053	17	33434013	17	35106994	2448053	2428997	rs1161017731	NC_000017.11:35106993:C:T	single nucleotide variant	synonymous variant|non-coding transcript variant|intron variant	Benign/Likely benign	Feb 21, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.472G>A (p.Glu158Lys)	RAD51D|RAD51L3-RFFL	E178K, E158K	Breast-ovarian cancer, familial, susceptibility to, 4	VCV000944866	17	33434015	17	35106996	944866	928225	rs762168532	NC_000017.11:35106995:C:T	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Nov 2, 2023	criteria provided, single submitter							
NM_002878.4(RAD51D):c.471G>C (p.Glu157Asp)	RAD51L3-RFFL|RAD51D	E157D, E177D	not provided|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000490142	17	33434016	17	35106997	490142	482968	rs55942401	NC_000017.11:35106996:C:G	single nucleotide variant	non-coding transcript variant|intron variant|missense variant	Uncertain significance	Aug 24, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.471G>A (p.Glu157=)	RAD51L3-RFFL|RAD51D		Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000482199	17	33434016	17	35106997	482199	478454	rs55942401	NC_000017.11:35106996:C:T	single nucleotide variant	synonymous variant|non-coding transcript variant|intron variant	Benign/Likely benign	Feb 21, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.470A>C (p.Glu157Ala)	RAD51D|RAD51L3-RFFL	E157A, E177A	Hereditary cancer-predisposing syndrome	VCV001742583	17	33434017	17	35106998	1742583	1798784	rs2142432195	NC_000017.11:35106997:T:G	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Oct 1, 2021	criteria provided, single submitter							
NM_002878.4(RAD51D):c.468T>G (p.Asp156Glu)	RAD51D|RAD51L3-RFFL	D156E, D176E	Hereditary cancer-predisposing syndrome	VCV000825101	17	33434019	17	35107000	825101	813568	rs1597862508	NC_000017.11:35106999:A:C	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Jul 5, 2019	criteria provided, single submitter							
NM_002878.4(RAD51D):c.467A>G (p.Asp156Gly)	RAD51D|RAD51L3-RFFL	D156G, D176G	Hereditary cancer-predisposing syndrome	VCV002448056	17	33434020	17	35107001	2448056	2429000	rs2091612637	NC_000017.11:35107000:T:C	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Mar 8, 2023	criteria provided, single submitter							
NM_002878.4(RAD51D):c.467A>C (p.Asp156Ala)	RAD51D|RAD51L3-RFFL	D156A, D176A	Breast-ovarian cancer, familial, susceptibility to, 4	VCV001503928	17	33434020	17	35107001	1503928	1424332	rs2091612637	NC_000017.11:35107000:T:G	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Nov 22, 2021	criteria provided, single submitter							
NM_002878.4(RAD51D):c.467A>T (p.Asp156Val)	RAD51L3-RFFL|RAD51D	D156V, D176V	Breast-ovarian cancer, familial, susceptibility to, 4	VCV000843274	17	33434020	17	35107001	843274	845224	rs2091612637	NC_000017.11:35107000:T:A	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Dec 19, 2019	criteria provided, single submitter							
NM_002878.4(RAD51D):c.465G>A (p.Gln155=)	RAD51D|RAD51L3-RFFL		Hereditary cancer-predisposing syndrome	VCV001742239	17	33434022	17	35107003	1742239	1798440	rs2091612665	NC_000017.11:35107002:C:T	single nucleotide variant	synonymous variant|non-coding transcript variant|intron variant	Likely benign	Jun 14, 2019	criteria provided, single submitter							
NM_002878.4(RAD51D):c.464A>G (p.Gln155Arg)	RAD51D|RAD51L3-RFFL	Q155R, Q175R	Breast-ovarian cancer, familial, susceptibility to, 4	VCV000850202	17	33434023	17	35107004	850202	845225	rs2091612704	NC_000017.11:35107003:T:C	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Nov 9, 2024	criteria provided, single submitter							
NM_002878.4(RAD51D):c.463C>T (p.Gln155Ter)	RAD51D|RAD51L3-RFFL	Q155*, Q175*	Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV000484775	17	33434024	17	35107005	484775	478600	rs1555568293	NC_000017.11:35107004:G:A	single nucleotide variant	nonsense|non-coding transcript variant|intron variant	Pathogenic/Likely pathogenic	Jan 12, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.462C>T (p.Thr154=)	RAD51L3-RFFL|RAD51D		Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV001742006	17	33434025	17	35107006	1742006	1801649	rs2091612775	NC_000017.11:35107005:G:A	single nucleotide variant	synonymous variant|non-coding transcript variant|intron variant	Benign/Likely benign	Feb 21, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.462C>G (p.Thr154=)	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV001622821	17	33434025	17	35107006	1622821	1627447	rs2091612775	NC_000017.11:35107005:G:C	single nucleotide variant	synonymous variant|non-coding transcript variant|intron variant	Benign/Likely benign	Feb 21, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.461C>T (p.Thr154Ile)	RAD51D|RAD51L3-RFFL	T154I, T174I	Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV001715819	17	33434026	17	35107007	1715819	1773764	rs2091612838	NC_000017.11:35107006:G:A	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Dec 12, 2022	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.461C>G (p.Thr154Ser)	RAD51D|RAD51L3-RFFL	T154S, T174S	Breast-ovarian cancer, familial, susceptibility to, 4	VCV001002698	17	33434026	17	35107007	1002698	997503	rs2091612838	NC_000017.11:35107006:G:C	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Jan 10, 2020	criteria provided, single submitter							
NM_002878.4(RAD51D):c.456T>C (p.Ala152=)	RAD51L3-RFFL|RAD51D		not provided|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000416198	17	33434031	17	35107012	416198	401879	rs921214343	NC_000017.11:35107011:A:G	single nucleotide variant	synonymous variant|non-coding transcript variant|intron variant	Benign/Likely benign	Feb 21, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.455C>T (p.Ala152Val)	RAD51D|RAD51L3-RFFL	A172V, A152V	Hereditary cancer-predisposing syndrome	VCV003942381	17	33434032	17	35107013	3942381	4064160		NC_000017.11:35107012:G:A	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Apr 17, 2025	criteria provided, single submitter							
NM_002878.4(RAD51D):c.455C>A (p.Ala152Asp)	RAD51D|RAD51L3-RFFL	A152D, A172D	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000232172	17	33434032	17	35107013	232172	235886	rs767981911	NC_000017.11:35107012:G:T	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Feb 14, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.453G>A (p.Gln151=)	RAD51L3-RFFL|RAD51D		Breast-ovarian cancer, familial, susceptibility to, 4	VCV003903653	17	33434034	17	35107015	3903653	4019526		NC_000017.11:35107014:C:T	single nucleotide variant	synonymous variant|non-coding transcript variant|intron variant	Benign	Feb 21, 2025	criteria provided, single submitter							
NM_002878.4(RAD51D):c.453G>C (p.Gln151His)	RAD51D|RAD51L3-RFFL	Q151H, Q171H	Hereditary cancer-predisposing syndrome	VCV002448050	17	33434034	17	35107015	2448050	2428994	rs2142432491	NC_000017.11:35107014:C:G	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Jan 12, 2023	criteria provided, single submitter							
NM_002878.4(RAD51D):c.451C>T (p.Gln151Ter)	RAD51D|RAD51L3-RFFL	Q151*, Q171*	Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome|not provided	VCV000141452	17	33434036	17	35107017	141452	151166	rs587781756	NC_000017.11:35107016:G:A	single nucleotide variant	nonsense|non-coding transcript variant|intron variant	Pathogenic/Likely pathogenic	Jun 30, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.449T>C (p.Leu150Pro)	RAD51D|RAD51L3-RFFL	L170P, L150P	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV001508779	17	33434038	17	35107019	1508779	1439990	rs876660054	NC_000017.11:35107018:A:G	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Dec 20, 2023	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.449T>G (p.Leu150Arg)	RAD51D|RAD51L3-RFFL	L150R, L170R	Hereditary cancer-predisposing syndrome	VCV000232889	17	33434038	17	35107019	232889	235887	rs876660054	NC_000017.11:35107018:A:C	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Jul 14, 2015	criteria provided, single submitter							
NM_002878.4(RAD51D):c.446T>G (p.Leu149Arg)	RAD51D|RAD51L3-RFFL	L169R, L149R	Breast-ovarian cancer, familial, susceptibility to, 4	VCV000940416	17	33434041	17	35107022	940416	937889	rs2091613013	NC_000017.11:35107021:A:C	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Sep 4, 2024	criteria provided, single submitter							
NM_002878.4(RAD51D):c.445C>T (p.Leu149=)	RAD51D|RAD51L3-RFFL		Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000472608	17	33434042	17	35107023	472608	466748	rs1555568301	NC_000017.11:35107022:G:A	single nucleotide variant	synonymous variant|non-coding transcript variant|intron variant	Benign/Likely benign	Feb 21, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.444G>T (p.Gln148His)	RAD51D|RAD51L3-RFFL	Q148H, Q168H	Hereditary cancer-predisposing syndrome	VCV001740691	17	33434043	17	35107024	1740691	1798191	rs2142432635	NC_000017.11:35107023:C:A	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Jun 23, 2022	criteria provided, single submitter							
NM_002878.4(RAD51D):c.442C>T (p.Gln148Ter)	RAD51D|RAD51L3-RFFL	Q148*, Q168*	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|not provided|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000231972	17	33434045	17	35107026	231972	235888	rs773906955	NC_000017.11:35107025:G:A	single nucleotide variant	nonsense|non-coding transcript variant|intron variant	Pathogenic/Likely pathogenic	Jan 4, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.441C>G (p.Leu147=)	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV003649262	17	33434046	17	35107027	3649262	3781271		NC_000017.11:35107026:G:C	single nucleotide variant	synonymous variant|non-coding transcript variant|intron variant	Benign/Likely benign	Feb 21, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.441C>A (p.Leu147=)	RAD51D|RAD51L3-RFFL		not provided|Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV000619912	17	33434046	17	35107027	619912	611227	rs1567728273	NC_000017.11:35107026:G:T	single nucleotide variant	synonymous variant|non-coding transcript variant|intron variant	Conflicting classifications of pathogenicity	Feb 22, 2025	criteria provided, conflicting classifications							
NM_002878.4(RAD51D):c.440T>G (p.Leu147Arg)	RAD51D|RAD51L3-RFFL	L147R, L167R	Breast-ovarian cancer, familial, susceptibility to, 4	VCV001351298	17	33434047	17	35107028	1351298	1407648	rs2142432705	NC_000017.11:35107027:A:C	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Jul 7, 2023	criteria provided, single submitter							
NM_002878.4(RAD51D):c.439C>T (p.Leu147Phe)	RAD51L3-RFFL|RAD51D	L147F, L167F	Breast-ovarian cancer, familial, susceptibility to, 4	VCV000574981	17	33434048	17	35107029	574981	571083	rs1567728278	NC_000017.11:35107028:G:A	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Oct 6, 2023	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.438C>T (p.Leu146=)	RAD51D|RAD51L3-RFFL		Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000416195	17	33434049	17	35107030	416195	402398	rs145452047	NC_000017.11:35107029:G:A	single nucleotide variant	synonymous variant|non-coding transcript variant|intron variant	Benign/Likely benign	Feb 21, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.437T>G (p.Leu146Arg)	RAD51D|RAD51L3-RFFL	L146R, L166R	Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV003663976	17	33434050	17	35107031	3663976	3795135		NC_000017.11:35107030:A:C	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Apr 5, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.437T>A (p.Leu146His)	RAD51D|RAD51L3-RFFL	L166H, L146H	Breast-ovarian cancer, familial, susceptibility to, 4	VCV000648875	17	33434050	17	35107031	648875	645809	rs1597862557	NC_000017.11:35107030:A:T	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Jan 12, 2023	criteria provided, single submitter							
NM_002878.4(RAD51D):c.436C>T (p.Leu146Phe)	RAD51D|RAD51L3-RFFL	L146F, L166F	Breast-ovarian cancer, familial, susceptibility to, 4|not provided|Hereditary cancer-predisposing syndrome	VCV000410559	17	33434051	17	35107032	410559	402590	rs371812219	NC_000017.11:35107031:G:A	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Jun 25, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.435C>T (p.Arg145=)	RAD51D|RAD51L3-RFFL		Hereditary cancer-predisposing syndrome	VCV002448057	17	33434052	17	35107033	2448057	2429001	rs1326314397	NC_000017.11:35107032:G:A	single nucleotide variant	intron variant|synonymous variant|non-coding transcript variant	Uncertain significance	Mar 10, 2023	criteria provided, single submitter							
NM_002878.4(RAD51D):c.434G>T (p.Arg145Leu)	RAD51L3-RFFL|RAD51D	R165L, R145L	Hereditary cancer-predisposing syndrome	VCV000924363	17	33434053	17	35107034	924363	913831	rs147264215	NC_000017.11:35107033:C:A	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Aug 15, 2019	criteria provided, single submitter							
NM_002878.4(RAD51D):c.434G>A (p.Arg145His)	RAD51L3-RFFL|RAD51D	R145H, R165H	Hereditary cancer-predisposing syndrome|not provided|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000187149	17	33434053	17	35107034	187149	184830	rs147264215	NC_000017.11:35107033:C:T	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Aug 7, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.433C>G (p.Arg145Gly)	RAD51D|RAD51L3-RFFL	R145G, R165G	Hereditary cancer-predisposing syndrome	VCV003222883	17	33434054	17	35107035	3222883	3386521	rs755173206	NC_000017.11:35107034:G:C	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Oct 19, 2023	criteria provided, single submitter							
NM_002878.4(RAD51D):c.433C>T (p.Arg145Cys)	RAD51D|RAD51L3-RFFL	R145C, R165C	Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome|not provided	VCV000231938	17	33434054	17	35107035	231938	235889	rs755173206	NC_000017.11:35107034:G:A	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Jan 7, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.432C>T (p.Ser144=)	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV003903926	17	33434055	17	35107036	3903926	4019799		NC_000017.11:35107035:G:A	single nucleotide variant	synonymous variant|non-coding transcript variant|intron variant	Benign	Feb 21, 2025	criteria provided, single submitter							
NM_002878.4(RAD51D):c.432C>A (p.Ser144=)	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV001542762	17	33434055	17	35107036	1542762	1523037	rs2142432832	NC_000017.11:35107035:G:T	single nucleotide variant	synonymous variant|non-coding transcript variant|intron variant	Likely benign	May 7, 2021	criteria provided, single submitter							
NM_002878.4(RAD51D):c.431C>G (p.Ser144Cys)	RAD51D|RAD51L3-RFFL	S144C, S164C	Breast-ovarian cancer, familial, susceptibility to, 4	VCV001720814	17	33434056	17	35107037	1720814	1774796	rs587781875	NC_000017.11:35107036:G:C	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Dec 29, 2022	criteria provided, single submitter							
NM_002878.4(RAD51D):c.431C>T (p.Ser144Phe)	RAD51D|RAD51L3-RFFL	S144F, S164F	See cases|Hereditary cancer|Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome|not specified|not provided	VCV000141609	17	33434056	17	35107037	141609	151323	rs587781875	NC_000017.11:35107036:G:A	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Jun 23, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.429T>A (p.Ala143=)	RAD51L3-RFFL|RAD51D		Breast-ovarian cancer, familial, susceptibility to, 4	VCV000749137	17	33434058	17	35107039	749137	755776	rs1597862584	NC_000017.11:35107038:A:T	single nucleotide variant	synonymous variant|non-coding transcript variant|intron variant	Likely benign	Dec 31, 2019	criteria provided, single submitter							
NM_002878.4(RAD51D):c.428C>G (p.Ala143Gly)	RAD51D|RAD51L3-RFFL	A143G, A163G	Hereditary cancer-predisposing syndrome	VCV003222882	17	33434059	17	35107040	3222882	3386520	rs752861378	NC_000017.11:35107039:G:C	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Sep 18, 2023	criteria provided, single submitter							
NM_002878.4(RAD51D):c.428C>T (p.Ala143Val)	RAD51D|RAD51L3-RFFL	A143V, A163V	Breast-ovarian cancer, familial, susceptibility to, 4	VCV001721368	17	33434059	17	35107040	1721368	1772702	rs752861378	NC_000017.11:35107039:G:A	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Oct 11, 2022	criteria provided, single submitter							
NM_002878.4(RAD51D):c.427G>T (p.Ala143Ser)	RAD51D|RAD51L3-RFFL	A163S, A143S	Hereditary cancer-predisposing syndrome	VCV000824751	17	33434060	17	35107041	824751	813569	rs1597862594	NC_000017.11:35107040:C:A	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Jul 24, 2018	criteria provided, single submitter							
NM_002878.4(RAD51D):c.426A>G (p.Thr142=)	RAD51D|RAD51L3-RFFL		Hereditary cancer-predisposing syndrome|not provided|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000808253	17	33434061	17	35107042	808253	797520	rs1597862600	NC_000017.11:35107041:T:C	single nucleotide variant	synonymous variant|non-coding transcript variant|intron variant	Likely benign	Dec 19, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.426A>C (p.Thr142=)	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV000759516	17	33434061	17	35107042	759516	771435	rs1597862600	NC_000017.11:35107041:T:G	single nucleotide variant	synonymous variant|non-coding transcript variant|intron variant	Likely benign	May 2, 2018	criteria provided, single submitter							
NM_002878.4(RAD51D):c.425C>A (p.Thr142Lys)	RAD51L3-RFFL|RAD51D	T142K, T162K	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV001719268	17	33434062	17	35107043	1719268	1774572	rs757099471	NC_000017.11:35107042:G:T	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Sep 14, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.425C>T (p.Thr142Ile)	RAD51D|RAD51L3-RFFL	T142I, T162I	Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV000824732	17	33434062	17	35107043	824732	813570	rs757099471	NC_000017.11:35107042:G:A	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Apr 7, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.425C>G (p.Thr142Arg)	RAD51D|RAD51L3-RFFL	T142R, T162R	Familial ovarian cancer|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000490141	17	33434062	17	35107043	490141	482969	rs757099471	NC_000017.11:35107042:G:C	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Dec 4, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.424A>T (p.Thr142Ser)	RAD51D|RAD51L3-RFFL	T162S, T142S	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000652651	17	33434063	17	35107044	652651	645810	rs1597862615	NC_000017.11:35107043:T:A	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Feb 2, 2022	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.423G>A (p.Leu141=)	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV001106107	17	33434064	17	35107045	1106107	1104722	rs2142432938	NC_000017.11:35107044:C:T	single nucleotide variant	synonymous variant|non-coding transcript variant|intron variant	Benign/Likely benign	Feb 21, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.422T>G (p.Leu141Arg)	RAD51D|RAD51L3-RFFL	L141R, L161R	Breast-ovarian cancer, familial, susceptibility to, 4	VCV002826866	17	33434065	17	35107046	2826866	2986668	rs780938875	NC_000017.11:35107045:A:C	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Jan 7, 2023	criteria provided, single submitter							
NM_002878.4(RAD51D):c.422T>C (p.Leu141Pro)	RAD51D|RAD51L3-RFFL	L141P, L161P	not provided|Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome|not specified|Hereditary breast ovarian cancer syndrome	VCV000186683	17	33434065	17	35107046	186683	184831	rs780938875	NC_000017.11:35107045:A:G	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Jun 12, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.421C>G (p.Leu141Val)	RAD51D|RAD51L3-RFFL	L141V, L161V	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000824689	17	33434066	17	35107047	824689	813571	rs1057523780	NC_000017.11:35107046:G:C	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Jan 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.421C>A (p.Leu141Met)	RAD51D|RAD51L3-RFFL	L141M, L161M	Hereditary cancer-predisposing syndrome	VCV000824688	17	33434066	17	35107047	824688	813572	rs1057523780	NC_000017.11:35107046:G:T	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Jun 5, 2019	criteria provided, single submitter							
NM_002878.4(RAD51D):c.421C>T (p.Leu141=)	RAD51D|RAD51L3-RFFL		not specified|Hereditary cancer-predisposing syndrome	VCV000390470	17	33434066	17	35107047	390470	375873	rs1057523780	NC_000017.11:35107046:G:A	single nucleotide variant	synonymous variant|non-coding transcript variant|intron variant	Likely benign	May 25, 2022	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.420G>T (p.Gly140=)	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV000629314	17	33434067	17	35107048	629314	618538	rs1567728317	NC_000017.11:35107047:C:A	single nucleotide variant	synonymous variant|non-coding transcript variant|intron variant	Benign/Likely benign	Feb 21, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.419G>A (p.Gly140Glu)	RAD51L3-RFFL|RAD51D	G140E, G160E	not provided|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4|not specified	VCV000182851	17	33434068	17	35107049	182851	180802	rs730881945	NC_000017.11:35107048:C:T	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Jan 9, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.418G>T (p.Gly140Trp)	RAD51D|RAD51L3-RFFL	G140W, G160W	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV002846128	17	33434069	17	35107050	2846128	3008488	rs2142432997	NC_000017.11:35107049:C:A	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Sep 16, 2023	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.417A>T (p.Gly139=)	RAD51L3-RFFL|RAD51D		Hereditary cancer-predisposing syndrome	VCV002448052	17	33434070	17	35107051	2448052	2428996	rs786202049	NC_000017.11:35107050:T:A	single nucleotide variant	synonymous variant|non-coding transcript variant|intron variant	Likely benign	Jan 16, 2023	criteria provided, single submitter							
NM_002878.4(RAD51D):c.417A>C (p.Gly139=)	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV000185278	17	33434070	17	35107051	185278	184832	rs786202049	NC_000017.11:35107050:T:G	single nucleotide variant	synonymous variant|non-coding transcript variant|intron variant	Benign/Likely benign	Feb 21, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.415G>A (p.Gly139Arg)	RAD51D|RAD51L3-RFFL	G139R, G159R	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000490140	17	33434072	17	35107053	490140	482971	rs745842748	NC_000017.11:35107052:C:T	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Aug 4, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.414T>A (p.Asn138Lys)	RAD51D|RAD51L3-RFFL	N138K, N158K	Hereditary cancer-predisposing syndrome	VCV001738249	17	33434073	17	35107054	1738249	1797485	rs1555568320	NC_000017.11:35107053:A:T	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Oct 2, 2022	criteria provided, single submitter							
NM_002878.4(RAD51D):c.414T>C (p.Asn138=)	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV000480541	17	33434073	17	35107054	480541	479187	rs1555568320	NC_000017.11:35107053:A:G	single nucleotide variant	synonymous variant|non-coding transcript variant|intron variant	Benign/Likely benign	Feb 21, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.413A>T (p.Asn138Ile)	RAD51D|RAD51L3-RFFL	N138I, N158I	Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV001738136	17	33434074	17	35107055	1738136	1797372	rs201676898	NC_000017.11:35107054:T:A	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Mar 17, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.413A>G (p.Asn138Ser)	RAD51L3-RFFL|RAD51D	N138S, N158S	Hereditary cancer-predisposing syndrome|not specified|not provided|Breast and/or ovarian cancer|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000127889	17	33434074	17	35107055	127889	133346	rs201676898	NC_000017.11:35107054:T:C	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Conflicting classifications of pathogenicity	Jun 10, 2025	criteria provided, conflicting classifications							
NM_002878.4(RAD51D):c.412A>G (p.Asn138Asp)	RAD51L3-RFFL|RAD51D	N138D, N158D	Hereditary cancer-predisposing syndrome|not specified|not provided|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000182858	17	33434075	17	35107056	182858	180803	rs141690729	NC_000017.11:35107055:T:C	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Mar 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.412A>C (p.Asn138His)	RAD51D|RAD51L3-RFFL	N138H, N158H	not specified|Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome|not provided	VCV000127888	17	33434075	17	35107056	127888	133345	rs141690729	NC_000017.11:35107055:T:G	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Conflicting classifications of pathogenicity	Mar 25, 2025	criteria provided, conflicting classifications							
NM_002878.4(RAD51D):c.411C>T (p.Ser137=)	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV000926841	17	33434076	17	35107057	926841	913832	rs2091614137	NC_000017.11:35107056:G:A	single nucleotide variant	synonymous variant|non-coding transcript variant|intron variant	Likely benign	May 19, 2023	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.410C>G (p.Ser137Cys)	RAD51D|RAD51L3-RFFL	S137C, S157C	Breast-ovarian cancer, familial, susceptibility to, 4	VCV003661297	17	33434077	17	35107058	3661297	3790956		NC_000017.11:35107057:G:C	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Aug 3, 2024	criteria provided, single submitter							
NM_002878.4(RAD51D):c.410C>A (p.Ser137Tyr)	RAD51D|RAD51L3-RFFL	S137Y, S157Y	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV002678185	17	33434077	17	35107058	2678185	2833208	rs2142433096	NC_000017.11:35107057:G:T	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Mar 22, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.410C>T (p.Ser137Phe)	RAD51D|RAD51L3-RFFL	S137F, S157F	Breast-ovarian cancer, familial, susceptibility to, 4	VCV001493231	17	33434077	17	35107058	1493231	1355430	rs2142433096	NC_000017.11:35107057:G:A	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Nov 24, 2020	criteria provided, single submitter							
NM_002878.4(RAD51D):c.409T>G (p.Ser137Ala)	RAD51D|RAD51L3-RFFL	S137A, S157A	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000472606	17	33434078	17	35107059	472606	467944	rs1555568327	NC_000017.11:35107058:A:C	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Jun 14, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.408T>A (p.Asp136Glu)	RAD51D|RAD51L3-RFFL	D136E, D156E	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000919949	17	33434079	17	35107060	919949	913833	rs1567728349	NC_000017.11:35107059:A:T	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Mar 6, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.408T>C (p.Asp136=)	RAD51D|RAD51L3-RFFL		Hereditary cancer-predisposing syndrome	VCV000629729	17	33434079	17	35107060	629729	618539	rs1567728349	NC_000017.11:35107059:A:G	single nucleotide variant	synonymous variant|non-coding transcript variant|intron variant	Likely benign	Oct 19, 2018	criteria provided, single submitter							
NM_002878.4(RAD51D):c.407A>T (p.Asp136Val)	RAD51D|RAD51L3-RFFL	D136V, D156V	Hereditary cancer-predisposing syndrome	VCV001737605	17	33434080	17	35107061	1737605	1787469	rs768197423	NC_000017.11:35107060:T:A	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Aug 28, 2022	criteria provided, single submitter							
NM_002878.4(RAD51D):c.407A>G (p.Asp136Gly)	RAD51D|RAD51L3-RFFL	D136G, D156G	not provided|not specified|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000232305	17	33434080	17	35107061	232305	235890	rs768197423	NC_000017.11:35107060:T:C	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Dec 26, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.406G>T (p.Asp136Tyr)	RAD51D|RAD51L3-RFFL	D156Y, D136Y	Hereditary cancer-predisposing syndrome	VCV001737539	17	33434081	17	35107062	1737539	1787403	rs2142433158	NC_000017.11:35107061:C:A	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Dec 11, 2021	criteria provided, single submitter							
NM_002878.4(RAD51D):c.405A>G (p.Val135=)	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4|not specified|Hereditary cancer-predisposing syndrome	VCV000507984	17	33434082	17	35107063	507984	506262	rs1555568330	NC_000017.11:35107062:T:C	single nucleotide variant	synonymous variant|non-coding transcript variant|intron variant	Benign/Likely benign	Feb 21, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.404T>C (p.Val135Ala)	RAD51D|RAD51L3-RFFL	V155A, V135A	Breast-ovarian cancer, familial, susceptibility to, 4	VCV001913258	17	33434083	17	35107064	1913258	1973474	rs1409370576	NC_000017.11:35107063:A:G	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Jul 30, 2022	criteria provided, single submitter							
NM_002878.4(RAD51D):c.404T>A (p.Val135Glu)	RAD51D|RAD51L3-RFFL	V135E, V155E	Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV000657311	17	33434083	17	35107064	657311	645811	rs1409370576	NC_000017.11:35107063:A:T	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	May 27, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.403G>T (p.Val135Leu)	RAD51D|RAD51L3-RFFL	V155L, V135L	Hereditary cancer-predisposing syndrome	VCV001737277	17	33434084	17	35107065	1737277	1790476	rs2142433203	NC_000017.11:35107064:C:A	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Apr 11, 2018	criteria provided, single submitter							
NM_002878.4(RAD51D):c.402T>A (p.Tyr134Ter)	RAD51D|RAD51L3-RFFL	Y134*, Y154*	Breast-ovarian cancer, familial, susceptibility to, 4	VCV003727171	17	33434085	17	35107066	3727171	3861396		NC_000017.11:35107065:A:T	single nucleotide variant	nonsense|non-coding transcript variant|intron variant	Pathogenic	Dec 12, 2024	criteria provided, single submitter							
NM_002878.4(RAD51D):c.402T>G (p.Tyr134Ter)	RAD51D|RAD51L3-RFFL	Y134*, Y154*	Breast-ovarian cancer, familial, susceptibility to, 4	VCV003148224	17	33434085	17	35107066	3148224	3307472	rs1419080369	NC_000017.11:35107065:A:C	single nucleotide variant	nonsense|non-coding transcript variant|intron variant	Pathogenic	Jan 4, 2024	criteria provided, single submitter							
NM_002878.4(RAD51D):c.402T>C (p.Tyr134=)	RAD51L3-RFFL|RAD51D		Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome|not provided	VCV000922691	17	33434085	17	35107066	922691	913834	rs1419080369	NC_000017.11:35107065:A:G	single nucleotide variant	synonymous variant|non-coding transcript variant|intron variant	Conflicting classifications of pathogenicity	Oct 13, 2023	criteria provided, conflicting classifications							
NM_002878.4(RAD51D):c.401A>G (p.Tyr134Cys)	RAD51D|RAD51L3-RFFL	Y134C, Y154C	Hereditary breast ovarian cancer syndrome	VCV000584938	17	33434086	17	35107067	584938	575987	rs1567728366	NC_000017.11:35107066:T:C	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Jul 2, 2018	criteria provided, single submitter							
NM_002878.4(RAD51D):c.400T>C (p.Tyr134His)	RAD51D|RAD51L3-RFFL	Y134H, Y154H	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV002678180	17	33434087	17	35107068	2678180	2833203	rs2142433261	NC_000017.11:35107067:A:G	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Aug 8, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.399A>G (p.Leu133=)	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV000935294	17	33434088	17	35107069	935294	937890	rs774111609	NC_000017.11:35107068:T:C	single nucleotide variant	synonymous variant|non-coding transcript variant|intron variant	Benign/Likely benign	Feb 21, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.397C>G (p.Leu133Val)	RAD51D|RAD51L3-RFFL	L133V, L153V	Hereditary cancer-predisposing syndrome|not provided|Breast-ovarian cancer, familial, susceptibility to, 4	VCV001736680	17	33434090	17	35107071	1736680	1793723	rs1555568338	NC_000017.11:35107070:G:C	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Dec 31, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.397C>A (p.Leu133Ile)	RAD51D|RAD51L3-RFFL	L133I, L153I	Hereditary cancer-predisposing syndrome	VCV000482204	17	33434090	17	35107071	482204	478606	rs1555568338	NC_000017.11:35107070:G:T	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	May 18, 2017	criteria provided, single submitter							
NM_002878.4(RAD51D):c.396C>T (p.Val132=)	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV000482190	17	33434091	17	35107072	482190	478460	rs1555568341	NC_000017.11:35107071:G:A	single nucleotide variant	synonymous variant|non-coding transcript variant|intron variant	Benign/Likely benign	Feb 21, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.395T>A (p.Val132Asp)	RAD51L3-RFFL|RAD51D	V132D, V152D	Breast-ovarian cancer, familial, susceptibility to, 4	VCV000539861	17	33434092	17	35107073	539861	531166	rs1555568342	NC_000017.11:35107072:A:T	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Jun 2, 2023	criteria provided, single submitter							
NM_002878.4(RAD51D):c.394G>A (p.Val132Ile)	RAD51D|RAD51L3-RFFL	V132I, V152I	Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000185178	17	33434093	17	35107074	185178	184833	rs201141245	NC_000017.11:35107073:C:T	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Conflicting classifications of pathogenicity	Jan 19, 2025	criteria provided, conflicting classifications							
NM_002878.4(RAD51D):c.393C>T (p.Asn131=)	RAD51D|RAD51L3-RFFL		Hereditary cancer-predisposing syndrome|not provided|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000186031	17	33434094	17	35107075	186031	184834	rs772605790	NC_000017.11:35107074:G:A	single nucleotide variant	synonymous variant|non-coding transcript variant|intron variant	Conflicting classifications of pathogenicity	May 14, 2025	criteria provided, conflicting classifications							
NM_002878.4(RAD51D):c.392A>C (p.Asn131Thr)	RAD51D|RAD51L3-RFFL	N151T, N131T	Breast-ovarian cancer, familial, susceptibility to, 4	VCV001043705	17	33434095	17	35107076	1043705	1033229	rs1060502954	NC_000017.11:35107075:T:G	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Feb 7, 2020	criteria provided, single submitter							
NM_002878.4(RAD51D):c.392A>G (p.Asn131Ser)	RAD51D|RAD51L3-RFFL	N131S, N151S	Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV000410554	17	33434095	17	35107076	410554	402400	rs1060502954	NC_000017.11:35107075:T:C	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Jun 4, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.390A>G (p.Gln130=)	RAD51D|RAD51L3-RFFL		not specified	VCV003911250	17	33434097	17	35107078	3911250	4025225		NC_000017.11:35107077:T:C	single nucleotide variant	synonymous variant|non-coding transcript variant|intron variant	Likely benign	Feb 16, 2025	criteria provided, single submitter							
NM_002878.4(RAD51D):c.390A>T (p.Gln130His)	RAD51D|RAD51L3-RFFL	Q130H, Q150H	Hereditary cancer-predisposing syndrome	VCV001736083	17	33434097	17	35107078	1736083	1787242	rs2142433416	NC_000017.11:35107077:T:A	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Sep 25, 2022	criteria provided, single submitter							
NM_002878.4(RAD51D):c.388C>T (p.Gln130Ter)	RAD51D|RAD51L3-RFFL	Q130*, Q150*	Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV001735878	17	33434099	17	35107080	1735878	1787039	rs2142433436	NC_000017.11:35107079:G:A	single nucleotide variant	nonsense|non-coding transcript variant|intron variant	Pathogenic/Likely pathogenic	Nov 19, 2023	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.388C>G (p.Gln130Glu)	RAD51D|RAD51L3-RFFL	Q130E, Q150E	Hereditary cancer-predisposing syndrome	VCV001735875	17	33434099	17	35107080	1735875	1787036	rs2142433436	NC_000017.11:35107079:G:C	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Feb 24, 2021	criteria provided, single submitter							
NM_002878.4(RAD51D):c.386A>C (p.Gln129Pro)	RAD51D|RAD51L3-RFFL	Q149P, Q129P	Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV000959777	17	33434101	17	35107082	959777	949878	rs1165240216	NC_000017.11:35107081:T:G	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Jul 26, 2019	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.386A>G (p.Gln129Arg)	RAD51D|RAD51L3-RFFL	Q129R, Q149R	Hereditary cancer-predisposing syndrome	VCV000824321	17	33434101	17	35107082	824321	813573	rs1165240216	NC_000017.11:35107081:T:C	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Jan 24, 2019	criteria provided, single submitter							
NM_002878.4(RAD51D):c.385C>T (p.Gln129Ter)	RAD51D|RAD51L3-RFFL	Q149*, Q129*	Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000824313	17	33434102	17	35107083	824313	813574	rs1597862732	NC_000017.11:35107082:G:A	single nucleotide variant	nonsense|non-coding transcript variant|intron variant	Pathogenic/Likely pathogenic	Dec 4, 2023	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.384G>C (p.Leu128=)	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV003661629	17	33434103	17	35107084	3661629	3801308		NC_000017.11:35107083:C:G	single nucleotide variant	synonymous variant|non-coding transcript variant|intron variant	Likely benign	Aug 7, 2024	criteria provided, single submitter							
NM_002878.4(RAD51D):c.384G>T (p.Leu128=)	RAD51L3-RFFL|RAD51D		Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome|not specified	VCV000514421	17	33434103	17	35107084	514421	506264	rs1393403501	NC_000017.11:35107083:C:A	single nucleotide variant	synonymous variant|non-coding transcript variant|intron variant	Conflicting classifications of pathogenicity	Feb 21, 2025	criteria provided, conflicting classifications							
NM_002878.4(RAD51D):c.384G>A (p.Leu128=)	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV000492430	17	33434103	17	35107084	492430	484769	rs1393403501	NC_000017.11:35107083:C:T	single nucleotide variant	synonymous variant|non-coding transcript variant|intron variant	Benign/Likely benign	Feb 21, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.383T>C (p.Leu128Pro)	RAD51L3-RFFL|RAD51D	L148P, L128P	Hereditary cancer-predisposing syndrome	VCV002448049	17	33434104	17	35107085	2448049	2428993	rs2142433508	NC_000017.11:35107084:A:G	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Jan 5, 2023	criteria provided, single submitter							
NM_002878.4(RAD51D):c.382C>T (p.Leu128=)	RAD51D|RAD51L3-RFFL		not specified|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000472605	17	33434105	17	35107086	472605	466754	rs1438461174	NC_000017.11:35107085:G:A	single nucleotide variant	synonymous variant|non-coding transcript variant|intron variant	Benign/Likely benign	Feb 21, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.381C>G (p.Gly127=)	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV000492429	17	33434106	17	35107087	492429	484773	rs1555568350	NC_000017.11:35107086:G:C	single nucleotide variant	synonymous variant|non-coding transcript variant|intron variant	Benign/Likely benign	Feb 21, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.379G>A (p.Gly127Ser)	RAD51D|RAD51L3-RFFL	G127S, G147S	not provided|Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV000855551	17	33434108	17	35107089	855551	845226	rs876659085	NC_000017.11:35107088:C:T	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Conflicting classifications of pathogenicity	Oct 11, 2024	criteria provided, conflicting classifications							
NM_002878.4(RAD51D):c.379G>C (p.Gly127Arg)	RAD51D|RAD51L3-RFFL	G127R, G147R	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000231316	17	33434108	17	35107089	231316	235891	rs876659085	NC_000017.11:35107088:C:G	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Mar 8, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.378T>C (p.His126=)	RAD51D|RAD51L3-RFFL		Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV001121454	17	33434109	17	35107090	1121454	1126148	rs2142433584	NC_000017.11:35107089:A:G	single nucleotide variant	synonymous variant|non-coding transcript variant|intron variant	Benign/Likely benign	Feb 21, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.377A>C (p.His126Pro)	RAD51D|RAD51L3-RFFL	H126P, H146P	Hereditary cancer-predisposing syndrome	VCV001734823	17	33434110	17	35107091	1734823	1796615	rs144603589	NC_000017.11:35107090:T:G	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Jan 4, 2021	criteria provided, single submitter							
NM_002878.4(RAD51D):c.377A>G (p.His126Arg)	RAD51D|RAD51L3-RFFL	H126R, H146R	Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV000641939	17	33434110	17	35107091	641939	645812	rs144603589	NC_000017.11:35107090:T:C	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Oct 1, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.377A>T (p.His126Leu)	RAD51L3-RFFL|RAD51D	H126L, H146L	not provided|Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV000182857	17	33434110	17	35107091	182857	180804	rs144603589	NC_000017.11:35107090:T:A	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Nov 5, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.376C>G (p.His126Asp)	RAD51D|RAD51L3-RFFL	H126D, H146D	Breast-ovarian cancer, familial, susceptibility to, 4	VCV002163322	17	33434111	17	35107092	2163322	1887806	rs2142433613	NC_000017.11:35107091:G:C	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Jan 3, 2022	criteria provided, single submitter							
NM_002878.4(RAD51D):c.376C>A (p.His126Asn)	RAD51D|RAD51L3-RFFL	H126N, H146N	Hereditary cancer-predisposing syndrome	VCV001734742	17	33434111	17	35107092	1734742	1796534	rs2142433613	NC_000017.11:35107091:G:T	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Mar 15, 2019	criteria provided, single submitter							
NM_002878.4(RAD51D):c.374C>T (p.Ala125Val)	RAD51L3-RFFL|RAD51D	A125V, A145V	Hereditary cancer-predisposing syndrome|not provided|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000472604	17	33434113	17	35107094	472604	467620	rs1390812423	NC_000017.11:35107093:G:A	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Nov 6, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.373G>A (p.Ala125Thr)	RAD51D|RAD51L3-RFFL	A125T, A145T	not provided	VCV001304193	17	33434114	17	35107095	1304193	1294468	rs1597862772	NC_000017.11:35107094:C:T	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Sep 19, 2018	criteria provided, single submitter							
NM_002878.4(RAD51D):c.373G>T (p.Ala125Ser)	RAD51D|RAD51L3-RFFL	A125S, A145S	Breast-ovarian cancer, familial, susceptibility to, 4	VCV000641332	17	33434114	17	35107095	641332	645813	rs1597862772	NC_000017.11:35107094:C:A	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Apr 14, 2022	criteria provided, single submitter							
NM_002878.4(RAD51D):c.372G>T (p.Val124=)	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV002719321	17	33434115	17	35107096	2719321	2869957	rs1597862777	NC_000017.11:35107095:C:A	single nucleotide variant	synonymous variant|non-coding transcript variant|intron variant	Benign/Likely benign	Feb 21, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.372G>A (p.Val124=)	RAD51D|RAD51L3-RFFL		Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4|not provided	VCV000824136	17	33434115	17	35107096	824136	813575	rs1597862777	NC_000017.11:35107095:C:T	single nucleotide variant	synonymous variant|non-coding transcript variant|intron variant	Conflicting classifications of pathogenicity	Feb 21, 2025	criteria provided, conflicting classifications							
NM_002878.4(RAD51D):c.371T>C (p.Val124Ala)	RAD51D|RAD51L3-RFFL	V144A, V124A	Hereditary cancer-predisposing syndrome	VCV003942383	17	33434116	17	35107097	3942383	4064162		NC_000017.11:35107096:A:G	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Apr 4, 2025	criteria provided, single submitter							
NM_002878.4(RAD51D):c.370G>A (p.Val124Met)	RAD51D|RAD51L3-RFFL	V124M, V144M	Breast-ovarian cancer, familial, susceptibility to, 4|not provided	VCV001298699	17	33434117	17	35107098	1298699	1288561	rs776581316	NC_000017.11:35107097:C:T	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Apr 10, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.369T>A (p.Asn123Lys)	RAD51D|RAD51L3-RFFL	N143K, N123K	Hereditary cancer-predisposing syndrome	VCV001734047	17	33434118	17	35107099	1734047	1786466	rs2142433717	NC_000017.11:35107098:A:T	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Jul 6, 2020	criteria provided, single submitter							
NM_002878.4(RAD51D):c.369T>C (p.Asn123=)	RAD51D|RAD51L3-RFFL		Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV001089382	17	33434118	17	35107099	1089382	1082933	rs2142433717	NC_000017.11:35107098:A:G	single nucleotide variant	synonymous variant|non-coding transcript variant|intron variant	Benign/Likely benign	Feb 21, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.368A>G (p.Asn123Ser)	RAD51D|RAD51L3-RFFL	N123S, N143S	Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome|not provided	VCV000410550	17	33434119	17	35107100	410550	402403	rs918988936	NC_000017.11:35107099:T:C	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Nov 5, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.367A>G (p.Asn123Asp)	RAD51D|RAD51L3-RFFL	N123D, N143D	Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV001171959	17	33434120	17	35107101	1171959	1161346	rs2142433737	NC_000017.11:35107100:T:C	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Jun 2, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.365C>A (p.Ala122Glu)	RAD51D|RAD51L3-RFFL	A122E, A142E	Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV001063705	17	33434122	17	35107103	1063705	1050200	rs1489866177	NC_000017.11:35107102:G:T	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Jul 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.365C>T (p.Ala122Val)	RAD51D|RAD51L3-RFFL	A142V, A122V	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV001042992	17	33434122	17	35107103	1042992	1033230	rs1489866177	NC_000017.11:35107102:G:A	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Apr 28, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.364G>A (p.Ala122Thr)	RAD51D|RAD51L3-RFFL	A122T, A142T	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4|not provided	VCV001489023	17	33434123	17	35107104	1489023	1498515	rs2091615360	NC_000017.11:35107103:C:T	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Jun 6, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.363A>G (p.Ala121=)	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV003312402	17	33434124	17	35107105	3312402	3461944		NC_000017.11:35107104:T:C	single nucleotide variant	synonymous variant|non-coding transcript variant|intron variant	Benign/Likely benign	Feb 21, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.362C>T (p.Ala121Val)	RAD51D|RAD51L3-RFFL	A121V, A141V	Breast-ovarian cancer, familial, susceptibility to, 4	VCV001948506	17	33434125	17	35107106	1948506	1999622	rs2142433816	NC_000017.11:35107105:G:A	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Sep 22, 2022	criteria provided, single submitter							
NM_002878.4(RAD51D):c.361G>T (p.Ala121Ser)	RAD51D|RAD51L3-RFFL	A121S, A141S	Breast-ovarian cancer, familial, susceptibility to, 4	VCV003240258	17	33434126	17	35107107	3240258	3399245	rs1555568366	NC_000017.11:35107106:C:A	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Dec 17, 2023	criteria provided, single submitter							
NM_002878.4(RAD51D):c.361G>C (p.Ala121Pro)	RAD51D|RAD51L3-RFFL	A141P, A121P	Breast-ovarian cancer, familial, susceptibility to, 4	VCV000943850	17	33434126	17	35107107	943850	937891	rs1555568366	NC_000017.11:35107106:C:G	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Aug 8, 2019	criteria provided, single submitter							
NM_002878.4(RAD51D):c.361G>A (p.Ala121Thr)	RAD51D|RAD51L3-RFFL	A121T, A141T	Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000484777	17	33434126	17	35107107	484777	478610	rs1555568366	NC_000017.11:35107106:C:T	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Jun 27, 2023	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.360G>A (p.Met120Ile)	RAD51D|RAD51L3-RFFL	M140I, M120I	Hereditary cancer-predisposing syndrome	VCV000823986	17	33434127	17	35107108	823986	813576	rs1597862818	NC_000017.11:35107107:C:T	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Oct 18, 2018	criteria provided, single submitter							
NM_002878.4(RAD51D):c.359T>C (p.Met120Thr)	RAD51D|RAD51L3-RFFL	M120T, M140T	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV001494296	17	33434128	17	35107109	1494296	1350039	rs876660691	NC_000017.11:35107108:A:G	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Jul 6, 2023	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.359T>G (p.Met120Arg)	RAD51D|RAD51L3-RFFL	M120R, M140R	Hereditary cancer-predisposing syndrome	VCV000233863	17	33434128	17	35107109	233863	235893	rs876660691	NC_000017.11:35107108:A:C	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Sep 14, 2015	criteria provided, single submitter							
NM_002878.4(RAD51D):c.358A>G (p.Met120Val)	RAD51D|RAD51L3-RFFL	M120V, M140V	Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV001718843	17	33434129	17	35107110	1718843	1776347	rs876659998	NC_000017.11:35107109:T:C	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Conflicting classifications of pathogenicity	Nov 12, 2024	criteria provided, conflicting classifications							
NM_002878.4(RAD51D):c.358A>C (p.Met120Leu)	RAD51D|RAD51L3-RFFL	M120L, M140L	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000232804	17	33434129	17	35107110	232804	235894	rs876659998	NC_000017.11:35107109:T:G	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Mar 6, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.357T>G (p.Cys119Trp)	RAD51D|RAD51L3-RFFL	C119W, C139W	Hereditary cancer-predisposing syndrome	VCV002563034	17	33434130	17	35107111	2563034	2733491	rs1272809785	NC_000017.11:35107110:A:C	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Apr 23, 2023	criteria provided, single submitter							
NM_002878.4(RAD51D):c.357T>C (p.Cys119=)	RAD51L3-RFFL|RAD51D		Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV000492428	17	33434130	17	35107111	492428	485213	rs1272809785	NC_000017.11:35107110:A:G	single nucleotide variant	synonymous variant|non-coding transcript variant|intron variant	Benign/Likely benign	Feb 21, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.356G>C (p.Cys119Ser)	RAD51D|RAD51L3-RFFL	C119S, C139S	Breast-ovarian cancer, familial, susceptibility to, 4	VCV000582021	17	33434131	17	35107112	582021	571289	rs759730492	NC_000017.11:35107111:C:G	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Feb 17, 2018	criteria provided, single submitter							
NM_002878.4(RAD51D):c.356G>A (p.Cys119Tyr)	RAD51D|RAD51L3-RFFL	C119Y, C139Y	Hereditary cancer-predisposing syndrome|not specified|Breast-ovarian cancer, familial, susceptibility to, 4|not provided	VCV000234195	17	33434131	17	35107112	234195	235895	rs759730492	NC_000017.11:35107111:C:T	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Mar 21, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.355T>C (p.Cys119Arg)	RAD51D|RAD51L3-RFFL	C119R, C139R	Breast-ovarian cancer, familial, susceptibility to, 4|Breast and/or ovarian cancer|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|not provided|not specified|Familial ovarian cancer	VCV000182856	17	33434132	17	35107113	182856	180806	rs201313861	NC_000017.11:35107112:A:G	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Conflicting classifications of pathogenicity	Apr 2, 2025	criteria provided, conflicting classifications							
NM_002878.4(RAD51D):c.354C>T (p.Leu118=)	RAD51D|RAD51L3-RFFL		Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV001159891	17	33434133	17	35107114	1159891	1147042	rs2142433941	NC_000017.11:35107113:G:A	single nucleotide variant	synonymous variant|non-coding transcript variant|intron variant	Benign/Likely benign	Feb 21, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.352C>A (p.Leu118Ile)	RAD51D|RAD51L3-RFFL	L118I, L138I	Hereditary cancer-predisposing syndrome	VCV001732342	17	33434135	17	35107116	1732342	1789373	rs1597862842	NC_000017.11:35107115:G:T	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	May 1, 2022	criteria provided, single submitter							
NM_002878.4(RAD51D):c.352C>T (p.Leu118Phe)	RAD51D|RAD51L3-RFFL	L118F, L138F	Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV000823890	17	33434135	17	35107116	823890	813577	rs1597862842	NC_000017.11:35107115:G:A	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Mar 11, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.351T>C (p.Cys117=)	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV003903817	17	33434136	17	35107117	3903817	4019690		NC_000017.11:35107116:A:G	single nucleotide variant	synonymous variant|non-coding transcript variant|intron variant	Benign	Feb 21, 2025	criteria provided, single submitter							
NM_002878.4(RAD51D):c.351T>A (p.Cys117Ter)	RAD51D|RAD51L3-RFFL	C117*, C137*	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000539859	17	33434136	17	35107117	539859	530964	rs1555568382	NC_000017.11:35107116:A:T	single nucleotide variant	nonsense|non-coding transcript variant|intron variant	Pathogenic	Dec 4, 2023	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.350G>A (p.Cys117Tyr)	RAD51D|RAD51L3-RFFL	C117Y, C137Y	Breast-ovarian cancer, familial, susceptibility to, 4	VCV003627715	17	33434137	17	35107118	3627715	3761701		NC_000017.11:35107117:C:T	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Nov 6, 2024	criteria provided, single submitter							
NM_002878.4(RAD51D):c.350G>T (p.Cys117Phe)	RAD51D|RAD51L3-RFFL	C117F, C137F	Breast-ovarian cancer, familial, susceptibility to, 4	VCV002840196	17	33434137	17	35107118	2840196	3003417	rs2142434017	NC_000017.11:35107117:C:A	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	May 5, 2024	criteria provided, single submitter							
NM_002878.4(RAD51D):c.349T>G (p.Cys117Gly)	RAD51D|RAD51L3-RFFL	C117G, C137G	Breast-ovarian cancer, familial, susceptibility to, 4	VCV002840660	17	33434138	17	35107119	2840660	3000483	rs786201358	NC_000017.11:35107118:A:C	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Feb 25, 2023	criteria provided, single submitter							
NM_002878.4(RAD51D):c.349T>A (p.Cys117Ser)	RAD51D|RAD51L3-RFFL	C117S, C137S	not provided|Breast-ovarian cancer, familial, susceptibility to, 4|not specified|Hereditary cancer-predisposing syndrome	VCV000184247	17	33434138	17	35107119	184247	184835	rs786201358	NC_000017.11:35107118:A:T	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Mar 31, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.348A>G (p.Val116=)	RAD51D|RAD51L3-RFFL		Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV001731905	17	33434139	17	35107120	1731905	1792808	rs1233886388	NC_000017.11:35107119:T:C	single nucleotide variant	synonymous variant|non-coding transcript variant|intron variant	Likely benign	Mar 3, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.348A>T (p.Val116=)	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV001586965	17	33434139	17	35107120	1586965	1628905	rs1233886388	NC_000017.11:35107119:T:A	single nucleotide variant	synonymous variant|non-coding transcript variant|intron variant	Benign/Likely benign	Feb 21, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.347T>C (p.Val116Ala)	RAD51D|RAD51L3-RFFL	V116A, V136A	Hereditary cancer-predisposing syndrome	VCV003786508	17	33434140	17	35107121	3786508	3908949		NC_000017.11:35107120:A:G	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Feb 4, 2025	criteria provided, single submitter							
NM_002878.4(RAD51D):c.346G>A (p.Val116Ile)	RAD51D|RAD51L3-RFFL	V116I, V136I	not specified|Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV000484770	17	33434141	17	35107122	484770	478488	rs753009349	NC_000017.11:35107121:C:T	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Conflicting classifications of pathogenicity	Mar 4, 2025	criteria provided, conflicting classifications							
NM_002878.4(RAD51D):c.346G>T (p.Val116Leu)	RAD51L3-RFFL|RAD51D	V116L, V136L	Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV000482197	17	33434141	17	35107122	482197	479189	rs753009349	NC_000017.11:35107121:C:A	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Dec 17, 2023	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.346-1G>C	RAD51D|RAD51L3-RFFL		Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000484788	17	33434142	17	35107123	484788	478489	rs1555568386	NC_000017.11:35107122:C:G	single nucleotide variant	splice acceptor variant|intron variant	Pathogenic/Likely pathogenic	Jun 12, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.346-2A>G	RAD51D|RAD51L3-RFFL		Hereditary breast ovarian cancer syndrome	VCV003339773	17	33434143	17	35107124	3339773	3499037		NC_000017.11:35107123:T:C	single nucleotide variant	splice acceptor variant|intron variant	Likely pathogenic	Jun 3, 2024	criteria provided, single submitter							
NM_002878.4(RAD51D):c.346-3C>G	RAD51D|RAD51L3-RFFL		not provided	VCV001319172	17	33434144	17	35107125	1319172	1309425	rs758583343	NC_000017.11:35107124:G:C	single nucleotide variant	intron variant	Uncertain significance	Nov 3, 2021	criteria provided, single submitter							
NM_002878.4(RAD51D):c.346-3C>A	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV000410570	17	33434144	17	35107125	410570	401929	rs758583343	NC_000017.11:35107124:G:T	single nucleotide variant	intron variant	Uncertain significance	Oct 8, 2019	criteria provided, single submitter							
NM_002878.4(RAD51D):c.346-4C>A	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV003726043	17	33434145	17	35107126	3726043	3857951		NC_000017.11:35107125:G:T	single nucleotide variant	intron variant	Likely benign	Nov 25, 2024	criteria provided, single submitter							
NM_002878.4(RAD51D):c.346-4C>G	RAD51L3-RFFL|RAD51D		Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000492427	17	33434145	17	35107126	492427	484995	rs767328693	NC_000017.11:35107125:G:C	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Sep 28, 2024	criteria provided, conflicting classifications							
NM_002878.4(RAD51D):c.346-5C>G	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV002087982	17	33434146	17	35107127	2087982	2154941	rs750169840	NC_000017.11:35107126:G:C	single nucleotide variant	intron variant	Likely benign	Feb 17, 2024	criteria provided, single submitter							
NM_002878.4(RAD51D):c.346-5C>T	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome|not specified	VCV000823802	17	33434146	17	35107127	823802	815677	rs750169840	NC_000017.11:35107126:G:A	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Apr 29, 2025	criteria provided, conflicting classifications							
NM_002878.4(RAD51D):c.346-6C>T	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV000627734	17	33434147	17	35107128	627734	619510	rs1555568392	NC_000017.11:35107127:G:A	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Feb 21, 2025	criteria provided, conflicting classifications							
NM_002878.4(RAD51D):c.346-6C>A	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV000472601	17	33434147	17	35107128	472601	467621	rs1555568392	NC_000017.11:35107127:G:T	single nucleotide variant	intron variant	Likely benign	Feb 20, 2024	criteria provided, single submitter							
NM_002878.4(RAD51D):c.346-7C>T	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV000416206	17	33434148	17	35107129	416206	402410	rs1060504768	NC_000017.11:35107128:G:A	single nucleotide variant	intron variant	Likely benign	Feb 21, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.346-8A>T	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV000472602	17	33434149	17	35107130	472602	467808	rs756059587	NC_000017.11:35107129:T:A	single nucleotide variant	intron variant	Likely benign	Feb 21, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.346-8A>C	RAD51D|RAD51L3-RFFL		not provided	VCV000439295	17	33434149	17	35107130	439295	432888	rs756059587	NC_000017.11:35107129:T:G	single nucleotide variant	intron variant	Uncertain significance	Nov 9, 2018	criteria provided, single submitter							
NM_002878.4(RAD51D):c.346-8A>G	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV000239396	17	33434149	17	35107130	239396	242726	rs756059587	NC_000017.11:35107129:T:C	single nucleotide variant	intron variant	Likely benign	Feb 21, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.346-9C>A	RAD51L3-RFFL|RAD51D		not provided|Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV000239397	17	33434150	17	35107131	239397	242727	rs878854563	NC_000017.11:35107130:G:T	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Jul 24, 2024	criteria provided, conflicting classifications							
NM_002878.4(RAD51D):c.346-10C>T	RAD51L3-RFFL|RAD51D		Breast and/or ovarian cancer|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4|not provided	VCV000416203	17	33434151	17	35107132	416203	402595	rs779972784	NC_000017.11:35107131:G:A	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Jan 23, 2025	criteria provided, conflicting classifications							
NM_002878.4(RAD51D):c.346-12C>T	RAD51D|RAD51L3-RFFL		Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV001692728	17	33434153	17	35107134	1692728	1685168	rs878947834	NC_000017.11:35107133:G:A	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Feb 21, 2025	criteria provided, conflicting classifications							
NM_002878.4(RAD51D):c.346-13C>T	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV003903578	17	33434154	17	35107135	3903578	4019451		NC_000017.11:35107134:G:A	single nucleotide variant	intron variant	Likely benign	Feb 21, 2025	criteria provided, single submitter							
NM_002878.4(RAD51D):c.346-14G>A	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV002028062	17	33434155	17	35107136	2028062	2088537	rs2142434250	NC_000017.11:35107135:C:T	single nucleotide variant	intron variant	Likely benign	Aug 31, 2022	criteria provided, single submitter							
NM_002878.4(RAD51D):c.346-15T>G	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV002909604	17	33434156	17	35107137	2909604	3078273	rs1567728476	NC_000017.11:35107136:A:C	single nucleotide variant	intron variant	Likely benign	Nov 27, 2024	criteria provided, single submitter							
NM_002878.4(RAD51D):c.346-15T>C	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV002841196	17	33434156	17	35107137	2841196	2993349	rs1567728476	NC_000017.11:35107136:A:G	single nucleotide variant	intron variant	Likely benign	Feb 26, 2023	criteria provided, single submitter							
NM_002878.4(RAD51D):c.346-16A>G	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome|not specified	VCV000380266	17	33434157	17	35107138	380266	375985	rs749176675	NC_000017.11:35107137:T:C	single nucleotide variant	intron variant	Likely benign	Feb 21, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.346-17A>G	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV002833430	17	33434158	17	35107139	2833430	3001757	rs2509139456	NC_000017.11:35107138:T:C	single nucleotide variant	intron variant	Likely benign	Feb 1, 2023	criteria provided, single submitter							
NM_002878.4(RAD51D):c.346-19C>T	RAD51D|RAD51L3-RFFL		Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000629256	17	33434160	17	35107141	629256	619581	rs1567728479	NC_000017.11:35107140:G:A	single nucleotide variant	intron variant	Likely benign	Feb 21, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.345+23G>C	RAD51D|RAD51L3-RFFL		not specified	VCV003256342	17	33434362	17	35107343	3256342	3415104		NC_000017.11:35107342:C:G	single nucleotide variant	intron variant	Likely benign	Mar 4, 2025	criteria provided, single submitter							
NM_002878.4(RAD51D):c.345+18A>T	RAD51D|RAD51L3-RFFL		Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000492424	17	33434367	17	35107348	492424	484956	rs1555568465	NC_000017.11:35107347:T:A	single nucleotide variant	intron variant	Likely benign	May 10, 2023	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.345+17C>T	RAD51D|RAD51L3-RFFL		Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000492423	17	33434368	17	35107349	492423	484957	rs760529001	NC_000017.11:35107348:G:A	single nucleotide variant	intron variant	Likely benign	Jan 12, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.345+14C>T	RAD51L3-RFFL|RAD51D		Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000630497	17	33434371	17	35107352	630497	619584	rs1567728611	NC_000017.11:35107351:G:A	single nucleotide variant	intron variant	Likely benign	Mar 2, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.345+13C>G	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV001957027	17	33434372	17	35107353	1957027	2011999	rs2142436244	NC_000017.11:35107352:G:C	single nucleotide variant	intron variant	Likely benign	Apr 27, 2023	criteria provided, single submitter							
NM_002878.4(RAD51D):c.345+11G>T	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV002916820	17	33434374	17	35107355	2916820	3076882	rs2142436265	NC_000017.11:35107354:C:A	single nucleotide variant	intron variant	Likely benign	Oct 16, 2024	criteria provided, single submitter							
NM_002878.4(RAD51D):c.345+11G>A	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV001629787	17	33434374	17	35107355	1629787	1596310	rs2142436265	NC_000017.11:35107354:C:T	single nucleotide variant	intron variant	Likely benign	May 19, 2023	criteria provided, single submitter							
NM_002878.4(RAD51D):c.345+9G>C	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV003903458	17	33434376	17	35107357	3903458	4019332		NC_000017.11:35107356:C:G	single nucleotide variant	intron variant	Likely benign	Feb 21, 2025	criteria provided, single submitter							
NM_002878.4(RAD51D):c.345+8T>G	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV003904031	17	33434377	17	35107358	3904031	4019904		NC_000017.11:35107357:A:C	single nucleotide variant	intron variant	Likely benign	Feb 21, 2025	criteria provided, single submitter							
NM_002878.4(RAD51D):c.345+7G>T	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV000927960	17	33434378	17	35107359	927960	916718	rs1187944465	NC_000017.11:35107358:C:A	single nucleotide variant	intron variant	Likely benign	Feb 21, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.345+7G>A	RAD51L3-RFFL|RAD51D		Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000919131	17	33434378	17	35107359	919131	916483	rs1187944465	NC_000017.11:35107358:C:T	single nucleotide variant	intron variant	Likely benign	Jul 24, 2022	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.345+6T>C	RAD51L3-RFFL|RAD51D		Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000492425	17	33434379	17	35107360	492425	484778	rs1555568466	NC_000017.11:35107359:A:G	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Jan 11, 2025	criteria provided, conflicting classifications							
NM_002878.4(RAD51D):c.345+5A>C	RAD51D|RAD51L3-RFFL		Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000853861	17	33434380	17	35107361	853861	852196	rs878854562	NC_000017.11:35107360:T:G	single nucleotide variant	intron variant	Uncertain significance	Feb 4, 2020	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.345+5A>T	RAD51L3-RFFL|RAD51D		Hereditary cancer-predisposing syndrome|not specified|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000472600	17	33434380	17	35107361	472600	467950	rs878854562	NC_000017.11:35107360:T:A	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Mar 6, 2024	criteria provided, conflicting classifications							
NM_002878.4(RAD51D):c.345+5A>G	RAD51D|RAD51L3-RFFL		Hereditary cancer-predisposing syndrome|not specified|Breast-ovarian cancer, familial, susceptibility to, 4|not provided|Familial ovarian cancer	VCV000239395	17	33434380	17	35107361	239395	242728	rs878854562	NC_000017.11:35107360:T:C	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Feb 21, 2025	criteria provided, conflicting classifications							
NM_002878.4(RAD51D):c.345+4C>T	RAD51D|RAD51L3-RFFL		not provided|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4|Familial ovarian cancer	VCV000486282	17	33434381	17	35107362	486282	478461	rs918947511	NC_000017.11:35107361:G:A	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Nov 22, 2024	criteria provided, conflicting classifications							
NM_002878.4(RAD51D):c.345+3A>G	RAD51D|RAD51L3-RFFL		Hereditary cancer-predisposing syndrome	VCV002563032	17	33434382	17	35107363	2563032	2733489	rs2142436352	NC_000017.11:35107362:T:C	single nucleotide variant	intron variant	Uncertain significance	Apr 25, 2023	criteria provided, single submitter							
NM_002878.4(RAD51D):c.345+2T>C	RAD51D|RAD51L3-RFFL		Hereditary cancer-predisposing syndrome|not provided|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000231839	17	33434383	17	35107364	231839	235896	rs876659394	NC_000017.11:35107363:A:G	single nucleotide variant	splice donor variant|intron variant	Conflicting classifications of pathogenicity	Nov 15, 2024	criteria provided, conflicting classifications							
NM_002878.4(RAD51D):c.345+1G>T	RAD51D|RAD51L3-RFFL		Hereditary cancer-predisposing syndrome	VCV002563027	17	33434384	17	35107365	2563027	2733484	rs1567728636	NC_000017.11:35107364:C:A	single nucleotide variant	splice donor variant|intron variant	Uncertain significance	Apr 6, 2023	criteria provided, single submitter							
NM_002878.4(RAD51D):c.345G>C (p.Gln115His)	RAD51D|RAD51L3-RFFL	Q115H, Q135H	Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV000643598	17	33434385	17	35107366	643598	645814	rs1555568469	NC_000017.11:35107365:C:G	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Conflicting classifications of pathogenicity	Mar 26, 2024	criteria provided, conflicting classifications							
NM_002878.4(RAD51D):c.345G>A (p.Gln115=)	RAD51L3-RFFL|RAD51D		Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000492426	17	33434385	17	35107366	492426	484780	rs1555568469	NC_000017.11:35107365:C:T	single nucleotide variant	synonymous variant|non-coding transcript variant|intron variant	Conflicting classifications of pathogenicity	May 16, 2024	criteria provided, conflicting classifications							
NM_002878.4(RAD51D):c.344A>T (p.Gln115Leu)	RAD51D|RAD51L3-RFFL	Q115L, Q135L	Hereditary cancer-predisposing syndrome	VCV001731537	17	33434386	17	35107367	1731537	1792442	rs2091619885	NC_000017.11:35107366:T:A	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Sep 15, 2022	criteria provided, single submitter							
NM_002878.4(RAD51D):c.344A>G (p.Gln115Arg)	RAD51D|RAD51L3-RFFL	Q115R, Q135R	Breast-ovarian cancer, familial, susceptibility to, 4	VCV000934207	17	33434386	17	35107367	934207	937892	rs2091619885	NC_000017.11:35107366:T:C	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Jun 21, 2024	criteria provided, single submitter							
NM_002878.4(RAD51D):c.343C>T (p.Gln115Ter)	RAD51D|RAD51L3-RFFL	Q115*, Q135*	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000472599	17	33434387	17	35107368	472599	467952	rs1555568473	NC_000017.11:35107367:G:A	single nucleotide variant	nonsense|non-coding transcript variant|intron variant	Pathogenic	Dec 4, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.342T>G (p.Thr114=)	RAD51D|RAD51L3-RFFL		Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV003222881	17	33434388	17	35107369	3222881	3386519	rs2142436422	NC_000017.11:35107368:A:C	single nucleotide variant	synonymous variant|non-coding transcript variant|intron variant	Benign/Likely benign	Feb 21, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.342T>C (p.Thr114=)	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV002779136	17	33434388	17	35107369	2779136	2940287	rs2142436422	NC_000017.11:35107368:A:G	single nucleotide variant	synonymous variant|non-coding transcript variant|intron variant	Likely benign	May 25, 2023	criteria provided, single submitter							
NM_002878.4(RAD51D):c.341C>T (p.Thr114Ile)	RAD51D|RAD51L3-RFFL	T134I, T114I	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000945947	17	33434389	17	35107370	945947	928226	rs2091619941	NC_000017.11:35107369:G:A	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Mar 31, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.340A>C (p.Thr114Pro)	RAD51D|RAD51L3-RFFL	T114P, T134P	Breast-ovarian cancer, familial, susceptibility to, 4|not provided	VCV001496477	17	33434390	17	35107371	1496477	1359509	rs2142436441	NC_000017.11:35107370:T:G	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Jun 21, 2023	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.339A>G (p.Lys113=)	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV003903770	17	33434391	17	35107372	3903770	4019643		NC_000017.11:35107371:T:C	single nucleotide variant	synonymous variant|non-coding transcript variant|intron variant	Benign	Feb 21, 2025	criteria provided, single submitter							
NM_002878.4(RAD51D):c.339A>C (p.Lys113Asn)	RAD51D|RAD51L3-RFFL	K113N, K133N	Hereditary cancer-predisposing syndrome|not provided|Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary breast ovarian cancer syndrome	VCV000185853	17	33434391	17	35107372	185853	184836	rs786202507	NC_000017.11:35107371:T:G	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	May 8, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.337A>G (p.Lys113Glu)	RAD51D|RAD51L3-RFFL	K113E, K133E	Hereditary cancer-predisposing syndrome	VCV001171377	17	33434393	17	35107374	1171377	1161347	rs2142436494	NC_000017.11:35107373:T:C	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Mar 7, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.336C>T (p.Gly112=)	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV003240260	17	33434394	17	35107375	3240260	3399247	rs2142436504	NC_000017.11:35107374:G:A	single nucleotide variant	synonymous variant|non-coding transcript variant|intron variant	Conflicting classifications of pathogenicity	Feb 21, 2025	criteria provided, conflicting classifications							
NM_002878.4(RAD51D):c.335G>C (p.Gly112Ala)	RAD51D|RAD51L3-RFFL	G112A, G132A	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000234081	17	33434395	17	35107376	234081	235897	rs587782848	NC_000017.11:35107375:C:G	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Conflicting classifications of pathogenicity	Apr 13, 2021	criteria provided, conflicting classifications							
NM_002878.4(RAD51D):c.335G>A (p.Gly112Asp)	RAD51D|RAD51L3-RFFL	G112D, G132D	not provided|Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV000142955	17	33434395	17	35107376	142955	152669	rs587782848	NC_000017.11:35107375:C:T	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Jan 19, 2023	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.334G>C (p.Gly112Arg)	RAD51D|RAD51L3-RFFL	G112R, G132R	Breast-ovarian cancer, familial, susceptibility to, 4	VCV003710494	17	33434396	17	35107377	3710494	3847383		NC_000017.11:35107376:C:G	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Nov 11, 2024	criteria provided, single submitter							
NM_002878.4(RAD51D):c.334G>A (p.Gly112Ser)	RAD51L3-RFFL|RAD51D	G112S, G132S	Hereditary cancer-predisposing syndrome|Familial ovarian cancer|not specified|not provided|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000627674	17	33434396	17	35107377	627674	618540	rs753856224	NC_000017.11:35107376:C:T	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	May 21, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.333C>A (p.Ser111Arg)	RAD51D|RAD51L3-RFFL	S111R, S131R	Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV000583034	17	33434397	17	35107378	583034	569008	rs369396909	NC_000017.11:35107377:G:T	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Dec 4, 2023	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.333C>T (p.Ser111=)	RAD51L3-RFFL|RAD51D		Breast-ovarian cancer, familial, susceptibility to, 4|not provided|Hereditary cancer-predisposing syndrome	VCV000472598	17	33434397	17	35107378	472598	467955	rs369396909	NC_000017.11:35107377:G:A	single nucleotide variant	synonymous variant|non-coding transcript variant|intron variant	Benign/Likely benign	Feb 21, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.332G>A (p.Ser111Asn)	RAD51D|RAD51L3-RFFL	S111N, S131N	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000187017	17	33434398	17	35107379	187017	184837	rs786203407	NC_000017.11:35107378:C:T	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Dec 11, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.331A>C (p.Ser111Arg)	RAD51D|RAD51L3-RFFL	S111R, S131R	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4|not provided	VCV000854534	17	33434399	17	35107380	854534	845228	rs2091620231	NC_000017.11:35107379:T:G	single nucleotide variant	non-coding transcript variant|intron variant|missense variant	Uncertain significance	Jan 8, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.331A>G (p.Ser111Gly)	RAD51D|RAD51L3-RFFL	S131G, S111G	Breast-ovarian cancer, familial, susceptibility to, 4	VCV000836729	17	33434399	17	35107380	836729	845227	rs2091620231	NC_000017.11:35107379:T:C	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Mar 13, 2019	criteria provided, single submitter							
NM_002878.4(RAD51D):c.330T>C (p.Gly110=)	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV000746245	17	33434400	17	35107381	746245	755777	rs1597863254	NC_000017.11:35107380:A:G	single nucleotide variant	synonymous variant|non-coding transcript variant|intron variant	Likely benign	Jun 28, 2019	criteria provided, single submitter							
NM_002878.4(RAD51D):c.329G>T (p.Gly110Val)	RAD51D|RAD51L3-RFFL	G130V, G110V	Hereditary cancer-predisposing syndrome	VCV001729936	17	33434401	17	35107382	1729936	1792143	rs587780103	NC_000017.11:35107381:C:A	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Oct 3, 2015	criteria provided, single submitter							
NM_002878.4(RAD51D):c.329G>C (p.Gly110Ala)	RAD51D|RAD51L3-RFFL	G110A, G130A	Breast-ovarian cancer, familial, susceptibility to, 4|not provided|Hereditary cancer-predisposing syndrome	VCV000229820	17	33434401	17	35107382	229820	235898	rs587780103	NC_000017.11:35107381:C:G	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Jul 1, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.329G>A (p.Gly110Asp)	RAD51L3-RFFL|RAD51D	G110D, G130D	Hereditary cancer-predisposing syndrome|not provided	VCV000127887	17	33434401	17	35107382	127887	133344	rs587780103	NC_000017.11:35107381:C:T	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	May 1, 2017	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.326C>A (p.Pro109Gln)	RAD51D|RAD51L3-RFFL	P129Q, P109Q	Breast-ovarian cancer, familial, susceptibility to, 4	VCV003657715	17	33434404	17	35107385	3657715	3779670		NC_000017.11:35107384:G:T	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Jun 25, 2024	criteria provided, single submitter							
NM_002878.4(RAD51D):c.326C>T (p.Pro109Leu)	RAD51D|RAD51L3-RFFL	P129L, P109L	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000920315	17	33434404	17	35107385	920315	913835	rs2091620383	NC_000017.11:35107384:G:A	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Mar 6, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.325C>T (p.Pro109Ser)	RAD51D|RAD51L3-RFFL	P109S, P129S	Hereditary cancer-predisposing syndrome|not specified	VCV000933166	17	33434405	17	35107386	933166	921488	rs2091620469	NC_000017.11:35107385:G:A	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Mar 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.324C>G (p.Gly108=)	RAD51D|RAD51L3-RFFL		Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV003903955	17	33434406	17	35107387	3903955	4019828		NC_000017.11:35107386:G:C	single nucleotide variant	synonymous variant|non-coding transcript variant|intron variant	Conflicting classifications of pathogenicity	Apr 9, 2025	criteria provided, conflicting classifications							
NM_002878.4(RAD51D):c.324C>A (p.Gly108=)	RAD51D|RAD51L3-RFFL		Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV001729386	17	33434406	17	35107387	1729386	1795062	rs758132417	NC_000017.11:35107386:G:T	single nucleotide variant	synonymous variant|non-coding transcript variant|intron variant	Benign/Likely benign	Feb 21, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.324C>T (p.Gly108=)	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4|not specified|Hereditary cancer-predisposing syndrome	VCV000416202	17	33434406	17	35107387	416202	401882	rs758132417	NC_000017.11:35107386:G:A	single nucleotide variant	synonymous variant|non-coding transcript variant|intron variant	Benign/Likely benign	Feb 21, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.323G>A (p.Gly108Asp)	RAD51D|RAD51L3-RFFL	G128D, G108D	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000964158	17	33434407	17	35107388	964158	949879	rs2091620533	NC_000017.11:35107387:C:T	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	May 26, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.322G>A (p.Gly108Ser)	RAD51L3-RFFL|RAD51D	G108S, G128S	Hereditary cancer-predisposing syndrome	VCV000922372	17	33434408	17	35107389	922372	913836	rs2091620571	NC_000017.11:35107388:C:T	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Conflicting classifications of pathogenicity	May 8, 2025	criteria provided, conflicting classifications							
NM_002878.4(RAD51D):c.321A>G (p.Gly107=)	RAD51D|RAD51L3-RFFL		Hereditary cancer-predisposing syndrome	VCV001729035	17	33434409	17	35107390	1729035	1785325	rs111671763	NC_000017.11:35107389:T:C	single nucleotide variant	synonymous variant|non-coding transcript variant|intron variant	Likely benign	Apr 19, 2021	criteria provided, single submitter							
NM_002878.4(RAD51D):c.319G>A (p.Gly107Arg)	RAD51D|RAD51L3-RFFL	G127R, G107R	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV001728766	17	33434411	17	35107392	1728766	1788401	rs2142436729	NC_000017.11:35107391:C:T	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Jun 11, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.316G>A (p.Val106Ile)	RAD51D|RAD51L3-RFFL	V106I, V126I	Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV001376051	17	33434414	17	35107395	1376051	1470437	rs876659926	NC_000017.11:35107394:C:T	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Aug 12, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.316G>C (p.Val106Leu)	RAD51D|RAD51L3-RFFL	V106L, V126L	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000232692	17	33434414	17	35107395	232692	235899	rs876659926	NC_000017.11:35107394:C:G	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Mar 6, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.315T>C (p.Ile105=)	RAD51D|RAD51L3-RFFL		Hereditary cancer-predisposing syndrome	VCV002448048	17	33434415	17	35107396	2448048	2428992	rs1305215479	NC_000017.11:35107395:A:G	single nucleotide variant	synonymous variant|non-coding transcript variant|intron variant	Likely benign	Dec 23, 2022	criteria provided, single submitter							
NM_002878.4(RAD51D):c.315T>G (p.Ile105Met)	RAD51D|RAD51L3-RFFL	I105M, I125M	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV001728297	17	33434415	17	35107396	1728297	1791697	rs1305215479	NC_000017.11:35107395:A:C	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Jan 27, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.315T>A (p.Ile105=)	RAD51L3-RFFL|RAD51D		Hereditary cancer-predisposing syndrome	VCV000823023	17	33434415	17	35107396	823023	813578	rs1305215479	NC_000017.11:35107395:A:T	single nucleotide variant	synonymous variant|non-coding transcript variant|intron variant	Likely benign	Dec 13, 2017	criteria provided, single submitter							
NM_002878.4(RAD51D):c.314T>G (p.Ile105Ser)	RAD51D|RAD51L3-RFFL	I125S, I105S	Breast-ovarian cancer, familial, susceptibility to, 4	VCV002840191	17	33434416	17	35107397	2840191	3003412	rs368838910	NC_000017.11:35107396:A:C	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Mar 26, 2024	criteria provided, single submitter							
NM_002878.4(RAD51D):c.314T>C (p.Ile105Thr)	RAD51D|RAD51L3-RFFL	I105T, I125T	Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV000410567	17	33434416	17	35107397	410567	402596	rs368838910	NC_000017.11:35107396:A:G	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Mar 22, 2021	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.309T>C (p.Thr103=)	RAD51D|RAD51L3-RFFL		not specified|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000392863	17	33434421	17	35107402	392863	378128	rs1057524665	NC_000017.11:35107401:A:G	single nucleotide variant	synonymous variant|non-coding transcript variant|intron variant	Benign/Likely benign	Feb 20, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.308C>G (p.Thr103Ser)	RAD51D|RAD51L3-RFFL	T103S, T123S	Hereditary cancer-predisposing syndrome	VCV001692727	17	33434422	17	35107403	1692727	1685167	rs2142436864	NC_000017.11:35107402:G:C	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Sep 16, 2021	criteria provided, single submitter							
NM_002878.4(RAD51D):c.307A>G (p.Thr103Ala)	RAD51D|RAD51L3-RFFL	T103A, T123A	Hereditary cancer-predisposing syndrome|not provided|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000472597	17	33434423	17	35107404	472597	467624	rs781378161	NC_000017.11:35107403:T:C	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Jan 1, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.306G>C (p.Val102=)	RAD51L3-RFFL|RAD51D		Breast-ovarian cancer, familial, susceptibility to, 4	VCV003903860	17	33434424	17	35107405	3903860	4019733		NC_000017.11:35107404:C:G	single nucleotide variant	synonymous variant|non-coding transcript variant|intron variant	Benign	Feb 20, 2025	criteria provided, single submitter							
NM_002878.4(RAD51D):c.305T>C (p.Val102Ala)	RAD51D|RAD51L3-RFFL	V102A, V122A	Breast-ovarian cancer, familial, susceptibility to, 4	VCV001009285	17	33434425	17	35107406	1009285	997504	rs1555568494	NC_000017.11:35107405:A:G	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Jun 30, 2018	criteria provided, single submitter							
NM_002878.4(RAD51D):c.305T>G (p.Val102Gly)	RAD51L3-RFFL|RAD51D	V102G, V122G	Breast-ovarian cancer, familial, susceptibility to, 4	VCV000539850	17	33434425	17	35107406	539850	531090	rs1555568494	NC_000017.11:35107405:A:C	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Jun 28, 2023	criteria provided, single submitter							
NM_002878.4(RAD51D):c.304G>A (p.Val102Met)	RAD51D|RAD51L3-RFFL	V102M, V122M	Hereditary cancer-predisposing syndrome	VCV001331819	17	33434426	17	35107407	1331819	1322539	rs2142436933	NC_000017.11:35107406:C:T	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Mar 6, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.301G>A (p.Glu101Lys)	RAD51D|RAD51L3-RFFL	E101K, E121K	Breast-ovarian cancer, familial, susceptibility to, 4	VCV003666440	17	33434429	17	35107410	3666440	3792244		NC_000017.11:35107409:C:T	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Oct 2, 2024	criteria provided, single submitter							
NM_002878.4(RAD51D):c.301G>T (p.Glu101Ter)	RAD51D|RAD51L3-RFFL	E101*, E121*	Hereditary cancer-predisposing syndrome	VCV001798902	17	33434429	17	35107410	1798902	1856171	rs1060502951	NC_000017.11:35107409:C:A	single nucleotide variant	nonsense|non-coding transcript variant|intron variant	Pathogenic	Aug 3, 2018	criteria provided, single submitter							
NM_002878.4(RAD51D):c.301G>C (p.Glu101Gln)	RAD51L3-RFFL|RAD51D	E101Q, E121Q	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4|not provided	VCV000410544	17	33434429	17	35107410	410544	401932	rs1060502951	NC_000017.11:35107409:C:G	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Apr 6, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.300A>G (p.Gly100=)	RAD51D|RAD51L3-RFFL		Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV001798779	17	33434430	17	35107411	1798779	1856048	rs1555568499	NC_000017.11:35107410:T:C	single nucleotide variant	synonymous variant|non-coding transcript variant|intron variant	Benign/Likely benign	Feb 20, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.300A>C (p.Gly100=)	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome|not specified	VCV000508507	17	33434430	17	35107411	508507	506270	rs1555568499	NC_000017.11:35107410:T:G	single nucleotide variant	synonymous variant|non-coding transcript variant|intron variant	Benign/Likely benign	Feb 20, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.299G>A (p.Gly100Glu)	RAD51D|RAD51L3-RFFL	G100E, G120E	Breast-ovarian cancer, familial, susceptibility to, 4	VCV000860824	17	33434431	17	35107412	860824	845229	rs2091621042	NC_000017.11:35107411:C:T	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Mar 31, 2019	criteria provided, single submitter							
NM_002878.4(RAD51D):c.298G>A (p.Gly100Arg)	RAD51D|RAD51L3-RFFL	G100R, G120R	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000492422	17	33434432	17	35107413	492422	484781	rs1306179653	NC_000017.11:35107412:C:T	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Mar 6, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.297T>C (p.Thr99=)	RAD51L3-RFFL|RAD51D		Hereditary cancer-predisposing syndrome	VCV002563040	17	33434433	17	35107414	2563040	2733497	rs2142437037	NC_000017.11:35107413:A:G	single nucleotide variant	synonymous variant|non-coding transcript variant|intron variant	Likely benign	Jun 9, 2023	criteria provided, single submitter							
NM_002878.4(RAD51D):c.296C>T (p.Thr99Ile)	RAD51D|RAD51L3-RFFL	T99I, T119I	not specified|Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV000577716	17	33434434	17	35107415	577716	574441	rs1339099286	NC_000017.11:35107414:G:A	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Oct 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.295A>C (p.Thr99Pro)	RAD51D|RAD51L3-RFFL	T119P, T99P	not provided|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000801277	17	33434435	17	35107416	801277	789609	rs746416079	NC_000017.11:35107415:T:G	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Nov 11, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.295A>G (p.Thr99Ala)	RAD51D|RAD51L3-RFFL	T99A, T119A	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4|not provided	VCV000246346	17	33434435	17	35107416	246346	245016	rs746416079	NC_000017.11:35107415:T:C	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	May 5, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.294T>C (p.Tyr98=)	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4|not provided	VCV001879370	17	33434436	17	35107417	1879370	1936210	rs2142437081	NC_000017.11:35107416:A:G	single nucleotide variant	synonymous variant|non-coding transcript variant|intron variant	Benign/Likely benign	Feb 20, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.293A>C (p.Tyr98Ser)	RAD51L3-RFFL|RAD51D	Y118S, Y98S	Hereditary cancer-predisposing syndrome	VCV001797887	17	33434437	17	35107418	1797887	1853506	rs770147648	NC_000017.11:35107417:T:G	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Aug 9, 2022	criteria provided, single submitter							
NM_002878.4(RAD51D):c.293A>G (p.Tyr98Cys)	RAD51D|RAD51L3-RFFL	Y98C, Y118C	Hereditary cancer-predisposing syndrome|Familial ovarian cancer	VCV000482205	17	33434437	17	35107418	482205	478613	rs770147648	NC_000017.11:35107417:T:C	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	May 16, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.292T>C (p.Tyr98His)	RAD51D|RAD51L3-RFFL	Y98H, Y118H	Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV000639137	17	33434438	17	35107419	639137	645815	rs730881946	NC_000017.11:35107418:A:G	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Feb 2, 2023	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.292T>A (p.Tyr98Asn)	RAD51L3-RFFL|RAD51D	Y98N, Y118N	not specified|not provided|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000182855	17	33434438	17	35107419	182855	180807	rs730881946	NC_000017.11:35107418:A:T	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Jan 30, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.291C>T (p.Leu97=)	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV000743478	17	33434439	17	35107420	743478	755778	rs1597863353	NC_000017.11:35107419:G:A	single nucleotide variant	synonymous variant|non-coding transcript variant|intron variant	Benign/Likely benign	Feb 20, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.290T>G (p.Leu97Arg)	RAD51D|RAD51L3-RFFL	L97R, L117R	Hereditary cancer-predisposing syndrome	VCV003429741	17	33434440	17	35107421	3429741	3585752		NC_000017.11:35107420:A:C	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Jul 5, 2024	criteria provided, single submitter							
NM_002878.4(RAD51D):c.289C>G (p.Leu97Val)	RAD51D|RAD51L3-RFFL	L117V, L97V	Breast-ovarian cancer, familial, susceptibility to, 4	VCV001721657	17	33434441	17	35107422	1721657	1772991	rs2091621288	NC_000017.11:35107421:G:C	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Oct 14, 2022	criteria provided, single submitter							
NM_002878.4(RAD51D):c.289C>T (p.Leu97Phe)	RAD51D|RAD51L3-RFFL	L117F, L97F	Breast-ovarian cancer, familial, susceptibility to, 4	VCV000950183	17	33434441	17	35107422	950183	928227	rs2091621288	NC_000017.11:35107421:G:A	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	May 27, 2024	criteria provided, single submitter							
NM_002878.4(RAD51D):c.287G>C (p.Gly96Ala)	RAD51D|RAD51L3-RFFL	G96A, G116A	Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV002761280	17	33434443	17	35107424	2761280	2925046	rs775651936	NC_000017.11:35107423:C:G	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Jul 13, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.287G>T (p.Gly96Val)	RAD51D|RAD51L3-RFFL	G116V, G96V	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV001391314	17	33434443	17	35107424	1391314	1389994	rs775651936	NC_000017.11:35107423:C:A	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Aug 5, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.286G>T (p.Gly96Cys)	RAD51D|RAD51L3-RFFL	G96C, G116C	Breast-ovarian cancer, familial, susceptibility to, 4|not provided|Hereditary cancer-predisposing syndrome	VCV000231684	17	33434444	17	35107425	231684	235900	rs762951311	NC_000017.11:35107424:C:A	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Jan 28, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.285T>G (p.Ala95=)	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV002774206	17	33434445	17	35107426	2774206	2934936	rs113147933	NC_000017.11:35107425:A:C	single nucleotide variant	synonymous variant|non-coding transcript variant|intron variant	Benign/Likely benign	Feb 20, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.285T>A (p.Ala95=)	RAD51D|RAD51L3-RFFL		Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000821913	17	33434445	17	35107426	821913	813580	rs113147933	NC_000017.11:35107425:A:T	single nucleotide variant	synonymous variant|non-coding transcript variant|intron variant	Conflicting classifications of pathogenicity	Mar 17, 2021	criteria provided, conflicting classifications							
NM_002878.4(RAD51D):c.284C>T (p.Ala95Val)	RAD51D|RAD51L3-RFFL	A115V, A95V	Hereditary cancer-predisposing syndrome	VCV000922404	17	33434446	17	35107427	922404	913837	rs2091621455	NC_000017.11:35107426:G:A	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Jan 6, 2020	criteria provided, single submitter							
NM_002878.4(RAD51D):c.283G>C (p.Ala95Pro)	RAD51D|RAD51L3-RFFL	A115P, A95P	Hereditary cancer-predisposing syndrome	VCV003786511	17	33434447	17	35107428	3786511	3908952		NC_000017.11:35107427:C:G	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Dec 15, 2024	criteria provided, single submitter							
NM_002878.4(RAD51D):c.283G>A (p.Ala95Thr)	RAD51D|RAD51L3-RFFL	A95T, A115T	not specified|Hereditary cancer-predisposing syndrome	VCV000633387	17	33434447	17	35107428	633387	621561	rs1567728746	NC_000017.11:35107427:C:T	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Aug 1, 2019	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.282T>C (p.Asp94=)	RAD51D|RAD51L3-RFFL		Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV003644287	17	33434448	17	35107429	3644287	3765772		NC_000017.11:35107428:A:G	single nucleotide variant	synonymous variant|non-coding transcript variant|intron variant	Likely benign	May 23, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.281A>G (p.Asp94Gly)	RAD51D|RAD51L3-RFFL	D114G, D94G	Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV003429742	17	33434449	17	35107430	3429742	3585753		NC_000017.11:35107429:T:C	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Jul 16, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.280G>C (p.Asp94His)	RAD51D|RAD51L3-RFFL	D114H, D94H	Breast-ovarian cancer, familial, susceptibility to, 4	VCV000945656	17	33434450	17	35107431	945656	928228	rs2091621558	NC_000017.11:35107430:C:G	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Nov 22, 2024	criteria provided, single submitter							
NM_002878.4(RAD51D):c.278T>G (p.Leu93Arg)	RAD51D|RAD51L3-RFFL	L113R, L93R	Hereditary cancer-predisposing syndrome	VCV000926961	17	33434452	17	35107433	926961	913838	rs768717805	NC_000017.11:35107432:A:C	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Mar 6, 2024	criteria provided, single submitter							
NM_002878.4(RAD51D):c.276G>A (p.Leu92=)	RAD51D|RAD51L3-RFFL		Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV001535201	17	33434454	17	35107435	1535201	1531913	rs1057522424	NC_000017.11:35107434:C:T	single nucleotide variant	synonymous variant|non-coding transcript variant|intron variant	Likely benign	Mar 12, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.276G>T (p.Leu92=)	RAD51D|RAD51L3-RFFL		Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV001131806	17	33434454	17	35107435	1131806	1126149	rs1057522424	NC_000017.11:35107434:C:A	single nucleotide variant	synonymous variant|non-coding transcript variant|intron variant	Benign/Likely benign	Feb 20, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.276G>C (p.Leu92=)	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4|not specified|Hereditary cancer-predisposing syndrome	VCV000386129	17	33434454	17	35107435	386129	375987	rs1057522424	NC_000017.11:35107434:C:G	single nucleotide variant	synonymous variant|non-coding transcript variant|intron variant	Benign/Likely benign	Feb 20, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.273A>G (p.Lys91=)	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV002563037	17	33434457	17	35107438	2563037	2733494	rs2142437348	NC_000017.11:35107437:T:C	single nucleotide variant	synonymous variant|non-coding transcript variant|intron variant	Benign/Likely benign	Feb 20, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.272A>G (p.Lys91Arg)	RAD51D|RAD51L3-RFFL	K91R, K111R	Breast-ovarian cancer, familial, susceptibility to, 4	VCV003648647	17	33434458	17	35107439	3648647	3784504		NC_000017.11:35107438:T:C	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Apr 3, 2024	criteria provided, single submitter							
NM_002878.4(RAD51D):c.270T>A (p.Asp90Glu)	RAD51D|RAD51L3-RFFL	D90E, D110E	Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV000584559	17	33434460	17	35107441	584559	575608	rs1567728766	NC_000017.11:35107440:A:T	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Dec 16, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.269A>G (p.Asp90Gly)	RAD51D|RAD51L3-RFFL	D110G, D90G	Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV001098879	17	33434461	17	35107442	1098879	1087624	rs2142437395	NC_000017.11:35107441:T:C	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Aug 31, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.268G>C (p.Asp90His)	RAD51L3-RFFL|RAD51D	D110H, D90H	Breast-ovarian cancer, familial, susceptibility to, 4	VCV002131492	17	33434462	17	35107443	2131492	2189480	rs371561526	NC_000017.11:35107442:C:G	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Apr 28, 2022	criteria provided, single submitter							
NM_002878.4(RAD51D):c.268G>T (p.Asp90Tyr)	RAD51D|RAD51L3-RFFL	D90Y, D110Y	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000839959	17	33434462	17	35107443	839959	845230	rs371561526	NC_000017.11:35107442:C:A	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Jan 7, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.268G>A (p.Asp90Asn)	RAD51D|RAD51L3-RFFL	D90N, D110N	Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome|not provided	VCV000187680	17	33434462	17	35107443	187680	184839	rs371561526	NC_000017.11:35107442:C:T	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Dec 6, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.267T>C (p.Leu89=)	RAD51D|RAD51L3-RFFL		Hereditary cancer-predisposing syndrome	VCV003942375	17	33434463	17	35107444	3942375	4064154		NC_000017.11:35107443:A:G	single nucleotide variant	synonymous variant|non-coding transcript variant|intron variant	Likely benign	Mar 26, 2025	criteria provided, single submitter							
NM_002878.4(RAD51D):c.266T>C (p.Leu89Pro)	RAD51D|RAD51L3-RFFL	L89P, L109P	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000567175	17	33434464	17	35107445	567175	571298	rs1567728784	NC_000017.11:35107444:A:G	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Apr 8, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.265C>G (p.Leu89Val)	RAD51D|RAD51L3-RFFL	L89V, L109V	Breast-ovarian cancer, familial, susceptibility to, 4	VCV002109891	17	33434465	17	35107446	2109891	2163766	rs2142437449	NC_000017.11:35107445:G:C	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Mar 14, 2022	criteria provided, single submitter							
NM_002878.4(RAD51D):c.265C>T (p.Leu89Phe)	RAD51D|RAD51L3-RFFL	L109F, L89F	Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV001051075	17	33434465	17	35107446	1051075	1050201	rs2142437449	NC_000017.11:35107445:G:A	single nucleotide variant	missense variant|non-coding transcript variant|intron variant	Uncertain significance	Nov 28, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.264-1G>T	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV001012209	17	33434467	17	35107448	1012209	999966	rs2091622013	NC_000017.11:35107447:C:A	single nucleotide variant	splice acceptor variant|intron variant	Likely pathogenic	Oct 2, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.264-1G>A	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV000927404	17	33434467	17	35107448	927404	916433	rs2091622013	NC_000017.11:35107447:C:T	single nucleotide variant	splice acceptor variant|intron variant	Conflicting classifications of pathogenicity	Jun 25, 2024	criteria provided, conflicting classifications							
NM_002878.4(RAD51D):c.264-2A>G	RAD51D|RAD51L3-RFFL		Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000821619	17	33434468	17	35107449	821619	815678	rs1555568514	NC_000017.11:35107448:T:C	single nucleotide variant	splice acceptor variant|intron variant	Likely pathogenic	Jun 11, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.264-2A>C	RAD51L3-RFFL|RAD51D		Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV000482189	17	33434468	17	35107449	482189	479191	rs1555568514	NC_000017.11:35107448:T:G	single nucleotide variant	splice acceptor variant|intron variant	Likely pathogenic	May 15, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.264-3C>G	RAD51L3-RFFL|RAD51D		Hereditary cancer-predisposing syndrome	VCV002448055	17	33434469	17	35107450	2448055	2428999	rs1597863415	NC_000017.11:35107449:G:C	single nucleotide variant	intron variant	Uncertain significance	Feb 21, 2023	criteria provided, single submitter							
NM_002878.4(RAD51D):c.264-3C>T	RAD51D|RAD51L3-RFFL		Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000821621	17	33434469	17	35107450	821621	815679	rs1597863415	NC_000017.11:35107449:G:A	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Jan 23, 2025	criteria provided, conflicting classifications							
NM_002878.4(RAD51D):c.264-4T>C	RAD51D|RAD51L3-RFFL		Hereditary cancer-predisposing syndrome|not specified	VCV000390471	17	33434470	17	35107451	390471	375990	rs1057523781	NC_000017.11:35107450:A:G	single nucleotide variant	intron variant	Likely benign	Feb 25, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.264-5A>G	RAD51D|RAD51L3-RFFL		Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000919439	17	33434471	17	35107452	919439	916485	rs1169894160	NC_000017.11:35107451:T:C	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Feb 20, 2025	criteria provided, conflicting classifications							
NM_002878.4(RAD51D):c.264-5A>T	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV000492420	17	33434471	17	35107452	492420	485001	rs1169894160	NC_000017.11:35107451:T:A	single nucleotide variant	intron variant	Likely benign	Feb 20, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.264-6C>T	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV000923113	17	33434472	17	35107453	923113	915962	rs1567728794	NC_000017.11:35107452:G:A	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Feb 20, 2025	criteria provided, conflicting classifications							
NM_002878.4(RAD51D):c.264-7C>G	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV002767450	17	33434473	17	35107454	2767450	2923024	rs753529790	NC_000017.11:35107453:G:C	single nucleotide variant	intron variant	Likely benign	Oct 10, 2023	criteria provided, single submitter							
NM_002878.4(RAD51D):c.264-7C>T	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome|not specified|not provided	VCV000492421	17	33434473	17	35107454	492421	485007	rs753529790	NC_000017.11:35107453:G:A	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Apr 29, 2025	criteria provided, conflicting classifications							
NM_002878.4(RAD51D):c.264-8G>A	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV000539870	17	33434474	17	35107455	539870	530965	rs759532599	NC_000017.11:35107454:C:T	single nucleotide variant	intron variant	Likely benign	Feb 20, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.264-10C>T	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV003904006	17	33434476	17	35107457	3904006	4019879		NC_000017.11:35107456:G:A	single nucleotide variant	intron variant	Likely benign	Feb 20, 2025	criteria provided, single submitter							
NM_002878.4(RAD51D):c.264-13C>G	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV001569932	17	33434479	17	35107460	1569932	1623248	rs2142437587	NC_000017.11:35107459:G:C	single nucleotide variant	intron variant	Likely benign	Mar 13, 2022	criteria provided, single submitter							
NM_002878.4(RAD51D):c.264-14T>C	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV003903459	17	33434480	17	35107461	3903459	4019333		NC_000017.11:35107460:A:G	single nucleotide variant	intron variant	Likely benign	Feb 20, 2025	criteria provided, single submitter							
NM_002878.4(RAD51D):c.264-15C>T	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV003903709	17	33434481	17	35107462	3903709	4019582		NC_000017.11:35107461:G:A	single nucleotide variant	intron variant	Likely benign	Feb 20, 2025	criteria provided, single submitter							
NM_002878.4(RAD51D):c.264-15C>G	RAD51L3-RFFL|RAD51D		not specified	VCV000514428	17	33434481	17	35107462	514428	506277	rs56103933	NC_000017.11:35107461:G:C	single nucleotide variant	intron variant	Likely benign	Dec 26, 2017	criteria provided, single submitter							
NM_002878.4(RAD51D):c.264-19T>C	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV003681259	17	33434485	17	35107466	3681259	3815000		NC_000017.11:35107465:A:G	single nucleotide variant	intron variant	Likely benign	May 22, 2024	criteria provided, single submitter							
NM_002878.4(RAD51D):c.264-50C>T	RAD51D|RAD51L3-RFFL		not specified	VCV002576267	17	33434516	17	35107497	2576267	2741163	rs556011877	NC_000017.11:35107496:G:A	single nucleotide variant	intron variant	Likely benign	Mar 4, 2025	criteria provided, single submitter							
NM_002878.4(RAD51D):c.263+1920C>T	RAD51D|RAD51L3-RFFL		not provided	VCV001267774	17	33443600	17	35116581	1267774	1258110	rs28363264	NC_000017.11:35116580:G:A	single nucleotide variant	intron variant	Benign	Feb 7, 2019	criteria provided, single submitter							
NM_002878.4(RAD51D):c.263+1855G>A	RAD51D|RAD51L3-RFFL		not provided	VCV000683445	17	33443665	17	35116646	683445	668944	rs139512155	NC_000017.11:35116645:C:T	single nucleotide variant	intron variant	Likely benign	Jun 12, 2018	criteria provided, single submitter							
NM_002878.4(RAD51D):c.263+1816C>T	RAD51D|RAD51L3-RFFL		not provided	VCV000682476	17	33443704	17	35116685	682476	668947	rs145397692	NC_000017.11:35116684:G:A	single nucleotide variant	intron variant	Likely benign	Jun 18, 2018	criteria provided, single submitter							
NM_002878.4(RAD51D):c.263+1750G>A	RAD51D|RAD51L3-RFFL		not provided	VCV000679675	17	33443770	17	35116751	679675	669242	rs9915609	NC_000017.11:35116750:C:T	single nucleotide variant	intron variant	Benign	Jun 15, 2018	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.263+1644T>C	RAD51L3-RFFL|RAD51D		Breast-ovarian cancer, familial, susceptibility to, 4	VCV000803383	17	33443876	17	35116857	803383	791736	rs1597874516	NC_000017.11:35116856:A:G	single nucleotide variant	intron variant|splice donor variant	Uncertain significance	May 28, 2019	criteria provided, single submitter							
NM_002878.4(RAD51D):c.263+1642G>T	RAD51D|RAD51L3-RFFL	R108L	Hereditary breast ovarian cancer syndrome	VCV001210161	17	33443878	17	35116859	1210161	1200161	rs773367679	NC_000017.11:35116858:C:A	single nucleotide variant	missense variant|intron variant	Uncertain significance		criteria provided, single submitter							
NM_002878.4(RAD51D):c.263+1641C>T	RAD51D|RAD51L3-RFFL	R108C	Breast-ovarian cancer, familial, susceptibility to, 4|not provided	VCV000425128	17	33443879	17	35116860	425128	413462	rs142387263	NC_000017.11:35116859:G:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Oct 8, 2024	criteria provided, conflicting classifications							
NM_002878.4(RAD51D):c.263+1631C>T	RAD51D|RAD51L3-RFFL		not provided	VCV002647659	17	33443889	17	35116870	2647659	2811236	rs553120392	NC_000017.11:35116869:G:A	single nucleotide variant	synonymous variant|intron variant	Likely benign	Nov 1, 2022	criteria provided, single submitter							
NM_002878.4(RAD51D):c.263+1627C>T	RAD51D|RAD51L3-RFFL	A103V	Breast-ovarian cancer, familial, susceptibility to, 4	VCV000548805	17	33443893	17	35116874	548805	539351	rs188981311	NC_000017.11:35116873:G:A	single nucleotide variant	missense variant|intron variant	Likely benign	Oct 3, 2023	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.263+1621G>C	RAD51L3-RFFL|RAD51D	G101A	Hereditary cancer-predisposing syndrome	VCV000492419	17	33443899	17	35116880	492419	485214	rs1310166106	NC_000017.11:35116879:C:G	single nucleotide variant	missense variant|intron variant	Likely benign	Jul 21, 2015	criteria provided, single submitter							
NM_002878.4(RAD51D):c.263+1618G>A	RAD51L3-RFFL|RAD51D	R100Q	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000492418	17	33443902	17	35116883	492418	484966	rs748411608	NC_000017.11:35116882:C:T	single nucleotide variant	missense variant|intron variant	Likely benign	Mar 30, 2022	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.263+1610C>T	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV002921247	17	33443910	17	35116891	2921247	3081707	rs767039876	NC_000017.11:35116890:G:A	single nucleotide variant	synonymous variant|intron variant	Likely benign	Nov 2, 2023	criteria provided, single submitter							
NM_002878.4(RAD51D):c.263+1605G>A	RAD51D|RAD51L3-RFFL	A96T	Hereditary cancer-predisposing syndrome|not specified|Breast-ovarian cancer, familial, susceptibility to, 4|not provided	VCV000138880	17	33443915	17	35116896	138880	142583	rs147933658	NC_000017.11:35116895:C:T	single nucleotide variant	missense variant|intron variant	Benign/Likely benign	Feb 1, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.263+1588A>G	RAD51D|RAD51L3-RFFL	D90G	Hereditary cancer-predisposing syndrome|not specified|Breast-ovarian cancer, familial, susceptibility to, 4|not provided	VCV000138879	17	33443932	17	35116913	138879	142582	rs180869630	NC_000017.11:35116912:T:C	single nucleotide variant	missense variant|intron variant	Benign/Likely benign	Jun 1, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.263+1585C>G	RAD51D|RAD51L3-RFFL	T89R	Breast-ovarian cancer, familial, susceptibility to, 4	VCV000803384	17	33443935	17	35116916	803384	791737	rs1192914615	NC_000017.11:35116915:G:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	May 28, 2019	criteria provided, single submitter							
NM_002878.4(RAD51D):c.263+1578G>A	RAD51D|RAD51L3-RFFL	G87R	Hereditary cancer-predisposing syndrome	VCV000492416	17	33443942	17	35116923	492416	484972	rs1391871647	NC_000017.11:35116922:C:T	single nucleotide variant	missense variant|intron variant	Likely benign	Oct 20, 2015	criteria provided, single submitter							
NM_002878.4(RAD51D):c.263+1571T>C	RAD51D|RAD51L3-RFFL		not provided	VCV002647660	17	33443949	17	35116930	2647660	2811237	rs186563116	NC_000017.11:35116929:A:G	single nucleotide variant	synonymous variant|intron variant	Likely benign	Jul 1, 2024	criteria provided, single submitter							
NM_002878.4(RAD51D):c.263+1570T>A	RAD51D|RAD51L3-RFFL	L84H	Breast-ovarian cancer, familial, susceptibility to, 4|not specified	VCV000138878	17	33443950	17	35116931	138878	142581	rs376472075	NC_000017.11:35116930:A:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jul 30, 2021	criteria provided, conflicting classifications							
NM_002878.4(RAD51D):c.263+1566G>A	RAD51D|RAD51L3-RFFL	G83R	Breast-ovarian cancer, familial, susceptibility to, 4	VCV003581847	17	33443954	17	35116935	3581847	3712396		NC_000017.11:35116934:C:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Mar 13, 2024	criteria provided, single submitter							
NM_002878.4(RAD51D):c.263+1558A>G	RAD51D|RAD51L3-RFFL	K80R	RAD51D-related disorder	VCV002635399	17	33443962	17	35116943	2635399	2799404	rs747222668	NC_000017.11:35116942:T:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Nov 29, 2022	criteria provided, single submitter							
NM_002878.4(RAD51D):c.263+1551G>T	RAD51D|RAD51L3-RFFL	A78S	Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000803385	17	33443969	17	35116950	803385	791738	rs780006577	NC_000017.11:35116949:C:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jun 13, 2024	criteria provided, conflicting classifications							
NM_002878.4(RAD51D):c.263+1531C>T	RAD51D|RAD51L3-RFFL	S71L	Breast-ovarian cancer, familial, susceptibility to, 4	VCV002663994	17	33443989	17	35116970	2663994	2831464	rs572710839	NC_000017.11:35116969:G:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Oct 31, 2023	criteria provided, single submitter							
NM_002878.4(RAD51D):c.263+1521G>A	RAD51D|RAD51L3-RFFL	A68T	Breast-ovarian cancer, familial, susceptibility to, 4	VCV003581848	17	33443999	17	35116980	3581848	3712397		NC_000017.11:35116979:C:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Mar 13, 2024	criteria provided, single submitter							
NM_002878.4(RAD51D):c.263+1514G>T	RAD51D|RAD51L3-RFFL	Q65H	Breast-ovarian cancer, familial, susceptibility to, 4	VCV002678192	17	33444006	17	35116987	2678192	2833215	rs2142468546	NC_000017.11:35116986:C:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Mar 28, 2022	criteria provided, single submitter							
NM_002878.4(RAD51D):c.263+1509C>T	RAD51L3-RFFL|RAD51D	P64S	Breast-ovarian cancer, familial, susceptibility to, 4	VCV000371900	17	33444011	17	35116992	371900	358922	rs201506572	NC_000017.11:35116991:G:A	single nucleotide variant	missense variant|intron variant	Likely benign	Apr 2, 2021	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.263+1503C>T	RAD51D|RAD51L3-RFFL	Q62*	not specified	VCV001098799	17	33444017	17	35116998	1098799	1087550	rs753486358	NC_000017.11:35116997:G:A	single nucleotide variant	nonsense|intron variant	Uncertain significance	Aug 1, 2023	criteria provided, single submitter							
NM_002878.4(RAD51D):c.263+1478C>T	RAD51L3-RFFL|RAD51D		Hereditary cancer-predisposing syndrome	VCV000492415	17	33444042	17	35117023	492415	485012	rs200538950	NC_000017.11:35117022:G:A	single nucleotide variant	synonymous variant|intron variant	Likely benign	Apr 22, 2015	criteria provided, single submitter							
NM_002878.4(RAD51D):c.263+1474C>T	RAD51D|RAD51L3-RFFL	A52V	not provided|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000492414	17	33444046	17	35117027	492414	484784	rs201720876	NC_000017.11:35117026:G:A	single nucleotide variant	missense variant|intron variant	Likely benign	May 1, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.263+1450T>A	RAD51D|RAD51L3-RFFL		Hereditary breast ovarian cancer syndrome	VCV000584939	17	33444070	17	35117051	584939	575988	rs1567734484	NC_000017.11:35117050:A:T	single nucleotide variant	intron variant	Uncertain significance	Jul 2, 2018	criteria provided, single submitter							
NM_002878.4(RAD51D):c.263+1323C>A	RAD51D|RAD51L3-RFFL		not provided	VCV000683444	17	33444197	17	35117178	683444	668950	rs28363263	NC_000017.11:35117177:G:T	single nucleotide variant	intron variant	Likely benign	Jun 12, 2018	criteria provided, single submitter							
NM_002878.4(RAD51D):c.263+50T>G	RAD51D|RAD51L3-RFFL		not specified	VCV002691990	17	33445470	17	35118451	2691990	2852993	rs200995160	NC_000017.11:35118450:A:C	single nucleotide variant	intron variant	Likely benign	Mar 4, 2025	criteria provided, single submitter							
NM_002878.4(RAD51D):c.263+43T>C	RAD51D|RAD51L3-RFFL		not specified	VCV003256343	17	33445477	17	35118458	3256343	3415105		NC_000017.11:35118457:A:G	single nucleotide variant	intron variant	Likely benign	Mar 4, 2025	criteria provided, single submitter							
NM_002878.4(RAD51D):c.263+20G>T	RAD51D|RAD51L3-RFFL		not provided|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000420443	17	33445500	17	35118481	420443	409901	rs763380219	NC_000017.11:35118480:C:A	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Dec 5, 2024	criteria provided, conflicting classifications							
NM_002878.4(RAD51D):c.263+18G>C	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV001642363	17	33445502	17	35118483	1642363	1552461	rs1567735210	NC_000017.11:35118482:C:G	single nucleotide variant	intron variant	Likely benign	Oct 7, 2024	criteria provided, single submitter							
NM_002878.4(RAD51D):c.263+18G>A	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV000628362	17	33445502	17	35118483	628362	619512	rs1567735210	NC_000017.11:35118482:C:T	single nucleotide variant	intron variant	Likely benign	Oct 29, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.263+15T>G	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV003662639	17	33445505	17	35118486	3662639	3791009		NC_000017.11:35118485:A:C	single nucleotide variant	intron variant	Likely benign	Aug 16, 2024	criteria provided, single submitter							
NM_002878.4(RAD51D):c.263+14C>T	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV001623843	17	33445506	17	35118487	1623843	1594610	rs2142473334	NC_000017.11:35118486:G:A	single nucleotide variant	intron variant	Likely benign	Aug 14, 2021	criteria provided, single submitter							
NM_002878.4(RAD51D):c.263+11G>A	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV001534989	17	33445509	17	35118490	1534989	1531701	rs2142473360	NC_000017.11:35118489:C:T	single nucleotide variant	intron variant	Likely benign	Apr 10, 2024	criteria provided, single submitter							
NM_002878.4(RAD51D):c.263+9G>A	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV002760326	17	33445511	17	35118492	2760326	2921506	rs887322398	NC_000017.11:35118491:C:T	single nucleotide variant	intron variant	Likely benign	Feb 20, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.263+9G>C	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4|not specified	VCV000512418	17	33445511	17	35118492	512418	506279	rs887322398	NC_000017.11:35118491:C:G	single nucleotide variant	intron variant	Likely benign	Feb 20, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.263+8T>G	RAD51L3-RFFL|RAD51D		Breast-ovarian cancer, familial, susceptibility to, 4	VCV003904338	17	33445512	17	35118493	3904338	4020210		NC_000017.11:35118492:A:C	single nucleotide variant	intron variant	Likely benign	Feb 20, 2025	criteria provided, single submitter							
NM_002878.4(RAD51D):c.263+8T>C	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV001080444	17	33445512	17	35118493	1080444	1082934	rs1208695895	NC_000017.11:35118492:A:G	single nucleotide variant	intron variant	Likely benign	Feb 20, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.263+7G>T	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV000795452	17	33445513	17	35118494	795452	788117	rs56218020	NC_000017.11:35118493:C:A	single nucleotide variant	intron variant	Likely benign	Feb 20, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.263+7G>A	RAD51D|RAD51L3-RFFL		not specified|not provided|Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV000384514	17	33445513	17	35118494	384514	375997	rs56218020	NC_000017.11:35118493:C:T	single nucleotide variant	intron variant	Benign/Likely benign	Jan 22, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.263+5G>C	RAD51D|RAD51L3-RFFL		Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4|not provided	VCV001310864	17	33445515	17	35118496	1310864	1301568	rs1567735224	NC_000017.11:35118495:C:G	single nucleotide variant	intron variant	Uncertain significance	Jan 3, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.263+5G>A	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4|not provided|Hereditary cancer-predisposing syndrome	VCV000582731	17	33445515	17	35118496	582731	571299	rs1567735224	NC_000017.11:35118495:C:T	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Nov 16, 2023	criteria provided, conflicting classifications							
NM_002878.4(RAD51D):c.263+3T>G	RAD51D|RAD51L3-RFFL		Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV001794043	17	33445517	17	35118498	1794043	1842323	rs1286607815	NC_000017.11:35118497:A:C	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Jun 12, 2023	criteria provided, conflicting classifications							
NM_002878.4(RAD51D):c.263+2T>C	RAD51L3-RFFL|RAD51D		Breast-ovarian cancer, familial, susceptibility to, 4	VCV000239393	17	33445518	17	35118499	239393	242730	rs200564819	NC_000017.11:35118498:A:G	single nucleotide variant	splice donor variant|intron variant	Likely pathogenic	Jul 14, 2021	criteria provided, single submitter							
NM_002878.4(RAD51D):c.263+1G>T	RAD51D|RAD51L3-RFFL		Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV002039686	17	33445519	17	35118500	2039686	2091148	rs1555570242	NC_000017.11:35118499:C:A	single nucleotide variant	splice donor variant|intron variant	Conflicting classifications of pathogenicity	Oct 28, 2024	criteria provided, conflicting classifications							
NM_002878.4(RAD51D):c.263+1G>A	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4|not provided|Hereditary cancer-predisposing syndrome|RAD51D-related disorder	VCV000480542	17	33445519	17	35118500	480542	478624	rs1555570242	NC_000017.11:35118499:C:T	single nucleotide variant	splice donor variant|intron variant	Conflicting classifications of pathogenicity	Dec 23, 2024	criteria provided, conflicting classifications							
NM_002878.4(RAD51D):c.263G>T (p.Ser88Ile)	RAD51D|RAD51L3-RFFL	S88I	Breast-ovarian cancer, familial, susceptibility to, 4	VCV000663165	17	33445520	17	35118501	663165	645816	rs757467813	NC_000017.11:35118500:C:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Mar 10, 2020	criteria provided, single submitter							
NM_002878.4(RAD51D):c.263G>A (p.Ser88Asn)	RAD51D|RAD51L3-RFFL	S88N	Breast-ovarian cancer, familial, susceptibility to, 4	VCV000652589	17	33445520	17	35118501	652589	645817	rs757467813	NC_000017.11:35118500:C:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Sep 12, 2023	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.262A>G (p.Ser88Gly)	RAD51D|RAD51L3-RFFL	S88G	Hereditary cancer-predisposing syndrome	VCV000486281	17	33445521	17	35118502	486281	479192	rs1555570245	NC_000017.11:35118501:T:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jun 30, 2016	criteria provided, single submitter							
NM_002878.4(RAD51D):c.261C>T (p.Gly87=)	RAD51D|RAD51L3-RFFL		Hereditary cancer-predisposing syndrome	VCV002774207	17	33445522	17	35118503	2774207	2934937	rs2142473516	NC_000017.11:35118502:G:A	single nucleotide variant	synonymous variant|intron variant	Uncertain significance	Oct 2, 2023	criteria provided, single submitter							
NM_002878.4(RAD51D):c.260G>A (p.Gly87Asp)	RAD51L3-RFFL|RAD51D	G87D	Breast-ovarian cancer, familial, susceptibility to, 4|not provided|Hereditary cancer-predisposing syndrome	VCV000926223	17	33445523	17	35118504	926223	913839	rs2091775597	NC_000017.11:35118503:C:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Dec 4, 2023	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.259G>A (p.Gly87Ser)	RAD51D|RAD51L3-RFFL	G87S	Hereditary cancer-predisposing syndrome|not provided|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000472594	17	33445524	17	35118505	472594	467963	rs767681165	NC_000017.11:35118504:C:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Apr 19, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.258T>G (p.Ile86Met)	RAD51D|RAD51L3-RFFL	I86M	Breast-ovarian cancer, familial, susceptibility to, 4	VCV002117755	17	33445525	17	35118506	2117755	2179524	rs2142473544	NC_000017.11:35118505:A:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Mar 30, 2022	criteria provided, single submitter							
NM_002878.4(RAD51D):c.257T>G (p.Ile86Ser)	RAD51D|RAD51L3-RFFL	I86S	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV001515461	17	33445526	17	35118507	1515461	1505326	rs1312421615	NC_000017.11:35118506:A:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Mar 7, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.257T>C (p.Ile86Thr)	RAD51D|RAD51L3-RFFL	I86T	Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV001461354	17	33445526	17	35118507	1461354	1498185	rs1312421615	NC_000017.11:35118506:A:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Mar 6, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.256A>G (p.Ile86Val)	RAD51D|RAD51L3-RFFL	I86V	Hereditary cancer-predisposing syndrome	VCV002625302	17	33445527	17	35118508	2625302	2787285	rs587782063	NC_000017.11:35118507:T:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Aug 25, 2023	criteria provided, single submitter							
NM_002878.4(RAD51D):c.256A>T (p.Ile86Phe)	RAD51D|RAD51L3-RFFL	I86F	not specified|Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV000141859	17	33445527	17	35118508	141859	151573	rs587782063	NC_000017.11:35118507:T:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Mar 31, 2023	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.255C>G (p.Gly85=)	RAD51D|RAD51L3-RFFL		Hereditary cancer-predisposing syndrome	VCV003893826	17	33445528	17	35118509	3893826	4009707		NC_000017.11:35118508:G:C	single nucleotide variant	synonymous variant|intron variant	Likely benign	Nov 25, 2024	criteria provided, single submitter							
NM_002878.4(RAD51D):c.255C>T (p.Gly85=)	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV000232119	17	33445528	17	35118509	232119	235901	rs750714062	NC_000017.11:35118508:G:A	single nucleotide variant	synonymous variant|intron variant	Benign/Likely benign	Feb 20, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.254G>C (p.Gly85Ala)	RAD51D|RAD51L3-RFFL	G85A	Hereditary cancer-predisposing syndrome	VCV001171308	17	33445529	17	35118510	1171308	1161348	rs2091775772	NC_000017.11:35118509:C:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Mar 7, 2024	criteria provided, single submitter							
NM_002878.4(RAD51D):c.254G>T (p.Gly85Val)	RAD51L3-RFFL|RAD51D	G85V	Hereditary cancer-predisposing syndrome	VCV000924754	17	33445529	17	35118510	924754	913840	rs2091775772	NC_000017.11:35118509:C:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Dec 4, 2023	criteria provided, single submitter							
NM_002878.4(RAD51D):c.253G>A (p.Gly85Ser)	RAD51D|RAD51L3-RFFL	G85S	Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV000480537	17	33445530	17	35118511	480537	478469	rs1555570250	NC_000017.11:35118510:C:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Aug 5, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.252T>C (p.Thr84=)	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV003727940	17	33445531	17	35118512	3727940	3858563		NC_000017.11:35118511:A:G	single nucleotide variant	synonymous variant|intron variant	Likely benign	Mar 19, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.251C>T (p.Thr84Ile)	RAD51D|RAD51L3-RFFL	T84I	Hereditary cancer-predisposing syndrome	VCV001792509	17	33445532	17	35118513	1792509	1842097	rs2091775868	NC_000017.11:35118512:G:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Apr 2, 2020	criteria provided, single submitter							
NM_002878.4(RAD51D):c.251C>G (p.Thr84Ser)	RAD51D|RAD51L3-RFFL	T84S	Breast-ovarian cancer, familial, susceptibility to, 4	VCV000955937	17	33445532	17	35118513	955937	949880	rs2091775868	NC_000017.11:35118512:G:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Aug 24, 2019	criteria provided, single submitter							
NM_002878.4(RAD51D):c.250A>C (p.Thr84Pro)	RAD51D|RAD51L3-RFFL	T84P	Breast-ovarian cancer, familial, susceptibility to, 4	VCV001044249	17	33445533	17	35118514	1044249	1033231	rs200018296	NC_000017.11:35118513:T:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Feb 11, 2020	criteria provided, single submitter							
NM_002878.4(RAD51D):c.250A>G (p.Thr84Ala)	RAD51D|RAD51L3-RFFL	T84A	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000185051	17	33445533	17	35118514	185051	184840	rs200018296	NC_000017.11:35118513:T:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Sep 3, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.249C>T (p.Ser83=)	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV001618658	17	33445534	17	35118515	1618658	1580791	rs2142473667	NC_000017.11:35118514:G:A	single nucleotide variant	synonymous variant|intron variant	Likely benign	Nov 23, 2021	criteria provided, single submitter							
NM_002878.4(RAD51D):c.246G>A (p.Leu82=)	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV002878067	17	33445537	17	35118518	2878067	3039239	rs778585939	NC_000017.11:35118517:C:T	single nucleotide variant	synonymous variant|intron variant	Benign/Likely benign	Feb 20, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.243C>T (p.Ile81=)	RAD51L3-RFFL|RAD51D		Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV000743923	17	33445540	17	35118521	743923	755779	rs1483056988	NC_000017.11:35118520:G:A	single nucleotide variant	synonymous variant|intron variant	Benign/Likely benign	Feb 20, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.241A>T (p.Ile81Phe)	RAD51D|RAD51L3-RFFL	I81F	Breast-ovarian cancer, familial, susceptibility to, 4	VCV000582872	17	33445542	17	35118523	582872	571090	rs1567735288	NC_000017.11:35118522:T:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jun 27, 2018	criteria provided, single submitter							
NM_002878.4(RAD51D):c.240C>T (p.Ala80=)	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV002760585	17	33445543	17	35118524	2760585	2921765	rs2142473765	NC_000017.11:35118523:G:A	single nucleotide variant	synonymous variant|intron variant	Benign/Likely benign	Feb 20, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.240C>A (p.Ala80=)	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV001153453	17	33445543	17	35118524	1153453	1147043	rs2142473765	NC_000017.11:35118523:G:T	single nucleotide variant	synonymous variant|intron variant	Benign/Likely benign	Feb 20, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.239C>T (p.Ala80Val)	RAD51D|RAD51L3-RFFL	A80V	Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV000230011	17	33445544	17	35118525	230011	235902	rs876658332	NC_000017.11:35118524:G:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jan 14, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.238G>A (p.Ala80Thr)	RAD51D|RAD51L3-RFFL	A80T	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV001023241	17	33445545	17	35118526	1023241	1012710	rs2091776105	NC_000017.11:35118525:C:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jun 27, 2023	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.237T>G (p.Thr79=)	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV003903530	17	33445546	17	35118527	3903530	4019403		NC_000017.11:35118526:A:C	single nucleotide variant	synonymous variant|intron variant	Benign	Feb 20, 2025	criteria provided, single submitter							
NM_002878.4(RAD51D):c.236C>T (p.Thr79Ile)	RAD51D|RAD51L3-RFFL	T79I	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000955123	17	33445547	17	35118528	955123	949881	rs2091776134	NC_000017.11:35118527:G:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Oct 11, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.235A>C (p.Thr79Pro)	RAD51D|RAD51L3-RFFL	T79P	Breast-ovarian cancer, familial, susceptibility to, 4	VCV001055612	17	33445548	17	35118529	1055612	1050202	rs1597876667	NC_000017.11:35118528:T:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Aug 16, 2022	criteria provided, single submitter							
NM_002878.4(RAD51D):c.234C>T (p.Ser78=)	RAD51D|RAD51L3-RFFL		Hereditary cancer-predisposing syndrome|not specified|Breast-ovarian cancer, familial, susceptibility to, 4|not provided	VCV000183785	17	33445549	17	35118530	183785	184841	rs9901455	NC_000017.11:35118529:G:A	single nucleotide variant	synonymous variant|intron variant	Benign	Feb 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.233C>G (p.Ser78Cys)	RAD51D|RAD51L3-RFFL	S78C	Breast-ovarian cancer, familial, susceptibility to, 4	VCV001355953	17	33445550	17	35118531	1355953	1354249	rs1555570255	NC_000017.11:35118530:G:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	May 21, 2021	criteria provided, single submitter							
NM_002878.4(RAD51D):c.233C>T (p.Ser78Phe)	RAD51D|RAD51L3-RFFL	S78F	not provided|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000484766	17	33445550	17	35118531	484766	478483	rs1555570255	NC_000017.11:35118530:G:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	May 8, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.232T>G (p.Ser78Ala)	RAD51D|RAD51L3-RFFL	S78A	Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary breast ovarian cancer syndrome	VCV000584940	17	33445551	17	35118532	584940	575989	rs1567735315	NC_000017.11:35118531:A:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Nov 13, 2023	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.231C>T (p.Thr77=)	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV003904020	17	33445552	17	35118533	3904020	4019893		NC_000017.11:35118532:G:A	single nucleotide variant	synonymous variant|intron variant	Benign	Feb 20, 2025	criteria provided, single submitter							
NM_002878.4(RAD51D):c.231C>A (p.Thr77=)	RAD51D|RAD51L3-RFFL		Hereditary cancer-predisposing syndrome	VCV001789537	17	33445552	17	35118533	1789537	1847668	rs376670250	NC_000017.11:35118532:G:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Oct 12, 2020	criteria provided, single submitter							
NM_002878.4(RAD51D):c.231C>G (p.Thr77=)	RAD51L3-RFFL|RAD51D		not provided|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000185167	17	33445552	17	35118533	185167	184842	rs376670250	NC_000017.11:35118532:G:C	single nucleotide variant	synonymous variant|intron variant	Benign/Likely benign	Feb 20, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.230C>G (p.Thr77Ser)	RAD51D|RAD51L3-RFFL	T77S	Hereditary cancer-predisposing syndrome	VCV000821085	17	33445553	17	35118534	821085	813581	rs777826765	NC_000017.11:35118533:G:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jun 1, 2025	criteria provided, single submitter							
NM_002878.4(RAD51D):c.230C>T (p.Thr77Ile)	RAD51L3-RFFL|RAD51D	T77I	Hereditary cancer-predisposing syndrome|not provided|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000472593	17	33445553	17	35118534	472593	467636	rs777826765	NC_000017.11:35118533:G:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jul 29, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.229A>G (p.Thr77Ala)	RAD51L3-RFFL|RAD51D	T77A	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000490138	17	33445554	17	35118535	490138	482996	rs1555570264	NC_000017.11:35118534:T:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Dec 5, 2023	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.228G>T (p.Lys76Asn)	RAD51D|RAD51L3-RFFL	K76N	Hereditary cancer-predisposing syndrome	VCV001789085	17	33445555	17	35118536	1789085	1850756	rs2142473914	NC_000017.11:35118535:C:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Sep 21, 2021	criteria provided, single submitter							
NM_002878.4(RAD51D):c.227A>G (p.Lys76Arg)	RAD51D|RAD51L3-RFFL	K76R	Breast-ovarian cancer, familial, susceptibility to, 4	VCV001349017	17	33445556	17	35118537	1349017	1479028	rs2142473925	NC_000017.11:35118536:T:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Apr 26, 2021	criteria provided, single submitter							
NM_002878.4(RAD51D):c.226A>G (p.Lys76Glu)	RAD51D|RAD51L3-RFFL	K76E	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV001061773	17	33445557	17	35118538	1061773	1050203	rs2142473937	NC_000017.11:35118537:T:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Apr 7, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.225G>A (p.Leu75=)	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV001788587	17	33445558	17	35118539	1788587	1844647	rs2142473944	NC_000017.11:35118538:C:T	single nucleotide variant	synonymous variant|intron variant	Benign/Likely benign	Feb 20, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.224T>G (p.Leu75Arg)	RAD51D|RAD51L3-RFFL	L75R	not provided|Hereditary cancer-predisposing syndrome	VCV001788409	17	33445559	17	35118540	1788409	1844470	rs2142473963	NC_000017.11:35118539:A:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Apr 2, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.224T>C (p.Leu75Pro)	RAD51D|RAD51L3-RFFL	L75P	Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV001331092	17	33445559	17	35118540	1331092	1321767	rs2142473963	NC_000017.11:35118539:A:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Sep 27, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.223C>G (p.Leu75Val)	RAD51D|RAD51L3-RFFL	L75V	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV001703706	17	33445560	17	35118541	1703706	1696095	rs746929682	NC_000017.11:35118540:G:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jul 29, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.223C>A (p.Leu75Met)	RAD51D|RAD51L3-RFFL	L75M	not provided|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000642845	17	33445560	17	35118541	642845	645819	rs746929682	NC_000017.11:35118540:G:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jun 13, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.223C>T (p.Leu75=)	RAD51D|RAD51L3-RFFL		not provided|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000416205	17	33445560	17	35118541	416205	401884	rs746929682	NC_000017.11:35118540:G:A	single nucleotide variant	synonymous variant|intron variant	Benign/Likely benign	Feb 20, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.222A>G (p.Glu74=)	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV001788058	17	33445561	17	35118542	1788058	1847500	rs1567735340	NC_000017.11:35118541:T:C	single nucleotide variant	synonymous variant|intron variant	Benign/Likely benign	Feb 20, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.221A>G (p.Glu74Gly)	RAD51D|RAD51L3-RFFL	E74G	Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV000854828	17	33445562	17	35118543	854828	845231	rs2091776575	NC_000017.11:35118542:T:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jan 3, 2023	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.220G>C (p.Glu74Gln)	RAD51D|RAD51L3-RFFL	E74Q	Hereditary cancer-predisposing syndrome	VCV002448047	17	33445563	17	35118544	2448047	2428991	rs2142474014	NC_000017.11:35118543:C:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Dec 23, 2022	criteria provided, single submitter							
NM_002878.4(RAD51D):c.220G>A (p.Glu74Lys)	RAD51D|RAD51L3-RFFL	E74K	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV001361025	17	33445563	17	35118544	1361025	1383397	rs2142474014	NC_000017.11:35118543:C:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jun 24, 2021	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.219G>A (p.Glu73=)	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV002972022	17	33445564	17	35118545	2972022	3139737	rs2142474030	NC_000017.11:35118544:C:T	single nucleotide variant	synonymous variant|intron variant	Benign/Likely benign	Feb 20, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.218A>G (p.Glu73Gly)	RAD51D|RAD51L3-RFFL	E73G	Hereditary cancer-predisposing syndrome	VCV003786515	17	33445565	17	35118546	3786515	3908956		NC_000017.11:35118545:T:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Mar 3, 2025	criteria provided, single submitter							
NM_002878.4(RAD51D):c.217G>T (p.Glu73Ter)	RAD51D|RAD51L3-RFFL	E73*	Breast-ovarian cancer, familial, susceptibility to, 4	VCV002045040	17	33445566	17	35118547	2045040	2092613	rs369946779	NC_000017.11:35118546:C:A	single nucleotide variant	nonsense|intron variant	Pathogenic	Aug 16, 2022	criteria provided, single submitter							
NM_002878.4(RAD51D):c.217G>C (p.Glu73Gln)	RAD51D|RAD51L3-RFFL	E73Q	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000933410	17	33445566	17	35118547	933410	937893	rs369946779	NC_000017.11:35118546:C:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jan 29, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.217G>A (p.Glu73Lys)	RAD51D|RAD51L3-RFFL	E73K	not provided|Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV000187455	17	33445566	17	35118547	187455	184843	rs369946779	NC_000017.11:35118546:C:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	May 22, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.216C>G (p.Tyr72Ter)	RAD51D|RAD51L3-RFFL	Y72*	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV003148160	17	33445567	17	35118548	3148160	3307408	rs148690585	NC_000017.11:35118547:G:C	single nucleotide variant	nonsense|intron variant	Pathogenic	Jan 11, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.216C>A (p.Tyr72Ter)	RAD51D|RAD51L3-RFFL	Y72*	Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV000480544	17	33445567	17	35118548	480544	479194	rs148690585	NC_000017.11:35118547:G:T	single nucleotide variant	nonsense|intron variant	Pathogenic	Jun 14, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.216C>T (p.Tyr72=)	RAD51D|RAD51L3-RFFL		not provided|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4|not specified	VCV000138874	17	33445567	17	35118548	138874	142577	rs148690585	NC_000017.11:35118547:G:A	single nucleotide variant	synonymous variant|intron variant	Benign/Likely benign	Jan 27, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.215A>G (p.Tyr72Cys)	RAD51D|RAD51L3-RFFL	Y72C	Breast-ovarian cancer, familial, susceptibility to, 4	VCV001444429	17	33445568	17	35118549	1444429	1388394	rs2142474078	NC_000017.11:35118548:T:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jul 7, 2021	criteria provided, single submitter							
NM_002878.4(RAD51D):c.214T>C (p.Tyr72His)	RAD51D|RAD51L3-RFFL	Y72H	Hereditary cancer-predisposing syndrome	VCV002561563	17	33445569	17	35118550	2561563	2723934	rs1413506781	NC_000017.11:35118549:A:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Apr 27, 2023	criteria provided, single submitter							
NM_002878.4(RAD51D):c.213C>G (p.Leu71=)	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV000820790	17	33445570	17	35118551	820790	813582	rs745546403	NC_000017.11:35118550:G:C	single nucleotide variant	synonymous variant|intron variant	Benign/Likely benign	Feb 20, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.213C>T (p.Leu71=)	RAD51D|RAD51L3-RFFL		Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000482203	17	33445570	17	35118551	482203	478625	rs745546403	NC_000017.11:35118550:G:A	single nucleotide variant	synonymous variant|intron variant	Benign/Likely benign	Feb 20, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.211C>A (p.Leu71Ile)	RAD51D|RAD51L3-RFFL	L71I	Breast-ovarian cancer, familial, susceptibility to, 4	VCV003604424	17	33445572	17	35118553	3604424	3743175		NC_000017.11:35118552:G:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Feb 19, 2024	criteria provided, single submitter							
NM_002878.4(RAD51D):c.211C>T (p.Leu71Phe)	RAD51D|RAD51L3-RFFL	L71F	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000962391	17	33445572	17	35118553	962391	949882	rs2091776847	NC_000017.11:35118552:G:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Oct 29, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.210T>C (p.Asp70=)	RAD51D|RAD51L3-RFFL		Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV001661746	17	33445573	17	35118554	1661746	1608107	rs2142474139	NC_000017.11:35118553:A:G	single nucleotide variant	synonymous variant|intron variant	Likely benign	Mar 10, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.209A>T (p.Asp70Val)	RAD51L3-RFFL|RAD51D	D70V	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000490137	17	33445574	17	35118555	490137	482980	rs876660173	NC_000017.11:35118554:T:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Nov 18, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.209A>G (p.Asp70Gly)	RAD51L3-RFFL|RAD51D	D70G	Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV000233076	17	33445574	17	35118555	233076	235903	rs876660173	NC_000017.11:35118554:T:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Dec 24, 2022	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.208G>T (p.Asp70Tyr)	RAD51D|RAD51L3-RFFL	D70Y	not provided	VCV002682069	17	33445575	17	35118556	2682069	2843101	rs142189122	NC_000017.11:35118555:C:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Nov 7, 2022	criteria provided, single submitter							
NM_002878.4(RAD51D):c.208G>A (p.Asp70Asn)	RAD51D|RAD51L3-RFFL	D70N	not provided|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|not specified|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000127885	17	33445575	17	35118556	127885	133342	rs142189122	NC_000017.11:35118555:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jan 23, 2025	criteria provided, conflicting classifications							
NM_002878.4(RAD51D):c.207T>A (p.Ala69=)	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV003904032	17	33445576	17	35118557	3904032	4019905		NC_000017.11:35118556:A:T	single nucleotide variant	synonymous variant|intron variant	Benign	Feb 20, 2025	criteria provided, single submitter							
NM_002878.4(RAD51D):c.207T>C (p.Ala69=)	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV003429750	17	33445576	17	35118557	3429750	3585761		NC_000017.11:35118556:A:G	single nucleotide variant	synonymous variant|intron variant	Benign/Likely benign	Feb 20, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.205G>A (p.Ala69Thr)	RAD51D|RAD51L3-RFFL	A69T	not provided|Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV000418972	17	33445578	17	35118559	418972	409902	rs763439048	NC_000017.11:35118558:C:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	May 25, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.204C>T (p.Gly68=)	RAD51D|RAD51L3-RFFL		Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000187475	17	33445579	17	35118560	187475	184844	rs764351040	NC_000017.11:35118559:G:A	single nucleotide variant	synonymous variant|intron variant	Benign/Likely benign	Feb 20, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.204C>A (p.Gly68=)	RAD51D|RAD51L3-RFFL		Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000184660	17	33445579	17	35118560	184660	184845	rs764351040	NC_000017.11:35118559:G:T	single nucleotide variant	synonymous variant|intron variant	Benign/Likely benign	Feb 20, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.202G>A (p.Gly68Ser)	RAD51L3-RFFL|RAD51D	G68S	Breast-ovarian cancer, familial, susceptibility to, 4|not provided|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|not specified	VCV000410548	17	33445581	17	35118562	410548	401892	rs775045445	NC_000017.11:35118561:C:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Mar 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.201T>C (p.Asn67=)	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV003903572	17	33445582	17	35118563	3903572	4019445		NC_000017.11:35118562:A:G	single nucleotide variant	intron variant|synonymous variant	Benign	Feb 20, 2025	criteria provided, single submitter							
NM_002878.4(RAD51D):c.201T>A (p.Asn67Lys)	RAD51D|RAD51L3-RFFL	N67K	Hereditary cancer-predisposing syndrome	VCV002625300	17	33445582	17	35118563	2625300	2787283	rs2142474271	NC_000017.11:35118562:A:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Aug 22, 2023	criteria provided, single submitter							
NM_002878.4(RAD51D):c.201T>G (p.Asn67Lys)	RAD51D|RAD51L3-RFFL	N67K	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV001471055	17	33445582	17	35118563	1471055	1395282	rs2142474271	NC_000017.11:35118562:A:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Dec 25, 2023	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.200A>G (p.Asn67Ser)	RAD51D|RAD51L3-RFFL	N67S	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4|not specified|not provided	VCV000630041	17	33445583	17	35118564	630041	618542	rs546461804	NC_000017.11:35118563:T:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Jun 10, 2025	criteria provided, conflicting classifications							
NM_002878.4(RAD51D):c.199A>G (p.Asn67Asp)	RAD51D|RAD51L3-RFFL	N67D	Breast-ovarian cancer, familial, susceptibility to, 4	VCV001465033	17	33445584	17	35118565	1465033	1510860	rs2142474302	NC_000017.11:35118564:T:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Oct 2, 2021	criteria provided, single submitter							
NM_002878.4(RAD51D):c.198G>C (p.Val66=)	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV003658587	17	33445585	17	35118566	3658587	3797008		NC_000017.11:35118565:C:G	single nucleotide variant	synonymous variant|intron variant	Likely benign	Jul 3, 2024	criteria provided, single submitter							
NM_002878.4(RAD51D):c.198G>T (p.Val66=)	RAD51D|RAD51L3-RFFL		not provided|not specified|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000184496	17	33445585	17	35118566	184496	184847	rs200810304	NC_000017.11:35118565:C:A	single nucleotide variant	synonymous variant|intron variant	Benign/Likely benign	May 1, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.196G>C (p.Val66Leu)	RAD51D|RAD51L3-RFFL	V66L	Breast-ovarian cancer, familial, susceptibility to, 4	VCV002678182	17	33445587	17	35118568	2678182	2833205	rs56026142	NC_000017.11:35118567:C:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Aug 31, 2023	criteria provided, single submitter							
NM_002878.4(RAD51D):c.196G>T (p.Val66Leu)	RAD51D|RAD51L3-RFFL	V66L	not provided|Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV000419663	17	33445587	17	35118568	419663	409903	rs56026142	NC_000017.11:35118567:C:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Oct 24, 2024	criteria provided, conflicting classifications							
NM_002878.4(RAD51D):c.196G>A (p.Val66Met)	RAD51D|RAD51L3-RFFL	V66M	Breast and/or ovarian cancer|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|not provided|Breast-ovarian cancer, familial, susceptibility to, 4|not specified	VCV000141578	17	33445587	17	35118568	141578	151292	rs56026142	NC_000017.11:35118567:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 4, 2025	criteria provided, conflicting classifications							
NM_002878.4(RAD51D):c.195C>G (p.Pro65=)	RAD51L3-RFFL|RAD51D		Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV000239392	17	33445588	17	35118569	239392	242731	rs376616485	NC_000017.11:35118568:G:C	single nucleotide variant	synonymous variant|intron variant	Benign/Likely benign	Feb 20, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.195C>T (p.Pro65=)	RAD51L3-RFFL|RAD51D		Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4|not provided	VCV000230698	17	33445588	17	35118569	230698	235904	rs376616485	NC_000017.11:35118568:G:A	single nucleotide variant	synonymous variant|intron variant	Benign/Likely benign	Feb 20, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.194C>G (p.Pro65Arg)	RAD51D|RAD51L3-RFFL	P65R	Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome|not provided	VCV001783190	17	33445589	17	35118570	1783190	1843135	rs1597876790	NC_000017.11:35118569:G:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Feb 13, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.194C>T (p.Pro65Leu)	RAD51D|RAD51L3-RFFL	P65L	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000953755	17	33445589	17	35118570	953755	949883	rs1597876790	NC_000017.11:35118569:G:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jan 25, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.193C>G (p.Pro65Ala)	RAD51D|RAD51L3-RFFL	P65A	Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV000922070	17	33445590	17	35118571	922070	913842	rs766692136	NC_000017.11:35118570:G:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Dec 15, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.193C>T (p.Pro65Ser)	RAD51D|RAD51L3-RFFL	P65S	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000921725	17	33445590	17	35118571	921725	913841	rs766692136	NC_000017.11:35118570:G:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jul 23, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.192C>A (p.Phe64Leu)	RAD51D|RAD51L3-RFFL	F64L	Breast-ovarian cancer, familial, susceptibility to, 4	VCV002678178	17	33445591	17	35118572	2678178	2833201	rs1567735397	NC_000017.11:35118571:G:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Oct 19, 2023	criteria provided, single submitter							
NM_002878.4(RAD51D):c.192C>G (p.Phe64Leu)	RAD51L3-RFFL|RAD51D	F64L	Hereditary cancer-predisposing syndrome	VCV002563030	17	33445591	17	35118572	2563030	2733487	rs1567735397	NC_000017.11:35118571:G:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Apr 1, 2023	criteria provided, single submitter							
NM_002878.4(RAD51D):c.192C>T (p.Phe64=)	RAD51D|RAD51L3-RFFL		Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000584941	17	33445591	17	35118572	584941	575990	rs1567735397	NC_000017.11:35118571:G:A	single nucleotide variant	synonymous variant|intron variant	Conflicting classifications of pathogenicity	Feb 20, 2025	criteria provided, conflicting classifications							
NM_002878.4(RAD51D):c.191T>G (p.Phe64Cys)	RAD51D|RAD51L3-RFFL	F64C	Hereditary cancer-predisposing syndrome	VCV001782655	17	33445592	17	35118573	1782655	1846020	rs2142474380	NC_000017.11:35118572:A:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Feb 28, 2020	criteria provided, single submitter							
NM_002878.4(RAD51D):c.190T>A (p.Phe64Ile)	RAD51D|RAD51L3-RFFL	F64I	Breast-ovarian cancer, familial, susceptibility to, 4	VCV003726068	17	33445593	17	35118574	3726068	3857976		NC_000017.11:35118573:A:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Oct 3, 2024	criteria provided, single submitter							
NM_002878.4(RAD51D):c.190T>C (p.Phe64Leu)	RAD51D|RAD51L3-RFFL	F64L	RAD51D-related disorder|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV001057566	17	33445593	17	35118574	1057566	1050204	rs371182137	NC_000017.11:35118573:A:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Nov 5, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.189T>C (p.Ala63=)	RAD51D|RAD51L3-RFFL		Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000820267	17	33445594	17	35118575	820267	813583	rs1597876804	NC_000017.11:35118574:A:G	single nucleotide variant	synonymous variant|intron variant	Likely benign	Nov 16, 2022	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.187G>C (p.Ala63Pro)	RAD51D|RAD51L3-RFFL	A63P	Hereditary cancer-predisposing syndrome	VCV003429732	17	33445596	17	35118577	3429732	3585743		NC_000017.11:35118576:C:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Aug 30, 2024	criteria provided, single submitter							
NM_002878.4(RAD51D):c.187G>T (p.Ala63Ser)	RAD51D|RAD51L3-RFFL	A63S	Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV001781869	17	33445596	17	35118577	1781869	1835265	rs777402267	NC_000017.11:35118576:C:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Apr 18, 2022	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.187G>A (p.Ala63Thr)	RAD51D|RAD51L3-RFFL	A63T	Hereditary cancer-predisposing syndrome|not provided|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000820232	17	33445596	17	35118577	820232	813584	rs777402267	NC_000017.11:35118576:C:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Dec 12, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.186G>T (p.Ser62=)	RAD51D|RAD51L3-RFFL		Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV001331880	17	33445597	17	35118578	1331880	1322600	rs746984258	NC_000017.11:35118577:C:A	single nucleotide variant	synonymous variant|intron variant	Benign/Likely benign	Feb 20, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.186G>A (p.Ser62=)	RAD51D|RAD51L3-RFFL		Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000232539	17	33445597	17	35118578	232539	235905	rs746984258	NC_000017.11:35118577:C:T	single nucleotide variant	synonymous variant|intron variant	Benign/Likely benign	Feb 20, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.185C>A (p.Ser62Ter)	RAD51L3-RFFL|RAD51D	S62*	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000410551	17	33445598	17	35118579	410551	401935	rs374357106	NC_000017.11:35118578:G:T	single nucleotide variant	nonsense|intron variant	Pathogenic	Jun 10, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.185C>G (p.Ser62Trp)	RAD51L3-RFFL|RAD51D	S62W	Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV000187224	17	33445598	17	35118579	187224	184849	rs374357106	NC_000017.11:35118578:G:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Feb 14, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.185C>T (p.Ser62Leu)	RAD51L3-RFFL|RAD51D	S62L	not provided|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|Breast and/or ovarian cancer|Breast-ovarian cancer, familial, susceptibility to, 4|not specified|Hereditary cancer	VCV000185036	17	33445598	17	35118579	185036	184848	rs374357106	NC_000017.11:35118578:G:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Feb 26, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.184T>C (p.Ser62Pro)	RAD51D|RAD51L3-RFFL	S62P	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV001781304	17	33445599	17	35118580	1781304	1838651	rs2142474470	NC_000017.11:35118579:A:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Apr 19, 2022	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.183C>A (p.Phe61Leu)	RAD51D|RAD51L3-RFFL	F61L	Breast-ovarian cancer, familial, susceptibility to, 4	VCV001474572	17	33445600	17	35118581	1474572	1503659	rs1185842552	NC_000017.11:35118580:G:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Mar 23, 2021	criteria provided, single submitter							
NM_002878.4(RAD51D):c.183C>G (p.Phe61Leu)	RAD51D|RAD51L3-RFFL	F61L	Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV000949917	17	33445600	17	35118581	949917	928229	rs1185842552	NC_000017.11:35118580:G:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Feb 2, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.183C>T (p.Phe61=)	RAD51D|RAD51L3-RFFL		not provided|Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV000484779	17	33445600	17	35118581	484779	478497	rs1185842552	NC_000017.11:35118580:G:A	single nucleotide variant	synonymous variant|intron variant	Conflicting classifications of pathogenicity	Jul 30, 2024	criteria provided, conflicting classifications							
NM_002878.4(RAD51D):c.182T>G (p.Phe61Cys)	RAD51D|RAD51L3-RFFL	F61C	Hereditary cancer-predisposing syndrome	VCV003942378	17	33445601	17	35118582	3942378	4064157		NC_000017.11:35118581:A:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Mar 15, 2025	criteria provided, single submitter							
NM_002878.4(RAD51D):c.182T>A (p.Phe61Tyr)	RAD51D|RAD51L3-RFFL	F61Y	Hereditary cancer-predisposing syndrome	VCV003429740	17	33445601	17	35118582	3429740	3585751		NC_000017.11:35118581:A:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jun 25, 2024	criteria provided, single submitter							
NM_002878.4(RAD51D):c.182T>C (p.Phe61Ser)	RAD51D|RAD51L3-RFFL	F61S	not provided	VCV001311049	17	33445601	17	35118582	1311049	1300430	rs2142474499	NC_000017.11:35118581:A:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Dec 4, 2019	criteria provided, single submitter							
NM_002878.4(RAD51D):c.181T>C (p.Phe61Leu)	RAD51D|RAD51L3-RFFL	F61L	Breast-ovarian cancer, familial, susceptibility to, 4	VCV002162327	17	33445602	17	35118583	2162327	1894624	rs2142474507	NC_000017.11:35118582:A:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Aug 7, 2024	criteria provided, single submitter							
NM_002878.4(RAD51D):c.180G>C (p.Gln60His)	RAD51D|RAD51L3-RFFL	Q60H	not provided	VCV001309259	17	33445603	17	35118584	1309259	1299958	rs1423192061	NC_000017.11:35118583:C:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Oct 7, 2019	criteria provided, single submitter							
NM_002878.4(RAD51D):c.180G>A (p.Gln60=)	RAD51D|RAD51L3-RFFL		Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000926804	17	33445603	17	35118584	926804	913843	rs1423192061	NC_000017.11:35118583:C:T	single nucleotide variant	synonymous variant|intron variant	Benign/Likely benign	Feb 20, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.180G>T (p.Gln60His)	RAD51D|RAD51L3-RFFL	Q60H	not provided|Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV000484767	17	33445603	17	35118584	484767	478492	rs1423192061	NC_000017.11:35118583:C:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Apr 10, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.179A>G (p.Gln60Arg)	RAD51D|RAD51L3-RFFL	Q60R	Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV001359897	17	33445604	17	35118585	1359897	1473770	rs780689600	NC_000017.11:35118584:T:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Aug 31, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.178C>G (p.Gln60Glu)	RAD51D|RAD51L3-RFFL	Q60E	Breast-ovarian cancer, familial, susceptibility to, 4	VCV003649572	17	33445605	17	35118586	3649572	3777534		NC_000017.11:35118585:G:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Apr 24, 2024	criteria provided, single submitter							
NM_002878.4(RAD51D):c.178C>T (p.Gln60Ter)	RAD51D|RAD51L3-RFFL	Q60*	Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV000484784	17	33445605	17	35118586	484784	478499	rs1555570285	NC_000017.11:35118585:G:A	single nucleotide variant	nonsense|intron variant	Pathogenic	Jul 22, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.177T>C (p.Ala59=)	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV000628162	17	33445606	17	35118587	628162	618543	rs1567735421	NC_000017.11:35118586:A:G	single nucleotide variant	synonymous variant|intron variant	Benign/Likely benign	Feb 20, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.176C>G (p.Ala59Gly)	RAD51D|RAD51L3-RFFL	A59G	Breast-ovarian cancer, familial, susceptibility to, 4	VCV002858158	17	33445607	17	35118588	2858158	3018204	rs2509182226	NC_000017.11:35118587:G:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Apr 22, 2023	criteria provided, single submitter							
NM_002878.4(RAD51D):c.175G>T (p.Ala59Ser)	RAD51D|RAD51L3-RFFL	A59S	Hereditary cancer-predisposing syndrome	VCV003429748	17	33445608	17	35118589	3429748	3585759		NC_000017.11:35118588:C:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Sep 5, 2024	criteria provided, single submitter							
NM_002878.4(RAD51D):c.174G>A (p.Leu58=)	RAD51D|RAD51L3-RFFL		Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000819985	17	33445609	17	35118590	819985	813585	rs1597876848	NC_000017.11:35118589:C:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Dec 1, 2023	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.173T>A (p.Leu58Gln)	RAD51D|RAD51L3-RFFL	L58Q	Breast-ovarian cancer, familial, susceptibility to, 4	VCV000998722	17	33445610	17	35118591	998722	997505	rs2091778221	NC_000017.11:35118590:A:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Nov 16, 2023	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.172C>T (p.Leu58=)	RAD51L3-RFFL|RAD51D		Hereditary cancer-predisposing syndrome	VCV003894423	17	33445611	17	35118592	3894423	4010303		NC_000017.11:35118591:G:A	single nucleotide variant	synonymous variant|intron variant	Likely benign	Jul 8, 2024	criteria provided, single submitter							
NM_002878.4(RAD51D):c.172C>G (p.Leu58Val)	RAD51D|RAD51L3-RFFL	L58V	Hereditary cancer-predisposing syndrome	VCV000484782	17	33445611	17	35118592	484782	479200	rs1555570286	NC_000017.11:35118591:G:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Apr 11, 2017	criteria provided, single submitter							
NM_002878.4(RAD51D):c.171G>C (p.Leu57=)	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV001643383	17	33445612	17	35118593	1643383	1587341	rs786202885	NC_000017.11:35118592:C:G	single nucleotide variant	synonymous variant|intron variant	Benign/Likely benign	Feb 20, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.171G>A (p.Leu57=)	RAD51D|RAD51L3-RFFL		Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4|not provided	VCV000186357	17	33445612	17	35118593	186357	184850	rs786202885	NC_000017.11:35118592:C:T	single nucleotide variant	synonymous variant|intron variant	Conflicting classifications of pathogenicity	Feb 20, 2025	criteria provided, conflicting classifications							
NM_002878.4(RAD51D):c.170T>C (p.Leu57Pro)	RAD51D|RAD51L3-RFFL	L57P	Breast-ovarian cancer, familial, susceptibility to, 4	VCV002096837	17	33445613	17	35118594	2096837	2157326	rs2142474612	NC_000017.11:35118593:A:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Dec 2, 2023	criteria provided, single submitter							
NM_002878.4(RAD51D):c.169C>T (p.Leu57=)	RAD51D|RAD51L3-RFFL		Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV002165061	17	33445614	17	35118595	2165061	1895200	rs2142474623	NC_000017.11:35118594:G:A	single nucleotide variant	synonymous variant|intron variant	Likely benign	Dec 29, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.168G>A (p.Val56=)	RAD51D|RAD51L3-RFFL		Hereditary cancer-predisposing syndrome	VCV003786516	17	33445615	17	35118596	3786516	3908957		NC_000017.11:35118595:C:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Feb 13, 2025	criteria provided, single submitter							
NM_002878.4(RAD51D):c.167T>G (p.Val56Gly)	RAD51D|RAD51L3-RFFL	V56G	Breast-ovarian cancer, familial, susceptibility to, 4|Breast and/or ovarian cancer	VCV001098881	17	33445616	17	35118597	1098881	1087626	rs745307359	NC_000017.11:35118596:A:C	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	May 3, 2021	criteria provided, conflicting classifications							
NM_002878.4(RAD51D):c.166G>A (p.Val56Met)	RAD51D|RAD51L3-RFFL	V56M	Breast-ovarian cancer, familial, susceptibility to, 4	VCV003661514	17	33445617	17	35118598	3661514	3801193		NC_000017.11:35118597:C:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Aug 6, 2024	criteria provided, single submitter							
NM_002878.4(RAD51D):c.166G>C (p.Val56Leu)	RAD51D|RAD51L3-RFFL	V56L	Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV000141843	17	33445617	17	35118598	141843	151557	rs587782052	NC_000017.11:35118597:C:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Nov 27, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.165G>A (p.Arg55=)	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV003903757	17	33445618	17	35118599	3903757	4019630		NC_000017.11:35118598:C:T	single nucleotide variant	synonymous variant|intron variant	Benign	Feb 20, 2025	criteria provided, single submitter							
NM_002878.4(RAD51D):c.165G>C (p.Arg55=)	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV000472591	17	33445618	17	35118599	472591	467975	rs1555570292	NC_000017.11:35118598:C:G	single nucleotide variant	synonymous variant|intron variant	Likely benign	Jun 24, 2023	criteria provided, single submitter							
NM_002878.4(RAD51D):c.164G>C (p.Arg55Pro)	RAD51D|RAD51L3-RFFL	R55P	Breast-ovarian cancer, familial, susceptibility to, 4	VCV003666443	17	33445619	17	35118600	3666443	3792247		NC_000017.11:35118599:C:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Oct 9, 2024	criteria provided, single submitter							
NM_002878.4(RAD51D):c.164G>T (p.Arg55Leu)	RAD51L3-RFFL|RAD51D	R55L	Breast-ovarian cancer, familial, susceptibility to, 4	VCV001442102	17	33445619	17	35118600	1442102	1474967	rs151198586	NC_000017.11:35118599:C:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jun 3, 2021	criteria provided, single submitter							
NM_002878.4(RAD51D):c.164G>A (p.Arg55Gln)	RAD51D|RAD51L3-RFFL	R55Q	Hereditary cancer-predisposing syndrome|not specified|Breast-ovarian cancer, familial, susceptibility to, 4|not provided|Hereditary breast ovarian cancer syndrome|Familial ovarian cancer	VCV000230266	17	33445619	17	35118600	230266	235906	rs151198586	NC_000017.11:35118599:C:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Apr 22, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.163C>A (p.Arg55=)	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV000232662	17	33445620	17	35118601	232662	235908	rs775268017	NC_000017.11:35118600:G:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Sep 19, 2019	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.163C>T (p.Arg55Trp)	RAD51D|RAD51L3-RFFL	R55W	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4|not specified|not provided	VCV000230594	17	33445620	17	35118601	230594	235907	rs775268017	NC_000017.11:35118600:G:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Feb 11, 2025	criteria provided, conflicting classifications							
NM_002878.4(RAD51D):c.162G>A (p.Arg54=)	RAD51D|RAD51L3-RFFL		Hereditary cancer-predisposing syndrome	VCV003942385	17	33445621	17	35118602	3942385	4064164		NC_000017.11:35118601:C:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Apr 11, 2025	criteria provided, single submitter							
NM_002878.4(RAD51D):c.161G>T (p.Arg54Met)	RAD51D|RAD51L3-RFFL	R54M	Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV000229750	17	33445622	17	35118603	229750	235909	rs876658172	NC_000017.11:35118602:C:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Nov 3, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.160A>C (p.Arg54=)	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV003671982	17	33445623	17	35118604	3671982	3805907		NC_000017.11:35118603:T:G	single nucleotide variant	synonymous variant|intron variant	Benign/Likely benign	Feb 20, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.158T>C (p.Leu53Pro)	RAD51D|RAD51L3-RFFL	L53P	Breast-ovarian cancer, familial, susceptibility to, 4	VCV001508112	17	33445625	17	35118606	1508112	1442766	rs2142474761	NC_000017.11:35118605:A:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jul 14, 2021	criteria provided, single submitter							
NM_002878.4(RAD51D):c.157C>T (p.Leu53=)	RAD51D|RAD51L3-RFFL		Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV001775651	17	33445626	17	35118607	1775651	1830848	rs2091778688	NC_000017.11:35118606:G:A	single nucleotide variant	synonymous variant|intron variant	Benign/Likely benign	Feb 20, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.156C>G (p.Ala52=)	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV002036270	17	33445627	17	35118608	2036270	2090326	rs2142474782	NC_000017.11:35118607:G:C	single nucleotide variant	synonymous variant|intron variant	Benign/Likely benign	Feb 20, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.154G>T (p.Ala52Ser)	RAD51D|RAD51L3-RFFL	A52S	Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV000950214	17	33445629	17	35118610	950214	928230	rs1555570297	NC_000017.11:35118609:C:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Oct 28, 2022	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.154G>A (p.Ala52Thr)	RAD51D|RAD51L3-RFFL	A52T	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000490136	17	33445629	17	35118610	490136	482977	rs1555570297	NC_000017.11:35118609:C:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Dec 5, 2023	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.152T>C (p.Val51Ala)	RAD51D|RAD51L3-RFFL	V51A	Breast-ovarian cancer, familial, susceptibility to, 4	VCV000410566	17	33445631	17	35118612	410566	402418	rs1060502962	NC_000017.11:35118611:A:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Feb 21, 2022	criteria provided, single submitter							
NM_002878.4(RAD51D):c.151G>T (p.Val51Phe)	RAD51D|RAD51L3-RFFL	V51F	Breast-ovarian cancer, familial, susceptibility to, 4	VCV003666367	17	33445632	17	35118613	3666367	3792171		NC_000017.11:35118612:C:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Nov 13, 2024	criteria provided, single submitter							
NM_002878.4(RAD51D):c.151G>C (p.Val51Leu)	RAD51D|RAD51L3-RFFL	V51L	Breast-ovarian cancer, familial, susceptibility to, 4	VCV002840195	17	33445632	17	35118613	2840195	3003416	rs2091778790	NC_000017.11:35118612:C:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Feb 23, 2023	criteria provided, single submitter							
NM_002878.4(RAD51D):c.151G>A (p.Val51Ile)	RAD51D|RAD51L3-RFFL	V51I	Breast-ovarian cancer, familial, susceptibility to, 4|not provided	VCV000954291	17	33445632	17	35118613	954291	949884	rs2091778790	NC_000017.11:35118612:C:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Aug 29, 2019	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.150G>A (p.Leu50=)	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV003903902	17	33445633	17	35118614	3903902	4019775		NC_000017.11:35118613:C:T	single nucleotide variant	synonymous variant|intron variant	Benign	Feb 20, 2025	criteria provided, single submitter							
NM_002878.4(RAD51D):c.150G>T (p.Leu50=)	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV001095448	17	33445633	17	35118614	1095448	1082935	rs2142474845	NC_000017.11:35118613:C:A	single nucleotide variant	synonymous variant|intron variant	Likely benign	Aug 17, 2019	criteria provided, single submitter							
NM_002878.4(RAD51D):c.149T>C (p.Leu50Pro)	RAD51D|RAD51L3-RFFL	L50P	Breast-ovarian cancer, familial, susceptibility to, 4	VCV002840178	17	33445634	17	35118615	2840178	3003399	rs2091778819	NC_000017.11:35118614:A:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Apr 24, 2024	criteria provided, single submitter							
NM_002878.4(RAD51D):c.148C>G (p.Leu50Val)	RAD51D|RAD51L3-RFFL	L50V	Breast-ovarian cancer, familial, susceptibility to, 4	VCV003892249	17	33445635	17	35118616	3892249	4008138		NC_000017.11:35118615:G:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Dec 2, 2024	criteria provided, single submitter							
NM_002878.4(RAD51D):c.146C>T (p.Ala49Val)	RAD51D|RAD51L3-RFFL	A49V	not specified|Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000127883	17	33445637	17	35118618	127883	133340	rs140317560	NC_000017.11:35118617:G:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 4, 2025	criteria provided, conflicting classifications							
NM_002878.4(RAD51D):c.145-1G>A	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV003148257	17	33445639	17	35118620	3148257	3307505	rs2142474934	NC_000017.11:35118619:C:T	single nucleotide variant	splice acceptor variant|intron variant	Likely pathogenic	Jan 4, 2024	criteria provided, single submitter							
NM_002878.4(RAD51D):c.145-2A>G	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV001477070	17	33445640	17	35118621	1477070	1417135	rs2142474941	NC_000017.11:35118620:T:C	single nucleotide variant	splice acceptor variant|intron variant	Likely pathogenic	Jun 9, 2023	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.145-3C>T	RAD51L3-RFFL|RAD51D		Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000492412	17	33445641	17	35118622	492412	484977	rs201974522	NC_000017.11:35118621:G:A	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Nov 19, 2024	criteria provided, conflicting classifications							
NM_002878.4(RAD51D):c.145-4G>T	RAD51D|RAD51L3-RFFL		Hereditary cancer-predisposing syndrome|not specified|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000384789	17	33445642	17	35118623	384789	374934	rs201361465	NC_000017.11:35118622:C:A	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Jun 10, 2025	criteria provided, conflicting classifications							
NM_002878.4(RAD51D):c.145-4G>A	RAD51D|RAD51L3-RFFL		Hereditary cancer-predisposing syndrome|not specified|RAD51D-related cancer predisposition|not provided|Breast and/or ovarian cancer|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000141453	17	33445642	17	35118623	141453	151167	rs201361465	NC_000017.11:35118622:C:T	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Mar 4, 2025	criteria provided, conflicting classifications							
NM_002878.4(RAD51D):c.145-6T>C	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV003903821	17	33445644	17	35118625	3903821	4019694		NC_000017.11:35118624:A:G	single nucleotide variant	intron variant	Likely benign	Feb 20, 2025	criteria provided, single submitter							
NM_002878.4(RAD51D):c.145-7T>C	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV003696791	17	33445645	17	35118626	3696791	3825522		NC_000017.11:35118625:A:G	single nucleotide variant	intron variant	Likely benign	Feb 20, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.145-7T>A	RAD51D|RAD51L3-RFFL		not provided	VCV000418747	17	33445645	17	35118626	418747	409904	rs1064793407	NC_000017.11:35118625:A:T	single nucleotide variant	intron variant	Uncertain significance	Mar 26, 2015	criteria provided, single submitter							
NM_002878.4(RAD51D):c.145-9C>G	RAD51D|RAD51L3-RFFL		Hereditary breast ovarian cancer syndrome	VCV003780520	17	33445647	17	35118628	3780520	3896486		NC_000017.11:35118627:G:C	single nucleotide variant	intron variant	Uncertain significance	May 26, 2023	criteria provided, single submitter							
NM_002878.4(RAD51D):c.145-9C>A	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV001345065	17	33445647	17	35118628	1345065	1443031	rs1555570311	NC_000017.11:35118627:G:T	single nucleotide variant	intron variant	Likely benign	Feb 20, 2024	criteria provided, single submitter							
NM_002878.4(RAD51D):c.145-9C>T	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV000472590	17	33445647	17	35118628	472590	466755	rs1555570311	NC_000017.11:35118627:G:A	single nucleotide variant	intron variant	Likely benign	Feb 20, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.145-10C>T	RAD51L3-RFFL|RAD51D		Breast-ovarian cancer, familial, susceptibility to, 4	VCV003904093	17	33445648	17	35118629	3904093	4019966		NC_000017.11:35118628:G:A	single nucleotide variant	intron variant	Likely benign	Feb 20, 2025	criteria provided, single submitter							
NM_002878.4(RAD51D):c.145-11C>T	RAD51L3-RFFL|RAD51D		Breast-ovarian cancer, familial, susceptibility to, 4	VCV003904097	17	33445649	17	35118630	3904097	4019970		NC_000017.11:35118629:G:A	single nucleotide variant	intron variant	Likely benign	Feb 20, 2025	criteria provided, single submitter							
NM_002878.4(RAD51D):c.145-11C>A	RAD51L3-RFFL|RAD51D		Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000492409	17	33445649	17	35118630	492409	484978	rs773851850	NC_000017.11:35118629:G:T	single nucleotide variant	intron variant	Likely benign	Jan 29, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.145-12G>A	RAD51D|RAD51L3-RFFL		not provided|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000421321	17	33445650	17	35118631	421321	409905	rs1064795057	NC_000017.11:35118630:C:T	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Apr 10, 2024	criteria provided, conflicting classifications							
NM_002878.4(RAD51D):c.145-13G>C	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV002758333	17	33445651	17	35118632	2758333	2910432	rs760867838	NC_000017.11:35118631:C:G	single nucleotide variant	intron variant	Likely benign	Sep 5, 2023	criteria provided, single submitter							
NM_002878.4(RAD51D):c.145-13G>T	RAD51L3-RFFL|RAD51D		not provided|Breast-ovarian cancer, familial, susceptibility to, 4|Breast and/or ovarian cancer|Hereditary cancer-predisposing syndrome	VCV000380544	17	33445651	17	35118632	380544	378131	rs760867838	NC_000017.11:35118631:C:A	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Jan 29, 2025	criteria provided, conflicting classifications							
NM_002878.4(RAD51D):c.145-14G>A	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV002780964	17	33445652	17	35118633	2780964	2940817	rs200470533	NC_000017.11:35118632:C:T	single nucleotide variant	intron variant	Uncertain significance	Nov 25, 2023	criteria provided, single submitter							
NM_002878.4(RAD51D):c.145-14G>C	RAD51D|RAD51L3-RFFL		Hereditary cancer-predisposing syndrome|RAD51D-related cancer predisposition|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000492410	17	33445652	17	35118633	492410	485224	rs200470533	NC_000017.11:35118632:C:G	single nucleotide variant	intron variant	Benign/Likely benign	Jan 22, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.145-15G>A	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV002148339	17	33445653	17	35118634	2148339	1871127	rs2091779348	NC_000017.11:35118633:C:T	single nucleotide variant	intron variant	Uncertain significance	Apr 25, 2024	criteria provided, single submitter							
NM_002878.4(RAD51D):c.145-16T>C	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV002835345	17	33445654	17	35118635	2835345	2999003	rs2509182836	NC_000017.11:35118634:A:G	single nucleotide variant	intron variant	Likely benign	Feb 8, 2023	criteria provided, single submitter							
NM_002878.4(RAD51D):c.145-17C>T	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV002712877	17	33445655	17	35118636	2712877	2879024	rs754131532	NC_000017.11:35118635:G:A	single nucleotide variant	intron variant	Likely benign	Feb 20, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.145-18T>C	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV000628025	17	33445656	17	35118637	628025	619625	rs1567735483	NC_000017.11:35118636:A:G	single nucleotide variant	intron variant	Likely benign	Feb 20, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.145-19G>A	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV003626744	17	33445657	17	35118638	3626744	3755385		NC_000017.11:35118637:C:T	single nucleotide variant	intron variant	Likely benign	Feb 20, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.145-20A>G	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome|not specified	VCV000492411	17	33445658	17	35118639	492411	484798	rs759639583	NC_000017.11:35118638:T:C	single nucleotide variant	intron variant	Likely benign	Feb 20, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.145-39G>T	RAD51D|RAD51L3-RFFL		not specified|not provided	VCV001207891	17	33445677	17	35118658	1207891	1198924	rs7207508	NC_000017.11:35118657:C:A	single nucleotide variant	intron variant	Benign/Likely benign	Mar 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.145-40C>T	RAD51D|RAD51L3-RFFL		not specified|not provided	VCV001213061	17	33445678	17	35118659	1213061	1203055	rs370850037	NC_000017.11:35118658:G:A	single nucleotide variant	intron variant	Benign/Likely benign	Mar 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.145-47G>C	RAD51D|RAD51L3-RFFL		not specified	VCV001697596	17	33445685	17	35118666	1697596	1689980	rs367563429	NC_000017.11:35118665:C:G	single nucleotide variant	intron variant	Likely benign	Mar 4, 2025	criteria provided, single submitter							
NM_002878.4(RAD51D):c.144+33G>C	RAD51D|RAD51L3-RFFL		not specified	VCV002576268	17	33446097	17	35119078	2576268	2741164	rs28363260	NC_000017.11:35119077:C:G	single nucleotide variant	intron variant	Likely benign	Mar 4, 2025	criteria provided, single submitter							
NM_002878.4(RAD51D):c.144+18A>T	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV001608679	17	33446112	17	35119093	1608679	1660097	rs1567735758	NC_000017.11:35119092:T:A	single nucleotide variant	intron variant	Likely benign	Aug 21, 2024	criteria provided, single submitter							
NM_002878.4(RAD51D):c.144+17C>T	RAD51D|RAD51L3-RFFL		Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000629363	17	33446113	17	35119094	629363	619671	rs1567735764	NC_000017.11:35119093:G:A	single nucleotide variant	intron variant	Likely benign	Dec 19, 2023	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.144+17C>G	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV000628012	17	33446113	17	35119094	628012	619674	rs1567735764	NC_000017.11:35119093:G:C	single nucleotide variant	intron variant	Likely benign	Nov 5, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.144+16C>G	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV002060970	17	33446114	17	35119095	2060970	2127537	rs2142476978	NC_000017.11:35119094:G:C	single nucleotide variant	intron variant	Likely benign	Oct 2, 2022	criteria provided, single submitter							
NM_002878.4(RAD51D):c.144+15T>G	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV002723104	17	33446115	17	35119096	2723104	2888329	rs2142476982	NC_000017.11:35119095:A:C	single nucleotide variant	intron variant	Likely benign	Mar 8, 2024	criteria provided, single submitter							
NM_002878.4(RAD51D):c.144+15T>C	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV001571152	17	33446115	17	35119096	1571152	1646380	rs2142476982	NC_000017.11:35119095:A:G	single nucleotide variant	intron variant	Likely benign	Jul 12, 2021	criteria provided, single submitter							
NM_002878.4(RAD51D):c.144+14C>T	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV003687218	17	33446116	17	35119097	3687218	3830479		NC_000017.11:35119096:G:A	single nucleotide variant	intron variant	Likely benign	Nov 7, 2024	criteria provided, single submitter							
NM_002878.4(RAD51D):c.144+14C>G	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV001570208	17	33446116	17	35119097	1570208	1623524	rs2091787170	NC_000017.11:35119096:G:C	single nucleotide variant	intron variant	Likely benign	Aug 21, 2024	criteria provided, single submitter							
NM_002878.4(RAD51D):c.144+13T>G	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV002912366	17	33446117	17	35119098	2912366	3073523	rs2509185022	NC_000017.11:35119097:A:C	single nucleotide variant	intron variant	Likely benign	Nov 1, 2022	criteria provided, single submitter							
NM_002878.4(RAD51D):c.144+9C>T	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV000756880	17	33446121	17	35119102	756880	776648	rs1597877583	NC_000017.11:35119101:G:A	single nucleotide variant	intron variant	Likely benign	Feb 20, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.144+8C>T	RAD51L3-RFFL|RAD51D		Breast-ovarian cancer, familial, susceptibility to, 4|RAD51D-related cancer predisposition	VCV000416201	17	33446122	17	35119103	416201	402605	rs1060504766	NC_000017.11:35119102:G:A	single nucleotide variant	intron variant	Likely benign	Feb 20, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.144+7T>A	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV003626358	17	33446123	17	35119104	3626358	3758189		NC_000017.11:35119103:A:T	single nucleotide variant	intron variant	Likely benign	Feb 20, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.144+7T>G	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV001141452	17	33446123	17	35119104	1141452	1147044	rs2142477052	NC_000017.11:35119103:A:C	single nucleotide variant	intron variant	Likely benign	Feb 20, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.144+7T>C	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV001106525	17	33446123	17	35119104	1106525	1104723	rs2142477052	NC_000017.11:35119103:A:G	single nucleotide variant	intron variant	Likely benign	Aug 5, 2020	criteria provided, single submitter							
NM_002878.4(RAD51D):c.144+5G>A	RAD51D|RAD51L3-RFFL		Hereditary cancer-predisposing syndrome|not provided|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000819223	17	33446125	17	35119106	819223	815680	rs876659159	NC_000017.11:35119105:C:T	single nucleotide variant	intron variant	Uncertain significance	Oct 3, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.144+5G>C	RAD51L3-RFFL|RAD51D		Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000231437	17	33446125	17	35119106	231437	235910	rs876659159	NC_000017.11:35119105:C:G	single nucleotide variant	intron variant	Uncertain significance	Aug 22, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.144+3G>A	RAD51D|RAD51L3-RFFL		Hereditary cancer-predisposing syndrome	VCV001772687	17	33446127	17	35119108	1772687	1836531	rs761057565	NC_000017.11:35119107:C:T	single nucleotide variant	intron variant	Uncertain significance	Sep 28, 2017	criteria provided, single submitter							
NM_002878.4(RAD51D):c.144+3G>T	RAD51D|RAD51L3-RFFL		Hereditary cancer-predisposing syndrome|not provided|Breast-ovarian cancer, familial, susceptibility to, 4|Familial ovarian cancer	VCV000472589	17	33446127	17	35119108	472589	467977	rs761057565	NC_000017.11:35119107:C:A	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Jan 14, 2025	criteria provided, conflicting classifications							
NM_002878.4(RAD51D):c.144+1G>A	RAD51D|RAD51L3-RFFL		Familial ovarian cancer	VCV004056282	17	33446129	17	35119110	4056282	4170220		NC_000017.11:35119109:C:T	single nucleotide variant	splice donor variant	Likely pathogenic	Mar 13, 2024	criteria provided, single submitter							
NM_002878.4(RAD51D):c.144+1G>T	RAD51D|RAD51L3-RFFL		Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV001098882	17	33446129	17	35119110	1098882	1087627	rs2142477107	NC_000017.11:35119109:C:A	single nucleotide variant	splice donor variant	Pathogenic/Likely pathogenic	Jan 15, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.144G>A (p.Lys48=)	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV002834934	17	33446130	17	35119111	2834934	3001986	rs2142477120	NC_000017.11:35119110:C:T	single nucleotide variant	synonymous variant|non-coding transcript variant	Uncertain significance	Feb 6, 2023	criteria provided, single submitter							
NM_002878.4(RAD51D):c.143A>C (p.Lys48Thr)	RAD51D|RAD51L3-RFFL	K48T	Hereditary cancer-predisposing syndrome	VCV001772668	17	33446131	17	35119112	1772668	1836512	rs786202365	NC_000017.11:35119111:T:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Dec 20, 2021	criteria provided, single submitter							
NM_002878.4(RAD51D):c.143A>G (p.Lys48Arg)	RAD51D|RAD51L3-RFFL	K48R	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000185676	17	33446131	17	35119112	185676	184852	rs786202365	NC_000017.11:35119111:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Oct 14, 2022	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.142A>C (p.Lys48Gln)	RAD51D|RAD51L3-RFFL	K48Q	Hereditary cancer-predisposing syndrome|not specified|Breast-ovarian cancer, familial, susceptibility to, 4|not provided	VCV000927893	17	33446132	17	35119113	927893	913844	rs2091787642	NC_000017.11:35119112:T:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Mar 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.141C>T (p.Tyr47=)	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000921676	17	33446133	17	35119114	921676	913845	rs771077929	NC_000017.11:35119113:G:A	single nucleotide variant	synonymous variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Feb 20, 2025	criteria provided, conflicting classifications							
NM_002878.4(RAD51D):c.141C>G (p.Tyr47Ter)	RAD51D|RAD51L3-RFFL	Y47*	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000641610	17	33446133	17	35119114	641610	645820	rs771077929	NC_000017.11:35119113:G:C	single nucleotide variant	nonsense|non-coding transcript variant	Pathogenic	Jun 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.141C>A (p.Tyr47Ter)	RAD51D|RAD51L3-RFFL	Y47*	Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV000581385	17	33446133	17	35119114	581385	571308	rs771077929	NC_000017.11:35119113:G:T	single nucleotide variant	nonsense|non-coding transcript variant	Pathogenic/Likely pathogenic	Mar 3, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.140A>G (p.Tyr47Cys)	RAD51D|RAD51L3-RFFL	Y47C	not provided|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000819144	17	33446134	17	35119115	819144	813586	rs776528342	NC_000017.11:35119114:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Dec 22, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.139T>C (p.Tyr47His)	RAD51D|RAD51L3-RFFL	Y47H	Hereditary cancer-predisposing syndrome	VCV003312403	17	33446135	17	35119116	3312403	3461945		NC_000017.11:35119115:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Apr 12, 2024	criteria provided, single submitter							
NM_002878.4(RAD51D):c.138T>A (p.Ser46=)	RAD51L3-RFFL|RAD51D		Breast-ovarian cancer, familial, susceptibility to, 4	VCV003904005	17	33446136	17	35119117	3904005	4019878		NC_000017.11:35119116:A:T	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign	Feb 20, 2025	criteria provided, single submitter							
NM_002878.4(RAD51D):c.137C>T (p.Ser46Phe)	RAD51D|RAD51L3-RFFL	S46F	not specified	VCV001704530	17	33446137	17	35119118	1704530	1699063	rs587780102	NC_000017.11:35119117:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jul 21, 2022	criteria provided, single submitter							
NM_002878.4(RAD51D):c.137C>G (p.Ser46Cys)	RAD51D|RAD51L3-RFFL	S46C	not specified|Hereditary cancer|Breast-ovarian cancer, familial, susceptibility to, 4|Breast and/or ovarian cancer|Familial ovarian cancer|not provided|Hereditary cancer-predisposing syndrome	VCV000127882	17	33446137	17	35119118	127882	133339	rs587780102	NC_000017.11:35119117:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Mar 5, 2025	criteria provided, conflicting classifications							
NM_002878.4(RAD51D):c.136T>G (p.Ser46Ala)	RAD51L3-RFFL|RAD51D	S46A	Hereditary cancer-predisposing syndrome	VCV000628784	17	33446138	17	35119119	628784	618544	rs980673532	NC_000017.11:35119118:A:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Dec 5, 2023	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.136T>C (p.Ser46Pro)	RAD51D|RAD51L3-RFFL	S46P	Breast-ovarian cancer, familial, susceptibility to, 4|not provided|Hereditary cancer-predisposing syndrome|RAD51D-related disorder	VCV000480525	17	33446138	17	35119119	480525	478627	rs980673532	NC_000017.11:35119118:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Dec 6, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.135G>A (p.Leu45=)	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV002448058	17	33446139	17	35119120	2448058	2429002	rs752907589	NC_000017.11:35119119:C:T	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign/Likely benign	Feb 20, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.135G>T (p.Leu45Phe)	RAD51D|RAD51L3-RFFL	L45F	Breast-ovarian cancer, familial, susceptibility to, 4	VCV002008565	17	33446139	17	35119120	2008565	2066515	rs752907589	NC_000017.11:35119119:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jun 19, 2022	criteria provided, single submitter							
NM_002878.4(RAD51D):c.135G>C (p.Leu45Phe)	RAD51D|RAD51L3-RFFL	L45F	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000819004	17	33446139	17	35119120	819004	813587	rs752907589	NC_000017.11:35119119:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Sep 25, 2023	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.133T>G (p.Leu45Val)	RAD51D|RAD51L3-RFFL	L45V	Breast-ovarian cancer, familial, susceptibility to, 4	VCV002871772	17	33446141	17	35119122	2871772	3031790	rs2142477257	NC_000017.11:35119121:A:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Feb 8, 2023	criteria provided, single submitter							
NM_002878.4(RAD51D):c.133T>C (p.Leu45=)	RAD51D|RAD51L3-RFFL		Hereditary cancer-predisposing syndrome	VCV001770341	17	33446141	17	35119122	1770341	1829446	rs2142477257	NC_000017.11:35119121:A:G	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Nov 7, 2020	criteria provided, single submitter							
NM_002878.4(RAD51D):c.132C>T (p.Gly44=)	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome|not provided	VCV000492408	17	33446142	17	35119123	492408	484799	rs761651126	NC_000017.11:35119122:G:A	single nucleotide variant	synonymous variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Mar 27, 2025	criteria provided, conflicting classifications							
NM_002878.4(RAD51D):c.131G>T (p.Gly44Val)	RAD51D|RAD51L3-RFFL	G44V	Breast-ovarian cancer, familial, susceptibility to, 4	VCV001044792	17	33446143	17	35119124	1044792	1033232	rs374730714	NC_000017.11:35119123:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jul 29, 2020	criteria provided, single submitter							
NM_002878.4(RAD51D):c.131G>C (p.Gly44Ala)	RAD51D|RAD51L3-RFFL	G44A	Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome|not specified|not provided	VCV000410546	17	33446143	17	35119124	410546	401937	rs374730714	NC_000017.11:35119123:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Nov 12, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.131G>A (p.Gly44Asp)	RAD51L3-RFFL|RAD51D	G44D	not specified|not provided|Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV000184924	17	33446143	17	35119124	184924	184853	rs374730714	NC_000017.11:35119123:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jun 10, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.130G>T (p.Gly44Cys)	RAD51D|RAD51L3-RFFL	G44C	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000492407	17	33446144	17	35119125	492407	485014	rs1555570408	NC_000017.11:35119124:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Dec 27, 2023	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.128G>A (p.Cys43Tyr)	RAD51D|RAD51L3-RFFL	C43Y	Breast-ovarian cancer, familial, susceptibility to, 4	VCV002713353	17	33446146	17	35119127	2713353	2875651	rs2091788178	NC_000017.11:35119126:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Mar 31, 2023	criteria provided, single submitter							
NM_002878.4(RAD51D):c.128G>C (p.Cys43Ser)	RAD51D|RAD51L3-RFFL	C43S	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV002448045	17	33446146	17	35119127	2448045	2428989	rs2091788178	NC_000017.11:35119126:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jul 29, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.127T>C (p.Cys43Arg)	RAD51D|RAD51L3-RFFL	C43R	Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV000946952	17	33446147	17	35119128	946952	928231	rs2091788219	NC_000017.11:35119127:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	May 6, 2023	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.126A>G (p.Lys42=)	RAD51D|RAD51L3-RFFL		Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4|not specified	VCV000472587	17	33446148	17	35119129	472587	467809	rs145361433	NC_000017.11:35119128:T:C	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign/Likely benign	Feb 20, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.125A>C (p.Lys42Thr)	RAD51D|RAD51L3-RFFL	K42T	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV001358185	17	33446149	17	35119130	1358185	1460484	rs2091788311	NC_000017.11:35119129:T:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Nov 4, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.124A>G (p.Lys42Glu)	RAD51D|RAD51L3-RFFL	K42E	Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV000999965	17	33446150	17	35119131	999965	997506	rs2091788355	NC_000017.11:35119130:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Nov 10, 2023	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.123G>C (p.Gln41His)	RAD51D|RAD51L3-RFFL	Q41H	Breast-ovarian cancer, familial, susceptibility to, 4	VCV001038568	17	33446151	17	35119132	1038568	1033233	rs2091788390	NC_000017.11:35119131:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Dec 3, 2020	criteria provided, single submitter							
NM_002878.4(RAD51D):c.122A>C (p.Gln41Pro)	RAD51D|RAD51L3-RFFL	Q41P	Hereditary cancer-predisposing syndrome	VCV000925398	17	33446152	17	35119133	925398	913846	rs750412372	NC_000017.11:35119132:T:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Mar 6, 2024	criteria provided, single submitter							
NM_002878.4(RAD51D):c.121C>T (p.Gln41Ter)	RAD51L3-RFFL|RAD51D	Q41*	Breast-ovarian cancer, familial, susceptibility to, 4	VCV001451423	17	33446153	17	35119134	1451423	1429677	rs2142477410	NC_000017.11:35119133:G:A	single nucleotide variant	nonsense|non-coding transcript variant	Pathogenic	Jan 4, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.119C>T (p.Ala40Val)	RAD51D|RAD51L3-RFFL	A40V	Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV000480534	17	33446155	17	35119136	480534	478630	rs1555570409	NC_000017.11:35119135:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Mar 6, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.118G>A (p.Ala40Thr)	RAD51D|RAD51L3-RFFL	A40T	Breast-ovarian cancer, familial, susceptibility to, 4	VCV001064045	17	33446156	17	35119137	1064045	1050205	rs2142477463	NC_000017.11:35119136:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Aug 26, 2021	criteria provided, single submitter							
NM_002878.4(RAD51D):c.117A>G (p.Val39=)	RAD51D|RAD51L3-RFFL		Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000922527	17	33446157	17	35119138	922527	913847	rs876660008	NC_000017.11:35119137:T:C	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign/Likely benign	Feb 20, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.117A>T (p.Val39=)	RAD51D|RAD51L3-RFFL		Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000232818	17	33446157	17	35119138	232818	235911	rs876660008	NC_000017.11:35119137:T:A	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign/Likely benign	Feb 20, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.116T>G (p.Val39Gly)	RAD51D|RAD51L3-RFFL	V39G	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000565429	17	33446158	17	35119139	565429	569017	rs1567735836	NC_000017.11:35119138:A:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jan 29, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.115G>A (p.Val39Ile)	RAD51D|RAD51L3-RFFL	V39I	Breast-ovarian cancer, familial, susceptibility to, 4	VCV001023006	17	33446159	17	35119140	1023006	1012711	rs2091788601	NC_000017.11:35119139:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Mar 18, 2020	criteria provided, single submitter							
NM_002878.4(RAD51D):c.114G>T (p.Glu38Asp)	RAD51D|RAD51L3-RFFL	E38D	Hereditary cancer-predisposing syndrome	VCV003312399	17	33446160	17	35119141	3312399	3461941		NC_000017.11:35119140:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Likely benign	Apr 3, 2024	criteria provided, single submitter							
NM_002878.4(RAD51D):c.114G>A (p.Glu38=)	RAD51D|RAD51L3-RFFL		Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV001138836	17	33446160	17	35119141	1138836	1126150	rs2142477518	NC_000017.11:35119140:C:T	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign/Likely benign	Feb 20, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.112G>A (p.Glu38Lys)	RAD51D|RAD51L3-RFFL	E38K	Breast-ovarian cancer, familial, susceptibility to, 4	VCV002678186	17	33446162	17	35119143	2678186	2833209	rs2142477536	NC_000017.11:35119142:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jul 12, 2023	criteria provided, single submitter							
NM_002878.4(RAD51D):c.110A>T (p.Glu37Val)	RAD51D|RAD51L3-RFFL	E37V	Breast-ovarian cancer, familial, susceptibility to, 4	VCV002153867	17	33446164	17	35119145	2153867	1892642	rs2509185546	NC_000017.11:35119144:T:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jun 29, 2022	criteria provided, single submitter							
NM_002878.4(RAD51D):c.109G>A (p.Glu37Lys)	RAD51D|RAD51L3-RFFL	E37K	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV001363621	17	33446165	17	35119146	1363621	1389441	rs876659848	NC_000017.11:35119145:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Aug 4, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.109G>C (p.Glu37Gln)	RAD51D|RAD51L3-RFFL	E37Q	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000232574	17	33446165	17	35119146	232574	235912	rs876659848	NC_000017.11:35119145:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Mar 10, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.108G>A (p.Leu36=)	RAD51D|RAD51L3-RFFL		not provided|Hereditary cancer-predisposing syndrome|not specified|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000185380	17	33446166	17	35119147	185380	184854	rs755962971	NC_000017.11:35119146:C:T	single nucleotide variant	synonymous variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Feb 20, 2025	criteria provided, conflicting classifications							
NM_002878.4(RAD51D):c.106C>T (p.Leu36=)	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV003903854	17	33446168	17	35119149	3903854	4019727		NC_000017.11:35119148:G:A	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign	Feb 20, 2025	criteria provided, single submitter							
NM_002878.4(RAD51D):c.106C>G (p.Leu36Val)	RAD51D|RAD51L3-RFFL	L36V	Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV000822108	17	33446168	17	35119149	822108	813588	rs1597877703	NC_000017.11:35119148:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jul 11, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.106C>A (p.Leu36Met)	RAD51D|RAD51L3-RFFL	L36M	not provided|Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV000657593	17	33446168	17	35119149	657593	645821	rs1597877703	NC_000017.11:35119148:G:T	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Dec 9, 2024	criteria provided, conflicting classifications							
NM_002878.4(RAD51D):c.105C>T (p.Asp35=)	RAD51D|RAD51L3-RFFL		not provided|Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV000472586	17	33446169	17	35119150	472586	467638	rs1555570413	NC_000017.11:35119149:G:A	single nucleotide variant	synonymous variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Apr 12, 2025	criteria provided, conflicting classifications							
NM_002878.4(RAD51D):c.104A>G (p.Asp35Gly)	RAD51L3-RFFL|RAD51D	D35G	Hereditary cancer-predisposing syndrome	VCV001776486	17	33446170	17	35119151	1776486	1837716	rs2091788848	NC_000017.11:35119150:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Dec 24, 2019	criteria provided, single submitter							
NM_002878.4(RAD51D):c.104A>T (p.Asp35Val)	RAD51D|RAD51L3-RFFL	D35V	Breast-ovarian cancer, familial, susceptibility to, 4	VCV000960713	17	33446170	17	35119151	960713	949885	rs2091788848	NC_000017.11:35119150:T:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Oct 26, 2022	criteria provided, single submitter							
NM_002878.4(RAD51D):c.101C>T (p.Ala34Val)	RAD51L3-RFFL|RAD51D	A34V	not specified|not provided|Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV000231115	17	33446173	17	35119154	231115	235913	rs876658968	NC_000017.11:35119153:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jan 29, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.100G>A (p.Ala34Thr)	RAD51D|RAD51L3-RFFL	A34T	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000539852	17	33446174	17	35119155	539852	531094	rs1555570419	NC_000017.11:35119154:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Feb 7, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.99T>C (p.Ser33=)	RAD51D|RAD51L3-RFFL		Hereditary cancer-predisposing syndrome	VCV003222896	17	33446175	17	35119156	3222896	3386534	rs2142477718	NC_000017.11:35119155:A:G	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Feb 29, 2024	criteria provided, single submitter							
NM_002878.4(RAD51D):c.98C>T (p.Ser33Phe)	RAD51D|RAD51L3-RFFL	S33F	Hereditary cancer-predisposing syndrome	VCV003786513	17	33446176	17	35119157	3786513	3908954		NC_000017.11:35119156:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jan 19, 2025	criteria provided, single submitter							
NM_002878.4(RAD51D):c.95T>G (p.Val32Gly)	RAD51D|RAD51L3-RFFL	V32G	Hereditary cancer-predisposing syndrome	VCV002563039	17	33446179	17	35119160	2563039	2733496	rs2509185761	NC_000017.11:35119159:A:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	May 25, 2023	criteria provided, single submitter							
NM_002878.4(RAD51D):c.94G>C (p.Val32Leu)	RAD51D|RAD51L3-RFFL	V32L	Hereditary cancer-predisposing syndrome	VCV003429749	17	33446180	17	35119161	3429749	3585760		NC_000017.11:35119160:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Oct 14, 2024	criteria provided, single submitter							
NM_002878.4(RAD51D):c.94G>A (p.Val32Ile)	RAD51D|RAD51L3-RFFL	V32I	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000231357	17	33446180	17	35119161	231357	235914	rs876659111	NC_000017.11:35119160:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Nov 4, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.93G>C (p.Leu31=)	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV001973207	17	33446181	17	35119162	1973207	2029773	rs779637010	NC_000017.11:35119161:C:G	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign/Likely benign	Feb 20, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.92T>C (p.Leu31Pro)	RAD51D|RAD51L3-RFFL	L31P	Hereditary cancer-predisposing syndrome	VCV001766497	17	33446182	17	35119163	1766497	1815074	rs2142477822	NC_000017.11:35119162:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Oct 26, 2023	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.91C>G (p.Leu31Val)	RAD51D|RAD51L3-RFFL	L31V	not specified	VCV003765078	17	33446183	17	35119164	3765078	3881247		NC_000017.11:35119163:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Mar 4, 2025	criteria provided, single submitter							
NM_002878.4(RAD51D):c.91C>T (p.Leu31=)	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV002877691	17	33446183	17	35119164	2877691	3038863	rs2142477835	NC_000017.11:35119163:G:A	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	May 23, 2023	criteria provided, single submitter							
NM_002878.4(RAD51D):c.90C>T (p.Asp30=)	RAD51L3-RFFL|RAD51D		Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome|not specified|not provided	VCV000492455	17	33446184	17	35119165	492455	484983	rs374725981	NC_000017.11:35119164:G:A	single nucleotide variant	synonymous variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Feb 20, 2025	criteria provided, conflicting classifications							
NM_002878.4(RAD51D):c.89A>G (p.Asp30Gly)	RAD51D|RAD51L3-RFFL	D30G	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000490147	17	33446185	17	35119166	490147	483003	rs1555570421	NC_000017.11:35119165:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jan 2, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.88G>A (p.Asp30Asn)	RAD51D|RAD51L3-RFFL	D30N	Hereditary cancer-predisposing syndrome	VCV001765047	17	33446186	17	35119167	1765047	1824541	rs2142477868	NC_000017.11:35119166:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Aug 4, 2021	criteria provided, single submitter							
NM_002878.4(RAD51D):c.88G>C (p.Asp30His)	RAD51D|RAD51L3-RFFL	D30H	Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV001063122	17	33446186	17	35119167	1063122	1050206	rs2142477868	NC_000017.11:35119166:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jul 28, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.86T>C (p.Val29Ala)	RAD51L3-RFFL|RAD51D	V29A	Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	VCV000584942	17	33446188	17	35119169	584942	575991	rs1567735899	NC_000017.11:35119168:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Mar 27, 2024	criteria provided, conflicting classifications							
NM_002878.4(RAD51D):c.85G>T (p.Val29Leu)	RAD51D|RAD51L3-RFFL	V29L	Breast-ovarian cancer, familial, susceptibility to, 4	VCV001470658	17	33446189	17	35119170	1470658	1394885	rs1555570422	NC_000017.11:35119169:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Feb 20, 2024	criteria provided, single submitter							
NM_002878.4(RAD51D):c.85G>A (p.Val29Met)	RAD51D|RAD51L3-RFFL	V29M	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000492453	17	33446189	17	35119170	492453	485016	rs1555570422	NC_000017.11:35119169:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Sep 20, 2023	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.84G>A (p.Val28=)	RAD51D|RAD51L3-RFFL		Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000822517	17	33446190	17	35119171	822517	813589	rs757325572	NC_000017.11:35119170:C:T	single nucleotide variant	synonymous variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Feb 20, 2025	criteria provided, conflicting classifications							
NM_002878.4(RAD51D):c.83-1G>A	RAD51D|RAD51L3-RFFL		Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4|not provided	VCV000936162	17	33446192	17	35119173	936162	940408	rs2091789413	NC_000017.11:35119172:C:T	single nucleotide variant	splice acceptor variant	Pathogenic/Likely pathogenic	Dec 22, 2023	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.83-2A>G	RAD51D|RAD51L3-RFFL		Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000835734	17	33446193	17	35119174	835734	851715	rs2091789428	NC_000017.11:35119173:T:C	single nucleotide variant	splice acceptor variant	Conflicting classifications of pathogenicity	Jul 19, 2023	criteria provided, conflicting classifications							
NM_002878.4(RAD51D):c.83-3C>G	RAD51D|RAD51L3-RFFL		Hereditary breast ovarian cancer syndrome	VCV000584943	17	33446194	17	35119175	584943	575992	rs1555570424	NC_000017.11:35119174:G:C	single nucleotide variant	intron variant	Uncertain significance	Jul 2, 2018	criteria provided, single submitter							
NM_002878.4(RAD51D):c.83-3C>T	RAD51D|RAD51L3-RFFL		Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000472624	17	33446194	17	35119175	472624	467978	rs1555570424	NC_000017.11:35119174:G:A	single nucleotide variant	intron variant	Uncertain significance	Aug 31, 2021	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.83-4T>G	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV002839088	17	33446195	17	35119176	2839088	2996359	rs1567735916	NC_000017.11:35119175:A:C	single nucleotide variant	intron variant	Likely benign	Feb 20, 2023	criteria provided, single submitter							
NM_002878.4(RAD51D):c.83-4T>C	RAD51D|RAD51L3-RFFL		Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000631020	17	33446195	17	35119176	631020	619589	rs1567735916	NC_000017.11:35119175:A:G	single nucleotide variant	intron variant	Likely benign	Feb 20, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.83-4T>A	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV000584944	17	33446195	17	35119176	584944	575993	rs1567735916	NC_000017.11:35119175:A:T	single nucleotide variant	intron variant	Uncertain significance	May 28, 2019	criteria provided, single submitter							
NM_002878.4(RAD51D):c.83-5T>G	RAD51D|RAD51L3-RFFL		Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000630001	17	33446196	17	35119177	630001	619590	rs1567735928	NC_000017.11:35119176:A:C	single nucleotide variant	intron variant	Uncertain significance	Sep 16, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.83-6T>C	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV003652623	17	33446197	17	35119178	3652623	3782059		NC_000017.11:35119177:A:G	single nucleotide variant	intron variant	Uncertain significance	May 8, 2024	criteria provided, single submitter							
NM_002878.4(RAD51D):c.83-8G>A	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV001629554	17	33446199	17	35119180	1629554	1532337	rs1567735932	NC_000017.11:35119179:C:T	single nucleotide variant	intron variant	Likely benign	Feb 20, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.83-8G>C	RAD51D|RAD51L3-RFFL		Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000628737	17	33446199	17	35119180	628737	619679	rs1567735932	NC_000017.11:35119179:C:G	single nucleotide variant	intron variant	Likely benign	Feb 20, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.83-11T>C	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV001644027	17	33446202	17	35119183	1644027	1651765	rs2142478047	NC_000017.11:35119182:A:G	single nucleotide variant	intron variant	Likely benign	Feb 20, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.83-13G>A	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV002003183	17	33446204	17	35119185	2003183	2055103	rs2142478052	NC_000017.11:35119184:C:T	single nucleotide variant	intron variant	Likely benign	Jun 8, 2022	criteria provided, single submitter							
NM_002878.4(RAD51D):c.83-15G>A	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV001596450	17	33446206	17	35119187	1596450	1633533	rs778766755	NC_000017.11:35119186:C:T	single nucleotide variant	intron variant	Likely benign	Feb 20, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.83-15G>C	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV000927773	17	33446206	17	35119187	927773	916434	rs778766755	NC_000017.11:35119186:C:G	single nucleotide variant	intron variant	Likely benign	Feb 20, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.83-16C>T	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV003013722	17	33446207	17	35119188	3013722	3174014	rs747782458	NC_000017.11:35119187:G:A	single nucleotide variant	intron variant	Likely benign	Feb 20, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.83-18T>C	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV001660798	17	33446209	17	35119190	1660798	1641900	rs772607779	NC_000017.11:35119189:A:G	single nucleotide variant	intron variant	Likely benign	Feb 20, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.83-18T>G	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV001446200	17	33446209	17	35119190	1446200	1391028	rs772607779	NC_000017.11:35119189:A:C	single nucleotide variant	intron variant	Likely benign	Nov 27, 2023	criteria provided, single submitter							
NM_002878.4(RAD51D):c.83-19A>T	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV003718031	17	33446210	17	35119191	3718031	3849145		NC_000017.11:35119190:T:A	single nucleotide variant	intron variant	Likely benign	Jan 20, 2025	criteria provided, single submitter							
NM_002878.4(RAD51D):c.83-19A>C	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV001572557	17	33446210	17	35119191	1572557	1658176	rs1057523591	NC_000017.11:35119190:T:G	single nucleotide variant	intron variant	Likely benign	Feb 20, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.83-19A>G	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4|not specified	VCV000389936	17	33446210	17	35119191	389936	375998	rs1057523591	NC_000017.11:35119190:T:C	single nucleotide variant	intron variant	Likely benign	Feb 20, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.83-20T>C	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV000492449	17	33446211	17	35119192	492449	485021	rs182793287	NC_000017.11:35119191:A:G	single nucleotide variant	intron variant	Benign/Likely benign	Feb 20, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.83-26A>G	RAD51D|RAD51L3-RFFL		Hereditary cancer-predisposing syndrome	VCV000492450	17	33446217	17	35119198	492450	484802	rs202048781	NC_000017.11:35119197:T:C	single nucleotide variant	intron variant	Likely benign	Feb 10, 2017	criteria provided, single submitter							
NM_002878.4(RAD51D):c.83-37C>A	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV000803386	17	33446228	17	35119209	803386	791739	rs763129236	NC_000017.11:35119208:G:T	single nucleotide variant	intron variant	Likely benign	May 28, 2019	criteria provided, single submitter							
NM_002878.4(RAD51D):c.83-45G>T	RAD51D|RAD51L3-RFFL		not specified	VCV003256344	17	33446236	17	35119217	3256344	3415106		NC_000017.11:35119216:C:A	single nucleotide variant	intron variant	Likely benign	Mar 4, 2025	criteria provided, single submitter							
NM_002878.4(RAD51D):c.82+128C>T	RAD51L3-RFFL|RAD51D		not provided	VCV000676535	17	33446423	17	35119404	676535	668956	rs28363258	NC_000017.11:35119403:G:A	single nucleotide variant	intron variant	Likely benign	Jun 16, 2018	criteria provided, single submitter							
NM_002878.4(RAD51D):c.82+32G>A	RAD51L3-RFFL|RAD51D		not specified	VCV001697597	17	33446519	17	35119500	1697597	1689981	rs368396213	NC_000017.11:35119499:C:T	single nucleotide variant	intron variant	Likely benign	Mar 4, 2025	criteria provided, single submitter							
NM_002878.4(RAD51D):c.82+19G>A	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV003708072	17	33446532	17	35119513	3708072	3840231		NC_000017.11:35119512:C:T	single nucleotide variant	intron variant	Likely benign	Apr 30, 2024	criteria provided, single submitter							
NM_002878.4(RAD51D):c.82+17G>A	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV002099860	17	33446534	17	35119515	2099860	2147418	rs1482129900	NC_000017.11:35119514:C:T	single nucleotide variant	intron variant	Likely benign	Feb 20, 2022	criteria provided, single submitter							
NM_002878.4(RAD51D):c.82+16C>T	RAD51D|RAD51L3-RFFL		Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000492446	17	33446535	17	35119516	492446	485230	rs1555570476	NC_000017.11:35119515:G:A	single nucleotide variant	intron variant	Likely benign	Dec 19, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.82+15G>C	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV001573535	17	33446536	17	35119517	1573535	1637250	rs778216370	NC_000017.11:35119516:C:G	single nucleotide variant	intron variant	Likely benign	Aug 7, 2024	criteria provided, single submitter							
NM_002878.4(RAD51D):c.82+15G>A	RAD51D|RAD51L3-RFFL		Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000630042	17	33446536	17	35119517	630042	619684	rs778216370	NC_000017.11:35119516:C:T	single nucleotide variant	intron variant	Likely benign	Nov 24, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.82+14C>T	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV003663984	17	33446537	17	35119518	3663984	3795143		NC_000017.11:35119517:G:A	single nucleotide variant	intron variant	Uncertain significance	Aug 29, 2024	criteria provided, single submitter							
NM_002878.4(RAD51D):c.82+14C>A	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV003650740	17	33446537	17	35119518	3650740	3781470		NC_000017.11:35119517:G:T	single nucleotide variant	intron variant	Likely benign	Apr 24, 2024	criteria provided, single submitter							
NM_002878.4(RAD51D):c.82+11G>A	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV000927038	17	33446540	17	35119521	927038	916437	rs2091796813	NC_000017.11:35119520:C:T	single nucleotide variant	intron variant	Uncertain significance	Apr 24, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.82+10T>A	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV001132490	17	33446541	17	35119522	1132490	1126151	rs1185845666	NC_000017.11:35119521:A:T	single nucleotide variant	intron variant	Likely benign	Feb 20, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.82+9G>A	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV000492448	17	33446542	17	35119523	492448	485235	rs747267285	NC_000017.11:35119522:C:T	single nucleotide variant	intron variant	Likely benign	Feb 20, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.82+8G>C	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV003663681	17	33446543	17	35119524	3663681	3798272		NC_000017.11:35119523:C:G	single nucleotide variant	intron variant	Likely benign	Oct 31, 2024	criteria provided, single submitter							
NM_002878.4(RAD51D):c.82+8G>A	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV002105816	17	33446543	17	35119524	2105816	2166277	rs2142479976	NC_000017.11:35119523:C:T	single nucleotide variant	intron variant	Likely benign	Feb 20, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.82+8G>T	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV001441593	17	33446543	17	35119524	1441593	1381670	rs2142479976	NC_000017.11:35119523:C:A	single nucleotide variant	intron variant	Likely benign	Feb 20, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.82+7G>A	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV003019616	17	33446544	17	35119525	3019616	3172124	rs1567736277	NC_000017.11:35119524:C:T	single nucleotide variant	intron variant	Uncertain significance	Jul 31, 2023	criteria provided, single submitter							
NM_002878.4(RAD51D):c.82+7G>C	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV002008949	17	33446544	17	35119525	2008949	2063022	rs1567736277	NC_000017.11:35119524:C:G	single nucleotide variant	intron variant	Likely benign	Feb 20, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.82+7G>T	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV001541795	17	33446544	17	35119525	1541795	1631678	rs1567736277	NC_000017.11:35119524:C:A	single nucleotide variant	intron variant	Likely benign	Feb 20, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.82+6C>T	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV002123102	17	33446545	17	35119526	2123102	2180996	rs2142479994	NC_000017.11:35119525:G:A	single nucleotide variant	intron variant	Uncertain significance	Apr 8, 2022	criteria provided, single submitter							
NM_002878.4(RAD51D):c.82+5C>G	RAD51L3-RFFL|RAD51D		Breast-ovarian cancer, familial, susceptibility to, 4	VCV003903672	17	33446546	17	35119527	3903672	4019545		NC_000017.11:35119526:G:C	single nucleotide variant	intron variant	Likely benign	Feb 20, 2025	criteria provided, single submitter							
NM_002878.4(RAD51D):c.82+5C>T	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV001497770	17	33446546	17	35119527	1497770	1376290	rs1308175462	NC_000017.11:35119526:G:A	single nucleotide variant	intron variant	Likely benign	Aug 28, 2024	criteria provided, single submitter							
NM_002878.4(RAD51D):c.82+4A>T	RAD51D|RAD51L3-RFFL		Hereditary cancer-predisposing syndrome	VCV003312406	17	33446547	17	35119528	3312406	3461948		NC_000017.11:35119527:T:A	single nucleotide variant	intron variant	Uncertain significance	May 15, 2024	criteria provided, single submitter							
NM_002878.4(RAD51D):c.82+3G>A	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV001762444	17	33446548	17	35119529	1762444	1816843	rs2142480043	NC_000017.11:35119528:C:T	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Feb 20, 2025	criteria provided, conflicting classifications							
NM_002878.4(RAD51D):c.82+2T>G	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV000827501	17	33446549	17	35119530	827501	815681	rs1597878498	NC_000017.11:35119529:A:C	single nucleotide variant	splice donor variant	Likely pathogenic	Mar 24, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.82+1G>C	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV003148245	17	33446550	17	35119531	3148245	3307493	rs786202788	NC_000017.11:35119530:C:G	single nucleotide variant	splice donor variant	Likely pathogenic	Sep 10, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.82+1G>T	RAD51L3-RFFL|RAD51D		Hereditary cancer-predisposing syndrome	VCV000492447	17	33446550	17	35119531	492447	484811	rs786202788	NC_000017.11:35119530:C:A	single nucleotide variant	splice donor variant	Likely pathogenic	Apr 3, 2019	criteria provided, single submitter							
NM_002878.4(RAD51D):c.82+1G>A	RAD51L3-RFFL|RAD51D		Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000186222	17	33446550	17	35119531	186222	184856	rs786202788	NC_000017.11:35119530:C:T	single nucleotide variant	splice donor variant	Likely pathogenic	Jan 3, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.82G>C (p.Val28Leu)	RAD51D|RAD51L3-RFFL	V28L	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV001762829	17	33446551	17	35119532	1762829	1813922	rs2142480064	NC_000017.11:35119531:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Nov 6, 2023	criteria provided, conflicting classifications							
NM_002878.4(RAD51D):c.82G>A (p.Val28Met)	RAD51D|RAD51L3-RFFL	V28M	Hereditary cancer-predisposing syndrome	VCV001762824	17	33446551	17	35119532	1762824	1813917	rs2142480064	NC_000017.11:35119531:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jul 29, 2020	criteria provided, single submitter							
NM_002878.4(RAD51D):c.81A>G (p.Thr27=)	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV001057281	17	33446552	17	35119533	1057281	1050207	rs2142480084	NC_000017.11:35119532:T:C	single nucleotide variant	synonymous variant|non-coding transcript variant	Uncertain significance	Sep 26, 2024	criteria provided, single submitter							
NM_002878.4(RAD51D):c.80C>T (p.Thr27Ile)	RAD51D|RAD51L3-RFFL	T27I	Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|not provided	VCV000480524	17	33446553	17	35119534	480524	479205	rs139642328	NC_000017.11:35119533:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Apr 18, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.80C>A (p.Thr27Lys)	RAD51D|RAD51L3-RFFL	T27K	not provided|Breast-ovarian cancer, familial, susceptibility to, 4|not specified|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000410557	17	33446553	17	35119534	410557	402606	rs139642328	NC_000017.11:35119533:G:T	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Jun 12, 2025	criteria provided, conflicting classifications							
NM_002878.4(RAD51D):c.79A>G (p.Thr27Ala)	RAD51D|RAD51L3-RFFL	T27A	Hereditary cancer-predisposing syndrome	VCV003774476	17	33446554	17	35119535	3774476	3890620		NC_000017.11:35119534:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Oct 30, 2024	criteria provided, single submitter							
NM_002878.4(RAD51D):c.79A>T (p.Thr27Ser)	RAD51D|RAD51L3-RFFL	T27S	Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV001761562	17	33446554	17	35119535	1761562	1813869	rs2142480115	NC_000017.11:35119534:T:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Sep 13, 2023	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.78G>C (p.Lys26Asn)	RAD51D|RAD51L3-RFFL	K26N	Breast-ovarian cancer, familial, susceptibility to, 4	VCV001993500	17	33446555	17	35119536	1993500	2049287	rs2142480132	NC_000017.11:35119535:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jan 20, 2023	criteria provided, single submitter							
NM_002878.4(RAD51D):c.78G>A (p.Lys26=)	RAD51D|RAD51L3-RFFL		Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV001761122	17	33446555	17	35119536	1761122	1816737	rs2142480132	NC_000017.11:35119535:C:T	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign/Likely benign	Feb 20, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.77A>G (p.Lys26Arg)	RAD51D|RAD51L3-RFFL	K26R	Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome|not provided	VCV000410565	17	33446556	17	35119537	410565	402422	rs1060502961	NC_000017.11:35119536:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Mar 6, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.75C>T (p.Ile25=)	RAD51D|RAD51L3-RFFL		Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4|not provided	VCV000472622	17	33446558	17	35119539	472622	467644	rs1555570482	NC_000017.11:35119538:G:A	single nucleotide variant	synonymous variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Feb 20, 2025	criteria provided, conflicting classifications							
NM_002878.4(RAD51D):c.74T>C (p.Ile25Thr)	RAD51D|RAD51L3-RFFL	I25T	Hereditary cancer-predisposing syndrome	VCV003222889	17	33446559	17	35119540	3222889	3386527	rs2091797279	NC_000017.11:35119539:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Nov 28, 2023	criteria provided, single submitter							
NM_002878.4(RAD51D):c.74T>A (p.Ile25Asn)	RAD51D|RAD51L3-RFFL	I25N	Hereditary cancer-predisposing syndrome	VCV000926315	17	33446559	17	35119540	926315	913848	rs2091797279	NC_000017.11:35119539:A:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Mar 6, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.73A>G (p.Ile25Val)	RAD51D|RAD51L3-RFFL	I25V	Breast-ovarian cancer, familial, susceptibility to, 4	VCV001475970	17	33446560	17	35119541	1475970	1423689	rs1597878522	NC_000017.11:35119540:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Nov 17, 2020	criteria provided, single submitter							
NM_002878.4(RAD51D):c.73A>C (p.Ile25Leu)	RAD51D|RAD51L3-RFFL	I25L	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000827019	17	33446560	17	35119541	827019	813590	rs1597878522	NC_000017.11:35119540:T:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Dec 3, 2020	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.72G>A (p.Arg24=)	RAD51D|RAD51L3-RFFL		Hereditary cancer-predisposing syndrome	VCV001758194	17	33446561	17	35119542	1758194	1822711	rs28363257	NC_000017.11:35119541:C:T	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Feb 7, 2021	criteria provided, single submitter							
NM_002878.4(RAD51D):c.72G>T (p.Arg24Ser)	RAD51D|RAD51L3-RFFL	R24S	Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV000239401	17	33446561	17	35119542	239401	242732	rs28363257	NC_000017.11:35119541:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Sep 8, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.71G>C (p.Arg24Thr)	RAD51D|RAD51L3-RFFL	R24T	Breast-ovarian cancer, familial, susceptibility to, 4	VCV002810871	17	33446562	17	35119543	2810871	2975385	rs947444435	NC_000017.11:35119542:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Oct 30, 2022	criteria provided, single submitter							
NM_002878.4(RAD51D):c.71G>A (p.Arg24Lys)	RAD51L3-RFFL|RAD51D	R24K	Hereditary cancer-predisposing syndrome|not provided|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000630484	17	33446562	17	35119543	630484	618545	rs947444435	NC_000017.11:35119542:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Jun 4, 2024	criteria provided, conflicting classifications							
NM_002878.4(RAD51D):c.70A>T (p.Arg24Trp)	RAD51D|RAD51L3-RFFL	R24W	Breast-ovarian cancer, familial, susceptibility to, 4	VCV000539855	17	33446563	17	35119544	539855	531168	rs781611267	NC_000017.11:35119543:T:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Aug 2, 2023	criteria provided, single submitter							
NM_002878.4(RAD51D):c.70A>G (p.Arg24Gly)	RAD51D|RAD51L3-RFFL	R24G	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000539853	17	33446563	17	35119544	539853	531460	rs781611267	NC_000017.11:35119543:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Jul 16, 2023	criteria provided, conflicting classifications							
NM_002878.4(RAD51D):c.69C>G (p.His23Gln)	RAD51D|RAD51L3-RFFL	H23Q	Breast-ovarian cancer, familial, susceptibility to, 4	VCV001472473	17	33446564	17	35119545	1472473	1397855	rs1597878540	NC_000017.11:35119544:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jun 23, 2023	criteria provided, single submitter							
NM_002878.4(RAD51D):c.69C>T (p.His23=)	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV000826759	17	33446564	17	35119545	826759	813591	rs1597878540	NC_000017.11:35119544:G:A	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign/Likely benign	Feb 20, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.68A>G (p.His23Arg)	RAD51D|RAD51L3-RFFL	H23R	Hereditary cancer-predisposing syndrome|not provided|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000418673	17	33446565	17	35119546	418673	409908	rs990062370	NC_000017.11:35119545:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Feb 3, 2024	criteria provided, conflicting classifications							
NM_002878.4(RAD51D):c.66C>G (p.Ser22Arg)	RAD51L3-RFFL|RAD51D	S22R	not provided	VCV000993235	17	33446567	17	35119548	993235	981156	rs876660902	NC_000017.11:35119547:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Nov 12, 2019	criteria provided, single submitter							
NM_002878.4(RAD51D):c.66C>T (p.Ser22=)	RAD51D|RAD51L3-RFFL		Hereditary cancer-predisposing syndrome|not provided|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000234177	17	33446567	17	35119548	234177	235915	rs876660902	NC_000017.11:35119547:G:A	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign/Likely benign	Feb 20, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.65G>A (p.Ser22Asn)	RAD51D|RAD51L3-RFFL	S22N	Breast-ovarian cancer, familial, susceptibility to, 4	VCV001469202	17	33446568	17	35119549	1469202	1370311	rs2142480287	NC_000017.11:35119548:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Feb 28, 2022	criteria provided, single submitter							
NM_002878.4(RAD51D):c.64A>G (p.Ser22Gly)	RAD51D|RAD51L3-RFFL	S22G	Breast-ovarian cancer, familial, susceptibility to, 4	VCV003657233	17	33446569	17	35119550	3657233	3793512		NC_000017.11:35119549:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jun 21, 2024	criteria provided, single submitter							
NM_002878.4(RAD51D):c.63G>A (p.Arg21=)	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV003904033	17	33446570	17	35119551	3904033	4019906		NC_000017.11:35119550:C:T	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign	Feb 20, 2025	criteria provided, single submitter							
NM_002878.4(RAD51D):c.62G>T (p.Arg21Met)	RAD51D|RAD51L3-RFFL	R21M	Breast-ovarian cancer, familial, susceptibility to, 4	VCV000946247	17	33446571	17	35119552	946247	928232	rs2091797738	NC_000017.11:35119551:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jun 27, 2019	criteria provided, single submitter							
NM_002878.4(RAD51D):c.61A>C (p.Arg21=)	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV003903491	17	33446572	17	35119553	3903491	4019364		NC_000017.11:35119552:T:G	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign	Feb 20, 2025	criteria provided, single submitter							
NM_002878.4(RAD51D):c.60C>T (p.Leu20=)	RAD51D|RAD51L3-RFFL		Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000760939	17	33446573	17	35119554	760939	771436	rs1597878552	NC_000017.11:35119553:G:A	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Jan 10, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.59T>G (p.Leu20Arg)	RAD51D|RAD51L3-RFFL	L20R	Breast-ovarian cancer, familial, susceptibility to, 4	VCV000472613	17	33446574	17	35119555	472613	466765	rs1555570486	NC_000017.11:35119554:A:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Mar 18, 2023	criteria provided, single submitter							
NM_002878.4(RAD51D):c.58C>G (p.Leu20Val)	RAD51D|RAD51L3-RFFL	L20V	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV003652178	17	33446575	17	35119556	3652178	3785458		NC_000017.11:35119555:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Mar 5, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.58C>T (p.Leu20Phe)	RAD51L3-RFFL|RAD51D	L20F	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000490144	17	33446575	17	35119556	490144	482981	rs1555570487	NC_000017.11:35119555:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Dec 5, 2023	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.57T>A (p.Leu19=)	RAD51L3-RFFL|RAD51D		Breast-ovarian cancer, familial, susceptibility to, 4	VCV002764130	17	33446576	17	35119557	2764130	2922299	rs2142480362	NC_000017.11:35119556:A:T	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Sep 29, 2023	criteria provided, single submitter							
NM_002878.4(RAD51D):c.56T>C (p.Leu19Pro)	RAD51D|RAD51L3-RFFL	L19P	Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	VCV000482186	17	33446577	17	35119558	482186	479207	rs1044486334	NC_000017.11:35119557:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jan 29, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.55C>T (p.Leu19Phe)	RAD51D|RAD51L3-RFFL	L19F	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000923860	17	33446578	17	35119559	923860	913849	rs2091797904	NC_000017.11:35119558:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Dec 4, 2023	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.54G>A (p.Gln18=)	RAD51D|RAD51L3-RFFL		Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV002028942	17	33446579	17	35119560	2028942	2081736	rs1331918329	NC_000017.11:35119559:C:T	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign/Likely benign	Feb 20, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.54G>C (p.Gln18His)	RAD51D|RAD51L3-RFFL	Q18H	Hereditary cancer-predisposing syndrome	VCV001747960	17	33446579	17	35119560	1747960	1810149	rs1331918329	NC_000017.11:35119559:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Sep 1, 2022	criteria provided, single submitter							
NM_002878.4(RAD51D):c.54G>T (p.Gln18His)	RAD51D|RAD51L3-RFFL	Q18H	Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV000539862	17	33446579	17	35119560	539862	531171	rs1331918329	NC_000017.11:35119559:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Dec 18, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.53A>G (p.Gln18Arg)	RAD51D|RAD51L3-RFFL	Q18R	Breast-ovarian cancer, familial, susceptibility to, 4|not specified|not provided|Hereditary cancer-predisposing syndrome	VCV000232535	17	33446580	17	35119561	232535	235916	rs546225564	NC_000017.11:35119560:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Sep 4, 2024	criteria provided, conflicting classifications							
NM_002878.4(RAD51D):c.52C>T (p.Gln18Ter)	RAD51D|RAD51L3-RFFL	Q18*	Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV003148120	17	33446581	17	35119562	3148120	3307368	rs2509188925	NC_000017.11:35119561:G:A	single nucleotide variant	nonsense|non-coding transcript variant	Pathogenic/Likely pathogenic	Mar 18, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.51C>G (p.Ile17Met)	RAD51D|RAD51L3-RFFL	I17M	Breast-ovarian cancer, familial, susceptibility to, 4	VCV002807465	17	33446582	17	35119563	2807465	2974537	rs769903986	NC_000017.11:35119562:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Aug 5, 2023	criteria provided, single submitter							
NM_002878.4(RAD51D):c.51C>T (p.Ile17=)	RAD51D|RAD51L3-RFFL		Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000232563	17	33446582	17	35119563	232563	235917	rs769903986	NC_000017.11:35119562:G:A	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign/Likely benign	Feb 20, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.50T>C (p.Ile17Thr)	RAD51D|RAD51L3-RFFL	I17T	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV001745347	17	33446583	17	35119564	1745347	1802400	rs1464129449	NC_000017.11:35119563:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Aug 17, 2022	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.49A>G (p.Ile17Val)	RAD51D|RAD51L3-RFFL	I17V	not specified|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4|not provided	VCV000659719	17	33446584	17	35119565	659719	645822	rs1002032036	NC_000017.11:35119564:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Oct 9, 2024	criteria provided, conflicting classifications							
NM_002878.4(RAD51D):c.48G>T (p.Met16Ile)	RAD51D|RAD51L3-RFFL	M16I	Breast-ovarian cancer, familial, susceptibility to, 4	VCV002671655	17	33446585	17	35119566	2671655	2839182	rs2142480482	NC_000017.11:35119565:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Feb 14, 2023	criteria provided, single submitter							
NM_002878.4(RAD51D):c.47T>C (p.Met16Thr)	RAD51L3-RFFL|RAD51D	M16T	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000208767	17	33446586	17	35119567	208767	205302	rs797044943	NC_000017.11:35119566:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Aug 14, 2024	criteria provided, conflicting classifications							
NM_002878.4(RAD51D):c.46A>C (p.Met16Leu)	RAD51D|RAD51L3-RFFL	M16L	Breast-ovarian cancer, familial, susceptibility to, 4	VCV002802716	17	33446587	17	35119568	2802716	2970238	rs2142480504	NC_000017.11:35119567:T:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Aug 16, 2022	criteria provided, single submitter							
NM_002878.4(RAD51D):c.46A>T (p.Met16Leu)	RAD51D|RAD51L3-RFFL	M16L	Breast-ovarian cancer, familial, susceptibility to, 4	VCV001513561	17	33446587	17	35119568	1513561	1468750	rs2142480504	NC_000017.11:35119567:T:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	May 21, 2023	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.46A>G (p.Met16Val)	RAD51D|RAD51L3-RFFL	M16V	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV001356302	17	33446587	17	35119568	1356302	1447051	rs2142480504	NC_000017.11:35119567:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Feb 1, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.45G>A (p.Glu15=)	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV002705989	17	33446588	17	35119569	2705989	2877314	rs2142480518	NC_000017.11:35119568:C:T	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Dec 28, 2023	criteria provided, single submitter							
NM_002878.4(RAD51D):c.44A>T (p.Glu15Val)	RAD51L3-RFFL|RAD51D	E15V	Breast-ovarian cancer, familial, susceptibility to, 4	VCV000660936	17	33446589	17	35119570	660936	645823	rs1567736383	NC_000017.11:35119569:T:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Sep 26, 2018	criteria provided, single submitter							
NM_002878.4(RAD51D):c.43G>T (p.Glu15Ter)	RAD51D|RAD51L3-RFFL	E15*	Breast-ovarian cancer, familial, susceptibility to, 4	VCV003148050	17	33446590	17	35119571	3148050	3307298	rs775510420	NC_000017.11:35119570:C:A	single nucleotide variant	nonsense|non-coding transcript variant	Pathogenic	Jan 3, 2024	criteria provided, single submitter							
NM_002878.4(RAD51D):c.43G>A (p.Glu15Lys)	RAD51D|RAD51L3-RFFL	E15K	Hereditary cancer-predisposing syndrome	VCV000824866	17	33446590	17	35119571	824866	813592	rs775510420	NC_000017.11:35119570:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Sep 26, 2018	criteria provided, single submitter							
NM_002878.4(RAD51D):c.42G>A (p.Glu14=)	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV002842029	17	33446591	17	35119572	2842029	3000566	rs2142480559	NC_000017.11:35119571:C:T	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Mar 2, 2023	criteria provided, single submitter							
NM_002878.4(RAD51D):c.41A>T (p.Glu14Val)	RAD51D|RAD51L3-RFFL	E14V	Breast-ovarian cancer, familial, susceptibility to, 4	VCV002767124	17	33446592	17	35119573	2767124	2926568	rs2142480572	NC_000017.11:35119572:T:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Oct 9, 2023	criteria provided, single submitter							
NM_002878.4(RAD51D):c.40G>C (p.Glu14Gln)	RAD51D|RAD51L3-RFFL	E14Q	Breast-ovarian cancer, familial, susceptibility to, 4	VCV002859721	17	33446593	17	35119574	2859721	3018481	rs562456790	NC_000017.11:35119573:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Apr 27, 2023	criteria provided, single submitter							
NM_002878.4(RAD51D):c.40G>A (p.Glu14Lys)	RAD51L3-RFFL|RAD51D	E14K	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000490139	17	33446593	17	35119574	490139	482978	rs562456790	NC_000017.11:35119573:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jan 23, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.39C>A (p.Thr13=)	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV002120372	17	33446594	17	35119575	2120372	2173092	rs146448657	NC_000017.11:35119574:G:T	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Apr 21, 2022	criteria provided, single submitter							
NM_002878.4(RAD51D):c.39C>T (p.Thr13=)	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV000480533	17	33446594	17	35119575	480533	478506	rs146448657	NC_000017.11:35119574:G:A	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign/Likely benign	Feb 20, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.39C>G (p.Thr13=)	RAD51D|RAD51L3-RFFL		Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4|not provided	VCV000184815	17	33446594	17	35119575	184815	184857	rs146448657	NC_000017.11:35119574:G:C	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign/Likely benign	Feb 20, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.38C>G (p.Thr13Ser)	RAD51D|RAD51L3-RFFL	T13S	Breast-ovarian cancer, familial, susceptibility to, 4	VCV000944880	17	33446595	17	35119576	944880	928233	rs1064795830	NC_000017.11:35119575:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Sep 2, 2024	criteria provided, single submitter							
NM_002878.4(RAD51D):c.38C>A (p.Thr13Asn)	RAD51D|RAD51L3-RFFL	T13N	Breast-ovarian cancer, familial, susceptibility to, 4	VCV000837248	17	33446595	17	35119576	837248	845232	rs1064795830	NC_000017.11:35119575:G:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Dec 27, 2019	criteria provided, single submitter							
NM_002878.4(RAD51D):c.38C>T (p.Thr13Ile)	RAD51D|RAD51L3-RFFL	T13I	not provided|Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV000422517	17	33446595	17	35119576	422517	409909	rs1064795830	NC_000017.11:35119575:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Nov 27, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.37A>G (p.Thr13Ala)	RAD51D|RAD51L3-RFFL	T13A	Hereditary cancer-predisposing syndrome	VCV001735032	17	33446596	17	35119577	1735032	1793371	rs2142480616	NC_000017.11:35119576:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	May 12, 2022	criteria provided, single submitter							
NM_002878.4(RAD51D):c.36T>C (p.Leu12=)	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV001660781	17	33446597	17	35119578	1660781	1641883	rs1256721417	NC_000017.11:35119577:A:G	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	May 20, 2021	criteria provided, single submitter							
NM_002878.4(RAD51D):c.36T>A (p.Leu12=)	RAD51D|RAD51L3-RFFL		Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV001171087	17	33446597	17	35119578	1171087	1161349	rs1256721417	NC_000017.11:35119577:A:T	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign/Likely benign	Feb 19, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.36T>G (p.Leu12=)	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV001129252	17	33446597	17	35119578	1129252	1126152	rs1256721417	NC_000017.11:35119577:A:C	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Jul 19, 2022	criteria provided, single submitter							
NM_002878.4(RAD51D):c.34C>T (p.Leu12Phe)	RAD51D|RAD51L3-RFFL	L12F	Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV000823855	17	33446599	17	35119580	823855	813593	rs773065220	NC_000017.11:35119579:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Sep 14, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.34C>G (p.Leu12Val)	RAD51D|RAD51L3-RFFL	L12V	not provided|Hereditary cancer-predisposing syndrome|not specified|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000472603	17	33446599	17	35119580	472603	467984	rs773065220	NC_000017.11:35119579:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Nov 21, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.33C>A (p.Gly11=)	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV003903804	17	33446600	17	35119581	3903804	4019677		NC_000017.11:35119580:G:T	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign	Feb 19, 2025	criteria provided, single submitter							
NM_002878.4(RAD51D):c.33C>T (p.Gly11=)	RAD51D|RAD51L3-RFFL		Hereditary cancer-predisposing syndrome|not specified|Breast-ovarian cancer, familial, susceptibility to, 4|not provided	VCV000231681	17	33446600	17	35119581	231681	235918	rs760444811	NC_000017.11:35119580:G:A	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign/Likely benign	Mar 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.32G>A (p.Gly11Asp)	RAD51D|RAD51L3-RFFL	G11D	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000857619	17	33446601	17	35119582	857619	845233	rs2091798661	NC_000017.11:35119581:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jul 16, 2023	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.31G>C (p.Gly11Arg)	RAD51D|RAD51L3-RFFL	G11R	Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV000484768	17	33446602	17	35119583	484768	479213	rs776471760	NC_000017.11:35119582:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Feb 25, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.31G>T (p.Gly11Cys)	RAD51D|RAD51L3-RFFL	G11C	Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV000480535	17	33446602	17	35119583	480535	478494	rs776471760	NC_000017.11:35119582:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Aug 13, 2023	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.30T>C (p.Pro10=)	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV003654854	17	33446603	17	35119584	3654854	3778949		NC_000017.11:35119583:A:G	single nucleotide variant	synonymous variant|non-coding transcript variant	Likely benign	Mar 28, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.29C>T (p.Pro10Leu)	RAD51L3-RFFL|RAD51D	P10L	Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4|not provided	VCV000472596	17	33446604	17	35119585	472596	467986	rs759505297	NC_000017.11:35119584:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Nov 23, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.28C>T (p.Pro10Ser)	RAD51D|RAD51L3-RFFL	P10S	Breast-ovarian cancer, familial, susceptibility to, 4|not provided|Hereditary cancer-predisposing syndrome	VCV000480536	17	33446605	17	35119586	480536	478513	rs1555570500	NC_000017.11:35119585:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Sep 14, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.27C>A (p.Cys9Ter)	RAD51D|RAD51L3-RFFL	C9*	Breast-ovarian cancer, familial, susceptibility to, 4	VCV000836489	17	33446606	17	35119587	836489	845234	rs200487648	NC_000017.11:35119586:G:T	single nucleotide variant	nonsense|non-coding transcript variant	Pathogenic	Nov 15, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.27C>T (p.Cys9=)	RAD51D|RAD51L3-RFFL		Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4|not provided	VCV000185973	17	33446606	17	35119587	185973	184858	rs200487648	NC_000017.11:35119586:G:A	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign/Likely benign	Feb 19, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.26G>A (p.Cys9Tyr)	RAD51D|RAD51L3-RFFL	C9Y	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4|Familial ovarian cancer	VCV000948086	17	33446607	17	35119588	948086	928234	rs140825795	NC_000017.11:35119587:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jan 7, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.26G>T (p.Cys9Phe)	RAD51D|RAD51L3-RFFL	C9F	Hereditary cancer-predisposing syndrome|not provided|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000472595	17	33446607	17	35119588	472595	467989	rs140825795	NC_000017.11:35119587:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jan 14, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.26G>C (p.Cys9Ser)	RAD51D|RAD51L3-RFFL	C9S	Breast and/or ovarian cancer|not provided|Hereditary cancer-predisposing syndrome|not specified|Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer	VCV000127886	17	33446607	17	35119588	127886	133343	rs140825795	NC_000017.11:35119587:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Mar 4, 2025	criteria provided, conflicting classifications							
NM_002878.4(RAD51D):c.24G>C (p.Leu8=)	RAD51D|RAD51L3-RFFL		Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV003429743	17	33446609	17	35119590	3429743	3585754		NC_000017.11:35119589:C:G	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign/Likely benign	Feb 19, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.23T>C (p.Leu8Pro)	RAD51D|RAD51L3-RFFL	L8P	Hereditary cancer-predisposing syndrome	VCV001790720	17	33446610	17	35119591	1790720	1841621	rs2142480837	NC_000017.11:35119590:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Sep 10, 2022	criteria provided, single submitter							
NM_002878.4(RAD51D):c.22C>A (p.Leu8Met)	RAD51D|RAD51L3-RFFL	L8M	Hereditary cancer-predisposing syndrome	VCV003942391	17	33446611	17	35119592	3942391	4064170		NC_000017.11:35119591:G:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	May 20, 2025	criteria provided, single submitter							
NM_002878.4(RAD51D):c.22C>T (p.Leu8=)	RAD51D|RAD51L3-RFFL		not provided|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4|not specified	VCV000416199	17	33446611	17	35119592	416199	402609	rs876659203	NC_000017.11:35119591:G:A	single nucleotide variant	synonymous variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Feb 19, 2025	criteria provided, conflicting classifications							
NM_002878.4(RAD51D):c.22C>G (p.Leu8Val)	RAD51D|RAD51L3-RFFL	L8V	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000231516	17	33446611	17	35119592	231516	235919	rs876659203	NC_000017.11:35119591:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Feb 19, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.21A>G (p.Gly7=)	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV002001559	17	33446612	17	35119593	2001559	2054760	rs2142480858	NC_000017.11:35119592:T:C	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign/Likely benign	Feb 20, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.20G>A (p.Gly7Glu)	RAD51D|RAD51L3-RFFL	G7E	not provided|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000472592	17	33446613	17	35119594	472592	467647	rs1555570504	NC_000017.11:35119593:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jul 24, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.19G>A (p.Gly7Arg)	RAD51D|RAD51L3-RFFL	G7R	Breast-ovarian cancer, familial, susceptibility to, 4	VCV002417510	17	33446614	17	35119595	2417510	1937578	rs1064795913	NC_000017.11:35119594:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Mar 28, 2022	criteria provided, single submitter							
NM_002878.4(RAD51D):c.19G>T (p.Gly7Ter)	RAD51D|RAD51L3-RFFL	G7*	Breast-ovarian cancer, familial, susceptibility to, 4	VCV000958257	17	33446614	17	35119595	958257	949887	rs1064795913	NC_000017.11:35119594:C:A	single nucleotide variant	nonsense|non-coding transcript variant	Pathogenic	Aug 8, 2019	criteria provided, single submitter							
NM_002878.4(RAD51D):c.19G>C (p.Gly7Arg)	RAD51D|RAD51L3-RFFL	G7R	Breast-ovarian cancer, familial, susceptibility to, 4|not provided	VCV000422649	17	33446614	17	35119595	422649	409910	rs1064795913	NC_000017.11:35119594:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Aug 16, 2022	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.18C>T (p.Val6=)	RAD51L3-RFFL|RAD51D		Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000820302	17	33446615	17	35119596	820302	813594	rs1200345768	NC_000017.11:35119595:G:A	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign/Likely benign	Feb 19, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.16G>C (p.Val6Leu)	RAD51D|RAD51L3-RFFL	V6L	Hereditary cancer-predisposing syndrome|not specified|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000928509	17	33446617	17	35119598	928509	917237	rs368198698	NC_000017.11:35119597:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Mar 18, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.16G>T (p.Val6Phe)	RAD51D|RAD51L3-RFFL	V6F	Hereditary cancer-predisposing syndrome	VCV000629010	17	33446617	17	35119598	629010	618546	rs368198698	NC_000017.11:35119597:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Dec 4, 2023	criteria provided, single submitter							
NM_002878.4(RAD51D):c.16G>A (p.Val6Ile)	RAD51L3-RFFL|RAD51D	V6I	Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV000186089	17	33446617	17	35119598	186089	184859	rs368198698	NC_000017.11:35119597:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Feb 26, 2024	criteria provided, conflicting classifications							
NM_002878.4(RAD51D):c.15G>T (p.Arg5Ser)	RAD51D|RAD51L3-RFFL	R5S	Breast-ovarian cancer, familial, susceptibility to, 4	VCV001511764	17	33446618	17	35119599	1511764	1459244	rs2142480932	NC_000017.11:35119598:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Oct 23, 2024	criteria provided, single submitter							
NM_002878.4(RAD51D):c.14G>C (p.Arg5Thr)	RAD51D|RAD51L3-RFFL	R5T	Hereditary cancer-predisposing syndrome	VCV003894518	17	33446619	17	35119600	3894518	4010398		NC_000017.11:35119599:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jul 26, 2024	criteria provided, single submitter							
NM_002878.4(RAD51D):c.14G>T (p.Arg5Met)	RAD51D|RAD51L3-RFFL	R5M	Breast-ovarian cancer, familial, susceptibility to, 4	VCV002847406	17	33446619	17	35119600	2847406	3012326	rs2091799333	NC_000017.11:35119599:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jun 3, 2024	criteria provided, single submitter							
NM_002878.4(RAD51D):c.14G>A (p.Arg5Lys)	RAD51L3-RFFL|RAD51D	R5K	not specified	VCV000917702	17	33446619	17	35119600	917702	906034	rs2091799333	NC_000017.11:35119599:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Feb 14, 2020	criteria provided, single submitter							
NM_002878.4(RAD51D):c.13A>G (p.Arg5Gly)	RAD51D|RAD51L3-RFFL	R5G	Hereditary cancer-predisposing syndrome	VCV002625304	17	33446620	17	35119601	2625304	2787287	rs876660779	NC_000017.11:35119600:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Sep 7, 2023	criteria provided, single submitter							
NM_002878.4(RAD51D):c.13A>C (p.Arg5=)	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV000819118	17	33446620	17	35119601	819118	813595	rs876660779	NC_000017.11:35119600:T:G	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign/Likely benign	Feb 19, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.13A>T (p.Arg5Trp)	RAD51D|RAD51L3-RFFL	R5W	Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV000233989	17	33446620	17	35119601	233989	235920	rs876660779	NC_000017.11:35119600:T:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Mar 24, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.12C>T (p.Leu4=)	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV000818846	17	33446621	17	35119602	818846	813596	rs786203193	NC_000017.11:35119601:G:A	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign/Likely benign	Feb 19, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.12C>G (p.Leu4=)	RAD51D|RAD51L3-RFFL		not provided|not specified|Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV000186752	17	33446621	17	35119602	186752	184860	rs786203193	NC_000017.11:35119601:G:C	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign/Likely benign	Feb 19, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.11T>C (p.Leu4Pro)	RAD51D|RAD51L3-RFFL	L4P	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV002849306	17	33446622	17	35119603	2849306	3009097	rs2142481000	NC_000017.11:35119602:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Nov 16, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.10C>G (p.Leu4Val)	RAD51D|RAD51L3-RFFL	L4V	Breast-ovarian cancer, familial, susceptibility to, 4	VCV000960004	17	33446623	17	35119604	960004	949888	rs1555570507	NC_000017.11:35119603:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Sep 29, 2019	criteria provided, single submitter							
NM_002878.4(RAD51D):c.10C>T (p.Leu4Phe)	RAD51D|RAD51L3-RFFL	L4F	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000492406	17	33446623	17	35119604	492406	484813	rs1555570507	NC_000017.11:35119603:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Dec 19, 2023	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.9G>A (p.Val3=)	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV003222897	17	33446624	17	35119605	3222897	3386535	rs2142481028	NC_000017.11:35119604:C:T	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign/Likely benign	Feb 19, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.7G>A (p.Val3Met)	RAD51D|RAD51L3-RFFL	V3M	not specified|Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV000231650	17	33446626	17	35119607	231650	235921	rs758124349	NC_000017.11:35119606:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Mar 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.6C>A (p.Gly2=)	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV000539865	17	33446627	17	35119608	539865	531100	rs1255954226	NC_000017.11:35119607:G:T	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign/Likely benign	Feb 19, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.6C>T (p.Gly2=)	RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome|not specified	VCV000512994	17	33446627	17	35119608	512994	506776	rs1255954226	NC_000017.11:35119607:G:A	single nucleotide variant	synonymous variant|non-coding transcript variant	Benign/Likely benign	Feb 19, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.5G>C (p.Gly2Ala)	RAD51L3-RFFL|RAD51D	G2A	not provided|Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV000480530	17	33446628	17	35119609	480530	478495	rs763716638	NC_000017.11:35119608:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Dec 15, 2024	criteria provided, conflicting classifications							
NM_002878.4(RAD51D):c.5G>A (p.Gly2Asp)	RAD51L3-RFFL|RAD51D	G2D	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000472614	17	33446628	17	35119609	472614	467991	rs763716638	NC_000017.11:35119608:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Jun 24, 2023	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.4G>T (p.Gly2Cys)	RAD51D|RAD51L3-RFFL	G2C	Breast-ovarian cancer, familial, susceptibility to, 4|not provided	VCV000421161	17	33446629	17	35119610	421161	409911	rs372082751	NC_000017.11:35119609:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	Feb 15, 2024	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.4G>A (p.Gly2Ser)	RAD51D|RAD51L3-RFFL	G2S	not provided|Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV000182866	17	33446629	17	35119610	182866	180809	rs372082751	NC_000017.11:35119609:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Uncertain significance	May 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.2T>C (p.Met1Thr)	RAD51D|RAD51L3-RFFL	M1T	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4|not provided	VCV000450694	17	33446631	17	35119612	450694	445755	rs1064794619	NC_000017.11:35119611:A:G	single nucleotide variant	missense variant|initiator_codon_variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Nov 22, 2023	criteria provided, conflicting classifications							
NM_002878.4(RAD51D):c.2T>A (p.Met1Lys)	RAD51D|RAD51L3-RFFL	M1K	Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome|not provided	VCV000449883	17	33446631	17	35119612	449883	445756	rs1064794619	NC_000017.11:35119611:A:T	single nucleotide variant	missense variant|initiator_codon_variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Sep 9, 2024	criteria provided, conflicting classifications							
NM_002878.4(RAD51D):c.2T>G (p.Met1Arg)	RAD51D|RAD51L3-RFFL	M1R	not provided|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary breast ovarian cancer syndrome	VCV000420660	17	33446631	17	35119612	420660	409912	rs1064794619	NC_000017.11:35119611:A:C	single nucleotide variant	missense variant|initiator_codon_variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Jan 5, 2024	criteria provided, conflicting classifications							
NM_002878.4(RAD51D):c.1A>C (p.Met1Leu)	RAD51D|RAD51L3-RFFL	M1L	Breast-ovarian cancer, familial, susceptibility to, 4	VCV000948946	17	33446632	17	35119613	948946	928235	rs561425038	NC_000017.11:35119612:T:G	single nucleotide variant	missense variant|initiator_codon_variant|non-coding transcript variant	Uncertain significance	Aug 11, 2024	criteria provided, single submitter							
NM_002878.4(RAD51D):c.1A>T (p.Met1Leu)	RAD51D|RAD51L3-RFFL	M1L	not provided|Hereditary cancer-predisposing syndrome|not specified|Familial ovarian cancer|Breast-ovarian cancer, familial, susceptibility to, 4	VCV000419798	17	33446632	17	35119613	419798	409913	rs561425038	NC_000017.11:35119612:T:A	single nucleotide variant	missense variant|initiator_codon_variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Aug 26, 2024	criteria provided, conflicting classifications							
NM_002878.4(RAD51D):c.1A>G (p.Met1Val)	RAD51D|RAD51L3-RFFL	M1V	not provided|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	VCV000127884	17	33446632	17	35119613	127884	133341	rs561425038	NC_000017.11:35119612:T:C	single nucleotide variant	missense variant|initiator_codon_variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Feb 27, 2025	criteria provided, conflicting classifications							
NM_002878.4(RAD51D):c.-1C>T	RAD51D|RAD51L3-RFFL		Hereditary cancer-predisposing syndrome	VCV000490135	17	33446633	17	35119614	490135	483004	rs1362923396	NC_000017.11:35119613:G:A	single nucleotide variant	5 prime UTR variant|non-coding transcript variant	Uncertain significance	Jan 28, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.-2A>G	RAD51D|RAD51L3-RFFL		Hereditary cancer-predisposing syndrome	VCV000927722	17	33446634	17	35119615	927722	913852	rs2091800072	NC_000017.11:35119614:T:C	single nucleotide variant	5 prime UTR variant|non-coding transcript variant	Uncertain significance	Mar 17, 2020	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.-2A>T	RAD51D|RAD51L3-RFFL		Hereditary cancer-predisposing syndrome	VCV000919256	17	33446634	17	35119615	919256	913851	rs2091800072	NC_000017.11:35119614:T:A	single nucleotide variant	5 prime UTR variant|non-coding transcript variant	Uncertain significance	Mar 6, 2020	criteria provided, single submitter							
NM_002878.4(RAD51D):c.-4G>C	RAD51D|RAD51L3-RFFL		Hereditary cancer-predisposing syndrome	VCV003942376	17	33446636	17	35119617	3942376	4064155		NC_000017.11:35119616:C:G	single nucleotide variant	5 prime UTR variant|non-coding transcript variant	Uncertain significance	Apr 25, 2025	criteria provided, single submitter							
NM_002878.4(RAD51D):c.-5G>A	RAD51D|RAD51L3-RFFL		Hereditary cancer-predisposing syndrome	VCV002620939	17	33446637	17	35119618	2620939	2792662	rs1302028963	NC_000017.11:35119617:C:T	single nucleotide variant	5 prime UTR variant|non-coding transcript variant	Uncertain significance	Jul 22, 2023	criteria provided, single submitter							
NM_002878.4(RAD51D):c.-7G>C	RAD51D|RAD51L3-RFFL		Hereditary cancer-predisposing syndrome	VCV000492405	17	33446639	17	35119620	492405	484986	rs553444507	NC_000017.11:35119619:C:G	single nucleotide variant	5 prime UTR variant|non-coding transcript variant	Likely benign	May 23, 2017	criteria provided, single submitter							
NM_002878.4(RAD51D):c.-7G>A	RAD51D|RAD51L3-RFFL		RAD51D-related cancer predisposition|Hereditary cancer-predisposing syndrome|not specified	VCV000492404	17	33446639	17	35119620	492404	485241	rs553444507	NC_000017.11:35119619:C:T	single nucleotide variant	5 prime UTR variant|non-coding transcript variant	Uncertain significance	Nov 29, 2022	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.-7G>T	RAD51D|RAD51L3-RFFL		not specified|Hereditary cancer-predisposing syndrome	VCV000389518	17	33446639	17	35119620	389518	375999	rs553444507	NC_000017.11:35119619:C:A	single nucleotide variant	5 prime UTR variant|non-coding transcript variant	Conflicting classifications of pathogenicity	Apr 3, 2019	criteria provided, conflicting classifications							
NM_002878.4(RAD51D):c.-8C>T	RAD51L3-RFFL|RAD51D		Hereditary cancer-predisposing syndrome	VCV000919624	17	33446640	17	35119621	919624	913853	rs2091800249	NC_000017.11:35119620:G:A	single nucleotide variant	5 prime UTR variant|non-coding transcript variant	Uncertain significance	Nov 1, 2023	criteria provided, single submitter							
NM_002878.4(RAD51D):c.-10T>G	RAD51D|RAD51L3-RFFL		not specified	VCV000507026	17	33446642	17	35119623	507026	505847	rs746408351	NC_000017.11:35119622:A:C	single nucleotide variant	5 prime UTR variant|non-coding transcript variant	Likely benign	Jan 20, 2017	criteria provided, single submitter							
NM_002878.4(RAD51D):c.-19G>A	RAD51L3-RFFL|RAD51D		Hereditary cancer-predisposing syndrome	VCV000920097	17	33446651	17	35119632	920097	913854	rs1410068473	NC_000017.11:35119631:C:T	single nucleotide variant	5 prime UTR variant|non-coding transcript variant	Likely benign	Dec 19, 2018	criteria provided, single submitter							
NM_002878.4(RAD51D):c.-22G>A	RAD51D|RAD51L3-RFFL		not specified	VCV000509214	17	33446654	17	35119635	509214	506028	rs756566632	NC_000017.11:35119634:C:T	single nucleotide variant	5 prime UTR variant|non-coding transcript variant	Likely benign	Apr 25, 2017	criteria provided, single submitter							
NM_002878.4(RAD51D):c.-27C>T	RAD51D|RAD51L3-RFFL		not specified	VCV000514429	17	33446659	17	35119640	514429	506285	rs1057521550	NC_000017.11:35119639:G:A	single nucleotide variant	5 prime UTR variant|non-coding transcript variant	Likely benign	Dec 26, 2017	criteria provided, single submitter							
NM_002878.4(RAD51D):c.-27C>A	RAD51D|RAD51L3-RFFL		not specified	VCV000383194	17	33446659	17	35119640	383194	374937	rs1057521550	NC_000017.11:35119639:G:T	single nucleotide variant	5 prime UTR variant|non-coding transcript variant	Likely benign	Jan 22, 2016	criteria provided, single submitter							
NM_002878.4(RAD51D):c.-28C>T	RAD51D|RAD51L3-RFFL		not specified	VCV000381992	17	33446660	17	35119641	381992	374943	rs375452513	NC_000017.11:35119640:G:A	single nucleotide variant	5 prime UTR variant|non-coding transcript variant	Likely benign	Dec 2, 2015	criteria provided, single submitter							
NM_002878.4(RAD51D):c.-34A>G	RAD51D|RAD51L3-RFFL		not specified	VCV000378461	17	33446666	17	35119647	378461	378139	rs372716334	NC_000017.11:35119646:T:C	single nucleotide variant	5 prime UTR variant|non-coding transcript variant	Likely benign	Dec 8, 2016	criteria provided, single submitter							
NM_002878.4(RAD51D):c.-38G>T	RAD51D|RAD51L3-RFFL		not provided|Hereditary cancer-predisposing syndrome|not specified	VCV001220696	17	33446670	17	35119651	1220696	345509	rs114252524	NC_000017.11:35119650:C:A	single nucleotide variant	5 prime UTR variant|non-coding transcript variant	Benign	Mar 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_002878.4(RAD51D):c.-43G>A	RAD51L3-RFFL|RAD51D		not specified	VCV000391939	17	33446675	17	35119656	391939	374944	rs776435937	NC_000017.11:35119655:C:T	single nucleotide variant	5 prime UTR variant|non-coding transcript variant	Likely benign	Dec 15, 2016	criteria provided, single submitter							
NM_002878.4(RAD51D):c.-48C>T	RAD51D|RAD51L3-RFFL		not specified	VCV000516566	17	33446680	17	35119661	516566	505856	rs759556682	NC_000017.11:35119660:G:A	single nucleotide variant	5 prime UTR variant|non-coding transcript variant	Likely benign	Aug 31, 2017	criteria provided, single submitter							
NM_002878.4(RAD51D):c.-48C>A	RAD51D|RAD51L3-RFFL		not specified	VCV000509620	17	33446680	17	35119661	509620	505858	rs759556682	NC_000017.11:35119660:G:T	single nucleotide variant	5 prime UTR variant|non-coding transcript variant	Likely benign	May 15, 2017	criteria provided, single submitter							
NM_002878.4(RAD51D):c.-126C>T	LOC130060715|RAD51D|RAD51L3-RFFL		Breast-ovarian cancer, familial, susceptibility to, 4	VCV000803387	17	33446758	17	35119739	803387	791740	rs781135655	NC_000017.11:35119738:G:A	single nucleotide variant	5 prime UTR variant|non-coding transcript variant	Likely benign	May 28, 2019	criteria provided, single submitter							
NM_002878.4(RAD51D):c.-139C>T	LOC130060715|RAD51D|RAD51L3-RFFL		Breast and Ovarian Cancer Susceptibility	VCV000322627	17	33446771	17	35119752	322627	345517	rs886052820	NC_000017.11:35119751:G:A	single nucleotide variant	5 prime UTR variant|non-coding transcript variant	Uncertain significance	Jun 14, 2016	criteria provided, single submitter							
NM_002878.4(RAD51D):c.-166C>T	LOC130060715|RAD51D|RAD51L3-RFFL		not specified	VCV003911251	17	33446798	17	35119779	3911251	4025226		NC_000017.11:35119778:G:A	single nucleotide variant	5 prime UTR variant	Likely benign	Feb 16, 2025	criteria provided, single submitter							
NM_002878.4(RAD51D):c.-238A>T	LOC130060715|RAD51D|RAD51L3-RFFL		not provided	VCV000322629	17	33446870	17	35119851	322629	344110	rs188262287	NC_000017.11:35119850:T:A	single nucleotide variant	5 prime UTR variant	Benign		criteria provided, single submitter							
NC_000017.11:g.35120008C>T	RAD51D|RAD51L3-RFFL		not provided	VCV001230782	17	33447027	17	35120008	1230782	1222032	rs114893073	NC_000017.11:35120007:C:T	single nucleotide variant		Benign	Mar 1, 2019	criteria provided, single submitter							
